cl_id,name,EC_No,CAS_No,cl_classification,sourse,num_of_notifiers,ghs_and_notifiers
228907,"1,2,3,6,7,8-Hexachlorodibenzofuran",694-837-4,57117-44-9,Acute Tox. 1;Acute Tox. 1;Acute Tox. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H330:38;H300:38;H310:38;H400:38;H410:38
228908,"Benzene-1,3,5-tricarbaldehyde",694-839-5,3163-76-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H315:39;H335:39;H319:39;H302:39
228909,"(3-Methylphenyl)(2,4,6-trimethylphenyl)iodonium Trifluoromethanesulfonate",694-840-0,197245-87-7,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H315:39;H335:38;H319:39;H301:38
228910,2-(methylsulfanyl)pyrimidine-4-carboxylic acid,694-841-6,1126-44-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;STOT SE 3,Notified C&L,2,H319:2;H335:2;H315:2;H302:1
228912,"1,1-dimethyl-2-(methylamino)ethyl-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate oxalat",937-809-1,,Acute Tox. 4,Notified C&L,1,H302:1
228913,"Mixture of N,N-dimethylformamide and cyclopentadiene",937-810-7,,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;Repr. 1B,Notified C&L,1,H319:1;H332:1;H312:1;H315:1;H226:1;H360:1;H302:1
228914,Reaction product of 2-ethylhexanal and cyclohexanone,700-817-9,,Not Classified,Notified C&L,1,Not classified:1
228915,Ethyl 4-{trans-4-[((2S)-2-hydroxy-3-{4-hydroxy-3-[(methylsulfonyl)amino]phenoxy}propyl)amino]cyclohexyl}benzoate hydrochloride,694-842-1,433212-21-6,Acute Tox. 3;Acute Tox. 3;Acute Tox. 4,Notified C&L,1,H332:1;H311:1;H301:1
228918,"Poly(oxy-1,2-ethanediyl), .alpha.-hexyl-.omega.-hydroxy- (CAS# 31726-34-8)",937-812-8,,Eye Dam. 1,Notified C&L,3,H318:3
228921,"6-(aminomethyl)-3,3-dimethyl-1,3-dihydro-2,1-benzoxaborol-1-ol",937-813-3,,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H315:1;H335:1;H319:1;H302:1
228925,"trans-3,6-Bis(4-acryloyloxybenzoyloxy)-1,4-dioxabicyclo[3.3.0]octane",694-850-5,256513-67-4,Not Classified,Notified C&L,2,Not classified:1;H413:1;H317:1
228926,"5-Phenyl-1,3-benzoxazole-2(3H)-thione",694-851-0,17371-99-2,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:2;H315:2;H335:1
228927,Hexanohydroxamic acid,694-852-6,4312-93-0,Acute Tox. 4,Notified C&L,6,H302:6
228928,"1,4-dioxane-2,5-dione",694-853-1,26780-50-7,Skin Sens. 1,Notified C&L,2,H317:2
228929,"Benzenesulfonic acid, 4-mono-C20-24 (even numbered)-alkyl derivs., magnesium salts",800-309-8,231297-75-9,Not Classified,REACH registration C&L,5,Not classified:4;H315:1
228930,"alcohol iso C9-11, > 2,5 EO, citrate, sodium salt",937-814-9,,Skin Irrit. 2;Eye Dam. 1,Notified C&L,1,H318:1;H315:1
228932,"Alcohol C10, ethoxylated",937-817-5,,Acute Tox. 4;Eye Dam. 1,Notified C&L,1,H318:1;H302:1
228934,(4-chloro-2-fluoro-5-methoxyphenyl)boronic acid,694-855-2,153122-60-2,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
228935,"4-[3-nitro-4-(piperidin-1-yl)phenyl]-1,2-dihydrophthalazin-1-one",694-856-8,218144-45-7,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
228936,"2-Methyl-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole",694-857-3,5094-12-2,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,2,H332:1;H312:1;H302:2;H315:1;H319:1
228938,methyl 6-bromo-1-benzofuran-2-carboxylate,937-818-0,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
228939,N-[4-chloro-2-(trifluoromethoxy)phenyl]acetamide,937-819-6,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
228940,"3-Carboxymethyl-1,3-dimethyl-thioureido acetic acid, di-sodium salt",694-858-9,335086-35-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
228943,"2,6-difluoro-3-[(propylsulfonyl)amino]benzoic acid",700-740-0,1103234-56-5,Not Classified,REACH registration C&L,3,Not classified:3
228948,4-(3-isocyanatobenzyl)morpholine,694-861-5,166740-66-5,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;Acute Tox. 4;Resp. Sens. 1,Notified C&L,1,H314:1;H332:1;H312:1;H318:1;H334:1;H302:1
228949,5-bromo-2-(hydroxymethyl)phenol,694-862-0,170434-11-4,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
228950,5-benzyl-2-chloropyridine,937-825-9,,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H332:1;H312:1;H315:1;H335:1;H302:1
228951,methyl 4-[(6-chloropyridin-3-yl)methyl]benzoate,937-826-4,,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H332:1;H312:1;H315:1;H335:1;H302:1
228952,methyl 4-[5-(hydroxymethyl)pyridin-2-yl]benzoate,937-828-5,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
228954,"Aluminum, triethyl(ethyl benzoate-kO')-, (T-4)-",694-864-1,71694-20-7,Flam. Sol. 1;Self-heat. 1;Water-react. 2,Notified C&L,3,H261:3;H228:3;H251:3
228955,"(1R)-N-prop-2-ynyl-2,3-dihydro-1H-inden-1-amine hydrochloride",937-829-0,,Acute Tox. 3;Skin Irrit. 2,Notified C&L,1,H315:1;H301:1
228956,"Carbamic acid, N-[(1R,4R)-4-amino-5-phenyl-1-(phenylmethyl)pentyl]-, 5-thiazolylmethyl ester, hydrochloride",700-848-8,1247119-33-0,Not Classified,Notified C&L,1,Not classified:1
228967,"4H,5H-pyrazolo[1,5-a]pyrimidin-5-one",694-865-7,29274-22-4,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,91,H332:90;H312:90;H302:90;H319:1;H335:1;H315:1
228970,ethyl 2-chloro-5-nitropyridine-4-carboxylate,937-840-0,,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H332:1;H312:1;H315:1;H335:1;H302:1
228971,ethyl 5-amino-2-chloropyridine-4-carboxylate,937-841-6,,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H332:1;H312:1;H315:1;H335:1;H302:1
228972,methyl 3-methoxy-4-(pyrrolidin-1-ylmethyl)benzoate,694-868-3,193964-75-9,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
228973,"trifluoromethyl 4-{1H-imidazo[4,5-b]pyridin-1-yl}piperidine-1-carboxylate",694-869-9,273757-37-2,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
228974,"methyl 3-iodoimidazo[1,2-a]pyridine-7-carboxylate",694-870-4,1009378-93-1,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
228975,2-methyl-2-[(2-methylpropyl)amino]propanenitrile,937-842-1,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
228976,"1-(piperidin-4-yl)-1H,2H,3H-imidazo[4,5-b]pyridin-2-one dihydrochloride",937-843-7,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
228981,"3,6-Dibromoquinoline",694-872-5,69268-39-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:2;H315:2;H302:1
228982,(4-amino-3-methoxyphenyl)methanol,694-873-0,148459-54-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
228983,"1-benzyl-3,3-dimethyl-azetidine",694-874-6,13509-71-2,Flam. Liq. 2;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H225:1;H315:1;H319:1;H302:1
228985,"Distillates (Fischer-Tropsch), C8-10-branched and linear",694-876-7,1345668-41-8,Flam. Liq. 2;Asp. Tox. 1;STOT SE 3;Muta. 1B;Carc. 1A;Aquatic Chronic 2,Notified C&L,1,H411:1;H350:1;H336:1;H225:1;H304:1;H340:1
228987,5-Chloro-2-(methylsulfonamido)benzoyl chloride,694-877-2,89938-78-3,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H315:1;H335:1;H319:1;H302:1
228988,"Benzoic acid 5-oxo-5,6-dihydro-2H-pyran-2-yl ester",694-878-8,582302-77-0,Acute Tox. 4,Notified C&L,39,H302:39;H315:1;H335:1;H319:1
228989,"2,3-Dihydropyrano[4,3,2-de]quinolin-7-boronic acid",937-847-9,,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H315:1;H335:1;H319:1;H302:1
228990,2-Bromoethoxyphosphinic acid sodium salt,937-848-4,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
228991,Combustion Products of Nickel oxid and silicic acid,937-850-5,,Acute Tox. 4;Skin Corr. 1A;Skin Sens. 1;Eye Dam. 1;Acute Tox. 2;Resp. Sens. 1;STOT SE 3;Muta. 1B;Carc. 1A;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H330:1;H340:1;H350:1;H314:1;H361:1;H313:1;H410:1;H317:1;H372:1;H318:1;H334:1;H335:1;H400:1;H302:1
228992,"{2-methylimidazo[1,2-a]pyridin-3-yl}methanol",694-879-3,30489-44-2,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,2,H332:1;H312:1;H302:1;Not classified:1
228995,[No public or meaningful name is available],694-883-5,,Flam. Liq. 2;Acute Tox. 4,Notified C&L,35,H225:35;H332:35
228996,ethyl 5-methylpyridine-2-carboxylate,694-884-0,55876-82-9,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
228997,"2,4-dioxo-2,4-dihydro-1H-3,1-benzoxazine-6-sulfonyl chloride",937-851-0,,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H314:1;H332:1;H312:1;H335:1;H302:1
228998,"1H-pyrrolo[2,3-b]pyridine-4-carboxylic acid",694-885-6,479553-01-0,Eye Irrit. 2,Notified C&L,42,H319:41;H335:3;H315:3;H332:2;H312:2;H302:2
228999,"methyl 3-cyano-1-methyl-1H-pyrrolo[2,3-b]pyridine-5-carboxylate",937-852-6,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
229000,"3-cyano-1-methyl-1H-pyrrolo[2,3-b]pyridine-5-carboxylic acid",937-853-1,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
229001,methyl 2-(piperazin-1-yl)pyrimidine-5-carboxylate,937-854-7,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
229002,2-{[(4-chlorophenyl)methyl]amino}-2-methylpropanenitrile,937-855-2,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
229003,2-[(4-methoxyphenyl)amino]-2-methylpropanenitrile,937-856-8,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H335:1;H312:1;H302:1
229004,"4-{1H-imidazo[4,5-b]pyridin-1-yl}piperidine hydrochloride",937-857-3,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
229005,"Fatty acids, C8-10 (even numbered), 3-methylbutyl esters",694-886-1,1365095-43-7,Not Classified,REACH registration C&L,10,Not classified:10
229006,4-methanesulfonyl-3-methylphenyl dimethyl phosphate,694-887-7,14086-35-2,Acute Tox. 2,Notified C&L,39,H300:39;H411:1;H311:1
229011,"2-Propenoic Acid, 2-[Methyl(Nonafluorobutyl)Sulfonyl]Amino]…",694-890-3,1017237-78-3,Aquatic Chronic 2,Notified C&L,29,H411:28;H400:1;H410:1
229012,[No public or meaningful name is available],694-891-9,154517-54-1,Skin Sens. 1;Resp. Sens. 1,Notified C&L,8,H334:8;H317:8
229016,(-)-N-(o-Chlorobenzyl)-alpha-methylphenethylamine,937-863-6,,Acute Tox. 4,Notified C&L,1,H302:1
229020,"Reaction mass of 5-methyl-4-oxo-3-penta-2,4-dien-1-ylcyclopent-2-en-1-yl 2,2-dimethyl-3-(2-methylprop-1-en-1-yl)cyclopropanecarboxylate and Distillates (petroleum), hydrotreated light",937-864-1,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,8,H332:8;H312:7;H302:8;H400:8;H410:8;H304:1
229022,propan-2-yl 2-({ethoxy[[](propan-2-yl)amino]phosphoryl}oxy)benzoate,694-894-5,31120-85-1,Acute Tox. 3;Acute Tox. 3;Acute Tox. 2,Notified C&L,1,H330:1;H311:1;H301:1
229023,"3,3'-(C16-18-(evennumbered), C18-unsaturated-alkylimino)dipropanenitrile",694-895-0,1319198-35-0,Acute Tox. 4;Skin Corr. 1B;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,1,H314:1;H410:1;H400:1;H302:1
229024,4-methanesulfinyl-3-methylphenyl dimethyl phosphate,694-896-6,6552-13-2,Acute Tox. 2,Notified C&L,39,H300:38;H311:1;H301:1
229026,"4-(2-phenylpropan-2-yl)phenyl 3-diazo-4-oxo-3,4-dihydronaphthalene-1-sulfonate",694-898-7,23121-00-8,Self-heat. 1;Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 4,REACH registration C&L,3,H319:2;H413:1;H251:1;H315:2;H335:1;Not classified:1
229027,"thiazol-5-ylmethyl N-[(1S,2S,4S)-4-amino-1-benzyl-2-hydroxy-5-phenyl-pentyl]carbamate dihydrochloride",694-899-2,162990-03-6,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
229028,"2-Propenoic acid, 2-cyano-, 1-methylheptyl ester",700-845-1,133978-15-1,Not Classified,REACH registration C&L,4,Not classified:4
229029,"5-[1-(2,3-dimethylphenyl)vinyl]-1H-imidazole",694-900-6,1021949-47-2,Acute Tox. 3;Eye Irrit. 2;Repr. 2;Lact.,Notified C&L,1,H319:1;H361:1;H362:1;H301:1
229030,"4-[(2,3-dimethylphenyl)carbonyl]-1-(triphenylmethyl)imidazole",694-901-1,176721-02-1,Acute Tox. 3;Eye Irrit. 2;Repr. 2;Lact.,Notified C&L,1,H319:1;H361:1;H362:1;H301:1
229031,"4-[1-(2,3-dimethylphenyl)-1-hydroxyethyl]-1-(triphenylmethyl)imidazole",694-902-7,176721-03-2,Acute Tox. 3;Eye Irrit. 2;Repr. 2;Lact.,Notified C&L,1,H319:1;H361:1;H362:1;H301:1
229032,"4-[(2,3-dimethylphenyl)hydroxymethyl]-1-(triphenylmethyl)imidazole",694-903-2,176721-01-0,Acute Tox. 3;Eye Irrit. 2;Repr. 2;Lact.,Notified C&L,1,H319:1;H361:1;H362:1;H301:1
229033,tert-butyl 4-(aminocarbonyl)tetrahydropyridine-1(2H)-carboxylate,694-904-8,91419-48-6,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
229037,"(2-oxidopropane-1,2,3-tricarboxylate)palladous (II) acid monohydrate",937-869-9,,Skin Corr. 1A;Skin Sens. 1;Eye Dam. 1,Notified C&L,1,H314:1;H317:1;H318:1
229046,"Reaction mass of Silicic acid, aluminum magnesium salt and Silicic acid, aluminum sodium salt",937-875-1,,Eye Irrit. 2,Notified C&L,1,H319:1
229050,"O,O'-Bis(3-aminopropyl)polyethylene glycol",937-878-8,,Flam. Liq. 3;Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1;Eye Dam. 1;Aquatic Chronic 1,Notified C&L,8,H314:8;H410:8;H226:8;H317:8;H318:8;H302:8
229051,(2-chlorothiophen-3-yl)boronic acid,694-909-5,177734-82-6,,Notified C&L,3,H319:3;H332:1;H312:1;H302:1;H335:2;H315:2
229053,4-bromo-2-(bromomethyl)-1-methoxybenzene,694-911-6,184970-28-3,,Notified C&L,2,H314:2;H335:1;H302:1
229058,"(2,5-dioxopyrrolidin-1-yl) 4-[(2,5-dioxopyrrol-1-yl)methyl]cyclohexane-1-carboxylate",694-914-2,64987-85-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
229059,"Phosphorus acid, alkyl substituted [1,1'-biphenyl]-2,2'-diyl-tetra-aryl ester",,,Not Classified,REACH registration C&L,1,Not classified:1
229060,4-Ethoxy-3-methylbenzeneboronic acid,694-915-8,850568-08-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
229061,Ethyl 1-hydroxycyclopropane-1-carboxylate,694-916-3,137682-89-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
229062,"4,6-Diiodopyrimidine",694-917-9,19646-06-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:2;H315:2
229063,Ethyl tetrahydropyran-4-ylacetate,694-918-4,103260-44-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
229064,"Benzyl ethyl piperidine-1,3-dicarboxylate",694-920-5,310454-53-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
229065,"Dimethyl cyclobutane-1,1-dicarboxylate",694-921-0,10224-72-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
229066,Dithiobis(phenylazide),694-922-6,37434-06-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
229067,3-(3-Hydroxyprop-1-yl)benzeneboronic acid,694-923-1,736989-98-3,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H332:1;H312:1;H315:1;H335:1;H302:1
229068,2-Fluoro-5-methoxyaniline,694-924-7,62257-15-2,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H332:1;H312:1;H315:1;H335:1;H302:1
229069,"5-(Chloroacetyl)-1,3-dihydro-2H-indol-2-one",694-925-2,65435-04-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:1;H315:2
229070,"4-(Trifluoromethyl)-L-phenylalanine, N-FMOC protected",694-926-8,247113-86-6,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H332:1;H312:1;H315:1;H335:1;H302:1
229071,4-Chloro-3-fluorophenylmagnesium bromide,694-927-3,170793-00-7,Skin Corr. 1B;Eye Dam. 1,Notified C&L,1,H314:1;H318:1
229075,n-methylatropinium hydroxide,694-928-9,150243-98-4,Skin Corr. 1B,Notified C&L,1,H314:1
229076,n-methylatropinium iodide,937-884-0,,Skin Irrit. 2,Notified C&L,1,H315:1
229081,"Poly(oxy-1,2-ethanediyl), α-(dodecylphenyl)-ω-hydroxy- (EO=10)",937-887-7,,Acute Tox. 4;Eye Dam. 1;Aquatic Chronic 2,Notified C&L,8,H318:8;H411:8;H302:8
229082,tetrakis[({bis[4-(dimethylamino)phenyl] and 4-(methylamino)phenyl} or {4-(dimethylamino)phenyl and bis[4-(methylamino)phenyl]} or {tris[4-(dimethylamino)phenyl]}methylium)]C12-(branched and/or linear)-alkyl-(4-sulfonatophenoxy)benzenesulfonate and oxybis[C12-(branched and/or linear)-alkyl-benzenesulfonate].,700-759-4,,Eye Dam. 1;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H318:1;H335:1;H400:1;H410:1
229083,Ethoxylated alkyl mercaptan,694-929-4,113923-40-3,Eye Irrit. 2,Notified C&L,1,H319:1
229084,"Poly(oxy-1,2-ethanediyl), α-(dodecylphenyl)-ω-hydroxy- (EO=12)",937-888-2,,Eye Dam. 1;Aquatic Chronic 3,Notified C&L,8,H412:8;H318:8
229085,ethylene glycol diacetate,937-889-8,,Skin Irrit. 2;Eye Irrit. 2;STOT RE 2;Aquatic Chronic 4,Notified C&L,1,H319:1;H373:1;H413:1;H315:1
229086,"(Z)-N-(3-ammoniopropyl)-N'-octadecenylpropane-1,3-diaminium acetate",700-764-1,,Acute Tox. 4;Skin Corr. 1C;STOT RE 2;Aquatic Acute 1,REACH registration C&L,5,H314:5;H373:5;H400:5;H302:5
229087,"(Z)-N-(3-ammoniopropyl)-N'-[3-octadecenylamino)propyl]propane-1,3-diaminium acetate",700-802-7,,Acute Tox. 4;Skin Corr. 1C;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,3,H314:3;H373:3;H302:3;H400:3;H410:3
229088,"N-(3-ammoniopropyl)-N'-(C16-C18, C18 unsatured)alkylpropane-1,3-diaminium triacetate",700-693-6,,Acute Tox. 4;Skin Corr. 1C;STOT RE 2;Aquatic Acute 1,REACH registration C&L,2,H314:2;H373:2;H400:2;H302:2
229089,"N-(3-ammoniopropyl)-N-[C16-C18, C18 unsatured]alkylpropane-1,3-diaminium triacetate",700-692-0,,Acute Tox. 4;Skin Corr. 1B;STOT RE 2;Aquatic Acute 1,REACH registration C&L,2,H314:2;H373:2;H400:2;H302:2
229090,3-cyclopentyl-1-methyl-1H-indole-6-carboxylic acid isopropylester,937-890-3,,Skin Sens. 1,Notified C&L,1,H317:1
229095,"(2R,5R)-1,6-Diphenylhexane-2,5-diamine dihydrochloride",700-856-1,1247119-31-8,Not Classified,REACH registration C&L,2,Not classified:2
229110,"(1-Octadecanaminium, N,N-dimethyl-N-octadecyl-, salt with 4,4-(3,3-dichloro1,1-biphenyl-4,4-diyl) bisazo(2-acetyl-1-oxo-2,1-ethanediyl)iminobisbenzenesulfonic acid (2:1))",694-939-9,127179-40-2,Aquatic Chronic 4,Notified C&L,15,H413:8;Not classified:7
229114,"2,2',2''-Nitrilotriethanol sulfate",,20261-61-4,Not Classified,Notified C&L,7,Not classified:7
229130,"Rosin, maleated, polymer with p-tert-butylphenol, formaldehyde, glycerol and pentaerythritol",,68140-03-4,Not Classified,Notified C&L,7,Not classified:7
229134,trans-4-(tetrahydro-5-propyl-pyran-2-yl)-phenol,937-897-1,,Not Classified,REACH registration C&L,2,Not classified:2
229136,1-Methylpyrrole-2-carbonitrile,694-966-6,34884-10-1,Eye Irrit. 2,Notified C&L,2,H319:2;H332:1;H312:1;H315:1;H302:1
229144,"Rosin, fumarated, polymer with diethylene glycol and pentaerythritol",,68152-50-1,Not Classified,Notified C&L,63,Not classified:63
229147,2-[3-[1-Octyl-4-(1H)quinolinylidene]-1-propenyl]-3-methylbenzothiazolium trifluoromethanesulfonate,937-904-8,,Acute Tox. 4;Eye Irrit. 2;Carc. 1A;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H319:1;H350:1;H410:1;H310:1;H400:1;H302:1
229148,dibenz-oxepine,937-905-3,,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H315:1;H335:1;H319:1;H301:1
229149,Palladium(II)oktanoat,694-971-3,92638-71-6,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
229150,"Nonanoic acid, rhodium(2+) salt",694-972-9,138573-13-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
229153,2-(2-nitrophenoxy)-benzaldehyde,694-973-4,66961-19-1,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H332:1;H312:1;H315:1;H335:1;H302:1
229155,Reaction mass of methanol and 1-(DIMETHOXYMETHYL)-2-(2'-NITROPHENOXY)BENZENE,937-909-5,,Flam. Liq. 1;Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;STOT SE 1,Notified C&L,1,H319:1;H224:1;H315:1;H370:1;H331:1;H225:1;H311:1;H301:1
229157,"O,O-(dipyridin-2-yl)",937-910-0,,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
229159,"N-C16-18-alkyl-(evennumbered, C18 unsaturated) trimethylpropane-1,3-diamine",695-101-5,1275611-65-8,Acute Tox. 3;Skin Corr. 1B;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,1,H301:1;H314:1;H372:1;H400:1;H410:1
229160,1-(DIMETHOXYMETHYL)-2-(2'-AMINOPHENOXY)BENZENE,937-912-1,,Skin Irrit. 2;Eye Irrit. 2;STOT SE 2,Notified C&L,1,H319:1;H335:1;H315:1
229162,3-methyl-N-{2-methyl-1-[[]2-methyl-4-(propan-2-yloxy)phenyl]-1-oxopropan-2-yl}thiophene-2-carboxamide,694-975-5,875915-78-9,Acute Tox. 4;STOT RE 2;Aquatic Chronic 2,Notified C&L,157,H411:157;H373:156;H332:156
229163,3-bromo-N-{2-bromo-4-chloro-6-[[](1-cyclopropylethyl)carbamoyl]phenyl}-1-(3-chloropyridin-2-yl)-1H-pyrazole-5-carboxamide,694-976-0,1031756-98-5,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,91,H400:91;H410:91
229164,3-Bromo-2-chloro-6-methylpyridine,694-977-6,185017-72-5,Acute Tox. 3;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,41,H315:41;H335:41;H318:39;H301:39;H319:2
229169,"Amides, C12-18(even numbered), N-[3-(dimethylamino)propyl]",938-095-4,,Acute Tox. 4;Skin Corr. 1A;Skin Sens. 1;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,4,H411:4;H314:4;H410:4;H317:4;H318:4;H400:4;H302:4
229172,"(RS)-2-methoxy-N-methyl-2-[α-(2,5-xylyloxy)-o-tolyl]acetamide; mandestrobin",694-980-2,173662-97-0,Aquatic Acute 1;Aquatic Chronic 1,Harmonised C&L,0,H400:0;H410:0
229177,"1-(2-chloroimidazo[1,2-α]pyridin-3-ylsulfonyl)-3-(4-hydroxy-6-methoxypyrimidin-2-yl)urea",694-981-8,178859-99-9,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,3,H400:3;H410:3
229178,"2-chloroimidazo[1,2-α]pyridine-",694-982-3,112566-17-3,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,3,H400:3;H410:3
229179,"2-chloroimidazo[1,2-α]pyridine-3-sulfonic acid",694-983-9,112581-52-9,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,3,H400:3;H410:3
229181,"1-3 dihydroxy-2,4bis-(4-(2-sulfooxyethanesulfonyl)-phenylazo) benzene disodium salt",937-924-7,,Not Classified,REACH registration C&L,1,Not classified:1
229184,[No public or meaningful name is available],694-986-5,117002-37-6,Skin Sens. 1;Eye Irrit. 2,Notified C&L,1,H319:1;H317:1
229185,"alcohol iso C9-11, > 2,5 EO, citrate",937-926-8,,Skin Irrit. 2;Eye Dam. 1,Notified C&L,1,H318:1;H315:1
229187,"(R)-1-((4-chlorophenyl)(phenyl)methyl)piperazine (3R,5S,E)-7-(4-(4-fluorophenyl)-6-isopropyl-2-(N-methylmethylsulfonamido)pyrimidin-5-yl)-3,5-dihydroxyhept-6-enoate",694-988-6,1235588-99-4,Not Classified,Notified C&L,1,Not classified:1
229191,"1,2-bis(5-ethoxy-7-fluoro-[1,2,4]triazolo[1,5-c]pyrimidin-2-yl)disulfane",937-929-4,,Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,1,H319:1;H411:1
229194,"2-ethyl-5a-hydroxy-5,6,7,8,5a,8a-hexahydroanthraquinone",937-932-0,,Acute Tox. 4,Notified C&L,1,H302:1
229205,"Methyl 2,2,2-trifluoroethyl carbonate",694-997-5,156783-95-8,Flam. Liq. 3,Notified C&L,3,H226:2;H315:1;H319:1;H317:1;H302:1
229207,4-bromo-1-cyclopropylpyridin-2(1H)-one,694-998-0,1193334-86-9,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
229208,"N,N'-(butane-1,4-diyl)bis(12-hydroxyoctadecanamide)",,,Not Classified,REACH registration C&L,1,Not classified:1
229209,Reaction mass of Calcium sulfide (Ca(Sx)) and calcium thiosulphate,937-936-2,,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Acute 1,Notified C&L,1,H319:1;H335:1;H400:1;H315:1
229211,C.I. Solvent Blue 136,800-171-9,359630-27-6,Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H318:1;H400:1;H410:1
229212,"1,4-diazabicyclo[3.2.2]Nonane dihydrochloride 95+%",694-999-6,150208-70-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
229216,Zeolite,695-002-7,308081-08-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
229217,NATURAL ALDEHYDE C-10 (DECANAL) 50%,937-939-9,,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 3,Notified C&L,2,H412:2;H319:2;H317:2;H315:2
229220,ethyl (3R)-3-hydroxybutanoate,695-003-2,24915-95-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 4,Notified C&L,1,H319:1;H335:1;H413:1;H315:1
229221,"3-N-cyclohexylpyridine-2,3-diamine",695-004-8,1286273-78-6,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
229222,[No public or meaningful name is available],695-005-3,88901-36-4,Acute Tox. 4,Notified C&L,1,H302:1
229223,6-bromo-2-fluoropyridin-3-amine,695-006-9,850220-97-2,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
229224,"imidazo[1,2-a]pyridine-7-carbohydrazide",695-007-4,421595-78-0,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
229225,"1-{1H-pyrrolo[2,3-b]pyridin-3-ylmethyl}piperidine",695-011-6,23616-64-0,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
229226,(5-methylpyridin-2-yl)methanol,695-009-5,22940-71-2,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,2,H332:1;H312:1;H302:1;H319:1;H335:1;H303:1;H315:1
229227,2-{[(4-fluorophenyl)methyl]amino}-2-methylpropanenitrile,937-943-0,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
229228,"3-(propan-2-yl)-1,2-oxazol-5-amine",695-010-0,88786-11-2,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,2,H332:1;H312:1;H302:1;H319:1;H335:1;H303:1;H315:1
229229,5-methylpyridine-2-carbaldehyde,695-012-1,4985-92-6,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,2,H332:1;H312:1;H302:2
229230,"tert-butyl 4-{1H-pyrrolo[2,3-b]pyridin-3-ylmethyl}piperazine-1-carboxylate",937-944-6,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
229231,ethyl 5-chloro-4-(trifluoromethyl)pyridine-2-carboxylate,937-945-1,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
229232,6-(4-methoxyphenyl)pyridine-3-carbaldehyde,937-946-7,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
229234,[No public or meaningful name is available],695-013-7,130751-49-4,Repr. 1A,Notified C&L,1,H360:1
229235,[No public or meaningful name is available],695-014-2,218433-98-8,Repr. 1A,Notified C&L,1,H360:1
229236,Pyroglutamyl-histidyl-tryptophyl-seryl-histidyl-asparagyl-tryptophyl-lysyl-prolyl-glycinamid (Acetatsalz),695-015-8,147859-97-0,Repr. 1A,Notified C&L,2,H360:1;H332:1;H361:1;H312:1;H317:1
229241,1-Benzyl-1H-pyrazole-4-boronic acid,695-016-3,852362-22-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;STOT SE 3,Notified C&L,1,H315:1;H335:1;H319:1;H302:1
229242,"3,5-Dimethylpyrazole-4-boronic acid, pinacol ester",695-017-9,857530-80-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:2;H315:2;H302:1
229243,Isoquinoline-4-boronic acid,695-018-4,192182-56-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
229245,1-Naphthalenemethanethiol,695-020-5,1076-67-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
229246,[No public or meaningful name is available],695-021-0,7722-15-8,,Notified C&L,39,H411:38;H302:39
229247,"2-{2-chloro-4-(methylsulfonyl)-3-[(tetrahydrofuran-2-ylmethoxy)methyl]benzoyl}cyclohexane-1,3-dione",695-022-6,473278-76-1,STOT RE 1;STOT RE 2;Aquatic Chronic 2,Notified C&L,1,H411:1;H373:1;H372:1
229248,[No public or meaningful name is available],695-023-1,1934-49-2,Acute Tox. 4,Notified C&L,1,H302:1
229250,"Hexanedioic acid, polymer with N-(2-aminoethyl)-1,2-ethanediamine, aziridine, (chloromethyl)oxirane and formic acid",695-024-7,113010-54-1,Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,83,H319:83;H411:83
229251,"Aziridine, homopolymer, N-valeryl derivs.",695-025-2,1360804-01-8,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Aquatic Acute 1,Notified C&L,83,H319:83;H317:83;H315:83;H400:83;H302:83
229252,"(1'R,6R,6aR,7R,13S,14S,16R)-5-Acetoxy-6',8,14-trihydroxy-7',9-dimethoxy-4,10,23-trimethyl-1',2',3',4',6a,7,12,13,14,16-decahydro-6H-spiro[6,16-(epithiopropanoxymethano)-7,13-imino-1,3-dioxolo[7,8]isoquino[3,2-b][3]benzazocine-20,1'-isoquinolin]-19-one",695-026-8,114899-77-3,Acute Tox. 2;Acute Tox. 4;Acute Tox. 4;Muta. 2;Repr. 2;STOT RE 2,Notified C&L,8,H300:8;H373:8;H332:8;H312:8;H361:8;H341:8
229265,"Reaction products of sulphuric acid, rock phosphate and humic acids, potassium salts",938-989-4,,Eye Dam. 1,REACH registration C&L,3,H318:3
229266,"Reaction products of phosphoric acid, rock phosphate and humic acids, potassium salts",938-988-9,,Eye Dam. 1,REACH registration C&L,1,H318:1
229272,"1-[(2-Isopropyl-1,3-thiazol-4-yl)methyl]-1-methyl-3-[(3S)-2-oxotetrahydrofuran-3-yl]urea",700-850-9,,Not Classified,Notified C&L,1,Not classified:1
229274,[No public or meaningful name is available],695-044-6,52952-31-5,Acute Tox. 4;Skin Corr. 1A;Skin Sens. 1;Eye Dam. 1;Aquatic Chronic 2,Notified C&L,441,H411:441;H314:441;H317:441;H318:441;H302:441
229275,[No public or meaningful name is available],695-045-1,1373140-13-6,Eye Dam. 1,Notified C&L,446,H318:446
229276,"Reaction mass of 2-Ethylhexyl N-(5-isocyanato-2-methylphenyl)carbamate and 2-Ethylhexyl N-(3-isocyanato-4-methylphenyl)carbamate and N,N'-(4-Methyl-1,3-phenylene)bis(carbamic acid) C,C'-bis(2-ethylhexyl) ester",937-955-6,,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Acute Tox. 4;Resp. Sens. 1;STOT SE 3;Carc. 2,REACH registration C&L,2,H319:2;H332:2;H317:2;H315:2;H334:2;H351:2;H335:2
229279,P-1057,,,Not Classified,REACH registration C&L,2,Not classified:2
229281,(2R)-2-{[(tert-butoxy)carbonyl]amino}pent-4-ynoic acid,695-047-2,63039-46-3,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,2,H332:1;H312:1;H302:1;H317:1
229284,"Benzene, dimethyl-, mono C14-16 (even numbered) sec alkyl derivs.",700-758-9,,Asp. Tox. 1,Notified C&L,1,H304:1
229288,"Reaction mass of 6-Methyl-2-(4-methyl-3-cyclohexen-1-yl)-5-hepten-2-ol and 6-Methyl-2-(4-methyl-3-cyclohexen-1-yl)-5-hepten-2-ol, 2-methanoate and 3,7,11-trimethyldodeca-2,6,10-trienyl formate",937-957-7,,Skin Sens. 1;Aquatic Acute 3;Aquatic Chronic 3,REACH registration C&L,1,H412:1;H402:1;H317:1
229289,"Reaction mass of 3,7,11-trimethyldodeca-2,6,10-trien-1-ol and 6-methyl-2-(4-methylcyclohex-3-en-1-yl)hept-5-en-2-ol",937-958-2,,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Aquatic Acute 2;Aquatic Chronic 2,REACH registration C&L,1,H319:1;H411:1;H317:1;H315:1;H401:1
229294,"Reaction mass of 1-Hydroxyhexyl 2-methanoate and 2-Hydroxyhexyl 1-methanoateand 1,2-Dihydroxyhexane and 1,2-Dihydroxyhexane, dimethanoate",937-959-8,,Eye Irrit. 2A,REACH registration C&L,1,H319:1
229298,"Reaction mass of 1-Hydroxyoctane, 2-methanoate and 1,2-Dihydroxyoctane, dimethanoate and 2-Hydroxyoctane 1-methanoate and 1,2-Dihydroxyoctane",937-960-3,,Skin Corr. 1;Eye Irrit. 2,REACH registration C&L,1,H314:1;H319:1
229299,Reaction mass of sulfur and Gum arabic,937-961-9,,Flam. Sol. 2;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H228:1;H315:1
229301,NATURAL PYRAZINES MIXTURE No. 18,937-964-5,,Flam. Liq. 3;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H226:1;H315:1;H335:1;H302:1
229302,NATURAL MIXED METHYL KETONES,937-965-0,,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,1,H319:1;H411:1;H226:1;H315:1;H335:1
229304,[No public or meaningful name is available],695-049-3,247068-82-2,Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 3,Notified C&L,1,H412:1;H319:1;H315:1
229305,Benzyl (S)-(−)-tetrahydro-5-oxo-3-furanylcarbamate,695-050-9,87219-29-2,Skin Sens. 1,Notified C&L,39,H317:38;H315:1;H335:1;H319:1;H302:1
229308,[No public or meaningful name is available],695-051-4,20115-17-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
229317,N-Benzyl-L-alaninol,695-054-0,6940-80-3,Not Classified,Notified C&L,2,Not classified:1;H319:1;H335:1;H315:1
229319,Halauxifen-methyl,695-056-1,943831-98-9,Aquatic Chronic 1,Notified C&L,213,H410:212;H400:55;H411:1
229324,"2,4,6-Tri(2,4-dihydroxyphenyl)-1,3,5-triazine",700-796-6,,Not Classified,Notified C&L,1,Not classified:1
229330,[No public or meaningful name is available],695-060-3,96096-55-8,Acute Tox. 4,Notified C&L,39,H302:39;H332:1
229331,6-(Piperidin-4-yloxy)-2H-isoquinolin-1-one hydrochloride,695-061-9,923262-96-8,Repr. 2,Notified C&L,1,H361:1
229332,"Benzenepropanoic acid, 3-(aminoiminomethyl)-a-[1-[[4-(1-oxido-4-pyridinyl)benzoyl]amino]ethyl]-, methyl ester, monohydrochloride",695-062-4,409081-12-5,Eye Irrit. 2,Notified C&L,1,H319:1
229333,"4-[5-(3,5-Dichloro-phenyl)-5-trifluoromethyl-4,5-dihydro-isoxazol-3-yl]-N-[(R)-(2-ethyl-3-oxo-isoxazolidin-4-yl)]-2-methyl-benzamide",937-975-5,,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,89,H400:89;H410:89
229336,"2-{2-Chloro-4-[(S)-5-(3,5-dichloro-phenyl)-5-trifluoromethyl-4,5-dihydro-isoxazol-3-yl]-benzenesulfinyl}-N-(2,2,2-trifluoro-ethyl)-acetamide",937-977-6,,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,89,H400:89;H410:89
229337,2-(6-Benzyl-pyridin-2-yl)-quinazoline,937-978-1,,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,89,H400:89;H410:89
229339,"1-(6-Methyl-pyridin-2-yl)-ethanone O-[3-(4',6'-dimethyl-[2,2']bipyridinyl-6-yl)-propyl]-oxime",937-979-7,,Aquatic Chronic 1,Notified C&L,89,H410:89
229344,1-(6-Methyl-pyridin-2-yl)-ethanone O-{3-[6-methyl-2-(6-methyl-pyridin-2-yl)-pyrimidin-4-yl]-propyl}-oxime,937-984-4,,Acute Tox. 3,Notified C&L,89,H301:89
229346,"2-Chloro-3-(2,2,2-trifluoroethoxy)pyridine",700-854-0,256473-04-8,Aquatic Chronic 2,Notified C&L,156,H411:156
229353,2-[(C14-15alkyloxy)methyl]oxirane,700-630-2,,Skin Irrit. 2;Skin Sens. 1,Notified C&L,1,H317:1;H315:1
229354,"2-({2-[4-(2,4,5-trimethylhexan-3-yl)phenoxy]ethoxy}methyl)oxirane",937-989-1,,Skin Irrit. 2;Skin Sens. 1,Notified C&L,1,H317:1;H315:1
229363,toluene-4-sulphonic acid monohydrate,695-067-1,6192-52-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,8,H319:8;H335:8;H315:8
229364,S-186,695-068-7,25293-64-5,Skin Sens. 1,Notified C&L,1,H317:1
229365,N-(2-chlorobenzyl)-1-phenylpropan-2-amine hydrochloride (1:1),695-069-2,1048649-80-4,Acute Tox. 4,REACH registration C&L,1,H302:1
229366,3-chloro-1H-indole-2-carbonitrile,695-070-8,74960-46-6,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H332:1;H312:1;H315:1;H335:1;H302:1
229367,"1-benzyl-4-(chloromethyl)-1H-1,2,3-triazole",695-071-3,70380-29-9,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H332:1;H312:1;H315:1;H335:1;H302:1
229368,"2-(isopropylthio)-3-(2,2,2-trifluoroethoxy)pyridine",696-441-7,256473-05-9,Aquatic Chronic 2,Notified C&L,89,H411:89
229369,5-chloro-4-(trifluoromethyl)pyridine-2-carboxylic acid,937-991-2,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
229370,[5-chloro-4-(trifluoromethyl)pyridin-2-yl]methanol,937-992-8,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
229371,[6-(4-methoxyphenyl)pyridin-3-yl]methanol,937-993-3,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
229372,2-chloro-5-[(4-methoxyphenyl)methyl]pyridine,937-994-9,,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H332:1;H312:1;H315:1;H335:1;H302:1
229374,"(S)-3-((S)-1-benzylpyrrolidin-3-yl) 5-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxilate (S)-2-hydroxysuccinate",695-073-4,104713-80-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
229376,"(S)-3-(1-benzylpyrrolidin-3-yl) 5-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate oxalate",937-995-4,,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
229377,"Reaction mass of 1,2,4,5-tetramethylbenzene and 99129-21-2",937-997-5,,Acute Tox. 4;Asp. Tox. 1;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H319:1;H410:1;H315:1;H336:1;H304:1;H400:1;H302:1
229378,Propan-2-yl N-[(S)-(pentafluorophenoxy)(phenoxy) phosphoryl]-L-alaninate,695-076-0,1334513-02-8,Skin Sens. 1;Resp. Sens. 1;Aquatic Chronic 4,REACH registration C&L,6,H334:4;H413:4;H317:4;H302:2
229381,(6-phenylpyridin-3-yl)methanol,695-077-6,4634-09-7,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
229382,"ethyl 2-(5-methyl-1H-1,2,4-triazol-3-yl)acetate",695-078-1,100187-10-8,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,2,H332:1;H312:1;H302:1;H319:1;H335:1;H315:1
229383,"(2S,4R)-1-[(tert-butoxy)carbonyl]-4-methylpyrrolidine-2-carboxylic acid",695-079-7,364750-80-1,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
229384,(S)-(-)-3-Aminotetrahydrofuran p-toluenesulfonate salt,695-080-2,104530-79-2,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3;STOT SE 3,Notified C&L,2,H319:1;H332:1;H312:1;H315:2;H335:1;H302:2;H226:1;H318:1
229387,Reaction mass of 701611-69- and 701611-70-,938-000-6,,Skin Sens. 1,Notified C&L,1,H317:1
229388,Bicyclo[1.1.1]pentan-1-amine Hydrochloride,695-081-8,22287-35-0,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,4,H332:1;H312:1;H302:1;H319:3;H335:2;H315:3
229390,"Sodium 4-[3-(4-iodophenyl)-2-(2,4-dinitrophenyl)-2H-5-tetrazolio]-1,3-benzene disulfonate",695-082-3,161617-45-4,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;STOT SE 3,Notified C&L,1,H332:1;H335:1;H312:1;H302:1
229391,8-Hydroxydiacetoxyscirpenol ,695-083-9,65041-92-1,Acute Tox. 3;Skin Irrit. 2,Notified C&L,39,H315:38;H301:39
229403,"2,6-di-tert-butyl-p-cresol",695-087-0,31194-40-8,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,156,H400:156;H410:156
229407,"1,3-diethyl-2,4-diisocyanato-5-methylbenzene",813-050-0,2162-70-1,Skin Sens. 1;Resp. Sens. 1;Aquatic Chronic 4,REACH registration C&L,2,H334:2;H413:2;H317:2
229409,"3,5-diethyltoluene-2,4(6)-diisocyanate",938-011-6,,Acute Tox. 3;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H332:1;H312:1;H315:1;H335:1;H301:1
229411,"Alcohols, C18-unsatd.",695-088-6,135458-18-3,Skin Irrit. 2,Notified C&L,83,H315:83
229420,"3-methyl-1,3-oxazolidine-2,4-dione",695-089-1,14422-90-3,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,2,H332:2;H312:2;H302:2;H319:1;H315:1;H335:1
229425,Reaction mass of octadec-1-ene and hexadec-1-ene and tetradec-1-ene,938-017-9,,Asp. Tox. 1,Notified C&L,2,H304:2
229428,[No public or meaningful name is available],695-090-7,34736-04-4,Acute Tox. 3,Notified C&L,1,H301:1
229429,"CIS-4-azatricyclo[5.2.2.0^{2,6}]undecane-3,5- dione",695-091-2,85922-86-7,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
229430,{[2-hydroxy-3-(phenylsulfanyl)propyl]sulfanyl}benzene,695-092-8,22910-07-2,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
229431,"(E)-3-methyl-4-(2,6,6-trimethylcyclohex-2-en-1-yl)but-3-en-2-one",695-097-5,15789-90-9,Skin Irrit. 2;Skin Sens. 1B;Eye Irrit. 2;Aquatic Chronic 2,REACH registration C&L,8,H319:8;H411:8;H317:8;H315:8
229433,"4,4'-(Ethyne-1,2-diyl)diphthalic Anhydride",695-093-3,129808-00-0,,Notified C&L,2,H319:2;H335:1;H315:2
229437,"(2S,3R)-3-phenylpyrrolidine-2-carboxylic acid hydrochloride",938-018-4,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
229438,"5-(prop-1-yn-1-yl)-2-benzofuran-1,3-dione",695-094-9,1240685-26-0,,Notified C&L,2,H319:2;H335:1;H315:2
229439,"3-(3-fluoro-4-methylphenyl)-1,2,4-oxadiazole",695-095-4,1146699-63-9,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
229441,Ferrous sulfate dihydrate,695-098-0,10028-21-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,90,H315:90;H319:83;H302:90;H332:7;H312:7;H318:7
229442,"(1S,3R)-3-{[(tert-butoxy)carbonyl]amino}cyclopentane-1-carboxylic acid",695-099-6,261165-05-3,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
229443,ethyl (2E)-3-(2-fluoro-5-nitrophenyl)prop-2-enoate,938-021-0,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
229445,"(4S)-3-[(2E)-3-(4-methylphenyl)prop-2-enoyl]-4-phenyl-1,3-oxazolidin-2-one",938-022-6,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
229446,Alkali salt of substituted alkyl amino sulfonyl triazinyl amino arylamido diazo aryl sulfonyl sulfonate,,,Not Classified,REACH registration C&L,1,Not classified:1
229450,"benzyl N-[(1R,3S)-3-(hydroxymethyl)cyclopentyl]carbamate",938-025-2,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
229451,"(1S,3R)-3-{[(benzyloxy)carbonyl]amino}cyclopentane-1-carboxylic acid",938-026-8,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
229452,"benzyl N-[(1R,3S)-3-aminocyclopentyl]carbamate oxalate",938-027-3,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
229453,1-Methyl-4-(1-methylvinyl)cyclohexan-1-ol,844-907-7,7299-41-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,26,H319:26;H315:26
229487,"Ethyl 4-oxo-1,4-dihydroquinoline-3-carboxylate",695-104-1,52980-28-6,Acute Tox. 4,REACH registration C&L,2,H302:1;H371:1
229508,2-(4-aminophenyl)-2-methylpropanenitrile,695-108-3,115279-57-7,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H332:1;H312:1;H315:1;H335:1;H302:1
229509,2-(4-methoxyphenyl)oxirane,695-109-9,6388-72-3,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Muta. 2;Carc. 2,Notified C&L,1,H332:1;H312:1;H351:1;H341:1;H302:1
229510,"2,4-Dichlorothieno[3,2-d]pyrimidine",695-110-4,16234-14-3,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,3,H319:3;H332:2;H312:2;H315:2;H335:2;H302:2;H301:1
229513,4-Bromo-3-fluorobenzyl Alcohol,695-112-5,222978-01-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
229514,1-bromo-4-(bromomethyl)-2-fluorobenzene,695-113-0,127425-73-4,Skin Corr. 1B,Notified C&L,3,H314:3
229515,2-methylpyridin-4-ol,695-114-6,18615-86-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H315:1;H335:1;H319:1;H302:1
229516,2-[2-[4-[(4-Chlorophenyl)phenylmethyl]-1-piperazinyl]ethoxy]acetic acid,695-115-1,83881-51-0,Acute Tox. 4,Notified C&L,10,H302:10
229526,6-bromo-4-chloro-3-nitroquinoline,695-117-2,723281-72-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H315:1;H335:1;H319:1;H302:1
229528,(2S)-5-(tert-butoxy)-2-{[(tert-butoxy)carbonyl]amino}-5-oxopentanoic acid,695-119-3,13726-84-6,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
229530,"Triglycerides, C12-24, even, saturated and unsaturated, oxidized",695-121-4,1178870-70-6,Not Classified,REACH registration C&L,2,Not classified:2
229545,"Sodium {[3-(2,2,2-trifluoroethoxy)pyridin-2-yl]sulfonyl}azanide",700-926-1,227605-94-9,Acute Tox. 3;Eye Irrit. 2,Notified C&L,156,H319:156;H301:156
229552,N-(2-formylphenyl)acetamide,695-135-0,13493-47-5,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
229555,"3,5-dichloro-1-methyl-1,2-dihydropyrazin-2-one",695-138-7,87486-33-7,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H315:1;H335:1;H319:1;H302:1
229556,"cis-4,4,4-Trifluoro-2-buten-1-ol",695-139-2,83706-98-3,Flam. Liq. 3,Notified C&L,1,H226:1
229565,"1-[(2,3-dichlorophenyl)carbonyl]-4-({5-fluoro-6-[(3-methyl-1H-pyrazol-5-yl)amino]pyridin-2-yl}methyl)piperidine-4-carboxylic acid hydrochloride",938-064-5,,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 1,Notified C&L,1,H319:1;H315:1;H302:1;H335:1;H410:1
229572,Sodium closo-Dodecaborate,695-146-0,12008-78-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
229573,Cesium tetrahydridoborate,695-147-6,19193-36-3,Water-react. 2;Acute Tox. 3;Acute Tox. 3;Skin Sens. 1B,Notified C&L,1,H317:1;H261:1;H311:1;H301:1
229574,"Sodium closo-Dodecaborate, 10B-enriched",938-068-7,,Flam. Sol. 2,Notified C&L,1,H228:1
229575,Triethylammonium Dodecaborate,695-148-1,12546-27-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
229576,"Lithium closo-Dodecaborate, Tetrahydrate",938-069-2,,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
229577,"Potassium Tetradeuteridoborate, 11B enriched",938-070-8,,Water-react. 1;Acute Tox. 3;Acute Tox. 3;Skin Corr. 1B,Notified C&L,1,H301:1;H314:1;H311:1;H260:1
229578,"Potassium Tetrahydridoborate, 11B enriched",938-071-3,,Water-react. 1;Acute Tox. 3;Acute Tox. 3;Skin Corr. 1B,Notified C&L,1,H301:1;H314:1;H311:1;H260:1
229579,"1,5-dimethyl (2R)-2-aminopentanedioate hydrochloride",695-149-7,27025-25-8,,Notified C&L,2,H240:1;H332:1;H312:1;H302:1;H319:1;H335:1;H315:1
229580,(2R)-2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)-3-hydroxypropanoic acid,695-150-2,116861-26-8,,Notified C&L,2,H319:2;H332:1;H312:1;H302:1;H335:1;H315:1
229582,"4-Methylbenzeneboronic acid, 10B enriched",938-072-9,,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
229584,[No public or meaningful name is available],695-152-3,180468-42-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
229585,"(2R,5S)-5-(4-Amino-5-fluoro-2-oxo-2H-pyrimidin-1-yl)-[1,3]oxathiolane-2-carboxylic Acid, (2S)-Isopropyl-(5R)-methyl-(1R)-cyclohexyl Ester",938-073-4,,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1A;Acute Tox. 4;Carc. 2;Repr. 1B;STOT RE 2;Aquatic Chronic 3,Notified C&L,1,H412:1;H314:1;H373:1;H332:1;H312:1;H351:1;H360:1;H302:1
229586,"Reaction mass of dodecyl laurate, dodecyl myristate, tetradecyl laurate and tetradecyl myristate",938-075-5,,Not Classified,Notified C&L,1,Not classified:1
229587,"Dodecan-1-ol and tetradecan-1-ol, esterification product with lauric acid and/or myristic acid , by-products from",938-076-0,,Asp. Tox. 1;Eye Irrit. 2,Notified C&L,1,H319:1;H304:1
229588,Reaction mass of 2-(2-thienyl)ethyl benzenesulphonate and toluene,939-726-6,,Flam. Liq. 2;Acute Tox. 4;Asp. Tox. 1;Skin Irrit. 2;STOT SE 3;Repr. 2;STOT RE 2,REACH registration C&L,1,H373:1;H315:1;H336:1;H225:1;H304:1;H361:1;H302:1
229589,Tetramethylarsonium Iodide,695-153-9,5814-20-0,Acute Tox. 3;Acute Tox. 3;Carc. 1A;STOT SE 1;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H301:1;H350:1;H410:1;H372:1;H331:1;H400:1;H370:1
229594,"(1R,12R)-7-bromo-9-methoxy-11-oxa-4-azatetracyclo[8.6.1.0^{1,12}.0^{6,17}]heptadeca-6(17),7,9,15-tetraen-14-one (1S,12S)-7-bromo-9-methoxy-11-oxa-4-azatetracyclo[8.6.1.0^{1,12}.0^{6,17}]heptadeca-6(17),7,9,15-tetraen-14-one dihydrochloride",938-391-3,,Skin Sens. 1,Notified C&L,1,H317:1
229598,"DIMETHYL (1R,4S,5S,6S)-4-AMINO-2-THIABICYCLO[3.1.0]HEXANE-4,6-DICARBOXYLATE 2,2-DIOXIDE HYDROCHLORIDE",938-082-3,,Eye Dam. 1;Repr. 2;STOT RE 1,Notified C&L,1,H318:1;H361:1;H372:1
229600,"4a,9a-Epoxyanthracene-9,10-dione, 6-ethyl-1,2,3,4-tetrahydro-",695-156-5,35301-66-7,Acute Tox. 4,Notified C&L,1,H302:1
229604,"Reaction mass of (R)-1-Fluoroethyl-2,2,2-trifluoroethyl carbonate and (S)-1-Fluoroethyl-2,2,2-trifluoroethyl carbonate",938-086-5,,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2,Notified C&L,1,H315:1;H319:1;H317:1;H302:1
229605,"N,N-bis(oxiran-2-ylmethyl)-4-4phenoxyaniline",695-157-0,1103707-31-8,Skin Sens. 1B;Aquatic Acute 1;Aquatic Chronic 2,Notified C&L,1,H411:1;H400:1;H317:1
229606,t-Butyl diethyl phosphonoacetate,695-158-6,27784-76-5,Eye Irrit. 2,Notified C&L,1,H319:1
229607,"(2R,3S,4S,5R)-5-(4-AMINO-2-OXOPYRIMIDIN-1(2H)-YL)-2-AZIDO-4-METHYL-2-{[(2-METHYLPROPANOYL)OXY]METHYL}TETRAHYDROFURAN-3-YL 2-METHYLPROPANOATE METHANESULFONATE (1:1)",938-087-0,,Eye Dam. 1,Notified C&L,7,H318:7
229608,"4-CYANO-N-[2-(4,4-DIMETHYL-1-CYCLOHEXEN-1-YL)-6-(2,2,6,6-TETRAMETHYLTETRAHYDRO-2H-PYRAN-4-YL)-3-PYRIDINYL]-1H-IMIDAZOLE-2-CARBOXAMIDE HYDROCHLORIDE (1:1)",695-159-1,1142364-35-9,Skin Sens. 1;Eye Dam. 1,Notified C&L,1,H318:1;H317:1
229609,"4-[(4-Chlorophenyl)thio]- 1-[9- ethyl-6-(2 -methylben zoyl) -9H-c arbazol-3-yl]butane-1,2-dion 2-(O-acetyloxime)",695-160-7,957763-23-4,Skin Sens. 1,Notified C&L,1,H317:1
229613,"Parathar, (1-34)-Human Parathyroid Hormone",695-161-2,99294-94-7,Repr. 2,Notified C&L,1,H361:1
229616,Reaction mass of heptanoic acid and nonanedioic acid and octanedioic acid,938-091-2,,Skin Corr. 1B;Eye Dam. 1,Notified C&L,1,H314:1;H318:1
229617,"4-[(4-methylphenyl)sulfonyl]benzene-1,2-diol",695-163-3,107065-85-0,Skin Sens. 1;Aquatic Chronic 2,REACH registration C&L,2,H411:2;H317:2
229618,"Reaction mass of nicotine and glycerol and propane-1,2-diol",938-092-8,,Acute Tox. 3;Acute Tox. 1;Aquatic Acute 1;Aquatic Chronic 2,Notified C&L,4,H310:2;H411:2;H400:2;H301:2;Not classified:1;H319:1;H373:1;H302:1
229620,4-Morpholineacetic acid,695-164-9,3235-69-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
229624,"1,3-Benzothiazole-6-carbaldehyde",695-167-5,19989-67-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
229625,"1-Bromo-3,5-Dimethoxybenzene",695-168-0,20469-65-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,5,H319:5;H335:4;H315:5
229627,[No public or meaningful name is available],695-169-6,,Acute Tox. 3;Acute Tox. 3;Skin Sens. 1;Resp. Sens. 1;Repr. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H410:1;H317:1;H334:1;H361:1;H400:1;H311:1;H301:1
229629,2-[2-[2-[2-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethyl methanesulfonate,700-859-8,477775-57-8,Not Classified,Notified C&L,1,Not classified:1
229630,[No public or meaningful name is available],695-170-1,170569-99-0,Acute Tox. 4,Notified C&L,1,H302:1
229631,"5-chloro-N-({(5R,5S)-2-oxo-3-[4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl}methyl) thiophene-2-carboxamide",938-101-5,,Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H302:1
229632,"Reaction product of {mixture of [poly(1~4)chlorosulfonylphthalocyaninato-N29, N30, N31, N32] copper (II) and [poly(1~3)chlorosulfonyl (tribenzo-heteromonocycle-5,10,15,20-tetraazaporphyrinato-N21, N22, N23, N24)]copper (II) and [poly(1~2)chlorosulfonyl(dibenzo-diheteromonocylce-5,10,15,20-tetraazaporphyrinato-N21, N22, N23, N24)]copper (II) and [monochlorosulfonyl(benzo-triheteromonocycle-5,10,15,20-tetraazaporphyrinato-N21, N22, N23, N24)] copper (II} and 2-[4-(2-aminoalkylamino)-6-(benzylamino)-1,3,5-heteromonocycle-2-ylamino]benzene-1,4-disulfonic acid and ammonia, water and sodium chloride",,,Aquatic Chronic 3,Notified C&L,1,H412:1
229635,"1,3-diethyl-1,1,3,3-tetramethyl-disiloxane",695-171-7,2295-17-2,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,22,H319:22;H335:22;H226:22;H315:22
229636,2(6-isocyanatohexylaminocarbonylamino)-6-methyl-4[1H]pyrimidinone,695-172-2,320393-85-9,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H332:1;H312:1;H315:1;H335:1;H302:1
229640,2-(4-Phenylbenzoyl)benzoic acid,700-862-4,42797-18-2,Aquatic Chronic 3,REACH registration C&L,4,H412:2;Not classified:1;H319:1;H315:1
229642,"Butene, polymer with 2-methyl-1-propene",,9044-17-1,,Notified C&L,2,H304:1;Not classified:1
229644,Tetraselmis Suecica Extract,695-179-0,1190750-79-8,Skin Sens. 1,Notified C&L,25,H317:25
229645,"2-Methyl-4-(4-methyl-d3-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine",695-180-6,786686-79-1,Acute Tox. 3;Skin Sens. 1;Eye Irrit. 2,Notified C&L,38,H319:38;H317:38;H301:38
229650,"6-(2,3-Dichlorophenyl)-1,2,4-triazine-3,5-diamine-13C3",695-182-7,1188265-38-4,Acute Tox. 3,Notified C&L,38,H301:38
229651,4-Vinylbenzyl acetate,695-183-2,1592-12-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
229652,Higher oligomers of polymeric MDI with castor oil,695-184-8,67700-69-0,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Acute Tox. 4;Resp. Sens. 1;STOT SE 3;Carc. 2;STOT RE 2,Notified C&L,8,H319:8;H373:8;H332:8;H317:8;H315:8;H334:8;H351:8;H335:8
229654,Higher oligomers of polymeric MDI with propoxylated glycerol,695-185-3,57029-46-6,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Acute Tox. 4;Resp. Sens. 1;STOT SE 3;Carc. 2;STOT RE 2,Notified C&L,63,H319:63;H373:63;H332:63;H317:63;H315:63;H334:63;H351:63;H335:63
229657,"Arsine, dichloromethyl-",,593-89-5,,Notified C&L,1,H300:1;H310:1;H330:1
229659,(2-bromoethoxy)phosphonoyl dichloride,695-191-6,4167-02-6,Met. Corr. 1;Acute Tox. 3;Skin Corr. 1B;Acute Tox. 3,Notified C&L,1,H290:1;H314:1;H331:1;H301:1
229660,"(1S)-1,5-Anhydro-1-C-(3-{[5-(4-fluorophenyl)thiophen-2-yl]methyl]}-4-methylphenyl)-D-glucitol",695-192-1,842133-18-0,Eye Dam. 1;Repr. 2,Notified C&L,3,H318:1;H361:2;H319:1;H411:2;H302:1;H362:1
229673,"Reaction mass of (1R)-1,2,2-trichloro-2-fluoroethyl trifluoromethyl ether and (1S)-1,2,2-trichloro-2-fluoroethyl trifluoromethyl ether",938-115-1,,Not Classified,Notified C&L,1,Not classified:1
229676,"Reaction mass of (Z)-1,2-dichloro-1-fluoro-2 -(trifluoromethoxy)ethylene and (E)-1,2-dichloro-1-fluoro-2-(trifluoromethoxy)ethylene",938-112-5,,Flam. Liq. 3,Notified C&L,1,H226:1
229681,"Fatty acid chlorides, C8-14 (even numbered), reaction products with glycine",938-147-6,,Eye Dam. 1,REACH registration C&L,3,H318:3
229686,Sophorolipids: fermentation products of glucose and rapeseed-oil fatty acids methyl esters with yeast Candida Bombicola,700-786-1,,Eye Irrit. 2,Notified C&L,1,H319:1
229689,"Reaction productReaction product of 1,1´-Methylenebis(4-substituted cyclohexane), [2-(substitutedmethyl)-3-prop-2-enoyloxy-2-(prop-2-enoyloxymethyl)propyl] prop-2-enoate and [3-prop-2-substituted-2,2-bis(prop-2-enoyloxymethyl)propyl] prop-2-enoate",,,Skin Irrit. 2;Skin Sens. 1A;Aquatic Chronic 2,Notified C&L,1,H411:1;H317:1;H315:1
229690,"4,4,6,6-Tetraethoxy-3,7-dioxa-4,6-disilanonane",695-200-3,18418-72-9,,Notified C&L,2,H319:2;H335:1;H315:1;H312:1;H301:1
229693,Heptanedioic acid bis-(3-tert-butyl-5-formyl-4-hydroxy-phenyl) ester,695-204-5,454423-39-3,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;STOT SE 3,Notified C&L,2,H319:1;H315:1;H331:1;H335:1;H311:1;H301:1;Not classified:1
229694,di-µ-oxo-bis-[(tetra-2-ethylhexanoate)molybdenum],700-831-5,,Skin Sens. 1;Eye Dam. 1;Repr. 2,REACH registration C&L,1,H318:1;H361:1;H317:1
229695,"Reaction products of 1,3- and 1,4-cyclohexanedialdehyde with phenol",938-121-4,,Acute Tox. 4;Muta. 2;STOT RE 2,Notified C&L,55,H373:55;H341:55;H302:55
229697,Reaction mass of 2-hydroxy-4-(methylthio)butanoic acid and 2-hydroxy-4-(methylthio)butanoic acid dimer,700-857-7,,Eye Dam. 1,Notified C&L,1,H318:1
229701,"3-Aminotetrahydrothiopene 1,1-dioxide hydrochloride",695-206-6,51642-03-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,91,H315:91;H335:91;H319:91;H302:90
229706,(R)-(+)-3-Aminotetrahydrofuran p-toluenesulfonate salt,695-209-2,111769-27-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;STOT SE 3,Notified C&L,1,H315:1;H335:1;H319:1;H302:1
229707,4-[(2R)-3-Amino-2-hydroxyprop-1-yl]morpholine,695-210-8,452105-38-3,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H332:1;H312:1;H315:1;H335:1;H302:1
229708,"2-Bromoethylamine, N-CBZ protected",695-211-3,53844-02-3,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H332:1;H312:1;H315:1;H335:1;H302:1
229709,"5,6-Dichloro-1H-indole",695-212-9,121859-57-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,21,H319:21;H332:19;H315:21;H335:20;H302:19;H312:1
229710,"2,2-Bis(trifluoromethyl)propanoyl fluoride",695-213-4,1735-87-1,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Acute Tox. 4,Notified C&L,1,H314:1;H332:1;H312:1;H302:1
229711,2-Aminoethyl methanethiosulphonate hydrobromide,695-215-5,16599-33-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
229712,"4,5-Dichloro-2-nitrobenzotrifluoride",695-216-0,50594-31-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
229713,"2-Chloro-4,5-diaminobenzotrifluoride",695-217-6,157590-59-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
229714,Perfluorononane,695-218-1,375-96-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
229715,"3-[N-Tris-(hydroxymethyl)methylamino]propanesulphonic acid, sodium salt",695-219-7,91000-53-2,Not Classified,Notified C&L,3,Not classified:2;H319:1;H335:1;H315:1
229716,"2,3-Dihydro-1-benzofuran-2-ylmethanol",695-220-2,66158-96-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;STOT SE 3,Notified C&L,2,H315:2;H335:2;H319:2;H302:1
229717,4-Chloro-6-(1H-pyrazol-1-yl)pyrimidine,695-221-8,114833-95-3,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H332:1;H312:1;H315:1;H335:1;H302:1
229718,2-(Difluoromethyl)-1H-benzimidazole,695-222-3,705-09-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:1;H315:2
229719,"2,3-Difluoro-4-nitroanisole",695-223-9,66684-59-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
229720,"4-Bromo-1,1-difluorobut-1-ene",695-224-4,147804-02-2,Flam. Liq. 3,Notified C&L,2,H226:1;Not classified:1
229721,4-(Ethylcarbamoyl)-3-fluorobenzeneboronic acid,695-226-5,874289-12-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
229722,4-(Dimethylcarbamoyl)-3-fluorobenzeneboronic acid,695-227-0,874289-13-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:2;H315:2
229725,"gas oil (polymer-derived), thermal cracked, full range",939-540-5,,Flam. Liq. 2;Asp. Tox. 1;Eye Irrit. 2;STOT SE 3;Muta. 1B;Carc. 1A;STOT RE 2;Aquatic Chronic 2,Notified C&L,1,H319:1;H411:1;H350:1;H373:1;H336:1;H225:1;H304:1;H340:1
229736,(R)-(+)-1-(2-Diphenylphosphino-1-naphthyl)isoquinoline,695-230-7,149341-34-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 4,Notified C&L,39,H319:39;H335:39;H413:38;H315:39
229738,[No public or meaningful name is available],695-231-2,335380-72-8,Repr. 1A,Notified C&L,1,H360:1
229739,[No public or meaningful name is available],695-232-8,133628-78-1,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Notified C&L,1,H331:1;H311:1;H301:1
229740,[No public or meaningful name is available],695-233-3,134009-10-2,Repr. 2,Notified C&L,1,H361:1
229741,[No public or meaningful name is available],695-234-9,134053-51-3,Repr. 2,Notified C&L,1,H361:1
229746,"Reaction mass of water and oleic acid, monoester with glycerol and 141464-42-8",938-135-0,,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
229750,CYCLOBUTYLMETHYLAMINE,695-238-0,4415-83-2,Flam. Liq. 2,Notified C&L,4,H225:2;H314:2;H302:1
229751,"Fatty acids tall-oil, ethoxylated",938-139-2,,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,20,H319:20;H315:20
229752,Pyr-His-Trp-Ser-Tyr-D-Ser(tBu)-D-Leu-Arg-Pro-Azagly-NH₂,938-140-8,,Repr. 2,Notified C&L,1,H361:1
229753,"Paraffin, petroleum, normal C5-C20",938-141-3,,Asp. Tox. 1,Notified C&L,20,H304:20
229754,Pyr-D-His-Trp-Ser-Tyr-D-Ser(tBu)-Leu-Arg-Pro-Azagly-NH₂,938-142-9,,Repr. 2,Notified C&L,1,H361:1
229755,Pyr-His-Trp-Ser-D-Tyr-D-Ser(tBu)-Leu-Arg-Pro-Azagly-NH₂,938-143-4,,Repr. 2,Notified C&L,1,H361:1
229757,"N-((E)-2,2,2-Trifluoroethylidene)-(R)-tert-butanesulfinamide",695-239-6,1219607-83-6,Flam. Liq. 3,Notified C&L,1,H226:1
229758,"N(E),S(S)-N-(2,2,2-Trifluoroethylidene)-tert-butanesulfinamide",695-240-1,929642-48-8,Flam. Liq. 3,Notified C&L,1,H226:1
229759,"2-Imidazolidinone, 1-[2-[bis(2-hydroxyethyl)amino]ethyl]-",695-241-7,88819-56-1,Skin Corr. 1B;Skin Sens. 1B;Eye Dam. 1,Notified C&L,1,H314:1;H317:1;H318:1
229760,1-{2-[bis(2-hydroxypropyl)amino]ethyl}imidazolidin-2-one,938-146-0,,Skin Corr. 1B;Skin Sens. 1B;Eye Dam. 1,Notified C&L,1,H314:1;H317:1;H318:1
229764,"Reaction mass of (2R,3S)-1,2,3,4-tetrachloro-1,1,2,3,4,4-hexafluorobutane, (2S,3S)-1,2,3,4-tetrachloro-1,1,2,3,4,4-hexafluorobutane and (2R,3R)-1,2,3,4-tetrachloro-1,1,2,3,4,4-hexafluorobutane.",938-148-1,,Not Classified,Notified C&L,1,Not classified:1
229767,"Reaction mass of (Z)-1,2-dichloro-1,2-difluoroethylene and (E)-1,2-dichloro-1,2-difluoroethylene",938-149-7,,Not Classified,Notified C&L,1,Not classified:1
229768,"Alcohols, C12-13-branched and linear, propoxylated",695-242-2,958238-74-9,Skin Irrit. 2;Eye Dam. 1;Aquatic Acute 1,Notified C&L,1,H318:1;H400:1;H315:1
229769,2-hydroxy-3-[(3-{[3-(4-methoxyphenyl)prop-2-enoyl]amino}propyl)(dimethyl)ammonio]propane-1-sulfonate,695-243-8,500731-87-3,Not Classified,Notified C&L,2,Not classified:2
229770,"1,3-Butadiene, 2-methyl-, homopolymer, maleated, 2-[(2-methyl-1-oxo-2-propen-1-yl)oxy]ethyl esters",695-244-3,848245-48-7,Skin Sens. 1,Notified C&L,20,H317:20;H412:1
229772,"Alcohols, C12-13-branched and linear, ethoxylated propoxylated",938-150-2,,Skin Irrit. 2;Eye Dam. 1;Aquatic Acute 1,Notified C&L,1,H318:1;H400:1;H315:1
229773,"Alcohols, C13, branched, Propoxylated (>2.5 moles propoxylated)",938-151-8,,Skin Irrit. 2;Eye Dam. 1;Aquatic Acute 1,Notified C&L,1,H318:1;H400:1;H315:1
229774,"Alcohols, C12-13-branched and linear, ethoxylated (>5 moles ethoxylated)",938-152-3,,Skin Irrit. 2;Eye Dam. 1;Aquatic Acute 1,Notified C&L,1,H318:1;H400:1;H315:1
229776,"4-[4-[4-[(3R, 5R)[5-(2,4-difluorophenyl) tetrahydro-5-(1H-1,2,4-triazol-1-yl-methyl)-furan-3-yl]methyloxy]phenyl]-1-piperazinyl]phenyl-2-[(1S,2S)(1-ethyl-2-phenylmethoxypropyl)]-2,4-dihydro-3Htriazol-3-one",938-153-9,,Skin Sens. 1;Aquatic Chronic 4,REACH registration C&L,3,H413:3;H317:3
229777,4-amino-1-(cyclohexen-3-yl)methylpiperidina,695-246-4,64730-01-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
229779,N-Methyl-C8/10-Alkyl Glucamide,938-156-5,,Eye Dam. 1,Notified C&L,31,H318:31
229781,N-Methyl-C12/18-Alkyl Glucamide,938-158-6,,Eye Dam. 1,Notified C&L,31,H318:31
229782,N-Methyl-C16/18-Alkyl Glucamide,938-159-1,,Eye Dam. 1,Notified C&L,31,H318:31
229783,N-Methyl-C8/18-Alkyl Glucamide,938-160-7,,Eye Dam. 1,Notified C&L,31,H318:31
229787,"Alcohols, C12-13-branched and linear, ethoxylated, propoxylated, Sulfated, Sodium Salts",938-161-2,,Skin Irrit. 2;Eye Dam. 1;Aquatic Acute 1,Notified C&L,1,H318:1;H400:1;H315:1
229788,"Alcohols, C13, branched, Propoxylated (<12PO), Sulfated, Sodium Salts",938-162-8,,Skin Irrit. 2;Eye Dam. 1;Aquatic Acute 1,Notified C&L,1,H318:1;H400:1;H315:1
229789,"Alcohols, C12-13-branched and linear, ethoxylated (>2.5 moles ethoxylated), Sulfated, Sodium Salts",938-163-3,,Skin Irrit. 2;Eye Dam. 1;Aquatic Acute 1,Notified C&L,1,H318:1;H400:1;H315:1
229790,"Alcohols, C12-13-branched and linear, propoxylated, sulfated, sodium salt",938-164-9,,Skin Irrit. 2;Eye Dam. 1;Aquatic Acute 1,Notified C&L,1,H318:1;H400:1;H315:1
229793,(2S)-3-metil-2-[pentanoil-[[4-[2-(2H-tetrazolo-5-il)fenil]fenil]metil]amino]acido butanoico,695-249-0,137862-53-4,Repr. 2;Aquatic Chronic 3,Notified C&L,1,H412:1;H361:1
229795,"(S)-Omeprazole potassium; 6-Methoxy-2-[(S)-[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazole potassium salt (1:1)",695-792-3,161796-84-5,Acute Tox. 4,Notified C&L,2,H302:2
229796,[No public or meaningful name is available],695-250-6,68458-49-1,Skin Corr. 1B;Eye Dam. 1,Notified C&L,21,H314:20;H318:21;H315:21;H410:1;H400:1
229797,"rac-Dimethylsilylenebis(4,5,6,7-tetrahydro-1-indenyl)zirconium dichloride",695-251-1,126642-97-5,Acute Tox. 4;Acute Tox. 4,Notified C&L,2,H332:1;H302:1;H400:1;H317:1;H410:1
229798,"6-(4-isopropyl-4H-1,2,4-triazol-3-yl)pyridin-2-amine",938-167-5,,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H315:1;H335:1;H319:1;H302:1
229802,[No public or meaningful name is available],695-252-7,68909-81-9,Skin Corr. 1B,Notified C&L,21,H314:21;H412:1;H318:1
229803,"Propanoic acid, 2,2-dimethyl-, tridecyl ester, branched",806-569-9,106436-39-9,Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H400:20;H317:20;H410:20;Not classified:18
229806,"1,7-Dibromo-3,4,9,10-perylenetetracarboxylic Dianhydride",695-253-2,118129-60-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,3,H319:3;H335:2;H315:3
229807,[No public or meaningful name is available],695-254-8,51838-31-4,Eye Dam. 1,Notified C&L,21,H318:21
229808,[No public or meaningful name is available],700-380-4,,Not Classified,REACH registration C&L,1,Not classified:1
229810,C14-16 (even numbered) and C16 (branched) saturated and unsaturated aliphatic hydrocarbons,700-762-0,,Asp. Tox. 1,Notified C&L,1,H304:1
229820,"Higher oligomers of the reaction of polymeric MDI with a mixture of 1,3-butanediol, [(1-methyl-1,2-ethanediyl)bis(oxy)]bis[propanol] and 1,2-propanediol",938-169-6,,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Acute Tox. 4;Resp. Sens. 1;STOT SE 3;Carc. 2;STOT RE 2,Notified C&L,8,H319:8;H373:8;H332:8;H317:8;H315:8;H334:8;H351:8;H335:8
229822,[No public or meaningful name is available],695-256-9,82102-37-2,Skin Corr. 1B,Notified C&L,40,H314:39;Not classified:1
229827,[No public or meaningful name is available],695-262-1,68171-42-6,Skin Irrit. 2,Notified C&L,441,H315:441
229828,"Poly[oxy(methyl-1,2-ethanediyl)], α-hydro-ω-hydroxy-polymers with reduced 1,1'-[methylenebis(oxy)]bis[2-chloroethane]-sodium sulfide(Na2(Sx))-1,2,3-trichloropropane polymer",695-263-7,405228-37-7,Repr. 1B,Notified C&L,2,H360:2
229829,2-(4-chlorophenyl)-3-methylbutanamide,938-171-7,,Acute Tox. 3;Skin Sens. 1;Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,3,H301:3;H317:3;H331:3;H400:3;H410:3
229830,N-[1-(4-chlorophenyl)-2-methylpropyl]-3-phenoxyphenylacetamide,938-172-2,,Acute Tox. 3;Skin Sens. 1;Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H301:1;H317:1;H331:1;H400:1;H410:1
229839,tert-butyl 4-(6-aminopyridin-3-yl)piperazine-1-carboxylate,695-268-4,571188-59-5,Acute Tox. 4,REACH registration C&L,7,H302:5;H319:2;H315:2;H335:1;H412:1;H402:1;H317:1;H318:1
229840,1-(4-Bromphenyl)-cyclobutancarboxylicacidamide,695-270-5,1032350-06-3,Acute Tox. 3;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,2,H319:2;H332:2;H312:2;H315:2;H335:2;H301:2
229843,"(R)-2-methoxy-N-methyl-2-[α-(2,5-xylyloxy)-o-tolyl]acetamide",938-180-6,,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H400:1;H410:1
229844,"(S)-2-methoxy-N-methyl-2-[α-(2,5-xylyloxy)-o-tolyl]acetamide",938-181-1,,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H400:1;H410:1
229849,2-hydroxy-2-methyl-propionic acid allyl ester,700-908-3,19444-21-4,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
229852,"Poli[oksy(metylo-1,2-etanodiylo)], a,a',a''-1,2,3-propanotriyltris[w-(oksiranylometoksy)]-, homopolimer",695-272-6,83712-85-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:2;H315:2
229854,"Poly(oxy, 2 ethandiyl) and sulfo-W-hydroxy; C10-C12 alviy ethers, ammonium salts",695-273-1,68890-88-0,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,21,H319:21;H315:21
229855,Reaction mass of 121-33-5 and 56-81-5 and 64-17-5,938-187-4,,Flam. Liq. 3;Eye Irrit. 2,Notified C&L,1,H319:1;H226:1
229857,"1-Octanesulfonic acid, sodium salt monohydrate",695-274-7,207596-29-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
229858,[No public or meaningful name is available],695-275-2,128000-15-7,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,25,H319:25;H315:25
229859,[No public or meaningful name is available],695-276-8,129783-36-4,Aquatic Chronic 2,Notified C&L,25,H411:25
229860,Polyurethane Resin,695-277-3,109159-24-2,Skin Sens. 1;Eye Irrit. 2,Notified C&L,25,H319:25;H317:25
229861,"2-Propenoic acid, 2-hydroxyethyl ester, reaction products with 1,6-diisocyanatohexane, dipropylene glycol, 5-isocyanato-1-(isocyanatomethyl)-1,3,3-trimethylcyclohexane and polyethylene-polypropylene glycol ether with trimethylolpropane (3:1)",695-278-9,187348-16-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,25,H319:25;H315:25
229862,"di C8-C10, branched, C9 rich, alkylnaphthalene sulphonic acid",939-714-0,,Eye Dam. 1,REACH registration C&L,1,H318:1
229863,Poly N-isopropylmethacrylamide MAPTAC copolymer,938-190-0,,Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,1,H319:1;H411:1
229864,"Reaction mass of propane-1,2-diol and water and Xanthan gum and decyl D-glucoside and 2,2'-methylenebis(6-(2H-benzotriazol-2-yl)-4-(1,1,3,3-tetramethylbutyl)phenol)",938-191-6,,Aquatic Chronic 4,Notified C&L,11,H413:11
229868,"2,3-dihydro-7-methoxy-1H-inden-4-ol",695-279-4,38998-04-8,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
229870,"Siloxanes and Silicones, Me Ph, [(ethenyldimethylsilyl)oxy]-terminated",695-281-5,225927-21-9,Eye Dam. 1,Notified C&L,14,H318:13;Not classified:1
229871,[No public or meaningful name is available],695-282-0,68410-62-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;STOT SE 3,Notified C&L,21,H319:21;H335:20;H315:21
229879,Portland cement clinker,938-200-3,,Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;STOT SE 3,Notified C&L,1,H318:1;H335:1;H317:1;H315:1
229880,"2-Pyrrolidinone, 1-ethenyl-, polymer with 1-eicosene",695-283-6,28211-18-9,Eye Irrit. 2,Notified C&L,74,H319:63;Not classified:11
229882,"Ethyl 2,2-difluoro-3-hydroxypropionate",695-285-7,380-41-6,Skin Irrit. 2,Notified C&L,3,H315:3;H335:2;H319:2;H302:1
229888,[No public or meaningful name is available],695-290-4,1215122-81-8,Acute Tox. 4;Skin Corr. 1B;Aquatic Acute 1,Notified C&L,1,H314:1;H400:1;H302:1
229889,3-(4-methoxycarbonyl-4-((1-oxopropyl)phenylamino)-1-piperidine) propanoic acid hydrochloride,695-292-5,132875-68-4,Acute Tox. 4;Skin Sens. 1;STOT SE 1,Notified C&L,1,H370:1;H317:1;H302:1
229890,2-(diethylamino)ethyl 4-(2-(octyloxy)benzamido)benzoate; oxalic acid,938-202-4,,Acute Tox. 4,Notified C&L,1,H300:1;H302:1
229895,"(4aR,4bS,6aS,7S,7aS,8aS,8bS,8cR)-5`-methoxy-4a,6a-dimethyl-4,4`,4a,4b,5`,6,6a,7a,8,8a,8b,8c-dodecahydro-3H,3`H-spiro[cyclopropa[4,5]cyclopenta[1,2-a]phenathrene-7,2`-furan]-2(5H)-one",695-294-6,71136-60-2,Skin Irrit. 2;Skin Sens. 1B;STOT RE 2;Aquatic Acute 2;Aquatic Chronic 2,REACH registration C&L,2,H411:2;H373:2;H317:2;H315:2;H401:2
229896,[No public or meaningful name is available],695-295-1,147060-74-0,Eye Irrit. 2,Notified C&L,1,H319:1
229897,"1-[4-[2-[4-[(6-chloro-[1,3]dioxolo[4,5-b]pyridin-7-yl)amino]-5-isopropoxy-quinazolin-7-yl]oxyethyl]piperazin-1-yl]ethanone",938-204-5,,Acute Tox. 3;STOT RE 1;STOT RE 1,Notified C&L,3,H372:3;H301:3
229902,"1H-Azepine, 1-[2-[4-(chloromethyl)phenoxy]ethyl]hexahydro-, hydrochloride (1:1)",695-296-7,223251-25-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,5,H319:3;H335:5;H315:5;H412:2;H317:2;H318:2;H302:2
229904,"1H-Indole, 3-methyl-5-(phenylmethoxy)-2-[4-(phenylmethoxy)phenyl]-",695-298-8,198479-63-9,Skin Corr. 1B,Notified C&L,3,H314:3
229906,[No public or meaningful name is available],695-299-3,914361-74-3,Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 2,Notified C&L,1,H318:1;H411:1;H315:1
229908,"(4-Chloro-3-(4-ethoxybenzyl)phenyl)((3aS,5R,6S,6aS)-6-hydroxy-2,2-dimethyltetrahydrofuro[2,3-d][1,3]dioxol-5-yl)methanone",695-300-7,1103738-30-2,Not Classified,REACH registration C&L,7,Not classified:7
229909,Copper tetraammine dichloride,695-301-2,10534-87-9,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H301:1;H319:1;H315:1;H400:1;H410:1
229910,"2-amino-4,6-dimethylpyridine-3-carboxamide",695-302-8,7144-20-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
229911,[No public or meaningful name is available],695-303-3,83933-03-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
229912,"2,2,6,6-tetramethylpiperidine hydrobromide (1:1)",695-304-9,935-21-7,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H315:1;H335:1;H319:1;H302:1
229913,"1-bromo-N,N,2-trimethylprop-1-en-1-amine",695-305-4,73630-93-0,Skin Corr. 1B;Eye Dam. 1,Notified C&L,1,H314:1;H318:1
229914,[No public or meaningful name is available],695-307-5,175354-30-0,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 2;STOT SE 3;Aquatic Chronic 4,Notified C&L,1,H319:1;H330:1;H413:1;H315:1;H335:1;H311:1;H301:1
229915,"8,8'-disulfanediyldiquinoline",695-308-0,1160-28-7,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H312:1;H315:1;H335:1;H302:1
229916,benzeneselenenyl iodide,695-309-6,81926-79-6,Acute Tox. 3;Acute Tox. 3;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H301:1;H373:1;H331:1;H400:1;H410:1
229917,"(1S,2S)-N,N'-dimethyl-1,2-diphenylethane-1,2-diaminium",695-310-1,70749-06-3,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1,Notified C&L,1,H314:1;H312:1;H318:1;H302:1
229918,1-benzoselenophene,695-311-7,272-30-0,Acute Tox. 3;Acute Tox. 3;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,2,H301:2;H373:2;H331:2;H400:2;H410:2
229919,"2-amino-2,3-dihydro-1H-indene-2-carboxylic acid",695-312-2,27473-62-7,Acute Tox. 4,Notified C&L,40,H302:39;H319:2;H335:2;H315:2
229920,"3,9,15,33-tetra-tert-butyl-19,22,25,28-tetraoxahexacyclo[15.12.7.17,11.131,35.05,29.013,18]octatriaconta-1(29),2,4,7(38),8,10,13,15,17,31(37),32,34-dodecaene-37,38-diol",695-313-8,171058-95-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
229921,1-methyl-2-imidazolidinone,695-314-3,694-32-6,Acute Tox. 4;Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,40,H319:40;H411:38;H302:40;H315:2;H312:1;H335:1
229922,Dibutylditellane,695-315-9,77129-69-2,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
229923,"(3Z)-3-[ethoxy(hydroxy)methylidene]-1-methylquinoline-2,4(1H,3H)-dione",695-316-4,57513-54-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H315:1;H335:1;H319:1;H302:1
229924,(2E)-3-phenylprop-2-en-1-amine hydrochloride,695-318-5,5586-89-0,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H315:1;H335:1;H319:1;H302:1
229925,1-benzothiophene-5-carbonitrile,695-319-0,2060-63-1,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,2,H319:2;H332:2;H312:2;H315:2;H335:2;H302:2
229926,"1-amino-2,3-dihydro-1H-indene-1-carboxylic acid",695-320-6,3927-71-7,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H315:1;H335:1;H319:1;H302:1
229927,"(3R)-2-(tert-butoxycarbonyl)-5-methyl-1,2,3,4-tetrahydroisoquinoline-3-carboxylate",695-321-1,155367-45-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
229928,[No public or meaningful name is available],695-322-7,,Acute Tox. 3;Acute Tox. 2;STOT RE 2,Notified C&L,1,H330:1;H373:1;H301:1
229929,"5,5'-Dibromo-2,2'-bithiophene",695-323-2,4805-22-5,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,2,H332:2;H312:2;H302:2
229930,5-nitro-1-benzothiophene-2-carboxylic acid,695-324-8,6345-55-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
229931,"1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid hydrochloride",695-325-3,77497-95-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
229932,[No public or meaningful name is available],695-326-9,931-57-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
229933,1-benzothiophene-5-carboxylic acid,695-327-4,2060-64-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:1;H315:1;H302:1
229934,"3,3,6,6-tetramethoxycyclohexa-1,4-diene",695-329-5,15791-03-4,Skin Corr. 1B;Eye Dam. 1,Notified C&L,1,H314:1;H318:1
229935,(3S)-3-phenyl-L-proline,695-330-0,118758-48-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H315:1;H335:1;H319:1;H302:1
229936,6-methylpyridazine-3-carbonitrile,695-331-6,49840-90-6,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,2,H332:2;H312:2;H302:2;H400:1;H410:1;H319:1;H315:1;H335:1
229937,"3,6-dimethylpyridazine",695-332-1,1632-74-2,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,2,H332:1;H312:1;H302:2;H400:1;H410:1;H315:1;H335:1;H319:1
229938,3-[(4R)-4-(propan-2-yl)cyclohex-1-en-1-yl]propanal,700-886-5,1378867-81-2,Skin Irrit. 2;Skin Sens. 1B;Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,1,H411:1;H400:1;H317:1;H315:1
229939,Bis-quaternary methacrylamide monomer,695-333-7,116745-35-8,Skin Corr. 1B,Notified C&L,20,H314:20
229942,"2,5-Dimethyl-2,5-di-(1-methylcyclohexylperoxy)-hex-3-yne",695-335-8,1354973-42-4,Org. Perox. C;Aquatic Chronic 4,Notified C&L,1,H413:1;H242:1
229943,"2-[4-(6,7-dimethoxyquinazolin-4-yl)oxyphenyl]-N-(1-isopropylpyrazol-4-yl)acetamide",938-210-8,,Muta. 2;Repr. 2;STOT RE 1;STOT RE 1,Notified C&L,3,H361:3;H341:3;H372:3
229944,"4-[(1S,2S)-2-(4-cyclobutylpiperazine-1-carbonyl)cyclopropyl]benzamide",938-211-3,,Repr. 2,Notified C&L,3,H361:3
229945,"N-[4-sila-4,4,4-tris(1,1-dimethyl-1-silaethoxy)butyl]vinyloxycarboxamide",695-336-3,134072-99-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H335:39;H315:39
229948,2-Chlorpyrimidine-5-boronic acid,695-338-4,1003845-06-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,20,H315:19;H335:19;H319:19;H302:19;Not classified:1
229949,"3-bromo-9-(2-bromoacetyl)-2,3,4,7-tetrahydro-1H-6-oxatetraphen-4-one",938-213-4,,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H315:1;H335:1;H319:1;H302:1
229950,"hydrogen N,N-dimethylaniline tetrakis(2,3,4,5,6-pentafluorophenyl)boranuide",695-340-5,118612-00-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
229951,"7-(4-Bromobenzoyl)-1,3-dihydro-2H-indol-2-one",695-341-0,91713-91-6,Not Classified,Notified C&L,2,Not classified:1;H314:1;H318:1
229952,"2-Amino-3-(4-bromobenzoyl)-benzene acetic acid, monosodium salt,sesquihydrate",695-342-6,120638-55-3,Acute Tox. 2;STOT RE 1,Notified C&L,2,H300:2;H372:2;H371:1;H360:1;H400:1
229953,"Benzenesulfonic acid, hydroxy-, monosodium salt, reaction products with formaldehyde and sulfonylbis[phenol], sodium salts, polymer",938-215-5,,Aquatic Chronic 2,Notified C&L,15,H411:15
229963,4-Fluoro-3-(methylsulphonyl)aniline,695-344-7,914636-44-5,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Notified C&L,1,H331:1;H311:1;H301:1
229964,"2,4-Dichloro-N-methylbenzylamine",695-345-2,5013-77-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:1;H335:1;H315:1;H314:1;H318:1
229965,4-Bromo-3-(trifluoromethyl)benzylamine,695-346-8,1159512-70-5,Skin Corr. 1B,Notified C&L,1,H314:1
229966,2-Aminophenylsulphur pentafluoride,695-347-3,1246998-10-6,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Notified C&L,1,H331:1;H311:1;H301:1
229967,2-(3-Bomopropoxy)oxane,695-348-9,33821-94-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:2;H315:2
229968,"Ethyl 1H-pyrrolo[2,3-b]pyridine-2-carboxylate",695-349-4,221675-35-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
229969,(4-fluoro-3-methoxyphenyl)boronic acid,695-351-5,854778-31-7,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,3,H319:3;H315:3;H335:2
229970,"2-(4,4,5,5,6,6,6-Heptafluorohex-1-yl)malonic acid",695-352-0,244022-64-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
229971,4-Methoxypyridine-2-carboxaldehyde,695-353-6,16744-81-3,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,2,H319:2;H332:2;H312:2;H315:2;H335:2;H302:2
229972,3-Amino-6-phenylpyridazine,695-354-1,14966-91-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:2;H315:2;H332:1;H302:1
229973,4-Bromo-2-methylbenzaldehyde,695-355-7,24078-12-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,176,H319:176;H335:176;H315:176
229974,3-Fluoroprop-1-yl toluene-4-sulphonate,695-356-2,312-68-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
229975,"1H-Imidazo-[4,5c]-kinolin- 1-(2metilpropil)-5-oxid",695-357-8,99010-63-6,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H315:2;H335:1;H319:2;H301:1
229976,Reaction mass of 119-61-9 and 947-19-3,938-223-9,,Eye Irrit. 2;Aquatic Chronic 1,Notified C&L,1,H319:1;H410:1
229979,"Echinocandin B, 1-[(4R,5R)-4,5-dihydroxy-L-ornithine]- (9CI)",695-359-9,79411-15-7,Acute Tox. 4,Notified C&L,1,H302:1
229980,"Amides, C18-unsatd., dimers, hydrogenated, N,N'-bis[3-(dimethylamino)propyl], polymers with di-Me, 3-hydroxypropyl Me siloxanes ethers with polyethylene glycol and polyethylene glycol mono (chloroacetate)",695-360-4,1383435-61-7,Skin Sens. 1,Notified C&L,446,H317:446
229981,"6-oxo- 6H‒Dibenz[c, e] [1, 2] oxaphosphorin 6-alkyl derivative",,,Not Classified,Notified C&L,1,Not classified:1
229987,Sulfonation products of disodium sulfite with (esterification products of C9-11 (branched and linear) Alkyl Polyglycosides with maleic anhydride),700-855-6,,Eye Irrit. 2,Notified C&L,1,H319:1
229993,[No public or meaningful name is available],695-362-5,202482-44-8,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H400:1;H410:1
229996,"Dodecanol-1, ethoxylated",938-230-7,,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,12,H319:12;H315:12
229997,"Octadecanol-1, ethoxylated",938-231-2,,Acute Tox. 4;Eye Dam. 1,Notified C&L,25,H318:25;H302:25
229998,Fatty alcohols C16-18 and C18 unsat ethoxylated,938-232-8,,Acute Tox. 4;Eye Dam. 1,Notified C&L,24,H318:24;H302:24
230004,3-bromo-4-fluoropyridine,695-366-7,116922-60-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,40,H315:39;H319:40;H302:40;H332:2;H312:2;H335:1
230009,"Isotridecanol, ethoxylated",938-239-6,,Acute Tox. 4;Eye Dam. 1,Notified C&L,25,H318:25;H302:25
230010,"Reaction mass of 3-[methoxy(dimethyl)silyl]propan-1-amine and 3,3'-(1,1,3,3-tetramethyldisiloxane-1,3-diyl)dipropan-1-amine",938-245-9,,Skin Corr. 1B;Eye Dam. 1,Notified C&L,2,H314:2;H318:2
230012,N-cyclopropyl-4-methyl-3-[6-(4-methylpiperazin-1-yl)-4-oxo-quinazolin-3-yl]benzamide,938-241-7,,Acute Tox. 3;Repr. 2;STOT RE 2;STOT RE 2,Notified C&L,3,H373:3;H361:3;H301:3
230013,"2,3-dichloro-N-(3-methoxypyrazin-2-yl)benzenesulfonamide",938-242-2,,Acute Tox. 4;Muta. 2;STOT RE 2;STOT RE 2,Notified C&L,3,H373:3;H341:3;H302:3
230014,"N-(2-aminophenyl)-4-[1-[(1,3-dimethylpyrazol-4-yl)methyl]-4-piperidyl]benzamide",938-243-8,,Acute Tox. 3;STOT RE 1;STOT RE 1,Notified C&L,3,H372:3;H301:3
230015,3-acetoxyquinuclidine R(-) tartrate,938-244-3,,Acute Tox. 3;Acute Tox. 3,Notified C&L,1,H311:1;H301:1
230016,"POLY(OXY-1,2-ETHANEDIYL),.ALPHA.-[2-[METHYLBIS[2-(1-OXOISOOCTADECYL)AMINO]ETHYL]AMMONIO]ETHYL]-.OMEGA.-HYDROXY-,METHYL SULFATE",695-368-8,185857-40-3,Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 1,Notified C&L,13,H319:13;H410:13;H315:13;H400:2
230017,3-Formylphenylboronic acid,938-246-4,,Skin Corr. 1B,Notified C&L,1,H314:1
230018,[No public or meaningful name is available],695-369-3,154303-05-6,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
230019,"1-(3,4-dimethoxyphenyl)propan-1-one",695-370-9,1835-04-7,Acute Tox. 4,Notified C&L,2,H302:1;H319:1;H335:1;H315:1
230020,"reaction product of bisphenol-A, bisphenol-F and epichlorohydrin",938-248-5,,Skin Sens. 1,Notified C&L,5,H317:5
230021,Polyisobutylene Succinate,938-249-0,,Eye Irrit. 2;STOT SE 3;Aquatic Chronic 3,Notified C&L,1,H412:1;H319:1;H335:1
230022,"Tetrakis{9-[2-(ethoxycarbonyl)phenyl]-3,6-bis(ethylamino)-2,7-dimethylxanthylium} C12-(branched and/or linear)-alkyl-(4-sulfonatophenoxy)benzenesulfonate and oxybis[C12-(branched and/or linear)-alkyl-benzenesulfonate]",700-761-5,,Acute Tox. 4;Skin Sens. 1B;Eye Dam. 1;STOT SE 3;Aquatic Chronic 2,Notified C&L,1,H411:1;H317:1;H318:1;H335:1;H302:1
230024,PVI,938-250-6,,Skin Sens. 1B,Notified C&L,1,H317:1;H410:1
230027,Stearylamine ethoxylated,938-251-1,,Aquatic Chronic 2,Notified C&L,11,H411:11
230028,2-(1H-imidazol-2-yl)-5-(trifluoromethyl)pyridine,938-252-7,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H332:1;H312:1;H302:1;H400:1;H410:1
230029,2-(1H-pyrazol-1-yl) pyridine,938-253-2,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H332:1;H312:1;H302:1;H400:1;H410:1
230030,4-phenylpyridazine,938-254-8,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H332:1;H312:1;H302:1;H400:1;H410:1
230031,"1-(3-chlorophenyl)-3,5-dimethyl-1H-pyrazole",938-255-3,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H332:1;H312:1;H302:1;H400:1;H410:1
230032,4-phenyl-3(2H)-pyridazinone,938-256-9,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H332:1;H312:1;H302:1;H400:1;H410:1
230033,3-hydroxy-2-phenyl-2-cyclohexen-1-one,938-257-4,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H332:1;H312:1;H302:1;H400:1;H410:1
230034,3-hydroxy-2-(2-methylphenyl)-2-cyclohexen-1-one,938-259-5,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H332:1;H312:1;H302:1;H400:1;H410:1
230035,"2-(2,2,7,7-Tetramethyltricyclo[6.2.1.0((1,6)]Undec-5 and 4-en-5-yl)propan-1-ol",695-374-0,929625-08-1,Skin Irrit. 2;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,40,H410:40;H400:40;H317:40;H315:40
230038,3-tert-butylphenylethylether,938-262-1,,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H400:1;H410:1
230039,"N-(2-chloro-1-methoxy)ethyl-2,6-difluorobenzamide",695-375-6,156778-34-6,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H400:1;H410:1
230040,"N-{2-chloro-1-(4-tert-butyl-ethoxyphenyl)}ethyl-2,6-difluorobenzamide",695-376-1,168552-08-7,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H400:1;H410:1
230041,2-amino-2-(4-tert-butyl-2-ethoxyphenyl)ethanol,938-263-7,,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H400:1;H410:1
230042,2-bromo-5-tert-butyl-2-ethoxyphenyl,938-264-2,,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H400:1;H410:1
230043,"N-(2,6-difluorobenzoyl)-4-tert-butyl-2-ethoxybenzamide",938-265-8,,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H400:1;H410:1
230044,"N-(2,6-difluorobenzoyl)-2-amino-2-(4-tert-butyl-2-ethoxyphenyl)ethanol",938-266-3,,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H400:1;H410:1
230045,"2-amino-2-(4-tert-butyl-2-ethoxyphenyl)ethyl-2,6-difluorobenzoate",938-267-9,,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H400:1;H410:1
230046,"4-(4-tert-butyl-2-ethoxyphenyl)-2-(2,6-difluorophenyl)oxazole",938-268-4,,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H400:1;H410:1
230047,2-[(4-fluorophenyl)amino]-2-methylpropanenitrile,695-377-7,121071-28-1,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
230049,"2,2,2-trichloro-1-{1H-pyrrolo[2,3-b]pyridin-3-yl}ethan-1-one",695-378-2,163220-69-7,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
230050,1-(2-chloropyridin-3-yl)ethan-1-one,695-379-8,55676-21-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,43,H315:42;H335:41;H319:42;H302:40;H331:1;H311:1;H301:1;H332:2;H312:1
230051,2-chloro-4-(trifluoromethyl)pyridine-3-carboxamide,938-271-0,,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H332:1;H312:1;H315:1;H335:1;H302:1
230052,"1-cyclohexyl-1H,2H,3H-imidazo[4,5-b]pyridin-2-one",938-272-6,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
230053,"1-cyclohexyl-1H-imidazo[4,5-b]pyridine",938-273-1,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
230054,2-methyl-2-{[(4-methylphenyl)methyl]amino}propanenitrile,938-274-7,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
230055,"3-bromo-8-nitroimidazo[1,2-a]pyridine",695-380-3,52310-43-7,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H332:1;H312:1;H315:1;H335:1;H302:1
230056,"ethyl 2-nitro-3-{1H-pyrrolo[2,3-b]pyridin-3-yl}propanoate",938-275-2,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
230057,5-amino-1-benzyl-1H-pyrrole-3-carbonitrile,938-276-8,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
230058,"1-(4,6-dichloropyridin-3-yl)ethan-1-one",695-381-9,887573-44-6,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,2,H319:2;H332:1;H312:1;H315:2;H335:2;H302:2
230059,N-[4-iodo-2-(trifluoromethoxy)phenyl]acetamide,938-277-3,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
230060,methyl 3-amino-5-bromo-4-hydroxybenzoate,695-382-4,260249-10-3,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
230061,"2,6-dichloro-4-(chloromethyl)pyridine",695-384-5,101990-72-1,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H332:1;H312:1;H315:1;H335:1;H302:1
230062,3-bromo-1H-indole-2-carbonitrile,938-278-9,,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H332:1;H312:1;H315:1;H335:1;H302:1
230063,"3H,4H-pyrido[3,4-d]pyrimidin-4-one",695-385-0,19178-25-7,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,2,H332:1;H312:1;H302:2;H315:1;H335:1;H319:1
230064,4-[(6-chloropyridin-3-yl)methyl]benzaldehyde,938-279-4,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
230065,3-iodo-1H-indole-2-carbonitrile,695-386-6,51796-65-7,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
230066,"3-iodo-8-nitroimidazo[1,2-a]pyridine",938-281-5,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
230067,"8-(benzyloxy)-3-chloroimidazo[1,2-a]pyridine",938-282-0,,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H332:1;H312:1;H315:1;H335:1;H302:1
230068,"9-benzyl-1,9-diazaspiro[5.5]undecane",695-387-1,1100748-66-0,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
230069,2-methyl-2-[(4-methylphenyl)amino]propanenitrile,695-388-7,101568-43-8,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
230070,"3-chloro-8-nitroimidazo[1,2-a]pyridine",695-389-2,52310-45-9,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H332:1;H312:1;H315:1;H335:1;H302:1
230071,"8-bromo-6-methoxy-3,4-dihydro-2H-1,4-benzoxazine",938-283-6,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
230072,"5-(1,3-dioxan-2-yl)-1-methyl-1H-indazol-3-amine",938-284-1,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
230073,"tert-butyl 4-{2-methyl-1H-imidazo[4,5-b]pyridin-1-yl}piperidine-1-carboxylate",938-285-7,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
230074,2-(benzylamino)-2-methylpropanenitrile hydrochloride,938-286-2,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
230075,"1-benzyl-5,5-dimethylimidazolidin-2-one",938-287-8,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
230078,"4-chloro-1-methyl-6-oxo-1,6-dihydropyridine-3-carboxylic acid",695-390-8,821791-59-7,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
230080,6-chloro-7-methyl-7H-purine,695-391-3,5440-17-5,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H332:1;H312:1;H315:1;H335:1;H302:1
230081,"imidazo[1,2-a]pyridin-8-amine",938-290-4,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
230082,4-chloro-2-(piperidin-1-yl)aniline,938-292-5,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
230085,"(2S,4R)-4-methylpyrrolidine-2-carboxylic acid hydrochloride",938-295-1,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
230086,"methyl (1S,3R)-3-{[(benzyloxy)carbonyl]amino}cyclopentane-1-carboxylate",938-296-7,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
230090,2-(Bromomethyl)-5-(trifluoromethyl)furan,695-392-9,17515-77-4,Skin Corr. 1B,Notified C&L,4,H314:4;H318:2;H332:1;H312:1;H302:1;H226:1
230091,"{(1R,2S,5R)-7-Oxo-2-[2-(piperidin-4-yl)carbamoyl]-1,6-diazabicyclo[3.2.1]oct-6-yl} hydrogen sulfate",938-300-7,,STOT RE 2,Notified C&L,35,H373:35
230092,(S)-(-)-1-Boc-4-oxopiperidine-2-carboxylic acid,695-393-4,198646-60-5,Eye Irrit. 2,Notified C&L,39,H319:39
230093,[No public or meaningful name is available],695-395-5,945218-53-1,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,38,H315:38;H335:38;H318:38;H302:38
230094,[No public or meaningful name is available],695-396-0,1072951-70-2,Skin Corr. 1B,Notified C&L,38,H314:38
230096,"Ruthenate(1-), bis[1,1'-(1R)-[1,1'-binaphthalene]-2,2'-diylbis[1,1-bis(3,5-dimethylphenyl)phosphine-κP]]tri-μ-chlorodichlorodi-, hydrogen, compd. with N-methylmethanamine (1:1:1)",695-398-1,944451-08-5,Flam. Sol. 2,Notified C&L,127,H228:127
230097,[No public or meaningful name is available],695-399-7,1011736-00-7,Skin Corr. 1B,Notified C&L,38,H314:38
230098,[No public or meaningful name is available],695-400-0,1092490-08-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
230099,[No public or meaningful name is available],695-401-6,1313437-89-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
230100,[No public or meaningful name is available],695-402-1,887919-36-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
230101,[No public or meaningful name is available],695-403-7,4397-55-1,Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1,Notified C&L,38,H314:38;H317:38;H302:38
230102,[No public or meaningful name is available],695-404-2,191654-69-0,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,38,H319:38;H332:38;H312:38;H315:38;H335:38;H302:38
230103,[No public or meaningful name is available],695-405-8,14812-03-4,Skin Sens. 1;Eye Dam. 1,Notified C&L,38,H318:38;H317:38
230104,[No public or meaningful name is available],695-406-3,36818-89-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
230105,[No public or meaningful name is available],695-407-9,53379-77-4,Acute Tox. 4;Acute Tox. 3;Skin Corr. 1B;Acute Tox. 3;Muta. 2;Carc. 1A;STOT SE 2;STOT RE 2,Notified C&L,38,H350:38;H314:38;H373:38;H331:38;H371:38;H341:38;H311:38;H302:38
230106,[No public or meaningful name is available],695-408-4,372965-00-9,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,38,H315:38;H335:38;H318:38;H302:38
230107,[No public or meaningful name is available],695-410-5,85760-60-7,Acute Tox. 4;Eye Irrit. 2,Notified C&L,38,H319:38;H302:38
230108,[No public or meaningful name is available],695-411-0,63313-71-3,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,38,H332:38;H312:38;H302:38
230109,[No public or meaningful name is available],695-412-6,207399-16-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
230110,Isopropylmagnesium chloride lithium chloride complex,695-413-1,745038-86-2,Skin Corr. 1B,Notified C&L,39,H314:39
230111,[No public or meaningful name is available],695-414-7,836615-83-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
230112,[No public or meaningful name is available],695-415-2,83907-40-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
230113,[No public or meaningful name is available],695-416-8,1257650-88-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
230114,[No public or meaningful name is available],695-417-3,48107-17-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
230115,[No public or meaningful name is available],695-418-9,1499-53-2,Acute Tox. 4;Eye Dam. 1,Notified C&L,38,H318:38;H302:38
230116,[No public or meaningful name is available],695-419-4,36177-86-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
230117,[No public or meaningful name is available],695-421-5,1975-81-1,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H312:38;H315:38;H335:38;H302:38
230118,"4-acetyl-3,5-dimethyl-1H-pyrrole-2-carboxylic acid",695-422-0,2386-28-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H335:39;H315:39
230119,[No public or meaningful name is available],695-423-6,2459-24-7,Eye Dam. 1,Notified C&L,38,H318:38
230120,[No public or meaningful name is available],695-424-1,62740-68-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
230121,[No public or meaningful name is available],695-425-7,7149-82-8,Acute Tox. 4;Eye Irrit. 2,Notified C&L,38,H319:38;H302:38
230122,Tetrafluorosuccinamide,695-426-2,377-37-7,Eye Irrit. 2,Notified C&L,39,H319:39
230123,1-methylcyclohexan-1-amine hydrochloride,695-427-8,89854-70-6,Acute Tox. 4,Notified C&L,40,H302:40;H319:2;H332:1;H312:1;H315:2;H335:2
230124,[No public or meaningful name is available],695-428-3,3645-69-0,Acute Tox. 4;Eye Dam. 1;Aquatic Acute 1,Notified C&L,38,H318:38;H400:38;H302:38
230125,2-(aminomethyl)benzoic acid hydrochloride,695-429-9,10017-39-7,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3;Aquatic Acute 1,Notified C&L,39,H315:39;H318:38;H335:39;H400:38;H302:39;H319:1
230126,3-Hydrazinylpyridine dihydrochloride,695-430-4,364727-74-2,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,39,H315:39;H335:39;H318:38;H302:39;H319:1
230127,1-methylcyclopentan-1-amine hydrochloride,695-432-5,102014-58-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H315:39;H335:39;H319:39;H302:39
230128,[No public or meaningful name is available],695-433-0,1201935-99-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
230129,[No public or meaningful name is available],695-434-6,52834-40-9,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,38,H315:38;H335:38;H318:38;H302:38
230130,[No public or meaningful name is available],695-435-1,1268340-98-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
230131,[No public or meaningful name is available],695-436-7,26903-26-4,Acute Tox. 4;Eye Irrit. 2;Aquatic Chronic 4,Notified C&L,38,H319:38;H413:38;H302:38
230132,[No public or meaningful name is available],695-437-2,1520-57-6,Flam. Liq. 2;Acute Tox. 4;Skin Corr. 1B,Notified C&L,38,H225:38;H314:38;H302:38
230133,[No public or meaningful name is available],695-438-8,1104636-68-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
230134,[No public or meaningful name is available],695-439-3,102342-85-8,Acute Tox. 4;Eye Dam. 1,Notified C&L,38,H318:38;H302:38
230135,[No public or meaningful name is available],695-440-9,111382-34-4,Acute Tox. 4;Eye Irrit. 2;Aquatic Chronic 4,Notified C&L,38,H319:38;H413:38;H302:38
230136,[No public or meaningful name is available],695-441-4,1173019-49-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H319:38;H315:38;H335:38;H400:38;H410:38
230137,[No public or meaningful name is available],695-443-5,88468-45-5,Flam. Liq. 3;Eye Dam. 1,Notified C&L,38,H318:38;H226:38
230138,[No public or meaningful name is available],695-444-0,200876-70-6,Acute Tox. 4;Acute Tox. 4;Repr. 1A;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H373:38;H332:38;H410:38;H360:38;H400:38;H302:38
230139,[No public or meaningful name is available],695-445-6,198992-86-8,Acute Tox. 4;Acute Tox. 4;Repr. 1A;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H373:38;H332:38;H410:38;H360:38;H400:38;H302:38
230140,[No public or meaningful name is available],695-446-1,200116-71-8,Acute Tox. 4;Acute Tox. 4;Repr. 1A;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H373:38;H332:38;H410:38;H360:38;H400:38;H302:38
230141,[No public or meaningful name is available],695-447-7,195195-40-5,Acute Tox. 4;Acute Tox. 4;Repr. 1A;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H373:38;H332:38;H410:38;H360:38;H400:38;H302:38
230142,[No public or meaningful name is available],695-448-2,198992-60-8,Acute Tox. 4;Acute Tox. 4;Repr. 1A;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H373:38;H332:38;H410:38;H360:38;H400:38;H302:38
230143,[No public or meaningful name is available],695-449-8,198337-55-2,Acute Tox. 4;Acute Tox. 4;Repr. 1A;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H373:38;H332:38;H410:38;H360:38;H400:38;H302:38
230144,[No public or meaningful name is available],695-450-3,201742-32-7,Acute Tox. 4;Acute Tox. 4;Repr. 1A;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H373:38;H332:38;H410:38;H360:38;H400:38;H302:38
230145,[No public or meaningful name is available],695-451-9,198992-61-9,Acute Tox. 4;Acute Tox. 4;Repr. 1A;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H373:38;H332:38;H410:38;H360:38;H400:38;H302:38
230146,[No public or meaningful name is available],695-452-4,1173022-10-0,Acute Tox. 4,Notified C&L,38,H332:38
230147,[No public or meaningful name is available],695-454-5,198972-00-8,Acute Tox. 4;Acute Tox. 4;Repr. 1A;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H373:38;H332:38;H410:38;H360:38;H400:38;H302:38
230148,[No public or meaningful name is available],695-455-0,200725-00-4,Acute Tox. 4;Acute Tox. 4;Repr. 1A;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H373:38;H332:38;H410:38;H360:38;H400:38;H302:38
230149,[No public or meaningful name is available],695-456-6,552332-04-4,Skin Corr. 1B;Eye Dam. 1,Notified C&L,38,H314:38;H318:38
230150,[No public or meaningful name is available],695-457-1,69342-46-7,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;Resp. Sens. 1;STOT SE 3,Notified C&L,38,H319:38;H315:38;H331:38;H334:38;H335:38;H311:38;H301:38
230151,[No public or meaningful name is available],695-458-7,1184171-66-1,Skin Corr. 1B,Notified C&L,38,H314:38
230152,[No public or meaningful name is available],695-459-2,72301-81-6,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;STOT SE 3;Repr. 1B,Notified C&L,38,H319:38;H360:38;H315:38;H331:38;H335:38;H311:38;H301:38
230153,[No public or meaningful name is available],695-460-8,58948-98-4,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,38,H319:38;H332:38;H312:38;H315:38;H335:38;H302:38
230154,"Potassium benzo[c][1,2,5]oxadiazole-5-trifluoroborate",695-461-3,1225608-24-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:38;H335:38;H315:38;H332:1;H312:1;H302:1
230155,"3-(2,5-Dimethylphenyl)-3-hydroxy-8-methoxy-1-azaspiro(4.5)decane-2,4-dione",695-462-9,1172134-11-0,Aquatic Chronic 2,Notified C&L,38,H411:38
230156,[No public or meaningful name is available],695-463-4,1204324-09-3,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H315:38;H335:38;H319:38;H302:38
230157,[No public or meaningful name is available],695-465-5,135942-11-9,Acute Tox. 4,Notified C&L,38,H302:38
230158,[No public or meaningful name is available],695-466-0,1201899-19-5,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,38,H315:38;H319:38;H302:38
230159,[No public or meaningful name is available],695-467-6,180854-44-8,Eye Irrit. 2,Notified C&L,38,H319:38
230160,[No public or meaningful name is available],695-468-1,103686-16-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
230161,[No public or meaningful name is available],695-469-7,36176-90-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
230162,[No public or meaningful name is available],695-470-2,80666-48-4,Acute Tox. 3;Acute Tox. 3;Acute Tox. 2;Repr. 2;STOT RE 1,Notified C&L,38,H330:38;H372:38;H361:38;H311:38;H301:38
230163,"(2S,2'S)-(-)-[N,N'-Bis(2-pyridylmethyl]-2,2'-bipyrrolidinebis(acetonitrile)iron(II) hexafluoroantimonate Fe(S,S-PDP)",695-471-8,959395-10-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H335:39;H315:39
230164,methyl 4-formyl-1H-pyrrole-2-carboxylate,695-472-3,40611-79-8,Skin Sens. 1,Notified C&L,39,H317:38;H315:1;H335:1;H319:1;H302:1
230165,Magnesium tetrahydridoborate,695-473-9,16903-37-0,Water-react. 2;Acute Tox. 3;Acute Tox. 3;Skin Corr. 1B;Acute Tox. 3,Notified C&L,39,H314:39;H331:39;H261:39;H311:39;H301:39
230166,[No public or meaningful name is available],695-474-4,331717-45-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
230167,[No public or meaningful name is available],695-476-5,1242733-91-0,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,38,H319:38;H332:38;H312:38;H315:38;H335:38;H302:38
230168,[No public or meaningful name is available],695-477-0,1135389-59-1,Flam. Liq. 2;Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,38,H319:38;H312:38;H332:38;H315:38;H225:38;H335:38;H302:38
230169,[No public or meaningful name is available],695-478-6,144634-74-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
230170,[No public or meaningful name is available],695-479-1,1294455-24-5,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,38,H319:38;H332:38;H312:38;H315:38;H335:38;H302:38
230174,"5-phenyl-1,2-oxazole",695-480-7,1006-67-3,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,196,H332:195;H312:195;H302:195;H319:2;H315:2;H335:2
230175,[No public or meaningful name is available],695-481-2,220497-88-1,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,38,H332:38;H312:38;H302:38
230176,[No public or meaningful name is available],695-482-8,63271-86-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
230177,"copper(1+);cyclopenta-1,3-diene;triethylphosphane",695-483-3,12261-30-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H335:39;H315:39
230178,[No public or meaningful name is available],695-484-9,177355-84-9,Acute Tox. 4;Eye Irrit. 2,Notified C&L,38,H319:38;H302:38
230179,[No public or meaningful name is available],695-485-4,668980-99-2,Eye Irrit. 2,Notified C&L,38,H319:38
230180,[No public or meaningful name is available],695-487-5,92751-19-4,Skin Corr. 1B,Notified C&L,38,H314:38
230181,[No public or meaningful name is available],695-488-0,96617-81-1,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Acute Tox. 4;Muta. 1B;Carc. 1B,Notified C&L,38,H350:38;H314:38;H332:38;H312:38;H302:38;H340:38
230182,[No public or meaningful name is available],695-489-6,1029145-99-0,Skin Corr. 1B,Notified C&L,38,H314:38
230183,[No public or meaningful name is available],695-490-1,485394-25-0,Aquatic Acute 1,Notified C&L,38,H400:38
230184,Sulfamethoxazole mixture with trimethoprim,,8064-90-2,,Notified C&L,38,Not classified:38
230185,[No public or meaningful name is available],695-492-2,420831-40-9,Eye Irrit. 2,Notified C&L,38,H319:38
230186,[No public or meaningful name is available],695-493-8,97845-58-4,Acute Tox. 4;Eye Irrit. 2,Notified C&L,38,H319:38;H302:38
230187,[No public or meaningful name is available],695-494-3,86426-17-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
230188,2-(Diisopropylsilyl)pyridine,695-495-9,1232692-92-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H335:38;H315:39
230189,tert-butyl N-(pent-4-yn-1-yl)carbamate,695-496-4,151978-50-6,Skin Corr. 1B,Notified C&L,39,H314:38;H319:1;H335:1;H315:1
230190,[No public or meaningful name is available],695-498-5,36763-53-8,Aquatic Acute 1,Notified C&L,38,H400:38
230191,[No public or meaningful name is available],695-499-0,917-71-5,Flam. Liq. 3;Acute Tox. 4;Skin Corr. 1A;Acute Tox. 3,Notified C&L,38,H314:38;H331:38;H226:38;H302:38
230192,[No public or meaningful name is available],695-500-4,562824-27-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
230193,[No public or meaningful name is available],695-502-5,41784-82-1,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H317:38;H315:38
230194,[No public or meaningful name is available],695-503-0,163163-79-9,Acute Tox. 4,Notified C&L,38,H302:38
230195,[No public or meaningful name is available],695-504-6,83395-39-5,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H315:38;H335:38;H319:38;H302:38
230196,[No public or meaningful name is available],695-505-1,307525-40-2,Aquatic Chronic 2,Notified C&L,38,H411:38
230197,[No public or meaningful name is available],695-506-7,15509-95-2,Acute Tox. 3,Notified C&L,38,H301:38
230198,"Pyridine, 3-[(2S)-2-azetidinylmethoxy]-5-iodo-, hydrochloride (1:2)",695-507-2,1217837-17-6,Acute Tox. 4,Notified C&L,194,H302:194
230199,[No public or meaningful name is available],695-508-8,620112-78-9,Acute Tox. 3,Notified C&L,38,H301:38
230200,[No public or meaningful name is available],695-509-3,15084-61-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
230201,"3,4-Diaminothiophene dihydrochloride",695-510-9,90069-81-1,Acute Tox. 3;Skin Sens. 1;Eye Dam. 1,Notified C&L,41,H318:40;H317:40;H301:41;H319:1;H315:1;H331:1;H335:1;H311:1
230202,[No public or meaningful name is available],695-511-4,207300-86-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
230203,N-hydroxy-4-phenylbutanamide,695-513-5,32153-46-1,Acute Tox. 4;Eye Irrit. 2,Notified C&L,39,H319:39;H302:39;H315:1;H335:1
230204,[No public or meaningful name is available],695-514-0,106359-61-9,Aquatic Acute 1,Notified C&L,38,H400:38
230205,[No public or meaningful name is available],695-515-6,4312-91-8,Acute Tox. 4,Notified C&L,38,H302:38
230206,Di-tert-butyl chloromethyl phosphate,695-516-1,229625-50-7,Acute Tox. 4,Notified C&L,42,H302:42;H319:1;H332:1;H315:1;H400:1
230207,tert-butyl N-[2-(2-hydroxyethoxy)ethyl]carbamate,695-517-7,139115-91-6,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,40,H315:40;H319:40;H301:40;H335:2
230208,[No public or meaningful name is available],695-518-2,1095661-17-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
230209,[No public or meaningful name is available],695-519-8,1062158-66-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
230210,[No public or meaningful name is available],695-520-3,1062158-63-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
230211,[No public or meaningful name is available],695-521-9,347841-40-1,Eye Irrit. 2,Notified C&L,38,H319:38
230212,[No public or meaningful name is available],695-522-4,125192-28-1,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,38,H315:38;H319:38;H301:38
230213,[No public or meaningful name is available],695-524-5,1194607-09-4,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,38,H319:38;H332:38;H312:38;H315:38;H335:38;H302:38
230214,[No public or meaningful name is available],695-525-0,444581-46-8,Eye Irrit. 2,Notified C&L,38,H319:38
230215,"4-bromo-2,3-dimethylthiophene",695-526-6,30153-46-9,Acute Tox. 4,Notified C&L,39,H302:39;H319:1;H332:1;H312:1;H315:1;H335:1
230216,[No public or meaningful name is available],695-527-1,916488-42-1,Acute Tox. 4;Eye Irrit. 2,Notified C&L,38,H319:38;H302:38
230217,[No public or meaningful name is available],695-528-7,96503-56-9,Eye Irrit. 2,Notified C&L,38,H319:38
230218,[No public or meaningful name is available],695-529-2,926936-73-4,Skin Corr. 1B;STOT SE 3,Notified C&L,38,H314:38;H335:38
230219,[No public or meaningful name is available],695-530-8,230283-74-6,Eye Irrit. 2,Notified C&L,38,H319:38
230220,[No public or meaningful name is available],695-531-3,862168-49-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
230221,"2-bromo-1,3,4-thiadiazole",695-532-9,61929-24-6,Acute Tox. 4;Skin Irrit. 2,Notified C&L,39,H315:39;H302:39
230222,[No public or meaningful name is available],695-533-4,412940-35-3,Acute Tox. 4;Eye Irrit. 2,Notified C&L,38,H319:38;H302:38
230223,[No public or meaningful name is available],695-535-5,199673-74-0,Aquatic Acute 1,Notified C&L,38,H400:38
230224,[No public or meaningful name is available],695-536-0,241800-98-6,Acute Tox. 3,Notified C&L,38,H301:38
230225,[No public or meaningful name is available],695-537-6,60899-33-4,Acute Tox. 4;Skin Sens. 1,Notified C&L,38,H317:38;H302:38
230226,[No public or meaningful name is available],695-538-1,871329-71-4,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,39,H319:39;H332:38;H312:38;H315:39;H335:39;H302:38
230227,[No public or meaningful name is available],695-539-7,1011460-68-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
230228,"2,4-Dimethylthiazole-5-boronic acid, pinacol ester",695-540-2,859833-13-9,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,41,H332:39;H312:39;H302:41;H315:3;H335:3;H319:3
230229,[No public or meaningful name is available],695-541-8,62306-78-9,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,38,H319:38;H332:38;H312:38;H315:38;H335:38;H302:38
230230,(6-Chloro-1H-benzotriazol-1-yloxy)tripyrrolidinophosphonium Hexafluorophosphate,695-542-3,893413-42-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,42,H319:40;H335:39;H315:40;Not classified:2
230231,[No public or meaningful name is available],695-543-9,1256841-61-8,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Acute Tox. 4,Notified C&L,38,H314:38;H332:38;H312:38;H302:38
230232,"methyl (15S,16R,18R)-16-hydroxy-15-methyl-3-oxo-28-oxa-4,14,19-triazaoctacyclo[12.11.2.1¹⁵,¹⁸.0²,⁶.0⁷,²⁷.0⁸,¹³.0¹⁹,²⁶.0²⁰,²⁵]octacosa-1(26),2(6),7(27),8(13),9,11,20(25),21,23-nonaene-16-carboxylate",695-544-4,97161-97-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H335:39;H315:39
230233,[No public or meaningful name is available],695-546-5,62306-80-3,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Acute Tox. 4,Notified C&L,38,H314:38;H332:38;H312:38;H302:38
230234,[No public or meaningful name is available],695-547-0,6374-91-0,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H315:38;H335:38;H319:38;H302:38
230235,"2-(2-Chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide",695-548-6,212631-79-3,Aquatic Acute 1,Notified C&L,39,H400:38;H361:1;H372:1
230236,4-(9H-Carbazol-9-yl)benzaldehyde,695-549-1,110677-45-7,Eye Irrit. 2,Notified C&L,39,H319:39;H315:1
230237,[No public or meaningful name is available],695-550-7,1222630-32-1,Skin Corr. 1B,Notified C&L,38,H314:38
230238,(4-formylthiophen-3-yl)boronic acid,695-551-2,4347-32-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H315:40;H335:40;H319:40;H302:40
230239,[No public or meaningful name is available],695-552-8,443890-11-7,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;STOT RE 2,Notified C&L,38,H332:38;H373:38;H312:38;H302:38
230240,[No public or meaningful name is available],695-553-3,854045-95-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
230241,[No public or meaningful name is available],695-554-9,1121960-90-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
230242,[No public or meaningful name is available],695-555-4,143367-56-0,Acute Tox. 2;Acute Tox. 2;Acute Tox. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H330:38;H300:38;H310:38;H400:38;H410:38
230243,[No public or meaningful name is available],695-557-5,173904-50-2,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H400:38;H410:38
230244,[No public or meaningful name is available],695-558-0,804565-39-7,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,38,H318:38;H335:38;H315:38
230245,[No public or meaningful name is available],695-559-6,1262538-11-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
230246,Triacetylresveratrol,695-560-1,42206-94-0,Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;STOT SE 3;Aquatic Acute 1,Notified C&L,39,H317:38;H315:39;H318:38;H335:38;H400:38;H319:1
230247,[No public or meaningful name is available],695-561-7,34772-97-9,Acute Tox. 4;Eye Dam. 1,Notified C&L,38,H318:38;H302:38
230248,[No public or meaningful name is available],695-562-2,1154062-74-4,Acute Tox. 4,Notified C&L,38,H302:38
230249,"(3S,9S,12R,15S,18R)-9,15-bis[(2S)-butan-2-yl]-3-[(2R)-butan-2-yl]-4,10,16-trimethyl-6,12,18-tri(propan-2-yl)-1,7,13-trioxa-4,10,16-triazacyclooctadecane-2,5,8,11,14,17-hexone",695-563-8,2503-13-1,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Notified C&L,39,H331:39;H311:39;H301:39
230250,[No public or meaningful name is available],695-564-3,2980-80-5,Acute Tox. 4,Notified C&L,38,H302:38
230251,[No public or meaningful name is available],695-565-9,58644-55-6,Acute Tox. 4,Notified C&L,38,H302:38
230252,2-(dimethylamino)-1-(piperazin-1-yl)ethan-1-one,695-566-4,670252-70-7,Acute Tox. 4;Acute Tox. 4,Notified C&L,39,H332:38;H302:39;H315:1;H335:1;H319:1
230253,(2-isocyanoethyl)dimethylamine,695-568-5,78375-49-2,Acute Tox. 4,Notified C&L,39,H302:38;H314:1;H331:1;H311:1;H301:1
230254,[No public or meaningful name is available],695-569-0,145295-99-4,Acute Tox. 4,Notified C&L,38,H302:38
230255,[No public or meaningful name is available],695-570-6,293311-03-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H315:38;H335:38;H319:38;H302:38
230256,[No public or meaningful name is available],695-571-1,907604-62-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
230257,[No public or meaningful name is available],695-572-7,775294-82-1,Acute Tox. 4,Notified C&L,38,H302:38
230258,[No public or meaningful name is available],695-573-2,182181-38-0,Acute Tox. 4,Notified C&L,38,H302:38
230259,[No public or meaningful name is available],695-574-8,90348-24-6,Acute Tox. 4,Notified C&L,38,H302:38
230260,[No public or meaningful name is available],695-575-3,20771-60-2,Acute Tox. 4,Notified C&L,38,H302:38
230261,[No public or meaningful name is available],695-576-9,15586-24-0,Acute Tox. 4,Notified C&L,38,H302:38
230262,[No public or meaningful name is available],695-577-4,117559-36-1,Skin Corr. 1B,Notified C&L,38,H314:38
230263,1-Isocyano-2-methoxyethane,695-579-5,43219-50-7,Acute Tox. 4,Notified C&L,39,H302:39
230264,[No public or meaningful name is available],695-580-0,286454-86-2,Skin Corr. 1B,Notified C&L,38,H314:38
230265,[No public or meaningful name is available],695-581-6,26601-80-9,Flam. Sol. 2,Notified C&L,38,H228:38
230266,[No public or meaningful name is available],695-582-1,799297-44-2,Skin Corr. 1B,Notified C&L,38,H314:38
230267,[No public or meaningful name is available],695-583-7,192057-60-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H315:38;H335:38;H319:38;H302:38
230268,[No public or meaningful name is available],695-584-2,146476-37-1,Skin Corr. 1B,Notified C&L,38,H314:38
230269,[No public or meaningful name is available],695-585-8,774225-25-1,Acute Tox. 4;Skin Irrit. 2,Notified C&L,38,H315:38;H302:38
230270,3-bromophenanthrene,695-586-3,715-50-4,Skin Irrit. 2;Eye Dam. 1;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,39,H315:39;H318:39;H335:39;H400:38;H410:39
230271,2-(1H-Imidazol-2-yl)pyridine,695-587-9,18653-75-3,Acute Tox. 4,Notified C&L,39,H302:39
230272,[No public or meaningful name is available],695-588-4,27914-73-4,Skin Corr. 1B,Notified C&L,38,H314:38
230273,[No public or meaningful name is available],695-590-5,1261254-46-9,Acute Tox. 3;Acute Tox. 3;Acute Tox. 2;STOT RE 1,Notified C&L,38,H372:38;H330:38;H311:38;H301:38
230274,[No public or meaningful name is available],695-591-0,103349-41-3,Pyr. Sol. 1;Water-react. 1;Skin Corr. 1B,Notified C&L,38,H314:38;H250:38;H260:38
230275,[No public or meaningful name is available],695-592-6,104208-01-7,Skin Sens. 1,Notified C&L,38,H317:38
230276,[No public or meaningful name is available],695-593-1,34007-71-1,Acute Tox. 4,Notified C&L,38,H302:38
230277,[No public or meaningful name is available],695-594-7,121340-53-2,Acute Tox. 2;Acute Tox. 1;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 2;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H319:38;H330:38;H300:38;H315:38;H310:38;H335:38;H400:38;H410:38
230278,prop-2-yn-1-yl 1H-imidazole-1-carboxylate,695-595-2,83395-38-4,Acute Tox. 4,REACH registration C&L,40,H302:40
230279,[No public or meaningful name is available],695-596-8,82998-18-3,Acute Tox. 4,Notified C&L,38,H302:38
230280,[No public or meaningful name is available],695-597-3,862873-06-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
230281,[No public or meaningful name is available],695-598-9,106132-78-9,Acute Tox. 4,Notified C&L,38,H302:38
230282,[No public or meaningful name is available],695-599-4,102052-95-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H315:38;H335:38;H319:38;H302:38
230283,[No public or meaningful name is available],695-600-8,52205-85-3,Skin Corr. 1B,Notified C&L,38,H314:38
230284,[No public or meaningful name is available],695-601-3,152248-67-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
230285,[No public or meaningful name is available],695-602-9,668985-31-7,Acute Tox. 4,Notified C&L,38,H302:38
230286,"1,3-benzodioxole-5-sulfonyl chloride",695-603-4,115010-10-1,Skin Corr. 1B,Notified C&L,39,H314:39
230287,[No public or meaningful name is available],695-605-5,189028-53-3,Skin Irrit. 2;Skin Sens. 1,Notified C&L,38,H317:38;H315:38
230288,[No public or meaningful name is available],695-606-0,161678-01-9,Flam. Liq. 2;Acute Tox. 4,Notified C&L,38,H225:38;H302:38
230289,[No public or meaningful name is available],695-607-6,869896-76-4,Acute Tox. 3;Eye Irrit. 2,Notified C&L,38,H319:38;H301:38
230290,[No public or meaningful name is available],695-608-1,75732-14-8,Ox. Sol. 2,Notified C&L,38,H272:38
230291,[No public or meaningful name is available],695-609-7,161754-92-3,Acute Tox. 4,Notified C&L,38,H302:38
230292,[No public or meaningful name is available],695-610-2,161055-41-0,Acute Tox. 4,Notified C&L,38,H302:38
230293,[No public or meaningful name is available],695-611-8,80696-29-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
230294,[No public or meaningful name is available],695-612-3,433967-28-3,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,38,H400:38;H410:38
230295,[No public or meaningful name is available],695-613-9,5852-78-8,Acute Tox. 4,Notified C&L,38,H302:38
230296,[No public or meaningful name is available],695-614-4,558484-21-2,Flam. Sol. 2,Notified C&L,38,H228:38
230297,Isoquinoline-4-carboxylic acid,695-616-5,7159-36-6,Acute Tox. 4;Eye Irrit. 2,Notified C&L,40,H319:40;H302:40;H332:1;H312:1;H315:2;H335:2
230298,[No public or meaningful name is available],695-617-0,698999-09-6,Acute Tox. 3,Notified C&L,38,H301:38
230299,[No public or meaningful name is available],695-618-6,75640-87-8,Eye Dam. 1,Notified C&L,38,H318:38
230300,ethyl 3-hydroxypropanoate,695-619-1,623-72-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:39;H335:39;H315:39;Not classified:1
230301,1-(3-bromophenyl)cyclopropane-1-carboxylic acid,695-620-7,124276-95-5,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,39,H332:38;H312:38;H302:39;H315:1;H335:1;H319:1
230302,Salidroside,695-621-2,10338-51-9,Eye Irrit. 2,Notified C&L,39,H319:39
230303,[No public or meaningful name is available],695-622-8,446254-47-3,Acute Tox. 1;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 1;STOT SE 3,Notified C&L,38,H319:38;H330:38;H300:38;H315:38;H335:38;H311:38
230304,[No public or meaningful name is available],695-623-3,126850-14-4,STOT SE 2,Notified C&L,38,H371:38
230305,"2-(1H-1,2,4-triazol-3-yl)pyridine",695-624-9,23195-62-2,Acute Tox. 4,Notified C&L,39,H302:39;H315:1;H335:1;H319:1
230306,[No public or meaningful name is available],695-625-4,19552-08-0,Aquatic Acute 1,Notified C&L,38,H400:38
230308,[No public or meaningful name is available],695-628-0,63826-56-2,Eye Dam. 1,Notified C&L,38,H318:38
230309,"(3S,6R,9S,12R,15S,18R)-3,9-bis[(2S)-butan-2-yl]-4,10,16-trimethyl-6,12,15,18-tetra(propan-2-yl)-1,7,13-trioxa-4,10,16-triazacyclooctadecane-2,5,8,11,14,17-hexone",695-629-6,4530-21-6,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Notified C&L,39,H331:39;H311:39;H301:39
230310,[No public or meaningful name is available],695-630-1,5808-99-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
230311,[No public or meaningful name is available],695-631-7,957753-00-3,Aquatic Acute 1,Notified C&L,38,H400:38
230312,[No public or meaningful name is available],695-632-2,194278-43-8,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,38,H319:38;H315:38
230313,[No public or meaningful name is available],695-633-8,111864-25-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
230314,"(3S,6R,9S,12R,15S,18R)-3-[(2S)-butan-2-yl]-4,10,16-trimethyl-6,9,12,15,18-penta(propan-2-yl)-1,7,13-trioxa-4,10,16-triazacyclooctadecane-2,5,8,11,14,17-hexone",695-634-3,19914-20-6,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Notified C&L,39,H331:39;H311:39;H301:39
230315,[No public or meaningful name is available],695-635-9,479423-30-8,Acute Tox. 4,Notified C&L,38,H302:38
230316,3-Bromo-5-methylbenzaldehyde,695-636-4,188813-04-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H315:40;H335:40;H319:40;H302:40;H332:2;H312:2
230317,[No public or meaningful name is available],695-638-5,71889-02-6,STOT SE 2,Notified C&L,38,H371:38
230318,"(3S,6R,9S,12R,15S,18R)-4,10,16-trimethyl-3,6,9,12,15,18-hexa(propan-2-yl)-1,7,13-trioxa-4,10,16-triazacyclooctadecane-2,5,8,11,14,17-hexone",695-639-0,917-13-5,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Notified C&L,39,H331:39;H311:39;H301:39
230319,[No public or meaningful name is available],695-640-6,1171919-75-7,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,38,H315:38;H335:38;H318:38;H302:38
230320,[No public or meaningful name is available],695-641-1,741259-87-0,Eye Irrit. 2,Notified C&L,38,H319:38
230321,[No public or meaningful name is available],695-642-7,899795-65-4,Skin Irrit. 2,Notified C&L,38,H315:38
230326,2-({2-[2-(tetradecyloxy)ethoxy]ethoxy}methyl)oxirane,938-309-6,,Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1,Notified C&L,1,H318:1;H317:1;H315:1
230327,C12-16 Alcohol ethoxylate propoxylate,695-643-2,68213-24-1,Aquatic Acute 1,Notified C&L,1,H400:1
230328,1-Fluoroethyl methyl carbonate,695-644-8,871562-93-5,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2,Notified C&L,1,H315:1;H319:1;H317:1;H302:1
230332,Capadenoson,695-646-9,544417-40-5,Repr. 2;STOT SE 1,Notified C&L,24,H361:24;H370:24
230333,"4-(chloromethyl)-2-(4-chlorophenyl)-1,3-thiazole",814-496-9,17969-22-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H315:2;H335:2;H319:1;H302:2;H332:1;H312:1;H318:1
230334,4-(2-Hydroxyethoxy)benzaldehyde,695-647-4,22042-73-5,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,24,H319:24;H315:24
230337,[No public or meaningful name is available],695-649-5,1273068-71-5,Repr. 2,Notified C&L,24,H361:24
230338,"2,4,4-trimethylpentyl phosphonic acid",695-650-0,960076-55-5,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,15,H319:15;H315:15;H290:1
230341,"Amines, tallow alkyl ethoxylated",938-315-9,,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,9,H315:9;H318:9;H302:9;H400:9;H410:9
230342,Amines tallow alkyl ethoxylated,938-316-4,,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 2,Notified C&L,9,H315:9;H411:9;H318:9;H302:9
230344,"(2R,4R)-1-[(tert-butoxy)carbonyl]-4-methoxypyrrolidine-2-carboxylic acid",695-651-6,200184-87-8,,Notified C&L,2,Not classified:1;H315:1;H335:1;H319:1;H302:1
230345,5-(5-(7-(Trifluoromethyl)quinolin-4-ylthio)pentyloxy)-2-(morpholinomethyl)-4H-pyran-4-one dihydrochloride,695-652-1,754240-09-0,Acute Tox. 4,Notified C&L,1,H302:1
230346,"Phosphinecarboxylicacid, dihydroxy-, oxide, trisodium salt",695-653-7,63585-09-1,Muta. 2;Repr. 2;STOT RE 2,Notified C&L,9,H373:9;H361:9;H341:9
230348,N-[4-(4-amino-1-piperidyl)-2-methoxy-phenyl]-5-chloro-4-(1H-indol-3-yl)pyrimidin-2-amine,938-320-6,,Acute Tox. 3;STOT SE 1;STOT SE 1,Notified C&L,3,H370:3;H301:3
230349,2-[4-[2-hydroxy-3-(isopropylamino)propoxy]phenyl]acetamide,938-321-1,,Repr. 1A;Lact.;Aquatic Chronic 2,Notified C&L,3,H411:3;H360:3;H362:3
230351,"(2E,4R)-5-{[1,1’-biphenyl]-4-yl}-4-[(tert-butoxycarbonyl)amino]-2-methylpent-2-enoic acid",695-654-2,1012341-48-8,Aquatic Chronic 2,Notified C&L,3,H412:1;Not classified:1;H411:1
230352,Reaction mass of hexyl methacrylate and dodecyl methacrylate and octyl methacrylate and decyl methacrylate,938-323-2,,Skin Sens. 1;Aquatic Chronic 1,Notified C&L,8,H317:8;H410:8
230355,(E)-3-ethoxyacrylic acid,695-656-3,6192-01-4,Skin Corr. 1B;Eye Dam. 1,Notified C&L,2,H314:1;H318:1;H317:1
230356,[No public or meaningful name is available],695-657-9,147086-81-5,Acute Tox. 4,Notified C&L,26,H302:26
230357,"z-1-[4-(2-Benzyloxyethoxy)-phenyl]-4-chloro-1,2-diphenyl-but-1-ene",938-325-3,,Not Classified,Notified C&L,1,Not classified:1
230362,2H-Tetrazol-5-amine,695-660-5,5378-49-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
230365,"1H,1H-Heptadecafluoro(2,5-dimethyl-3,6-dioxanonan-1-ol)",695-661-0,14548-74-4,Not Classified,Notified C&L,2,Not classified:1;H319:1;H335:1;H315:1
230366,"3-[4-(5-Chloro-pyrimidin-2-yl)-2,6-dimethyl-phenyl]-bicyclo[3.2.1]octane-2,4-dione",938-333-7,,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,89,H400:89;H410:89
230367,"3-[4-(5-Chloro-pyridin-2-yl)-2,6-dimethyl-phenyl]-bicyclo[3.2.1]octane-2,4-dione",938-334-2,,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,89,H400:89;H410:89
230371,(Phenanthren-9-yl)-phenyl-amine,695-662-6,3920-79-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,39,H315:39;H319:39;H302:38;H335:1
230372,"Propanoic acid, 2-hydroxy-, compd. with N-[3-(4-morpholinyl)propyl]isooctadecanamide (1:1)",695-663-1,72300-24-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,18,H319:18;H315:18
230373,"Phosphorodithioic acid, O,O-bis(2-methylpropyl) ester with N, N-dimethylmethanamine (1:1)",700-910-4,1354201-99-2,Acute Tox. 4;Skin Sens. 1;Eye Dam. 1,Notified C&L,1,H318:1;H317:1;H302:1
230374,N-Phenyl-N-pyren-1-yl-amine,938-335-8,,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
230376,"Higher oligomers of 1,1'-methylenebis(4-isocyanatobenzene) homopolymer reaction with alpha.-methyl-.omega.-hydroxypoly (oxy-1,2-ethanediyl)",938-337-9,,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Acute Tox. 4;Resp. Sens. 1;STOT SE 3;Carc. 2;STOT RE 2,Notified C&L,8,H319:8;H373:8;H332:8;H317:8;H315:8;H334:8;H351:8;H335:8
230377,Fluvastatin sodium hydrate,695-664-7,93957-54-1,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 3,Notified C&L,1,H412:1;H315:1;H318:1;H302:1
230378,"2,9-Dibenzyl-anthra[2,1,9-def:6,5,10-d'e'f']diisoquinoline-1,3,8,10-tetrone",695-665-2,52000-81-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
230385,"Propan-2-yl N-[(S)- ({[(2R)-1-(6-amino-9H-purin-9-yl)propan-2-yl]- oxy}methyl)(phenoxy)phosphoryl]-L-alaninate, (2E)-but-2-enedioate (2:1)",695-673-6,379270-38-9,STOT RE 2,Notified C&L,1,H373:1
230386,"ethyl 1-(4-methoxyphenyl)-7-oxo-6-(4-(2-oxo-1-piperidinyl)phenyl)-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylate",700-890-7,503614-91-3,Aquatic Chronic 3,REACH registration C&L,3,H412:3
230388,"(2R,4S)-2-methyl-4-[(2-methylpropan-2-yl)oxycarbonylamino]-5-(4-phenylphenyl)pentanoic acid",695-674-1,1012341-50-2,Aquatic Chronic 4,Notified C&L,2,H413:1;H315:1;H335:1;H319:1;H302:1
230389,"[1,1'-Biphenyl]-4-pentanoic acid, γ-amino-α-methyl-, ethyl ester, hydrochloride (1:1), (αR,γS)-",695-675-7,149690-12-0,Acute Tox. 4;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,2,H410:1;H400:1;H317:1;H302:1;Not classified:1
230390,2-(oxan-4-yl)ethan-1-ol,695-676-2,4677-18-3,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;STOT SE 3,Notified C&L,3,H319:3;H312:2;H226:2;H315:3;H335:3;H302:2;H332:1
230391,1-{2-[2-hydroxy-3-({2-hydroxy-3-[2-(3-phenylpropanoyl)phenoxy]propyl}(propyl)amino)propoxy]phenyl}-3-phenylpropan-1-one,938-340-5,,Acute Tox. 4,Notified C&L,42,H302:42
230392,"Phosphonium, tetrabutyl-, 1,1,2,2,3,3,4,4-octafluorohexanedioate (2:1)",695-677-8,651332-39-7,Acute Tox. 4;Acute Tox. 4;Aquatic Chronic 2,Notified C&L,4,H411:3;H312:4;H302:4
230393,1-cyclohexyl-3-(2-ethylhexyl)urea,700-889-1,541523-61-9,Skin Sens. 1,Notified C&L,25,H317:25
230395,"9-(2-bromo-1-hydroxyethyl)-2,3,4,7-tetrahydro-1H-6-oxatetraphen-4-one",938-341-0,,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H315:1;H335:1;H319:1;H302:1
230396,3-Methoxy-5-(trifluoromethyl)phenylboronic Acid (contains varying amounts of Anhydride),695-679-9,871332-97-7,,Notified C&L,3,H319:3;H335:2;H315:3;H302:1
230397,Tert-butyl4-(2-aminophenyl)piperazine-1-carboxylate,695-680-4,170017-74-0,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,157,H319:157;H332:157;H312:157;H315:157;H335:157;H302:157
230400,"(2R,3R)-2,3-dihydroxybutanedioate (S)-1-(dimethylamino)ethylferrocene",695-682-5,111614-65-4,Flam. Liq. 2;Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;STOT SE 1,Notified C&L,11,H301:11;H331:11;H225:11;H311:11;H370:11
230401,"(1E,2E)-3-Anilino-2-methyl-N-phenyl-2-propen-1-iminium chloride",695-683-0,6684-11-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
230403,3-Acetylphenyl ethyl(methyl)-carbamate,695-684-6,855300-09-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,3,H319:3;H335:3;H315:3
230404,"2-Butenedioic acid (2Z)-, polymer with 2-propenoic acid, compd. with 2-methyloxirane polymer with oxirane 2-aminopropyl methyl ether",938-343-1,,Eye Irrit. 2,Notified C&L,8,H319:8
230407,"1,2-Ethanediamine, N1,N2-bis(2-aminoethyl)-, polymer with oxirane (EO = 5.5)",938-344-7,,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1,Notified C&L,8,H315:8;H318:8;H302:8
230409,"2-[(6-chloro-2-methylpyrimidin-4-yl)amino]-N-(2-chloro-6-methylphenyl)-1,3-thiazole-5-carboxamide",695-686-7,302964-08-5,Repr. 1B;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,3,H360:3;H400:3;H372:3;H410:3
230411,1-Carbethoxyazepan-4-one,695-687-2,56515-89-0,Acute Tox. 4,Notified C&L,1,H302:1
230420,"2,9,11,13-Tetraazanonadecanethioic acid, 19-isocyanato-11-(6-isocyanatohexyl)-10,12-dioxo-, S-[3-(trimethoxysilyl)propyl] ester",695-688-8,85702-90-5,Flam. Liq. 3;Skin Sens. 1;Resp. Sens. 1,Notified C&L,4,H334:4;H226:4;H317:4
230441,"Hexane, methyl-",695-689-3,25495-88-9,Flam. Liq. 2;Asp. Tox. 1;Skin Irrit. 2,Notified C&L,4,H225:4;H304:4;H315:4;H336:1;H400:1;H410:1
230443,"(1R)-2-AMINO-1-(2,2-DIMETHYL-4H-1,3-BENZODIOXIN-6-YL)ETHANOL",695-691-4,208925-08-0,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1B;Eye Irrit. 2,Notified C&L,2,H315:2;H319:2;H317:2;H302:2
230444,"3-Isocyanatomethyl-3,5,5-trimethylcyclohexyl isocyanate homopolymer, uretdione type",938-351-5,,Skin Irrit. 2;Skin Sens. 1;Acute Tox. 4;Resp. Sens. 1,REACH registration C&L,1,H334:1;H332:1;H317:1;H315:1
230446,Reaction mass of 5-ethyl-3-hydroxy-5-methoxy-4-methylfuran-2(5H)-one and (5E)-5-ethylidene-3-hydroxy-4-methylfuran-2(5H)-one,938-352-0,,Flam. Liq. 2;Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Carc. 1A;Repr. 1A;STOT SE 2,Notified C&L,1,H350:1;H332:1;H312:1;H371:1;H362:1;H225:1;H360:1;H302:1
230447,1-fluoro-3-iodopropane,695-693-5,462-40-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,7,H319:7;H335:6;H315:7;H226:5
230448,3-Chloro-4-ethoxybenzeneboronic acid,695-694-0,279261-81-3,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,3,H332:1;H312:1;H302:1;H319:2;H315:2;H335:1
230449,2-fluoro-4-methoxy-1-nitrobenzene,695-695-6,446-38-8,Skin Corr. 1B;STOT SE 3;Aquatic Chronic 3,Notified C&L,41,H412:38;H314:38;H335:41;H319:3;H315:3
230450,"2-[bis(2-hydroxyethyl)amino]-2-(hydroxymethyl)-1,3-propanediol hydrochloride",695-696-1,124763-51-5,Eye Irrit. 2,REACH registration C&L,6,H319:6;H335:2;H315:2
230451,Sulphosuccinimidyl 6-[3-(2-pyridyldithio)propionamido]hexanoate,695-697-7,169751-10-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
230452,(1-Methylpyrazol-3-yl)methanamine,695-698-2,612511-81-6,Skin Corr. 1B,Notified C&L,3,H314:2;H315:1;H335:1;H318:1;H302:1
230453,4-[(Acetylamino)methyl]benzeneboronic acid,695-699-8,850568-41-1,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H332:1;H312:1;H315:1;H335:1;H302:1
230454,Acyl transferase Lov D enzyme,938-353-6,,Skin Sens. 1;Resp. Sens. 1,Notified C&L,1,H334:1;H317:1
230457,"Immunoglobulin G1, anti-(human p185neu receptor) (human-mouse monoclonal rhuMab HER2 .gamma.1-chain), disulfide with human-mouse monoclonal rhuMab HER2 light chain, dimer",695-702-2,180288-69-1,Repr. 1A,Notified C&L,1,H360:1
230458,"Reaction products of 12-hydroxyoctadecanoic acid with ethane-1,2-diamine and hexane-1,6-diamine and 1,3-phenylenedimethanamine",700-825-2,,Acute Tox. 4;Aquatic Chronic 4,Notified C&L,2,H332:1;H413:1;Not classified:1
230463,"Immunoglobulin G1, anti-(human CD20 (antigen)) (human-mouse monoclonal IDEC-C2B8 .gamma.1-chain), disulfide with human-mouse monoclonal IDEC-C2B8 .kappa.-chain, dimer",695-706-4,174722-31-7,STOT RE 1,Notified C&L,1,H372:1
230464,1-235-Tumor necrosis factor receptor (human) fusion protein with 236-467-immunoglobulin G1 (human .gamma.1-chain Fc fragment) (9CI),695-708-5,185243-69-0,Carc. 2,Notified C&L,1,H351:1
230469,Biogas product of anaerobic degradation of sewage sludge in the dairy industry,938-355-7,,Flam. Gas 1;Press. Gas (Comp.),Notified C&L,1,H220:1;H280:1
230470,"1,17-dihydroxy-3-oxo-10,11,18-trimethoxy-2,14,16-trimethyl- 5-phenyl-4,19-dioxabicyclo[13.3.1]nonadec-12-ene",695-712-7,122547-72-2,Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,90,H400:90;H317:90;H410:90
230478,"Estr-4-ene-3,11,17-trione 3-(ethylene dithioketal) 17-(2,2-dimethylpropane-1,3-diyl ketal)",695-716-9,1174931-74-8,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,16,H400:16;H410:16
230479,"(S)-isopropyl-2-((S)-(((2R,3R,4R,5R)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-4-fluoro-3- hydroxy-4-methyltetrahydrofuran-2-yl) methoxy)(phenoxy)phosphorylamino)propanoate",695-717-4,1190307-88-0,STOT RE 2,Notified C&L,3,H373:2;H302:1;H372:1
230481,"4-((4-((4-[(E)-2-Cyanoethenyl]- 2,6-dimethylphenyl)amino) pyrimidin-2-yl)amino) benzonitril",695-719-5,500287-72-9,Acute Tox. 4;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,9,H319:7;H410:7;H400:7;H302:9
230485,"Phosphate(1-), trifluorotris(1,1,2,2,2-pentafluoroethyl)-, lithium (1:1), (OC-6-21)-",695-721-6,206057-04-7,Acute Tox. 2;Skin Corr. 1B;Eye Dam. 1;Aquatic Chronic 3,Notified C&L,83,H300:83;H314:83;H412:83;H318:83
230487,1-Ethyl-3-methylimidazolium benzoate,695-723-7,150999-33-0,Eye Dam. 1,REACH registration C&L,106,H318:84;Not classified:22
230489,1-(2-Hydroxyethyl)-3-methylimidazolium Chloride,695-725-8,61755-34-8,Acute Tox. 4;Eye Irrit. 2,Notified C&L,85,H319:84;H302:83;Not classified:1;H315:1
230490,Reaction products of Trimesitylphosphin sulfonation,938-358-3,,Skin Corr. 1A;Eye Dam. 1;STOT SE 3,Notified C&L,1,H314:1;H335:1;H318:1
230491,"Benzenesulfonic acid, 4-C10-13-sec-alkyl derivs., compds. with triethanolamine",695-726-3,121617-08-1,Skin Corr. 1C;Eye Dam. 1;Aquatic Chronic 3,Notified C&L,131,H412:117;H314:117;H318:131;H315:14
230492,"Benzeneacetic acid, 4-(1,1-dimethylethyl)-2-ethoxy-a-oxo-, ethyl ester",695-727-9,478190-99-7,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H400:1;H410:1
230493,"(R)-5-tert-butyl-2-[2-(2,6-difluorophenyl)-4,5-dihydro-1,3-oxazol-4-yl] phenetole",938-359-9,,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H400:1;H410:1
230494,"(S)-5-tert-butyl-2-[2-(2,6-difluorophenyl)-4,5-dihydro-1,3-oxazol-4-yl] phenetole",938-360-4,,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H400:1;H410:1
230495,"(4,6-dimethoxypyrimidin-2-yl) urea",695-728-4,151331-81-6,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,3,H319:2;H335:2;H315:2;H410:1;H400:1;H302:1
230498,"Reaction mass of 2-deoxy-2,2-difluoro-3,5-bis-O-(3-fluorobenzoyl)-1-O-(methylsulfonyl)-α-D-ribofuranose and 2-deoxy-2,2-difluoro-3,5-bis-O-(3-fluorobenzoyl)-1-O-(methylsulfonyl)-β-D-ribofuranose",938-647-4,,,,0,No data
230502,Pentapotassium ({[(hydroxyphosphinato)methyl](phosphonatomethyl)nitroryl}methyl)phosphonate,700-903-6,255830-15-0,Not Classified,REACH registration C&L,27,Not classified:27
230504,[No public or meaningful name is available],695-730-5,292618-32-7,Acute Tox. 1;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Carc. 2,Notified C&L,1,H319:1;H300:1;H315:1;H351:1;H335:1
230505,[No public or meaningful name is available],695-731-0,52434-75-0,Repr. 1A,Notified C&L,1,H360:1
230506,"1,2-Dimethyl-3-(trifluoromethyl)-1H-pyrazol-2-ium trilflate",938-362-5,,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
230507,"1,2-Dimethyl-3-(trifluoromethyl)-1H-pyrazol-2-ium trifluoroacetate",938-363-0,,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
230508,Methacryloxypropyl-methylsiloxane)-dimethylsiloxane copolymer,695-732-6,104780-61-2,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:2;H315:2
230509,Sodium salts of Mono- and di-[reaction products of dodecyl alcohol and ethylene oxide]phosphates,,,Skin Irrit. 2;Eye Dam. 1;Aquatic Acute 1,Notified C&L,1,H318:1;H400:1;H315:1
230510,rec TNF-α (human),695-733-1,94948-59-1,Repr. 2,Notified C&L,2,H361:2
230512,"ethyl 2-[[(1R,2S,5R)-5-methyl-2-propan-2-ylcyclohexanecarbonyl]amino]acetate",695-735-2,68489-14-5,Aquatic Chronic 2,REACH registration C&L,41,H411:5;H319:36
230513,"2-Fluoro-N-Methyl-4-[7-[(quinolin-6-yl)methyl]imidazol-[1,2,3]-[1,2,4]triazin-2-yl]benzamide dihydrochloride",695-736-8,1197376-85-4,STOT RE 2,Notified C&L,2,H371:1;H373:1;H319:1;H332:1;H312:1;H315:1;H335:1;H301:1
230517,"Fatty acids, C16-18 (even numbered), compds. with triethanolamine",938-367-2,,Not Classified,Notified C&L,1,Not classified:1
230519,"Reaction mass of butane-1,3-diol and water and 1007871-75-1",938-368-8,,Eye Irrit. 2,Notified C&L,2,H319:2
230538,[No public or meaningful name is available],695-739-4,,Flam. Liq. 3;Asp. Tox. 1;Skin Sens. 1;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H319:1;H226:1;H317:1;H304:1;H400:1;H410:1
230539,2-(4-bromo-3-fluorophenyl)acetonitrile,695-741-5,499983-13-0,Acute Tox. 3;Acute Tox. 3;Acute Tox. 2,Notified C&L,2,H330:1;H311:2;H301:2;H319:1;H331:1
230541,Solid recovered fuel,700-869-2,,Not Classified,REACH registration C&L,18,Not classified:18
230542,"2-[(6-chloro-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl]benzonitrile",695-742-0,865758-96-9,Skin Sens. 1,REACH registration C&L,4,H317:4
230543,"4,5α-epoxy-3,14-dihydroxy-17ξ-methyl-morphinan-6-ol",938-376-1,,Acute Tox. 4;Skin Sens. 1;Acute Tox. 4;Resp. Sens. 1,Notified C&L,1,H334:1;H332:1;H317:1;H302:1
230544,"4,5α-epoxy-3,14-dihydroxy-17ξ-methyl-17ξ-oxy-morphinan-6-one",938-377-7,,Acute Tox. 4;Skin Sens. 1;Acute Tox. 4;Resp. Sens. 1,Notified C&L,1,H334:1;H332:1;H317:1;H302:1
230545,"17-Allyl-4,5-alpha-epoxy-3-allyl-14-hydroxymorphinan-6-one",938-378-2,,Acute Tox. 4;Skin Sens. 1;Acute Tox. 4;Resp. Sens. 1,Notified C&L,1,H334:1;H332:1;H317:1;H302:1
230546,"17-(butyl)-4,5α-epoxy- 3,14-dihydroxymorphinan-6-one",938-379-8,,Acute Tox. 4;Acute Tox. 4;Repr. 2;Lact.,Notified C&L,1,H361:1;H332:1;H362:1;H302:1
230548,Potassium (2S)-4-carboxy-2-(tetradecanoylamino)butanoate,700-938-7,72716-26-8,Not Classified,Notified C&L,1,Not classified:1
230549,"Ammonium 6H-dibenzo[c,e][1,2]oxaphosphinin-6-olate 6-oxide",700-893-3,,Not Classified,Notified C&L,1,Not classified:1
230550,(1-[2-[5-METHYL-3-(TRIFLUOROMETHYL)-1H-PYRAZOL-1-YL]ACETYL]-4-HETEROMONOCYCLECARBOTHIOAMIDE),,,,Notified C&L,34,Not classified:34
230551,[No public or meaningful name is available],695-743-6,,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,11,H319:11;H411:11;H317:11;H315:11
230552,"Copolymer of N,N-bis(trimethoxysilylpropyl)amine and hexane-1,6-diisocyanate",938-380-3,,Skin Sens. 1;Resp. Sens. 1,Notified C&L,1,H334:1;H317:1
230553,"Copolymer of 1,2-ethanediol, 2-hydroxyethyl acrylate and 3-isocyanatomethyl-3,5,5-trimethylcyclohexyl isocyanate",938-381-9,,Skin Sens. 1,Notified C&L,1,H317:1
230554,"N,N-dibutylbutan-1-aminium bis[2-(hydroxy-kO)benzoato(2-)-kO]borate(1-)",700-906-2,22450-96-0,Not Classified,REACH registration C&L,2,Not classified:2
230555,"2-((3-Aminopyrazolo(1,5-a)pyridin-2-yl)oxy)ethanol hydrochloride",695-745-7,1079221-49-0,Skin Sens. 1B;Aquatic Chronic 2,Notified C&L,2,H411:2;H317:2;H319:1;H302:1
230557,"(2R)-2-hydroxy-2-phenylacetic acid-tert.-butyl-[(1S,2R)-2-aminocyclohexyl]carbamate",695-746-2,1391731-16-0,Not Classified,Notified C&L,2,Not classified:1;H319:1;H335:1;H315:1
230558,"N,N,2,8-tetramethyl-5,11-dioxa-2,8-diazatridecan-13-amine",695-748-3,65286-55-7,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1;Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,10,H412:10;H314:10;H312:10;H317:2;H318:10;H302:10
230562,"Reaction mass of Pentasodium 2-amino-1-((4-(4-(4-((2-(sulfonatooxy)ethyl)sulfonyl)phenyl)amino-6-chloro-1,3,5-triazin)aminodisulfonatophenyl)diazenyl)-8-hydroxy-naphthalenedisulfonate and Tetrasodium 2-amino-1-((4-(4-(4-(vinylsulfonyl)phenyl)amino-6-chloro-1,3,5-triazin)aminodisulfonatophenyl)diazenyl)-8-hydroxy-naphthalenedisulfonate",,,Not Classified,Notified C&L,1,Not classified:1
230565,"Reaction product of N2,N2'-1,6-hexanediylbis[N4,N6-dibutyl-N2,N4,N6-tris(2,2,6,6-tetramethyl-4-piperidinyl)-1,3,5-triazine-2,4,6-triamine and hydrogen peroxide and butanal",700-878-1,,Not Classified,Notified C&L,83,Not classified:83
230566,"1,2-Ethanediamine, N1,N1-bis[3-(trimethoxysilyl)propyl]-",695-749-9,74956-86-8,Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1,Notified C&L,47,H318:47;H317:33;H315:33;H335:14
230572,Diethyl 2-(fluoromethoxy)malonate,938-385-0,,Eye Irrit. 2,Notified C&L,1,H319:1
230573,"Resin acids and Rosin acids, reaction products with formaldehyde, calcium salts",696-130-6,1364681-45-7,Skin Sens. 1B,Notified C&L,84,H317:84
230575,"2-Allyl-1-[6-(1-hydroxy-1-methyl-ethyl)-2-pyridyl]-6-[4-(4-methylpiperazin-1-yl)anilino]pyrazolo[3,4-d]pyrimidin-3-one hemihydrate",695-750-4,1277170-60-1,Acute Tox. 4;Muta. 1B;STOT RE 1,Notified C&L,37,H340:37;H372:37;H302:37;H411:1;H360:1
230584,"3-Fluoro-4-(N-morpholinomethyl)phenylboronic acid, pinacol ester",695-754-6,1073354-74-1,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
230585,"4'-Butyl-4-ethoxy-2,3-difluoro-1,1'-biphenyl",695-755-1,1229661-51-1,Skin Sens. 1B,REACH registration C&L,1,H317:1
230586,5-Bromo-3-chloro-2-methoxypyridine,695-756-7,848366-28-9,,Notified C&L,3,H319:3;H335:2;H315:3;H302:1
230589,"1,3-Benzenedicarboxylic acid, polymer with 2,2-dimethyl-1,3-propanediol, 1,2-ethanediol, hexanedioic acid and 1,6-hexanediol",695-759-3,69929-19-7,Acute Tox. 4;Eye Irrit. 2,Notified C&L,26,H319:25;H302:25;Not classified:1
230590,4-tert-butyl-2-ethoxybenzamide,938-392-9,,Aquatic Chronic 1,Notified C&L,1,H410:1
230592,"1,3-Bis(1-isocyanato-1-methylethyl)benzene homopolymer",695-760-9,157299-02-0,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Acute Tox. 2;Resp. Sens. 1,Notified C&L,446,H319:446;H330:446;H317:446;H315:446;H334:446
230593,"[1,3-bis(2,6-diisopropyl phenyl)imidazol-2-ylidene][1,3-divinyl-1,1,3,3-tetramethyl disiloxane]platinum(0)",695-761-4,849830-54-2,Flam. Sol. 1;Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4,Notified C&L,1,H319:1;H312:1;H332:1;H315:1;H228:1;H302:1
230594,"[1,3-bis(cyclohexyl)imidazol-2-ylidene][1,3-divinyl-1,1,3,3-tetramethyldisiloxane]platinum(0)",695-763-5,400758-55-6,Flam. Sol. 1;Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4,Notified C&L,1,H319:1;H312:1;H332:1;H315:1;H228:1;H302:1
230595,"Methyl 2-(chloromethyl)-1,3-oxazole-4-carboxylate",695-764-0,208465-72-9,Skin Corr. 1B,Notified C&L,2,H314:2
230596,4-Chloro-2-hydroxybenzaldehyde,695-765-6,2420-26-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,3,H319:3;H335:2;H315:3
230597,Perfluoro(3-iodoprop-1-ene),695-766-1,431-65-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
230598,4-Chloro-2-hydroxybenzonitrile,695-767-7,30818-28-1,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H332:1;H312:1;H315:1;H335:1;H302:1
230599,(1E)-(Pent-1-en-1-yl)boronic acid,695-768-2,59239-44-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
230600,Disuccinimidyl tartrate,695-769-8,77658-91-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
230601,4-Bromo-2-chloro-1-methyl-1H-benzimidazole,695-770-3,1240610-45-0,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H332:1;H312:1;H315:1;H335:1;H302:1
230602,"3-(Aminomethyl)benzeneboronic acid, N-BOC protected",695-771-9,199609-62-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:2;H315:2
230603,5-Bromopyridine-3-sulphonyl chloride hydrochloride,695-772-4,913836-25-6,Skin Corr. 1B,Notified C&L,1,H314:1
230604,6-Chloro-5-methoxynicotinic acid,695-774-5,915107-39-0,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H332:1;H312:1;H315:1;H335:1;H302:1
230605,5-Amino-2-fluoroisonicotinic acid,695-775-0,171178-43-1,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H332:1;H312:1;H315:1;H335:1;H302:1
230606,4-Amino-3-methoxybenzeneboronic acid. pinacol ester,695-776-6,461699-81-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:2;H315:2
230607,1-Allyl-3-bromobenzene,695-777-1,18257-89-1,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H332:1;H312:1;H315:1;H335:1;H302:1
230608,Pentafluoroethylsulfonyl chloride,695-778-7,64773-40-6,Skin Corr. 1B,Notified C&L,2,H314:2;H335:1;H318:1
230614,"2,7-Naphthalenedisulfonic acid, 5-(acetylamino)-3-[2-[5-[[4-chloro-6-[[3-[[2-(sulfooxy)ethyl]sulfonyl]phenyl]amino]-1,3,5-triazin-2-yl]amino]-2-sulfophenyl]diazenyl]-4-hydroxy-, sodium salt (1:4)",695-779-2,80019-35-8,Skin Sens. 1;Aquatic Chronic 2,REACH registration C&L,17,H411:17;H317:17
230624,"Reaction mass of 2-[4-[(Hexahydro-2,4,6-trioxo-5-pyrimidyl) azo]phenyl]-6-methylbenzothiazole-7-sulphonic acid, compound with 2,2',2''-nitrilotris[ethanol] (1:1) and Lithium 2-[4-[(hexahydro-2,4,6-trioxopyrimidin-5-yl)azo]phenyl]-6-methylbenzothiazole-7-sulphonate",938-398-1,,Not Classified,REACH registration C&L,110,Not classified:110
230626,N'-hydroxycyclopropanecarboximidamide,695-783-4,51285-13-3,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3;STOT SE 3,Notified C&L,1,H301:1;H319:1;H312:1;H332:1;H315:1;H335:1;H302:1
230627,4-Methylpyridine-3-boronic acid,695-785-5,148546-82-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,3,H319:3;H335:3;H315:3
230628,ethyl 5-amino-3-methylisothiazole-4-carboxylate,695-786-0,34859-65-9,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3;STOT SE 3,Notified C&L,1,H319:1;H332:1;H312:1;H315:1;H335:1;H302:1
230629,"2,3-dimethyl-1H-indole-5-carboxylic acid",695-787-6,14844-73-6,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;STOT SE 3,Notified C&L,2,H319:2;H312:1;H315:2;H335:2;H302:1
230633,3-[4-(4'-Trifluoromethylbenzyloxy)phenyl] tetralone,695-790-2,287974-84-9,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;Muta. 1B;Repr. 1B;Aquatic Chronic 1,Notified C&L,1,H410:1;H332:1;H312:1;H302:1;H360:1;H340:1
230635,"Acetic acid, (((1R,2R,3aS,9aS)-2,3,3a,4,9,9a-hexahydro-2-hydroxy-1-((3S)-3-hydroxyoctyl)-1H-benz(f)inden-5-yl)oxy)-, monosodium salt",695-793-9,289480-64-4,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;Repr. 2,Notified C&L,4,H331:2;H361:2;H311:2;H301:3;Not classified:1
230636,H-His-Gly-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Leu-Ser-Lys-Gln -Met-Glu-Glu-Glu-Ala-Val-Arg-Leu-Phe-Ile-Glu-Trp-Leu-Lys -Asn-Gly-Gly-Pro-Ser-Ser-Gly -Ala-Pro-Pro-Pro-Ser- NH2,695-794-4,,Acute Tox. 4;Repr. 2,Notified C&L,2,H361:2;H302:2
230637,"1-(6-Amino-9-beta-D-ribofuranosyl-9H-purin-2-yl)-N-methyl-1H-pyrazole-4-carboxamide, monohydrate",695-796-5,875148-45-1,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,4,H319:3;H332:3;H312:3;H315:3;H335:2;H302:3;H300:1;H310:1;H330:1;H370:1
230638,"(2S)-5-methoxy-N-propyl-1,2,3,4-tetrahydronaphthalen-2-amine hydrochloride (1:1)",695-797-0,93601-86-6,Acute Tox. 4;Aquatic Chronic 4,REACH registration C&L,2,H412:1;H319:1;H413:1;H336:1;H228:1;H302:1;Not classified:1
230640,Organo copper compound,695-799-1,85737-14-0,Acute Tox. 4,Notified C&L,3,H302:3
230641,"1-BUTANOL, 4-AMINO-, DIETHER WITH POLYTETRAMETHYLENE GLYCOL",695-800-5,27417-83-0,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,19,H400:19;H410:19
230646,"7-amino-3-{(E)-[5-({4-(2-chloroethyl)butanoyl}amino)]diazenyl}-4-hydroxy-8-[(E)-(4-{2-(sulfonatooxy)ethyl}) diazenyl]naphthalene, polysulfonate, polysulfonyl, polyphenyl, sodium/potassium salt",,,Skin Sens. 1,REACH registration C&L,1,H317:1
230647,N-(2-chlorothiazol-5-ylmethyl)- N’ -nitroguanidine,938-400-0,,Flam. Sol. 1;Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H319:1;H410:1;H332:1;H312:1;H315:1;H228:1;H335:1;H400:1;H302:1
230649,N-(2-chlorothiazol-5-ylmethyl)-N’-methylguanidine,938-401-6,,Acute Tox. 4;Aquatic Chronic 1,Notified C&L,1,H410:1;H302:1
230650,N-(2-chlorothiazol-5-ylmethyl)- N’-methylurea,938-402-1,,Acute Tox. 4;Aquatic Chronic 1,Notified C&L,1,H410:1;H302:1
230651,"2,7-Dioxa-3,6-disilaoctane, 3,3,6-trimethoxy-6-methyl-",695-801-0,96186-79-7,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,22,H319:22;H335:22;H226:22;H315:22
230652,[No public or meaningful name is available],695-802-6,83512-85-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
230655,[No public or meaningful name is available],695-805-2,160683-19-2,Skin Sens. 1;Aquatic Chronic 3,Notified C&L,1,H412:1;H317:1
230656,"19-Norpregna-4,9-diene-3,20-dione, 17-(acetyloxy)- (9CI)",695-806-8,14340-04-6,Acute Tox. 4;Repr. 1B;Aquatic Chronic 4,Notified C&L,1,H360:1;H413:1;H302:1
230657,"19-Norpregn-9(11)-ene-3,20-dione, 17-(acetyloxy)-5,10-epoxy-, cyclic 3-(1,2-ethanediyl acetal), (5a,10a)- (9CI)",695-807-3,240806-32-0,Acute Tox. 4;Repr. 1B;Aquatic Chronic 4,Notified C&L,1,H360:1;H413:1;H302:1
230658,2-chloropyrimidin-5-amine,695-808-9,56621-90-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;STOT SE 3,Notified C&L,2,H319:2;H335:2;H315:2;H303:1
230660,[No public or meaningful name is available],695-809-4,435273-75-9,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H332:1;H312:1;H315:1;H335:1;H302:1
230661,[No public or meaningful name is available],695-811-5,146464-94-0,Acute Tox. 3;Repr. 1A,Notified C&L,1,H360:1;H301:1
230662,[No public or meaningful name is available],695-812-0,146464-93-9,Acute Tox. 3;Repr. 1A,Notified C&L,1,H360:1;H301:1
230663,[No public or meaningful name is available],695-813-6,146464-92-8,Acute Tox. 3;Repr. 1A,Notified C&L,1,H360:1;H301:1
230664,[No public or meaningful name is available],695-814-1,304853-99-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Repr. 1B;STOT RE 2,Notified C&L,1,H319:1;H335:1;H373:1;H315:1;H360:1
230665,[No public or meaningful name is available],695-815-7,146464-91-7,Acute Tox. 3;Repr. 1A,Notified C&L,1,H360:1;H301:1
230670,4-(1-methoxycarbonyl-but-3-ynyl),695-816-2,146464-90-6,Acute Tox. 3;Repr. 1B,Notified C&L,2,H360:1;H301:1;H315:1;H335:1;H319:1;H302:1
230671,(2S)-2-(methylamino)propanoic acid,695-817-8,3913-67-5,Not Classified,Notified C&L,3,Not classified:2;H319:1
230679,"3,3-Diethoxy-1-propanol",695-818-3,16777-87-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
230680,"2-{2-[(2,5-dimethylphenoxy)methyl]phenyl}-2-methoxy-N-methylacetamide",695-819-9,173662-97-0,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,90,H400:90;H410:90
230683,"(3R,5S,6E)-7-[4-(4-fluorophenyl)-6-(1-methylethyl)-2-[methyl(methylsulfonyl)amino]-5-pyrimidinyl]-3,5-dihydroxy-6-heptenoic acid, sodium salt (CAS Name)",938-417-3,,Aquatic Chronic 1,Notified C&L,3,H410:3
230684,"Lignin, alkali, reaction products with dimethylamine and formaldehyde",938-418-9,,Eye Irrit. 2;STOT SE 3,Notified C&L,5,H319:5;H335:5
230689,"5-methoxy-N-propyl-1,2,3,4-tetrahydronaphthalen-2-aminium chloride",938-419-4,3904-24-3,Not Classified,Notified C&L,1,Not classified:1
230693,"4-Butoxy-2,3-difluor-4'-methyl-1,1'-biphenyl",938-422-0,,Not Classified,REACH registration C&L,2,Not classified:2
230694,"N-(2-Aminoethyl-2-(2,6-dichlorophenoxy)) propanamide Hydrochloride",695-822-5,344443-16-9,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Notified C&L,1,H331:1;H311:1;H301:1
230695,"2-(2,6-dichlorophenoxy) propionitrile",695-823-0,78302-27-9,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Notified C&L,1,H331:1;H311:1;H301:1
230700,"Phospholane, 1,1'-(1,2-phenylene)bis[2,5-bis(1-methylethyl)-, (2R, 2'R, 5R, 5'R)",695-824-6,136705-65-2,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3;STOT SE 3,Notified C&L,2,H319:2;H332:1;H312:1;H315:2;H335:1;H302:1
230701,[No public or meaningful name is available],695-825-1,321709-40-4,Repr. 2,Notified C&L,1,H361:1
230702,"(R)-1-Phenylethanamine (3R,5S,E)-7-(2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)-3,5-dihydroxyhept-6-enoate",695-826-7,147511-70-4,Acute Tox. 4;STOT RE 2;Aquatic Chronic 4,Notified C&L,1,H373:1;H413:1;H302:1
230706,Reaction mass of 64228-78-0 and 75-05-8,938-426-2,,Flam. Liq. 2;Acute Tox. 4;Eye Irrit. 2;Acute Tox. 4,Notified C&L,1,H319:1;H332:1;H312:1;H225:1;H302:1
230707,Reaction mass of 64228-81-5 and 75-09-2,938-427-8,,Acute Tox. 4;Carc. 2,Notified C&L,1,H351:1;H302:1
230708,"5-benzoyl-2,3-dihydro-1H-pyrrolizin-1-ol",695-827-2,154476-25-2,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
230713,"5-Benzoyl-2,3-dihydro-1H-pyrrolizin-1-one",695-828-8,113502-52-6,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
230715,ARTEMETHER,695-829-3,,Self-react. D;Acute Tox. 4,Notified C&L,2,H302:2;H242:2
230716,"Oxirane, methyl, polymer with oxirane, monohydrogen sulfate, C9-C11 alkyl ethers, sodium salts",695-830-9,113133-73-6,Eye Irrit. 2;Aquatic Chronic 3,Notified C&L,1,H412:1;H319:1
230717,"Europio (III) Tris[4,4,4-trifluoro-1-(2-tienil)-1,3-butandione] (1,10-fenantrolina)",938-433-0,,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2B;STOT SE 3,Notified C&L,1,H315:1;H335:1;H319:1;H301:1
230718,"Phosphorodithioic acid, O,O-bis(2-ethylhexyl) ester, sodium salt",695-831-4,20709-58-4,Eye Dam. 1,Notified C&L,441,H318:441
230719,"4,7-BIS(7’,8’-DIBUTILBENZO[1’,2’-B’:4’,3’-B’′]DITIEN-5’-IL)-BENZO[C][1,2,5]TIADIAZOLO",938-434-6,,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2B,Notified C&L,1,H315:1;H319:1;H302:1
230724,[No public or meaningful name is available],695-833-5,32949-41-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:2;H315:2
230725,[No public or meaningful name is available],695-834-0,7360-09-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:2;H315:2
230726,[No public or meaningful name is available],695-835-6,30895-79-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:2;H315:2
230732,Dimethyl [3-chloro-5-(trifluoromethyl)pyridin-2-yl]({[2-(trifluoromethyl)benzoyl]amino}methyl)malonate,700-912-5,895525-76-5,Not Classified,REACH registration C&L,2,Not classified:2
230733,[No public or meaningful name is available],695-840-3,,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
230735,"Spiro[2H-isoindole-2,1'-piperazinium], 4'-(1,2-benzisothiazol-3-yl)octahydro-, (3aR,7aR)-, methanesulfonate (1:1)",695-841-9,186204-37-5,STOT SE 3;Carc. 2,REACH registration C&L,2,H336:1;H351:1;H332:1;H312:1;H302:1
230736,"(1R,2R,6S,7S)-4-{[(1R,2R)-2-{[4-(1,2-benzothiazol-3- yl)piperazin-1-yl]methyl}cyclohexyl]methyl}-4- azatricyclo[5.2.1.0^{2,6}]decane-3,5-dione hydrochloride",938-440-9,,Acute Tox. 4;Skin Sens. 1;Acute Tox. 4;Repr. 2,Notified C&L,1,H361:1;H332:1;H317:1;H302:1
230743,Mercaptanised Vinyl Norbornene,695-845-0,1354570-75-4,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 1,Notified C&L,22,H319:22;H410:22;H317:22;H315:22
230745,Reaction mass of 75-09-2 and 96946-42-8,938-443-5,,Acute Tox. 3;Carc. 2,Notified C&L,1,H351:1;H301:1
230754,2-cyanoethyl-(2EZ)-2-[(3-nitrophenyl)methylidene]-3-oxobutanoate,695-846-6,102993-38-4,Acute Tox. 4,Notified C&L,1,H302:1
230755,2-methyl-1-(methylamino)propan-2-ol-4-methylbenzenesulfonate,938-450-3,,Acute Tox. 4,Notified C&L,1,H302:1
230757,Bükkfa fűrészpor digerált fuganedves,938-452-4,,Flam. Sol. 2;Skin Corr. 1B,Notified C&L,1,H314:1;H228:1
230758,"(2,4-dimethylpentadienyl)(ethyl-cyclopentadienyl) ruthenium",695-847-1,501652-75-1,Flam. Liq. 2;Acute Tox. 2;Asp. Tox. 1;Skin Irrit. 2;Eye Irrit. 2;Muta. 2;STOT SE 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H319:1;H400:1;H300:1;H410:1;H315:1;H225:1;H304:1;H341:1;H370:1
230760,"3-methyl 5-[2-methyl-1-(methylamino)propan-2-yl] -2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate oxalic salt",695-848-7,957214-95-8,Acute Tox. 4,Notified C&L,1,H302:1
230765,"2-(2-carboxyethyl)-1,2,3,4-tetrahydro-6,7-dimethoxy-1-veratryl-isoquinoline hidrochloride",695-850-8,110817-19-1,Acute Tox. 4,Notified C&L,1,H302:1
230767,"2,4-Difluoro-5-iodobenzoic acid",695-851-3,161531-51-7,Skin Corr. 1B,Notified C&L,2,H314:2;H332:2;H312:2;H302:2
230768,"2-(Difluoromethyl)1,3-difluorobenzene",695-852-9,91624-89-4,Flam. Liq. 3,Notified C&L,1,H319:1;H332:1;H312:1;H315:1;H226:1;H335:1;H302:1
230770,3-Fluoro-2-methylpyridine,695-855-5,15931-15-4,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H335:1;H226:1;H315:1
230771,"2,4-Bis-(trifluoromethyl)pyrimidine-5-carboxylic acid ethyl ester",695-856-0,188781-15-9,Flam. Liq. 3,Notified C&L,1,H319:1;H335:1;H226:1;H315:1
230773,7-Bromoindole-2-carboxylic acid,695-858-1,16732-71-1,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,39,H319:38;H315:38;H314:1
230775,"Tributylphenol polyglycolether (6 EO), methylcapped",938-457-1,,Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,31,H319:31;H411:31;H315:31
230776,"Amides, C8-10 (even-numbered), N-hydroxyethyl",938-458-7,,Skin Irrit. 2;Eye Dam. 1,REACH registration C&L,1,H318:1;H315:1
230777,4-isothiocyanato-2-(trifluoromethyl)benzonitrile,700-928-2,143782-23-4,Acute Tox. 4;Skin Sens. 1,Notified C&L,4,H317:3;H302:4;H341:1;H319:1;H332:1;H312:1;H315:1;H335:1
230783,1-(4-Methoxyphenyl)ethanamine,700-847-2,6298-96-0,Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1A;Eye Dam. 1;Aquatic Acute 3;Aquatic Chronic 3,REACH registration C&L,124,H412:84;H314:124;H402:1;H317:84;H318:85;H302:124;H312:1
230784,1-(3-methoxyphenyl)ethanamine,700-849-3,62409-13-6,Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1A;Eye Dam. 1;Aquatic Acute 3;Aquatic Chronic 3,REACH registration C&L,85,H412:84;H314:85;H402:1;H317:84;H318:85;H302:85;H332:83
230785,"(1R)-1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline di-toluoyl-D-tartaric acid salt",695-859-7,50720-58-6,Acute Tox. 4,Notified C&L,1,H302:1
230786,"2(1H)-Isoquinolinepropanoic acid, 1-[(3,4-dimethoxyphenyl)methyl]-3,4-dihydro-6,7-dimethoxy-, methyl ester, (1R)-",695-860-2,1075726-75-8,Acute Tox. 4,Notified C&L,1,H302:1
230787,"(2R)-1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-(3-methoxy-3-oxopropyl)-2-methyl-1,2,3,4-tetrahydroisoquinolin-benzenesulfonate",695-861-8,1075726-90-7,Acute Tox. 4,Notified C&L,1,H302:1
230788,"(2R)-2-(2-carboxyehyl)-1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-2-ium",695-862-3,1075727-06-8,Acute Tox. 4,Notified C&L,1,H302:1
230791,"4-Amino-1-[2-deoxy-3,5-bis-O-(4-methylbenzoyl)-beta-D-ribofuranosyl]-1,3,5-triazin-2(1H)-one",695-863-9,10302-79-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Muta. 2;Repr. 1B,Notified C&L,1,H319:1;H360:1;H315:1;H335:1;H341:1;H302:1
230793,(2S)-2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)-3-(naphthalen-2-yl)propanoic acid,695-866-5,112883-43-9,,Notified C&L,2,Not classified:1;H315:1;H335:1;H319:1;H302:1
230795,"C14-18 alpha-olefin epoxide, reaction products with boric acid",939-580-3,,Skin Sens. 1B,REACH registration C&L,6,H317:6
230796,Phosphoric ester of an ethoxylated alcohol (CAS #68460-10-6),938-461-3,,Skin Corr. 1B,Notified C&L,4,H314:4
230798,"Benzenepropanoic acid, 3,5-bis(1,1-dimethylethyl)-4-hydroxy-, 1-[2-[3-[3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl]-1-oxopropoxy]ethy",695-869-1,73754-27-5,Aquatic Chronic 4,Notified C&L,25,H413:25
230805,"1,5-Cyclooctdiene(1,3,5-cyclooctatriene)ruthenium(0)",695-871-2,42516-72-3,Flam. Sol. 1;Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;Aquatic Chronic 4,Notified C&L,1,H319:1;H413:1;H312:1;H332:1;H315:1;H228:1;H302:1
230806,[No public or meaningful name is available],695-872-8,340795-93-9,Skin Irrit. 2;Eye Dam. 1,Notified C&L,1,H318:1;H315:1
230807,1-(2-aminopropoxy)-2-[2-(2-aminopropoxy)propoxy]propane,695-873-3,9046-10-0,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;Aquatic Chronic 3,Notified C&L,444,H412:277;H314:426;H312:203;H318:339;H302:221;H304:42;H411:55;H335:44;H315:18;H311:2;H301:2
230808,"2-Pyridinamine, 3-[(2-methyl-3-pyridinyl)oxy]-5-(2-pyridinylthio)-",695-874-9,1065608-94-7,Aquatic Chronic 3,Notified C&L,1,H412:1
230809,4-Isocyanato-1-methyl-1H-pyrazole,695-875-4,1174064-57-3,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;Resp. Sens. 1;STOT SE 3;STOT SE 3,Notified C&L,2,H319:2;H315:2;H331:1;H334:2;H335:2;H302:1;H332:1;H312:1;H301:1
230813,"2-Thiabicyclo[3.1.0]hexane-4,6-dicarboxylic acid, 4-amino-, 4,6-dimethyl ester, 2,2-dioxide, (1R,4S,5S,6S)- Hydrochloride (1:1)",695-877-5,635317-62-3,Eye Dam. 1;Repr. 2;STOT RE 1,Notified C&L,1,H318:1;H361:1;H372:1
230814,acetalization product beween glucose and 12-hydroxystearyl alcohol,700-891-2,,Not Classified,Notified C&L,1,Not classified:1
230815,Dimethyldioxolanyl-tosyl-thiadiazole,938-467-6,,Aquatic Chronic 2,Notified C&L,1,H411:1
230816,"Reaction mass of orthophosphoric acid and 2-Propenoic acid, 2-methyl-, 2-hydroxyethyl ester, phosphate",938-468-1,,Skin Corr. 1A,Notified C&L,1,H314:1
230817,"3-(2,2-Dimethyl-1,3-dioxolan-4-yl)-5-(p-tolylthio)-1,2,4-thiadiazol",938-469-7,,Aquatic Chronic 2,Notified C&L,1,H411:1
230819,[No public or meaningful name is available],939-060-6,,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2;Repr. 2;Aquatic Chronic 3,Notified C&L,1,H412:1;H319:1;H315:1;H225:1;H361:1
230822,Reaction mass of (8R)-(11S)-11-[(4-hydroxyphenyl)methyl]-8-alkyl-polyoxo-1-phenyl-polyaza-2-oxadodecane and (8R)-(11R)-11-[(4-hydroxyphenyl)methyl]-8-alkyl-polyoxo-1-phenyl-polyaza-2-oxadodecane,,,Skin Sens. 1B,Notified C&L,1,H317:1
230823,"(1S)-1,5-anhydro-2,3,4,6-tetrakis-O-(2,2-dimethylpropanoyl)-1-(3-{[5-(4-fluorophenyl)-2-thienyl]methyl}-4-methylphenyl)-D-glucitol",695-878-0,1283129-18-9,Aquatic Chronic 4,REACH registration C&L,1,H413:1
230824,Grapefruit oil,938-471-8,8016-20-4,Flam. Liq. 3;Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,3,H226:3;H317:3;H315:3;H304:3;H400:3;H410:3
230828,"N-Hydroxy-2,2-dimethylpropanimidamide",695-879-6,42956-75-2,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3;STOT SE 3,Notified C&L,1,H319:1;H332:1;H312:1;H315:1;H335:1;H302:1
230829,"1,2-Dimethyl-3-(trifluoromethyl)-1H-pyrazol-2-ium 4-toluenesulfonate",938-474-4,,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
230830,bis[1-carbamimidoyl-kN'-urea-kO)]copper(2+) dinitrate,800-038-5,1071838-81-7,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1B;Eye Dam. 1;Muta. 2;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,4,H400:4;H373:4;H410:4;H317:4;H315:4;H318:4;H341:4;H302:4
230831,"2-propenoic acid, 1,1'-(1,9-nonanediyl) ester",807-336-4,107481-28-7,Not Classified,Notified C&L,18,Not classified:17;H411:1;H317:1
230832,"7H-6,9a-Methano-4H-cyclopenta[9,10]cyclopropa[5,6]cyclodeca[1,2-d]-1,3-dioxin-13-one, 6,6a,7a,8,9,12,12a,12b-octahydro-12,12a-dihydroxy-2,2,7,7,9,11-hexamethyl-, (6R,6aR,7aR,9R,9aS,12S,12aR,12bR)-",695-880-1,77573-43-4,Skin Irrit. 2;Eye Dam. 1,Notified C&L,1,H318:1;H315:1
230833,Reaction mass of 67801-33-6 and 821-55-6,938-476-5,,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
230834,"7-[(3R)-3-amino-1-oxo-4-(2,4,5-trifluorophenyl)butyl]-5,6,7,8-tetrahydro-3-(trifluoromethyl)--[1,2,4]triazolo[4,3,-a]pyrazine fumarate",695-881-7,1264510-30-6,Eye Irrit. 2;STOT RE 2,Notified C&L,1,H319:1;H373:1
230835,"(3R)-3-amino-1-[3-(trifluoromethyl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]-4-(2,4,5-trifluorophenyl)butan-1-one;sulphuric acid",695-882-2,1169707-31-6,Eye Irrit. 2;STOT RE 2,Notified C&L,2,H319:2;H373:1
230836,thiol-derivatised silica gel,938-477-0,,Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H335:1;H332:1
230839,"2-Benzofurancarboxamide, 5-(4-(4-(5-cyano-1H-indol-3-yl)butyl)-1-piperazinyl)-, hydrochloride (1:1)",695-883-8,163521-08-2,Eye Irrit. 2;Carc. 2;Repr. 2;STOT RE 2;Aquatic Chronic 4,Notified C&L,4,H319:2;H413:1;H373:1;H351:1;H361:3;H400:1;H410:1;H362:1;H332:1;H312:1;H315:1;H302:1
230840,"Benzenesulfonic acid, di-C10-14-alkyl derivs., calcium salts",939-603-7,,Skin Sens. 1B,REACH registration C&L,478,H317:472;Not classified:6
230841," 4-(2,2,2-trifluoroethoxy)-1,3-dioxolan-2-one",938-478-6,,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2,Notified C&L,1,H315:1;H319:1;H317:1;H302:1
230842,"3-Chloro-4,5-difluorobenzoic acid",695-884-3,150444-95-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:2;H315:2
230843,4-(2-Cyanoprop-2-yl)benzeneboronic acid,695-885-9,850568-67-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
230844,2-Bromo-5-methoxypyridine,695-886-4,105170-27-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,4,H319:4;H335:3;H315:4
230845,1-[4-(Trifluoromethyl)phenyl]ethylamine,695-888-5,15996-84-6,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Acute Tox. 4,Notified C&L,3,H314:2;H332:2;H312:2;H302:2;H319:1;H335:2;H315:1;H227:1
230846,5-Amino-pyrazine-2-carbonitrile,695-889-0,113305-94-5,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,2,H319:2;H332:2;H312:2;H315:2;H335:2;H302:2
230847,"4-Bromo-N,N-diethylbenzenesulphonamide",695-890-6,90944-62-0,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H332:1;H312:1;H315:1;H335:1;H302:1
230848,"4,6-Dichloronicotinic Acid73027-79-9",695-891-1,73027-79-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,4,H319:4;H335:3;H315:4
230849,4-(4-Piperidyl)pyridine,695-892-7,581-45-3,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,4,H319:4;H315:4;H335:3
230850,Hexamethoxyphosphazene,695-893-2,957-13-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
230851,"Perfluoro(2,3-dimethylbutane)",695-894-8,354-96-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
230852,3-Fluoro-2-nitroaniline,695-895-3,567-63-5,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;STOT SE 3,Notified C&L,2,H319:2;H315:2;H331:1;H335:2;H311:1;H301:1;H332:1;H312:1;H302:1
230853,"Benzo[b]furan-5-boronic acid, pinacol ester",695-896-9,519054-55-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
230854,2-Chloropyrimidine-4-carboxamide,695-897-4,22536-66-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
230855,Isoquinoline-8-carboxylic acid,695-899-5,61563-43-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
230856,2-Bromo-4-chlorobenzonitrile,695-900-9,57381-49-4,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;STOT SE 3,Notified C&L,2,H319:2;H315:2;H331:2;H335:2;H311:2;H301:2
230857,3-Chloro-5-methylbenzeneboronic acid,695-901-4,913836-14-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
230862,5-Bromo-2-indanone,695-903-5,174349-93-0,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H332:1;H312:1;H315:1;H335:1;H302:1
230864,"(2S,3S,5S)-5-amino-2-(dibenzylamino)-1,6-diphenylhexan-3-ol succinate",938-481-2,,Eye Irrit. 2;Aquatic Chronic 4,REACH registration C&L,1,H319:1;H413:1
230867,"19-Norpregna-5(10),9(11)-diene-3,20-dione, 17-hydroxy-, cyclic 3,20-bis(1,2-ethanediyl acetal), (5α,10α)-",695-904-0,54201-84-2,Not Classified,Notified C&L,3,Not classified:2;H319:1;H332:1;H312:1;H315:1;H335:1;H302:1
230870,"trans-2-[4'-[difluoro(3,4,5-trifluorophenoxy)methyl]-2,3',5'-trifluoro[1,1'-biphenyl]-4-yl]-5-butyl-1,3-dioxane",695-906-1,1256753-06-6,Not Classified,REACH registration C&L,2,Not classified:2
230872,"1,2,4-tricarboxy-3-carboxymethyl cyclopentane",695-907-7,24434-90-0,Acute Tox. 3;Acute Tox. 3;Skin Corr. 1B;Acute Tox. 3,Notified C&L,1,H314:1;H331:1;H311:1;H301:1
230873,"Crude oil (petroleum) with recycled naphtha, distilled, cracked, hydrotreated and hydrodesulfurized",700-919-3,,Flam. Liq. 1;Asp. Tox. 1;STOT SE 3;Carc. 1B;STOT RE 2;Aquatic Chronic 4,REACH registration C&L,2,H413:2;H350:2;H224:2;H373:2;H336:2;H304:2
230880,Lime Expressed Terpeneless,938-491-7,,Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1;Aquatic Acute 1,Notified C&L,3,H304:3;H400:3;H317:3;H315:3
230881,"(3R)-3,7-dimethyloct-6-enenitrile",695-909-8,35931-93-2,Not Classified,REACH registration C&L,2,Not classified:2
230882,Reaction mass of menthol and p-menthan-3-one,938-492-2,,Skin Irrit. 2;Skin Sens. 1;Aquatic Chronic 2,Notified C&L,1,H411:1;H317:1;H315:1
230883,"2H-Benzimidazol-2-one, 1,3-dihydro-5-methyl-",695-910-3,5400-75-9,Acute Tox. 4,Notified C&L,84,H302:84;H315:1;H319:1
230884,"2H-Benzimidazol-2-one, 1,3-dihydro-5-methyl-6-nitro-",695-911-9,83573-62-0,Acute Tox. 4;Skin Sens. 1;STOT RE 2;Aquatic Chronic 3,Notified C&L,83,H412:83;H373:83;H317:83;H302:83
230887,"1,2-Benzenediamine, 5-bromo-3-fluoro-",695-912-4,517920-69-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:2;H315:2
230888,"Reaction mass of d-p-mentha-1(6),8-dien-2-one and (R)-p-mentha-1,8-diene",938-494-3,,Acute Tox. 4;Skin Sens. 1;Aquatic Chronic 2,Notified C&L,1,H411:1;H317:1;H302:1
230890,Lime lemon flavour,938-495-9,,Flam. Liq. 2;Asp. Tox. 1;Skin Sens. 1;Aquatic Chronic 2,Notified C&L,3,H225:3;H304:3;H411:3;H317:3
230891,Lime Oil,938-496-4,,Flam. Liq. 3;Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1;Aquatic Chronic 1,Notified C&L,3,H226:3;H317:3;H315:3;H304:3;H410:3
230892,"4-(2-bromoethyl)-3,5-dimethyl-1H-pyrazole",695-914-5,83467-28-1,Skin Corr. 1B;Eye Dam. 1,Notified C&L,1,H314:1;H318:1
230895,"Reaction mass of pin-2(3)-ene and trans-menthone and p-menth-4(8)-en-3-one and 4-allylveratrole and 7-methyl-3-methyleneocta-1,6-diene and isomenthone and (R)-p-mentha-1,8-diene and 2-(1-mercapto-1-methylethyl)-5-methylcyclohexan-1-one",938-498-5,84649-93-4,Acute Tox. 4;Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1;Aquatic Chronic 1,Notified C&L,1,H317:1;H315:1;H302:1;H304:1;H410:1
230896,N-{4-[1-(2-amino-4-hydroxypteridin-6-yl)pent-4-yn-2-yl]benzoyl}-L-glutamic acid,938-499-0,,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Muta. 2;Repr. 1B,Notified C&L,1,H319:1;H315:1;H360:1;H341:1;H301:1
230897,"Polyoxyethylene (5) c8-10 ether phosphate, compd. with 2-aminoethanol",938-500-4,,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
230899,"Morpholine, ethoxylated, propoxylated, aminated",938-503-0,,Acute Tox. 3;Skin Corr. 1B;Eye Dam. 1,Notified C&L,8,H314:8;H311:8;H318:8
230900,"Benzene, C14-24-branched and linear alkyl derivs.",695-916-6,115733-08-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,8,H319:8;H315:8
230902,Distillate of aerobic enzymatic oxidation products of patchouli oil alpha-guaiene rich fraction,700-880-2,,Skin Sens. 1;Aquatic Chronic 2,Notified C&L,1,H411:1;H317:1
230903,Reaction mass of disodium 2-(stearoylamino)pentanedioate and octadecanoic acid,938-521-9,,Not Classified,REACH registration C&L,84,Not classified:1;H319:83
230905,Apple Flavour,938-505-1,,Flam. Liq. 3;Skin Sens. 1;Aquatic Chronic 3,Notified C&L,3,H412:3;H226:3;H317:3
230907,"1,1,1,3,4,4,5,5,5-nonafluoro-2-(trifluoromethyl)pent-2-ene",695-918-7,13429-24-8,Flam. Liq. 2,Notified C&L,3,H225:2;H335:1;H319:1;H315:1;H411:1;H400:1;H302:1
230909,disodium 4-hydroxy-3-[2-[4-({4-[2-(1-hydroxy-4-sulfonatonaphthalen-2-yl)diazen-1-yl]-3-methoxyphenyl}(phenyl)methyl)-2-methoxyphenyl]diazen-1-yl]naphthalene-1-sulfonate,700-924-0,,Not Classified,REACH registration C&L,2,Not classified:2
230910,flavour1,938-507-2,,Flam. Liq. 3;Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,3,H226:3;H317:3;H315:3;H304:3;H400:3;H410:3
230913,"Benzenesulfonic acid, di-C10-14-alkyl derivs.",939-461-6,,,,0,No data
230915,"14-O-{[(1R,2R,4R)-4-Amino-2-hydroxy-cyclohexylsulfanyl]-acetyl}-mutilin Acetate",695-920-8,1350636-82-6,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1B;Eye Dam. 1;Acute Tox. 2,Notified C&L,4,H330:2;H317:2;H315:2;H318:2;H302:3;H411:1;H361:1;H362:1
230917,5-tert-Butyl-2-methyl-benzenesulfonyl Chloride,695-922-9,63452-62-0,Skin Sens. 1;Eye Irrit. 2,Notified C&L,1,H319:1;H317:1
230919,N-Didecyl-N-dipolyethoxyammonium borate/Didecylpolyoxethylammonium borate (Polymeric betaine),695-923-4,214710-34-6,Acute Tox. 4;Skin Corr. 1B;Aquatic Acute 1;Aquatic Chronic 3,Notified C&L,66,H412:66;H314:66;H400:66;H302:66;H318:33;H410:33
230920,Reaction mass of 16291-96-6 and 7704-34-9 and 7757-79-1 and 7782-42-5,938-508-8,,Expl. 1.4,Notified C&L,20,H204:20
230921,Reaction mass of 2537-36-2 and 7778-74-7,938-509-3,,Ox. Sol. 1;Acute Tox. 4,Notified C&L,20,H271:20;H302:20
230929,"Fatty acids, C18 unsatd., reaction products with triethanolamine",938-513-5,,Not Classified,REACH registration C&L,8,Not classified:8
230933,Residue from Transvinylization,938-517-7,,Acute Tox. 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H410:1;H400:1;H301:1
230936,Tris(methylcyclopentadienyl)scandium,938-520-3,,Flam. Sol. 2;Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,22,H319:22;H312:22;H332:22;H315:22;H228:22;H335:22;H302:22
230937,Reaction mass of 10377-58-9 and 109-88-6 and 15571-48-9 and 2414-98-4,938-522-4,,Flam. Sol. 1;Self-heat. 1,Notified C&L,1,H319:1;H228:1;H251:1
230938,"1,1'-(benzene-1,3-diyldimethanediyl)bis(1H-pyrrole-2,5-dione)",695-930-2,13676-53-4,Skin Sens. 1;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,2,H319:2;H400:2;H317:2;H410:2
230942,[No public or meaningful name is available],695-931-8,693217-62-8,Aquatic Chronic 2,Notified C&L,25,H411:25
230943,[No public or meaningful name is available],695-932-3,68555-89-5,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Acute Tox. 4;STOT SE 3;STOT RE 2,Notified C&L,25,H319:25;H373:25;H332:25;H317:25;H315:25;H334:25;H335:25
230947,4-Chloro-N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-phenylalanine,695-934-4,175453-08-4,,Notified C&L,2,Not classified:1;H319:1;H335:1;H315:1
230949,Methyl 6-chloropyridazine-4-carboxylate,695-936-5,1093860-48-0,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;STOT SE 3,Notified C&L,3,H315:3;H335:3;H319:3;H302:3
230951,"Solvate of potassium 5-methoxy-2-{(S)-[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}benzimidazol-1-ide with ethanol(1:2)",700-921-4,,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1;Acute Tox. 4,Notified C&L,1,H314:1;H332:1;H312:1;H317:1;H302:1
230952,[No public or meaningful name is available],938-528-7,,Aquatic Chronic 4,REACH registration C&L,1,H413:1
230957,"Alcohols, C8-18, ethoxylated, polymer",938-530-8,,Eye Dam. 1,Notified C&L,1,H318:1
230958,"Isopropyl N,N,N',N' tetraisopropyl phosphorodiamidite",938-531-3,,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Acute Tox. 4;STOT SE 3;STOT SE 3,Notified C&L,1,H319:1;H312:1;H317:1;H315:1;H332:1;H335:1;H302:1
230960,Oxidised Crude Tall Oil,938-639-0,,Aquatic Chronic 3,REACH registration C&L,3,H412:3
230961,"Lithium bis[ethanedioato(2-)-κO1,κO2]difluorophosphate(1-)",695-938-6,678966-16-0,Acute Tox. 3;Eye Dam. 1,REACH registration C&L,5,H318:2;H301:3;H314:2;H332:2;H312:2;H302:2;H319:1;H317:1;H315:1;H311:1
230962,"Alcohols, C12-14(even numbered), ethoxylated, sulphates, sodium salts (polymer)",938-533-4,,Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 3,Notified C&L,1,H412:1;H318:1;H315:1
230963,Reaction mass of 1309-37-1 and 61790-53-2 and 64-17-5 and 7440-67-7,938-535-5,,Expl. 1.4,Notified C&L,20,H204:20
230964,[No public or meaningful name is available],695-939-1,61012-19-9,Repr. 1A,Notified C&L,2,H360:2
230965,[No public or meaningful name is available],695-940-7,,Skin Sens. 1,Notified C&L,1,H317:1
230968,"2-Methoxycarbonylmethyl-26hydroxy-6,6-dimethyl-2-tetrahydropyrane-carboxylic acid cyclohexylamine salt",938-536-0,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;Not classified:1;H302:1
230969,"Alcohols C8-C10-(even numbered), ethoxylated (polymer)",938-537-6,,Eye Dam. 1,Notified C&L,1,H318:1
230970,"Ammonium (3R,5R)-3,5-dihydroxy-7-[(1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-[[(2S)-2-methylbutanoyl]oxy]-1,2,6,7,8,8a-hexahydronaphtalen-1-yl]heptanoate",695-943-3,151006-11-0,Acute Tox. 4;Skin Sens. 1;Carc. 2;Repr. 2;Lact.,REACH registration C&L,1,H317:1;H362:1;H351:1;H361:1;H302:1
230971,Copolimero Poliammideammino-Epicloridrina,938-538-1,25212-19-5,Carc. 1B,Notified C&L,1,H350:1
230980,BR6747,938-543-9,,Skin Irrit. 2;Skin Sens. 1A;Eye Irrit. 2;Carc. 1B;Aquatic Chronic 2,Notified C&L,1,H319:1;H411:1;H350:1;Not classified:1;H317:1;H315:1
230985,BR154,938-549-1,,Flam. Liq. 2;Skin Sens. 1;Eye Dam. 1;STOT SE 3;Carc. 1B;Aquatic Chronic 3,Notified C&L,1,H412:1;H319:1;H350:1;Not classified:1;H317:1;H225:1;H335:1
230986,BR127 PRIMER,938-550-7,,Flam. Liq. 2;Eye Irrit. 2;STOT SE 3;STOT SE 3;Carc. 1B;Aquatic Chronic 3,Notified C&L,1,H412:1;H319:1;H350:1;Not classified:1;H225:1;H335:1
230999,Reaction mass of sodium chloride and water and sodium hydrogen N-(1-oxododecyl)-L-glutamate,938-564-3,,Eye Irrit. 2,Notified C&L,11,H319:11
231000,Reaction mass of denatonium benzoate and water,938-565-9,,Eye Irrit. 2;Acute Tox. 4,Notified C&L,11,H319:11;H332:11
231004,"Reaction mass of citric acid and water and 3,4-dihydro-2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-2H-benzopyran-6-ol and Glycerides, C16-18 and C18-unsatd. mono- and di- and Glycerides, palm-oil mono-, di- and tri-, hydrogenated, citrates and 141464-42-8",938-570-6,,Eye Dam. 1,Notified C&L,11,H318:11
231005,"Reaction mass of propylidynetrimethanol and 2-ethylpropane-1,3-diol",938-571-1,,Eye Dam. 1,REACH registration C&L,4,H318:4
231007,"Reaction mass of 2-ethyl-2-(methoxymethyl)-propane-1,3-diol and 2-ethylpropane-1,3-diol",938-572-7,,Eye Dam. 1,REACH registration C&L,3,H318:3
231008,"Poly(oxy-1,2-ethanediyl), .alpha.-hydro-.omega.-hydroxy-, mono(C8-18 and C18-unsatd. alkyl) ethers, phosphates",695-947-5,68909-67-1,Skin Corr. 1B;Eye Dam. 1,Notified C&L,7,H314:7;H318:7
231009,"Poly(oxy-1,2-ethanediyl),a-hydro-w-hydroxy-, mono-C11-13-branched alkyl ethers, phosphates",695-948-0,68909-69-3,Skin Corr. 1B;Eye Dam. 1,Notified C&L,6,H314:6;H318:6
231012,"2-Butenedioic acid (2E)-, di-C12-14 (even numbered)-alkyl esters",938-575-3,,Not Classified,REACH registration C&L,7,Not classified:7
231014,"2-Butenedioic acid (2E)-, di-C14-16 (even numbered)-alkyl esters",695-949-6,1187576-41-5,Not Classified,REACH registration C&L,8,Not classified:8
231015,"4-[[[5-[3-[(2-bromo-4-formyl-5-methoxyphenyl)carbamoyl]propyl]-2-phenylphenyl]carbamoyl]oxy]-1,1-dimethylpiperidin-1-ium, bromate",938-577-4,,Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;Not classified:1
231016,"4-[[[5-[3-[[2-bromo-4-[[[(2R)-2-hydroxy-2-(8-hydroxy-2-oxo 1,2-dihydroquinolin-5-yl)ethyl]amino]methyl]-5-methoxyphenyl]carbamoyl]propyl]-2-phenylphenyl]carbamoyl]oxy]-1,1-dimethylpiperidin-1-ium, fumarate",938-579-5,,Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;Not classified:1
231017,"4, 4’,4’’-Triamino-triphenyl-acetonitrile",695-950-1,4439-05-8,Skin Sens. 1;Eye Dam. 1;Carc. 2,Notified C&L,1,H318:1;H351:1;H317:1
231019,"Dodecanoic acid, (1R,6R,22R,27R)-1,27-dihexyl-9,19-dihydroxy-9,19- dioxido-14-oxo-6,22-bis [(1,3-dioxotetradecyl)amino]-4,8,10,18,20,24,-hexaoxa-13,15-diaza-9,19-dephosphaheptacosane- 1,27-diyl ester, disodium salt",938-582-1,,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Notified C&L,1,Not classified:1;H331:1;H311:1;H301:1
231020,"(4S,5R)-5-(3,5-bis(trifluoromethyl)phenyl)-4-methyloxazolidin-2-one",695-951-7,875444-08-9,Skin Sens. 1,Notified C&L,36,H317:36
231021,[No public or meaningful name is available],695-952-2,518048-03-8,Aquatic Chronic 3,Notified C&L,35,H412:35
231022,1-(allyloxy)-2-methyl-1-oxopropan-2-yl 2-chloro-5-isocyanatobenzoate,695-953-8,204918-22-9,Acute Tox. 4;Skin Sens. 1;Acute Tox. 4;Aquatic Chronic 2,Notified C&L,90,H411:90;H332:90;H317:90;H302:89;H301:1
231026,6-Aminoindan-1-one,695-954-3,69975-65-1,Acute Tox. 4;Acute Tox. 4,Notified C&L,2,H312:2;H302:2;H319:1;H332:1;H315:1;H335:1
231027,"Pyrazolo[1,5-a]pyrimidine-5-carboxylic acid",695-955-9,1086375-50-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:2;H315:2;H335:1;H302:1
231028,"N1-(1-oxo-2,3-dihydro-1H-inden-5-yl)acetamide",695-956-4,58161-35-6,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
231029,Chromium(II) acetate hydrate,695-958-5,628-52-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
231030,"2-(Trifluoromethyl)pyridine-4-boronic acid, pinacol ester",695-959-0,1036990-42-7,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,2,H319:2;H332:2;H312:2;H315:2;H335:2;H302:2
231031,2-(trifluoromethyl)pyridin-4-ol,695-960-6,170886-13-2,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,3,H319:3;H332:1;H312:1;H315:3;H335:2;H302:1
231032,"1H-Indole-4-boronic acid, pinacol ester",695-961-1,388116-27-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:40;H335:40;H315:40
231033,Methyl 2-Amino-4-bromobenzoate,695-962-7,135484-83-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,3,H319:3;H335:2;H315:3;H302:1
231034,2-Aminopyrimidine-4-carboxylic acid,695-963-2,2164-65-0,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,2,H319:2;H332:1;H312:1;H315:2;H335:2;H302:2
231035,5-Methoxypyrazine-2-carboxylic Acid,695-964-8,40155-42-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,20,H315:20;H335:19;H319:20;H302:18
231036,2-Bromo-5-hydroxybenzotrifluoride,695-965-3,320-49-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,65,H319:65;H335:64;H315:65
231037,3-Amino-2-(methylamino)-5-(trifluoromethyl)pyridine,695-966-9,172648-55-4,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,159,H332:158;H312:158;H302:158;H319:2;H315:2;H335:1
231038,5-Chloro-2-pyridinecarboxaldehyde,695-967-4,31181-89-2,Skin Sens. 1;Eye Irrit. 2,Notified C&L,41,H319:41;H317:39;H315:2;H332:1;H312:1;H335:1;H302:1
231039,4-(Hydroxymethyl)-2-(trifluoromethyl)pyridine,695-969-5,131747-61-0,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,19,H315:19;H335:19;H319:19;H302:19;H332:1;H312:1
231040,4-(Difluoromethyl)benzeneboronic acid,695-970-0,946525-43-5,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,2,H319:2;H332:1;H312:1;H315:2;H335:2;H302:2
231041,5-Methylpyrazine-2-carboxaldehyde,695-971-6,50866-30-3,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,3,H319:3;H332:3;H312:1;H315:3;H335:3;H302:3
231042,3-Bromo-5-methylpyridine-2-carboxylic acid,695-972-1,1211515-68-2,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,2,H319:2;H332:2;H312:2;H315:2;H335:2;H302:2
231044,"Alcohols, C10-14(even numbered), ethoxylated (polymer)",938-587-9,,Eye Dam. 1,Notified C&L,1,H318:1
231045,"Alcohols, C16-18, C18-unsaturated (even numbered), ethoxylated (polymer)",938-588-4,,Skin Irrit. 2,Notified C&L,8,H315:8
231046,"(Z)-Octadec-9-en-1-ol, ethoxylated (polymer)",938-590-5,,Skin Irrit. 2,Notified C&L,3,H315:3
231048,2-Chloro-4-(1H-pyrazol-5-yl)benzonitrile,938-592-6,,Acute Tox. 4,Notified C&L,1,H302:1
231049,Potassium 1-carba-closo-dodecahydrododecaborate,695-973-7,92468-39-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
231050,Bis(Triethylammonium)-closo-Decaborate,695-974-2,12551-36-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
231051,"1,2-Bis(hydroxymethyl)-1,2-dicarba-closo-dodecaborane",695-975-8,19610-37-8,Flam. Sol. 2;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H228:1;H315:1
231052,"nido,nido-Octadecaborane(22)",695-976-3,21107-56-2,Flam. Sol. 2;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H228:1;H315:1
231053,"Lithium Tetradeuteroborate, 11B-enriched",938-593-1,,Water-react. 1;Acute Tox. 3;Acute Tox. 3;Skin Corr. 1B;Acute Tox. 3,Notified C&L,1,H314:1;H331:1;H260:1;H311:1;H301:1
231054,"Sodium Tetrahydridoborate, 11B-enriched",938-594-7,,Water-react. 1;Acute Tox. 3;Skin Corr. 1B;Repr. 1B,Notified C&L,1,H301:1;H314:1;H360:1;H260:1
231055,"Decan-1-ol, ethoxylated (polymer)",938-595-2,,Eye Dam. 1,Notified C&L,5,H318:3;H319:2
231056,"Dimethylsulfide-Deuteroborane Complex, 11B enriched",938-596-8,,Flam. Liq. 2;Water-react. 1;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,1,H315:1;H318:1;H260:1;H225:1;H335:1
231057,"Tetradecahydrodecaborane, 11B-enriched",938-597-3,,Flam. Sol. 1;Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 2,Notified C&L,1,H319:1;H330:1;H315:1;H228:1;H311:1;H301:1
231058,"Dimethylsulfide-Borane Complex, 11B-enriched",938-598-9,,Flam. Liq. 2;Water-react. 1;Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,1,H315:1;H318:1;H260:1;H225:1;H335:1;H311:1;H301:1
231059,"1,2-Dicarba-closo-dodecaborane(12)",938-599-4,,Flam. Sol. 2;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H315:1;H228:1;H319:1;H302:1
231060,"Calcium Dodecaborate, monohydrate",938-600-8,,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
231061,2-[(2-hydroxypropyl)(C16-18 sat. C18 unsat. alkyl)amino]propan-1-ol,695-977-9,1309955-79-0,Acute Tox. 4;Skin Corr. 1C;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 2,Notified C&L,1,H411:1;H314:1;H318:1;H400:1;H302:1
231064,Elemental tellurium and bismuth concentrate resulting from leaching and cementation,700-872-9,,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3;Repr. 1A;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,1,H335:1;H373:1;H410:1;H315:1;H318:1;H360:1;H400:1;H302:1
231066,"1,7-Bis(hydroxydimethylsilyl)-1,7-dicarba-closo-dodecaborane(12)",938-603-4,,Flam. Sol. 2;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H228:1;H315:1
231067,Triethylammonium 1-carba-closo-dodecaborate,938-605-5,,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
231068,"1-(4-Hydroxyphenyl)-1,2-dicarba-closo-dodecaborane(12)",938-606-0,,Flam. Sol. 2;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H228:1;H315:1
231069,"1-(4-Hydroxyphenyl)-1,7-dicarba-closo-dodecaborane(12)",938-607-6,,Flam. Sol. 2;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H228:1;H315:1
231070,"1,7-Bis(4-hydroxyphenyl)-1,7-dicarba-closo-dodecaborane(12)",938-608-1,,Flam. Sol. 2;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H228:1;H315:1
231071,"1,7-Bis(4-carboxyphenyl)-1,7-dicarba-closo-dodecaborane(12)",938-609-7,,Flam. Sol. 2;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H228:1;H315:1
231072,"1-Carbonylchloride -1,2-dicarba-closo-dodecaborane(12)",938-610-2,,Flam. Sol. 2;Acute Tox. 4;Skin Corr. 1B,Notified C&L,1,H314:1;H228:1;H302:1
231073,"Tetramethylammonium 12-Mercaptoundecahydro-dodecaborate, 10B-enriched",938-611-8,,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
231074,"4-borono-2-fluoro-phenylalanine, 10B enriched",938-612-3,,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
231075,"esterification product of 2-hydroxypropane-1,3-diyl-bis(2-methylprop-2-enoate) and 3-hydroxypropane-1,2-diyl-bis(2-methylprop-2-enoate) and diphosphorus pentoxide",700-757-3,,Eye Dam. 1,Notified C&L,1,H318:1
231091,"(1R,2S,5R)-5-methyl-2-(propan-2-yl)cyclohexyl (ethylamino)(oxo)acetate",700-185-4,1122460-01-8,Skin Irrit. 2,REACH registration C&L,1,H315:1
231096,"Nonylphenol, ethoxylated (polymer)",938-618-6,,Eye Dam. 1;Aquatic Chronic 4,Notified C&L,1,H318:1;H413:1
231097,"Octylphenol, ethoxylated (polymer)",938-620-7,,Acute Tox. 4;Eye Dam. 1;Aquatic Chronic 3,Notified C&L,1,H412:1;H318:1;H302:1
231099,2-Chloro-N-phenethyl-acetamide,695-978-4,13156-95-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
231101,Reaction mass of 470-67-7 and 586-62-9,938-623-3,,Flam. Liq. 3;Asp. Tox. 1;Aquatic Chronic 2,Notified C&L,1,H304:1;H411:1;H226:1
231102,"1-Naphthalenesulfonic acid, 3-diazo-3,4-dihydro-4-oxo-, ester with 4,4'-[1-[4-[1-(4-hydroxyphenyl)-1- methylethyl]phenyl]ethylidene]bis[phenol]",695-980-5,135668-77-8,Self-react. D;Repr. 2,Notified C&L,1,H361:1;H242:1
231107,methyl 5-bromo-4-oxopentanoate,695-983-1,53856-93-2,Not Classified,Notified C&L,2,Not classified:1;H319:1;H333:1;H313:1;H315:1;H303:1;H335:1
231111,"Fatty acids, coco, tetraesters with bis[2,2-bis(hydroxymethyl)butyl] adipate",700-772-5,1190961-28-4,Not Classified,REACH registration C&L,442,Not classified:442
231113,"Reaction mass of 2-octyldodecyl 2-hydroxypropanoate, 2-Octyldodecan-1-ol and 2-octyldodecyl 2-[(2-hydroxypropanoyl)oxy]propanoate",700-839-9,,Not Classified,REACH registration C&L,1,Not classified:1
231114,"Reaction mass of isomers 4-[[2-[(Aminocarbonyl)amino]-4-[(2,6-difluoro-4-pyrimidyl)-amino]phenyl]azo]-1,3-benzenedisulfonic acid, sodium salt and 4-[[2-[(Aminocarbonyl)amino]-4-[(4,6-difluoro-2-pyrimidyl)-amino]phenyl]azo]-1,3-benzenedisulfonic acid, sodium salt",700-936-6,,Skin Sens. 1B,REACH registration C&L,2,H317:2
231115,"Reaction mass of 1,2,2,6,6-pentamethylpiperidin-4-yl hexadecanoate and 1,2,2,6,6-pentamethylpiperidin-4-yl octadecanoate",700-792-4,,Skin Sens. 1B;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H400:1;H317:1;H410:1
231116,"Reaction products of diazotised anthranilic acid and resorcinol, subsequently coupled with diazotised 5-aminonaphthalene-1-sulfonic acid and chelated with chromium (3+), sodium salts",700-942-9,,Not Classified,REACH registration C&L,12,Not classified:12
231117,"Reaction mass of disodium 2-{[2-(acylamino)-4-({4-chloro-6-[(3-sulfonatophenyl)amino]-1,3,5-triazin-2-yl}amino)phenyl]diazenyl}-(vinylsulfonyl)benzenesulfonate and trisodium 2-{[2-(acylamino)-4-({4-chloro-6-[(3-sulfonatophenyl)amino]-1,3,5-triazin-2-yl}amino)phenyl]diazenyl}-{[2-(sulfonatooxy)ethyl]sulfonyl}benzenesulfonate",,,Eye Dam. 1,Notified C&L,1,H318:1
231118,"(4aR,5S,8R,8aS)-1,2,3,4,4a,5,8,8a-octahydro-1,4:5,8-dimethanonaphthalene",700-678-4,,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1B;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H317:1;H315:1;H302:1;H400:1;H410:1
231120,Reaction mass of L-alanyl-L-glutamine and potassium chloride,700-887-0,,Not Classified,REACH registration C&L,1,Not classified:1
231122,"(4aR*, 8aR*)-1-bromo-4a,5,9,10,11,12-hexahydro-3-methoxy-6H-benzofuro[3a,3,2-ef] [2]benzazepin-6-one hydrochloride (1:1)",700-867-1,,Acute Tox. 4;Skin Sens. 1B;Eye Irrit. 2;Muta. 2;Repr. 2;STOT RE 2;Aquatic Chronic 3,REACH registration C&L,2,H412:2;H319:2;H373:2;H317:2;H361:2;H341:2;H302:2
231123,2-{[(4-chloro-3-methyl-1-oxidopyridin-2-yl)methyl]sulfanyl}-1H-benzimidazole,700-935-0,,Not Classified,Notified C&L,1,Not classified:1
231124,"Reaction mass of 3-[(2-aminoethyl)ammonio]propane-1-sulfonate and 3,3'-(ethane-1,2-diyldiammonio)dipropane-1-sulfonate and ethane-1,2-diamine",700-580-1,,Skin Sens. 1;Resp. Sens. 1,REACH registration C&L,1,H334:1;H317:1
231132,4-pyrazol-1-yl-pyridine hydrochloride,700-747-9,,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H332:1;H312:1;H315:1;H335:1;H302:1
231136,"Biphenyl-2-yl-(9,9-dimethyl-9H-fluoren-2-yl)-(9,9’-spirobifluoren-2-yl)-amine",700-681-0,1364603-07-5,Not Classified,REACH registration C&L,1,Not classified:1
231143,Condensation products of tetramethylenediamine with hydrogenated fatty acids of castor-oil,,,Not Classified,Notified C&L,1,Not classified:1
231145,"5-nitro-2-(propylthio)pyrimidine-4,6(1H,5H)-dione",700-477-1,1315610-28-6,Acute Tox. 4;Skin Sens. 1;Acute Tox. 4,REACH registration C&L,1,H332:1;H317:1;H302:1
231147,N-((3(5)-Methyl-1H-pyrazol-1-yl)methyl)acetamide,700-208-8,,Eye Irrit. 2;Repr. 1B,REACH registration C&L,4,H319:4;H360:4
231148,"fatty acids, C16-C18 and C18 unsaturated isopentyl esters, epoxidized",700-659-0,,Not Classified,REACH registration C&L,1,Not classified:1
231159,"Reaction product of propylidynetrimethanol, propoxylated, reaction products with ammonia and 2,2-Dimethyl-3-(4-morpholinyl)propanal",700-879-7,,Skin Sens. 1B;Eye Irrit. 2;Aquatic Chronic 2,REACH registration C&L,1,H319:1;H411:1;H317:1
231160,"Alkane-alpha,omega-diyl bis{[(trimethoxysilyl)propyl]carbamate}_M2",,,Not Classified,REACH registration C&L,1,Not classified:1
231169,"bis[2-(4,4-dimethylpentan-2-yl)-5,7,7-trimethyloctyl] (2E)-but-2-enedioate",700-897-5,,Not Classified,REACH registration C&L,2,Not classified:2
231170,"1,4-Butanediyl 3-(2,4-dimethyl-1,3-dioxolan-2-yl)propanoate",700-652-2,1259300-69-0,Aquatic Chronic 3,REACH registration C&L,1,H412:1
231171,"Reaction mass of (3Z)-4-ethyl-6-(2,6,6-trimethylcyclohex-2-en-1-yl)hex-3-en-1-ol and (4E)-4-[2-(2,6,6-trimethylcyclohex-2-en-1-yl)ethyl]hex-4-en-1-ol and (4E)-4-ethyl-6-(2,6,6-trimethylcyclohex-2-en-1-yl)hex-4-en-1-ol and (4Z)-4-ethyl-6-(2,6,6-trimethylcyclohex-2-en-1-yl)hex-4-en-1-ol",700-901-5,,Not Classified,Notified C&L,1,Not classified:1
231173,"Reaction mass (E)-4-(2-chloro-1,2-diphenylvinyl)phenyl 2-chloroethyl ether and (Z)-4-(2-chloro-1,2-diphenylvinyl)phenyl 2-chloroethyl ether",700-415-3,,Repr. 1B,Notified C&L,1,H360:1
231176,"Reaction mass of 5,5'-{(phenylmethanediyl)bis[benzene-4,1-diyl-diazene-2,1-diyl]}bis{1-[3-(dimethylamino)propyl]-4-methyl-6-oxo-3-(pyridinium-1-yl)-1,6-dihydropyridin-2-olate} hydrochloride and 5,5’-[3,4’-(phenylmethanediyl)diphenylene]bis(diazene-2,1-diyl)bis{1-[3-(dimethylamino)propyl]-4-methyl-6-oxo-3-(pyridinium-1-yl)-1,6-dihydropyridin-2-olate} hydrochloride",700-312-3,,Acute Tox. 4;Skin Sens. 1;Eye Dam. 1;Aquatic Chronic 2,REACH registration C&L,33,H318:33;H411:33;H317:33;H302:33
231177,Reaction mass of sodium 4-chloro-5-alkylbenzotriazolide and sodium 5-chloro-4-alkylbenzotriazolide and sodium 4-chloro-7-alkylbenzotriazolide and sodium 5-chloro-6-alkylbenzotriazolide,,,Skin Corr. 1B;Aquatic Chronic 3,Notified C&L,1,H412:1;H314:1
231179,"Cuprate(4-), [2-[[4-chloro-6-[ethyl[3-[[2-(sulfooxy)ethyl]sulfonyl]phenyl]amino]-1,3,5-triazin-2-yl]amino]-5-(hydroxy-kO)-6-[2-[2-[2-[2-(hydroxy-kO)-5-sulfophenyl]diazenyl-kN1]-4,5-dimethoxyphenyl]diazenyl-kN2]-1,7-naphthalenedisulfonato(6-)]-, hydrogen sodium (1:2:2)",700-941-3,,Skin Sens. 1A,Notified C&L,1,H317:1
231180,Reaction mass of glycyl-L-glutamine and potassium chloride,700-909-9,,Not Classified,REACH registration C&L,1,Not classified:1
231185,"Cyclohexane, 1,4-bis(ethoxymethyl)-",700-868-7,54889-63-3,Skin Irrit. 2;Aquatic Chronic 3,REACH registration C&L,85,H412:85;H315:85
231186,"lithium 3-((3,4-dicyanophenyl)sulfonyl)propane-1-sulfonate)",700-777-2,,Skin Sens. 1,Notified C&L,1,H317:1
231190,2-ethoxyethyl (2Z)-2-cyano-2-[3-(3-methoxypropylamino)cyclohex-2-en-1-ylidene]acetate,700-860-3,1419401-88-9,Aquatic Acute 3;Aquatic Chronic 3,REACH registration C&L,1,H412:1;H402:1
231191,"dodecanoic acid, mono and diester with oxybis(propanediol)",700-672-1,,Not Classified,Notified C&L,1,Not classified:1
231194,"Reaction mass of 3-[3-(1,1,1,3,5,5,5-heptamethyltrisiloxan-3-yl)propoxy]-2-hydroxypropyl methacrylate and 1-[3-(1,1,1,3,5,5,5-heptamethyltrisiloxan-3-yl)propoxy]-3-hydroxypropan-2-yl methacrylate.",700-334-3,,Skin Sens. 1B;Aquatic Chronic 4,REACH registration C&L,2,H413:2;H317:2
231196,Copper phtalocyanine monosulfonated and disulfonated,700-870-8,,Aquatic Chronic 3,Notified C&L,1,H412:1
231197,"Reaction mass of 3-(2-{3-cyanato-5-[2-(3-cyanatoaryl)heteropolycycle-5-yl]aryl}heteropolycycle-5-yl)aryl cyanate and heteropolycycle -2,5-diyldi-3,1-arylene dicyanate",,,Skin Sens. 1B;Aquatic Chronic 4,Notified C&L,1,H413:1;H317:1
231202,"Reaction mass of sodium aqua[5-{[2-hydroxy-4-(hydroxy-kO)-5-{[2-(hydroxy-kO)-3,5-dinitrophenyl]diazenyl}phenyl]diazenyl}naphthalene-1-sulfonato(3-)]ferrate(1-) and sodium diaqua(chloro)[5-{[2-hydroxy-4-(hydroxy-kO)-5-{[2-(hydroxy-kO)-3,5-dinitrophenyl]diazenyl-kN2}phenyl]diazenyl}naphthalene-1-sulfonato(3-)]ferrate(1-)",700-899-6,,Aquatic Chronic 3,REACH registration C&L,3,H412:3
231203,"Potassium bis[oxalato(2-)-k2O1,O2]borate(1-)",700-881-8,83145-78-2,Acute Tox. 4;Skin Sens. 1;Eye Dam. 1,REACH registration C&L,2,H318:2;H317:2;H302:2
231207,2-({[4-(3-methoxypropoxy)-3-methyl-1-oxidopyridin-2-yl]methyl}sulfanyl)-1H-benzimidazole,700-940-8,,Not Classified,Notified C&L,1,Not classified:1
231208,"Reaction mass of 4-ethyl-6-(2,6,6-trimethylcyclohex-2-en-1-yl)hex-2-ene-1,4-diol and 4-ethyl-6-(2,6,6-trimethylcyclohex-2-en-1-yl)hexane-1,4-diol",700-895-4,,Not Classified,Notified C&L,1,Not classified:1
231212,"Reaction mass of 3-[3-(9-butyl-1,1,3,3,5,5,7,7,9,9-decamethylpentasiloxanyl)propoxy]-2-hydroxypropyl 2-methylprop-2-enoate and 1-[3-(9-butyl-1,1,3,3,5,5,7,7,9,9-decamethylpentasiloxanyl)propoxy]-3-hydroxypropan-2-yl 2-methylprop-2-enoate",700-043-1,,Skin Sens. 1B;Aquatic Chronic 4,REACH registration C&L,2,H413:2;H317:2
231215,"Reaction mass of 1-(2,6,6-trimethylcyclohex-2-en-1-yl)pentan-3-one and 4-ethyl-6-(2,6,6-trimethylcyclohex-2-en-1-yl)hex-2-yne-1,4-diol",695-734-7,,Not Classified,Notified C&L,1,Not classified:1
231219,"7-Isopropyl-2H,4H-1,5-benzodioxepin-3-one",700-012-2,950919-28-5,Acute Tox. 4;Skin Sens. 1B;STOT SE 3;Aquatic Chronic 3,REACH registration C&L,2,H412:2;H336:2;H317:2;H302:2
231221,"Reaction mass of 3-(3,3-dimethyl-2,3-dihydro-1H-inden-5-yl)propanal and 3-(1,1-dimethyl-2,3-dihydro-1H-inden-5-yl)propanal and 3-(1,1-dimethyl-2,3-dihydro-1H-inden-4-yl)propanal",700-617-1,,Acute Tox. 4;Skin Sens. 1B;Aquatic Chronic 2,REACH registration C&L,1,H411:1;H317:1;H302:1
231222,"O,O,O',O'-tetraoctyl-(branched and linear) S,S'-{methylenebis[imino(3-oxopropane-3,1-diyl)]} bis(phosphorothioate)",700-945-5,,Not Classified,REACH registration C&L,443,Not classified:443
231227,"Reaction mass of (3E)-4-ethyl-6-(2,6,6-trimethylcyclohex-2-en-1-yl)hex-3-en-1-yl acetate and (3Z)-4-ethyl-6-(2,6,6-trimethylcyclohex-2-en-1-yl)hex-3-en-1-yl acetate and (4E)-4-[2-(2,6,6-trimethylcyclohex-2-en-1-yl)ethyl]hex-4-en-1-yl acetate and (4E)-4-ethyl-6-(2,6,6-trimethylcyclohex-2-en-1-yl)hex-4-en-1-yl acetate and (4Z)-4-ethyl-6-(2,6,6-trimethylcyclohex-2-en-1-yl)hex-4-en-1-yl acetate",700-894-9,,Not Classified,Notified C&L,1,Not classified:1
231228,"Biphenyl-4,4'-diyl tetraphenyl bis(phosphate)",700-627-6,17270-01-8,Not Classified,Notified C&L,2,Not classified:2
231231,Reaction products of ricinoleic acid and linoleic acid and oleic acid with sodium hydroxide and tin (II) chloride,700-814-2,,Skin Sens. 1A;Aquatic Chronic 2,REACH registration C&L,1,H411:1;H317:1
231232,bis[C11-14-(branched and linear)-alkyl]aminium nonadecaoxohexatungstate,700-718-0,,Skin Sens. 1A;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H400:1;H317:1;H410:1
231238,"E. coli fusion protein HMR 1964, concentrated",,,Not Classified,Notified C&L,1,Not classified:1
231241,Reaction mass of sodium (8R)-(11S)-(12S)-12-hydroxy-11-[(4-hydroxyphenyl)methyl]-8-alkyl-polyoxo-1- phenyl-12-sulfonato-polyaza-2-oxadodecane and sodium (8R)-(11S)-(12R)-12-hydroxy-11-[(4-hydroxyphenyl)methyl]-8-alkyl-polyoxo-1- phenyl-12-sulfonato-polyaza-2-oxadodecane,,,Skin Sens. 1B,REACH registration C&L,2,H317:2
231243,Alkylated Naphthalene,,,Not Classified,Notified C&L,1,Not classified:1
231245,"reaction products of ethylene glycol, urea and paraformaldehyde",700-934-5,,Skin Sens. 1B;Eye Irrit. 2;Muta. 2;Carc. 1B,Notified C&L,1,H319:1;H341:1;H317:1;H350:1
231246,Renewable hydrocarbons of wood origin (gasoline type fraction),700-918-8,,Flam. Liq. 2;Asp. Tox. 1;Skin Irrit. 2;STOT SE 3;Muta. 1B;Carc. 1B;Repr. 2;Aquatic Chronic 2,REACH registration C&L,1,H411:1;H350:1;H315:1;H336:1;H225:1;H304:1;H361:1;H340:1
231247,"5,12-dihydroquinolino[2,3-b]acridine-7,14-dione and (mono and bis)-[(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)methyl]-5,12-dihydroquinolino[2,3-b]acridine-7,14-dione",700-776-7,,Not Classified,REACH registration C&L,84,Not classified:84
231249,"Crude heparin, sodium salt",700-816-3,,Not Classified,REACH registration C&L,1,Not classified:1
231251,Leucophor 1111X,700-932-4,,Not Classified,REACH registration C&L,1,Not classified:1
231253,Renewable hydrocarbons (diesel type fraction),700-916-7,,Asp. Tox. 1;Skin Irrit. 2;Aquatic Chronic 3,REACH registration C&L,1,H412:1;H304:1;H315:1
231254,"1-(5-propyl-1,3-benzodioxol-2-yl)-1-ethanone",700-902-0,1370699-98-1,Skin Irrit. 2;Skin Sens. 1A;STOT SE 3;STOT SE 3;Aquatic Chronic 3,Notified C&L,25,H412:25;H336:25;H317:25;H315:25
231257,Alkylnaphthalene,,,Not Classified,Notified C&L,1,Not classified:1
231268,"1,4-Benzenedicarboxylic acid, 1,4-diisononyl ester",700-453-0,59802-05-0,Not Classified,REACH registration C&L,1,Not classified:1
231270,"Reaction mass of 5-[(2R)-butan-2-yl]-2-[(1R,2R)-2,4-dimethylcyclohex-3-en-1-yl]-5-methyl-1,3-dioxane and 5-[(2R)-butan-2-yl]-2-[(1R,2S)-2,4-dimethylcyclohex-3-en-1-yl]-5-methyl-1,3-dioxane and 5-[(2R)-butan-2-yl]-2-[(1S,2R)-2,4-dimethylcyclohex-3-en-1-yl]-5-methyl-1,3-dioxane and 5-[(2R)-butan-2-yl]-2-[(1S,2S)-2,4-dimethylcyclohex-3-en-1-yl]-5-methyl-1,3-dioxane and 5-[(2S)-butan-2-yl]-2-[(1S,2R)-2,4-dimethylcyclohex-3-en-1-yl]-5-methyl-1,3-dioxane and 5-[(2S)-butan-2-yl]-2-[(1S,2S)-2,4-dimethylcyclohex-3-en-1-yl]-5-methyl-1,3-dioxane",700-927-7,,Aquatic Chronic 2,REACH registration C&L,1,H411:1
231275,"3,6,7-Trimethyl-2,6-octadienal",700-523-0,1891-67-4,Skin Irrit. 2;Skin Sens. 1B;Eye Irrit. 2,Notified C&L,22,H319:22;H317:22;H315:22
231277,Pure sodium heparinate,700-834-1,,Not Classified,REACH registration C&L,2,Not classified:2
231280,"Reaction mass of estra-1,3,5(10)-triene-3,17β-diol 3-[bis(2-chloroethyl)carbamate] 17-(dihydrogen phosphate) and pyridinium chloride and water",938-628-0,,Carc. 2;Repr. 1B,Notified C&L,1,H351:1;H360:1
231282,"Disodium 4-amino-5-hydroxy-3,6-bis{(E)-[4-(vinylsulfonyl)phenyl]diazenyl}naphthalene-2,7-disulfonate",695-988-9,100556-82-9,Skin Sens. 1;Resp. Sens. 1,REACH registration C&L,2,H334:2;H317:2
231284,"2-methyl-1,2-ben­zothiazol-3(2",695-989-4,2527-66-4,Acute Tox. 3;Acute Tox. 4;Skin Corr. 1C;Eye Dam. 1;Skin Sens. 1A;Aquatic Acute 1;Aquatic Chronic 2,Harmonised C&L,0,H411:0;H314:0;H410:0;H312:0;H317:0;H318:0;H400:0;H301:0
231285,"6-[3-tert-butyl-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-2-methoxyphenyl]-2-naphthyl 1,1,2,2,3,3,4,4,4-nonafluorobutane-1-sulfonate",695-991-5,1355646-97-7,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,3,H315:3;H319:2;H301:3
231286,zinc dibenzyldithiocarbamate oil treated,938-630-1,,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H400:1;H410:1
231287,4-Methoxybenzylmagnesium chloride,695-992-0,38769-92-5,Skin Corr. 1B,Notified C&L,39,H314:39;H318:1
231289,"N-benzyl-2-(2-chloroethoxy)-N,N-dimethylethanaminium chloride",938-632-2,,Acute Tox. 4;Eye Irrit. 2,Notified C&L,1,H319:1;H302:1
231291,[No public or meaningful name is available],695-999-9,405213-20-9,Skin Irrit. 2,Notified C&L,3,H315:3
231292,"Poly(oxy-1,2-ethanediyl), .alpha.-(2-methyl-1-oxo-2-propenyl)-.omega.-hydroxy-, C12-alkyl ether",695-994-1,136505-03-8,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2,Notified C&L,1,H319:1;H317:1;H315:1
231297,"lithio 4-[1-(2,4-diaminopteridin-6-yl)pent-4-yn-2-yl]benzoate",938-638-5,,Acute Tox. 3;Skin Irrit. 2;Repr. 1A,Notified C&L,1,H315:1;H360:1;H301:1
231299,benzyl (4-bromo-3-fluorophenyl)carbamate,695-996-2,510729-01-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H315:1;H319:1;H302:1
231300,"1-Nitrate-1,3-propandiol",695-997-8,100502-66-7,Self-react. C,Notified C&L,3,H242:1;H315:2;H319:1;H302:2;H361:1;H318:1
231301,"1-Piperazinecarboxylic acid, 4-[2-(ethoxycarbonyl)-5-benzofuranyl]-, 1,1-dimethylethyl ester",695-998-3,183288-43-9,Aquatic Chronic 2,Notified C&L,1,H411:1
231302,"Reaction products of 1H-imidazole-1-ethanol, 4,5-dihydro-, 2-(C11-C13 odd-numbered alkyl) derivs. and sodium hydroxide and chloroacetic acid",938-645-3,,Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,4,H412:4;H319:4
231303,N-Carbethoxy-4-(S)-N-(4'-carboxypiperidinyl)-azepane,938-641-1,,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
231307,"Fatty acids, C18 unsaturated, reaction products with diethylenetriamine, acetate salts",938-649-5,,Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,6,H317:6;H315:6;H318:6;H400:6;H410:6
231308,"2,2-dimethylpropyl N-((S)-(((2R,3R,4R,5R)-5-(2-amino-6-methoxy-9H-purin-9-yl)-3,4-dihydroxy-4-methyltetrahydro-2-furanyl)methoxy)(1-naphthyloxy)phosphoryl)-L-alaninate",938-646-9,,Acute Tox. 3;STOT RE 1,Notified C&L,4,H372:4;H301:4
231311,(4-chloro-2-fluoro-3-methoxyphenyl)boronic acid,696-001-4,944129-07-1,Acute Tox. 3;Acute Tox. 4;Skin Corr. 1B,Notified C&L,56,H314:55;H312:55;H301:55;H319:1;H335:1;H315:1
231313,"1-butyl-1,1,3,3,5,5,7,7,9,9-decamethylpentasiloxane",696-005-6,121263-53-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,3,H319:2;H335:2;H315:2;Not classified:1
231314,"5-[carbamimidoyl-(4-methoxy-2,3,6-trimethyl-phenyl)sulfonyl-amino]-(2R)-2-[(9H-fluoren-9-ylmethoxycarbonyl)methylamino]pentanoic acid",938-650-0,,Acute Tox. 4;Acute Tox. 4;Repr. 1B,Notified C&L,1,H332:1;H360:1;H312:1
231315,2-bromo-7-iodo-9H-fluorene,696-006-1,123348-27-6,Not Classified,REACH registration C&L,2,Not classified:1;H319:1;H315:1
231317,"Nonylphenol, propoxylated",696-008-2,9064-15-7,Acute Tox. 4;Eye Dam. 1;Aquatic Chronic 2,Notified C&L,1,H318:1;H411:1;H302:1
231318,"Amines, N-tallow alkyltrimethylenedi-, ethoxylated, propoxylated",938-652-1,,Eye Irrit. 2,Notified C&L,1,H319:1
231319,"Condensation products of Dihydrofuran-2,5-dione, mono-alkenyl derivs. with polyethylene amine and acetic anhydride",,,Not Classified,REACH registration C&L,1,Not classified:1
231320,"Alkenes, C11-14, hydroformylation products, distn. residues, reaction products with maleic anhydride and sodium bisulfite, sodium salts",938-654-2,,Skin Sens. 1;Eye Irrit. 2,REACH registration C&L,59,H319:59;H317:59
231321,"(3aR,12bR)-rel-5-chloro-2,3,3a,12b-tetrahydro-1H-dibenz[2,3:6,7]oxepino[4,5-c]pyrrole hydrochloride",696-009-8,1170701-78-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H315:1;H335:1;H319:1;H302:1
231324,"1,3-Isobenzofurandione, hexahydro-, reaction products with epichlorohydrin",696-026-0,1395383-69-3,Skin Sens. 1;Aquatic Chronic 3,REACH registration C&L,20,H412:20;H317:20
231331,1-(8-oxo-6-oxatetraphen-3-yl)ethenyl,938-661-0,,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H315:1;H335:1;H319:1;H302:1
231332,"3-bromo-9-(2-bromo-1-hydroxyethyl)-2,3,4,7-tetrahydro-1H-6-oxatetraphen-4-one",938-662-6,,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H315:1;H335:1;H319:1;H302:1
231333,(2-bromoethoxy)phosphonoyl dibromide,938-663-1,,Met. Corr. 1;Acute Tox. 3;Acute Tox. 3;Skin Corr. 1B;Acute Tox. 3;STOT SE 3;Carc. 1B;Aquatic Chronic 2,Notified C&L,1,H411:1;H350:1;H314:1;H290:1;H331:1;H335:1;H311:1;H301:1
231344,"Hydroxido potassium zirconium carbonate, where there are 0, 1 or 2 hydroxide groups and 2, 3 or 4 potassium atoms and 2, 3 or 4 carbonate groups.",938-677-8,,Not Classified,REACH registration C&L,8,Not classified:8
231345,"Sucrose and glycerol, reaction products with C12-18, C18unsatd. fatty acids",938-754-6,,Not Classified,REACH registration C&L,1,Not classified:1
231349,Stearyl dimethicone,938-675-7,,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
231353,"Amines, C14-16 (even numbered)-alkyldimethyl, N-oxides",938-679-9,,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,12,H411:12;H315:12;H318:12;H400:12;H302:12
231355,"Copper, bis(1-phenyl-1,3-butanedionato-κO1,κO3)-",,14128-84-8,,Notified C&L,1,H319:1;H335:1;H315:1
231358,POLY(DIMETHOXYSILOXANE),696-021-3,25498-02-6,,Notified C&L,3,H318:2;H335:2;H315:2;H225:1;H319:1
231360,"1-[2-(2,4-dimethylphenyl)sulfanylphenyl]piperazine;hydrobromide",696-022-9,960203-27-4,Acute Tox. 4;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,46,H410:45;H400:44;H317:44;H302:45;H336:1;H361:2;H373:1
231366,"Reaction product of higher oligomers of 4,4'-methylenediphenyl diisocyanate, 2-butoxyethanol and 2-(2-Butoxyethoxy)ethanol",696-028-1,1334537-35-7,Not Classified,Notified C&L,2,Not classified:2
231371,1-Acetoxy-2-acetoxymethylnaphthalene,938-685-1,,Skin Sens. 1;Aquatic Chronic 2,Notified C&L,1,H411:1;H317:1
231380,"2-Chloro-3,5-dimethylpyrazine",696-037-0,38557-72-1,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,2,H319:2;H332:1;H312:1;H315:2;H335:1;H302:1
231381,"2-hydroxy-1-{1-[4-(2-hydroxy-2-methylpropanoyl)phenyl]-1,3,3-trimethyl-2,3-dihydro-1H-inden-5-yl}-2-methylpropan-1-one",696-038-6,135452-43-6,Not Classified,Notified C&L,1,Not classified:1
231383,Reaction mass of 3-deoxy-D-pentulose and D-lactulose,938-691-4,,Not Classified,Notified C&L,1,Not classified:1
231384,"Poly[oxy(1-oxo-1,6-hexanediyl)], .alpha.-(7-oxabicyclo[4.1.0]hept-3-ylmethyl)-.omega.-[(7-oxabicyclo[4.1.0]hept-3-ylcarbonyl)oxy]-",696-039-1,139198-19-9,Not Classified,Notified C&L,4,Not classified:3;H317:1
231385,[No public or meaningful name is available],696-040-7,141668-35-1,Acute Tox. 4;Skin Sens. 1;Muta. 2;Aquatic Chronic 2,Notified C&L,1,H411:1;H341:1;H317:1;H302:1
231388,"(1R,2S,6R,7S)-4-{[(1R,2R)-2-{[4-(1,2-benzothiazol-3- yl)piperazin-1-yl]methyl}-cyclohexyl]methyl}-4- azatricyclo[5.2.1.0^{2,6}]decane-3,5-dione",696-042-8,367514-87-2,STOT SE 3;Carc. 2,REACH registration C&L,2,H336:1;H351:1;H361:1;H332:1;H317:1;H302:1
231394,"1-cyclopropyl-butane-1,3-dione",696-044-9,21573-10-4,Flam. Liq. 3;Skin Irrit. 2;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,157,H226:157;H317:156;H315:157;H400:156;H410:156;H412:1;H319:1;H335:1
231395,"2-(3,3,3-trifluoro-propyl)-benzenesulfonamide",696-045-4,94125-42-5,Skin Sens. 1B;Aquatic Chronic 3,Notified C&L,156,H412:156;H317:156
231396,"1-[2-(2,4-dichloro-phenyl)-pent-1-ylidene]-2-acetylhydrazine",696-047-5,89586-70-9,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,156,H400:156;H410:156
231398,"2-{[1,1'-bi(cyclopropane)]-2-yl}aniline",696-049-6,890408-75-0,Skin Sens. 1B;Acute Tox. 4;STOT RE 2;Aquatic Chronic 2,Notified C&L,156,H411:156;H373:156;H332:156;H317:156
231399,"2-(4-chloro-phenyl)-3-ethyl-5-oxo-2,5-dihydro-pyridazine-4-carboxylic acid potassium salt",696-050-1,82697-71-0,Eye Irrit. 2,Notified C&L,194,H319:194
231400,[No public or meaningful name is available],696-051-7,105088-01-5,Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,156,H400:156;H317:156;H410:156
231401,Reaction mass of 106-24-1 and 5989-27-5 and 78-70-6 and 89-83-8,938-696-1,,Acute Tox. 4;Asp. Tox. 1;Skin Corr. 1B;STOT SE 3;Aquatic Chronic 2,Notified C&L,1,H411:1;H314:1;H304:1;H335:1;H302:1
231402,[No public or meaningful name is available],696-053-8,347840-07-7,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H315:38;H335:38;H319:38;H301:38
231403,[No public or meaningful name is available],696-054-3,65100-45-0,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H315:38;H335:38;H319:38;H301:38
231404,[No public or meaningful name is available],696-055-9,1020719-76-9,Acute Tox. 3,Notified C&L,56,H301:56
231405,[No public or meaningful name is available],696-056-4,203784-52-5,Acute Tox. 4,Notified C&L,56,H302:56
231406,[No public or meaningful name is available],696-058-5,1246832-91-6,Acute Tox. 3,Notified C&L,56,H301:56
231410,Sodium cobalt tetracarbonyl,696-062-7,14878-28-5,Acute Tox. 4;Skin Sens. 1;Acute Tox. 1;Carc. 2;Aquatic Chronic 3,Notified C&L,1,H412:1;H330:1;H317:1;H351:1;H302:1
231412,"Alcohols, C10-12, ethoxylated",938-698-2,,Acute Tox. 4;Eye Dam. 1,Notified C&L,8,H318:8;H302:8
231413,[No public or meaningful name is available],696-063-2,38343-57-6,Repr. 2,Notified C&L,1,H361:1
231414,[No public or meaningful name is available],696-064-8,4314-67-4,Repr. 2,Notified C&L,1,H361:1
231415,"2-N-[4-[bis(2-aminoethylsulfanyl)arsanyl]phenyl]-1,3,5-triazine-2,4,6-triamine dihydrochloride",696-065-3,89141-50-4,Acute Tox. 3;Eye Irrit. 2;Acute Tox. 4,Notified C&L,2,H319:2;H332:2;H301:1;H302:1
231416,"N-(4-Vinylbenzyl)-N,N-dimethylamine",696-066-9,2245-52-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
231418,ethenyl 2-propylheptanoate,938-701-7,,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
231419,2-Isopropyl-5-methylhexanoic acid,696-067-4,4384-07-0,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1,Notified C&L,1,H315:1;H318:1;H302:1
231421,"m-TDI oligomers, isocyanurate",938-708-5,,Skin Sens. 1B;Resp. Sens. 1,REACH registration C&L,5,H334:4;H317:5;H331:1;H330:1;H351:1;H332:1
231426,5-fluoro-2-[[1-(2-hydroxyethyl)-1H-indazol-5-yl]oxy]-benzonitrile,696-069-5,945614-25-5,Aquatic Chronic 2,Notified C&L,1,H411:1
231428,C9-15 ALKYL PHOSPHATE,696-070-0,190454-07-0,Skin Corr. 1B,Notified C&L,19,H314:19
231429,"3-(Dibenz[b,e]oxepin-11(6H)-ylidene)-N-(methyl-d3)-1-propanamine",938-709-0,,Acute Tox. 4;Aquatic Acute 1,Notified C&L,38,H400:38;H302:38
231430,"lauric acid (CAS number: 143-07-7 , EC number: 205-582-1)",938-710-6,,Eye Dam. 1,Notified C&L,1,H318:1
231431,"Barium compound with Lithium, 1:4",938-711-1,,Water-react. 1;Skin Corr. 1B;STOT SE 3,Notified C&L,4,H314:4;H335:4;H260:4
231436,"3,6,9,12,15,18,21,24-Octaoxahexatriacontan-1-ol",696-071-6,3055-98-9,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,41,H318:41;H335:41;H315:41
231437,2-Formyl-5-methylbenzeneboronic acid,696-072-1,40138-17-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
231438,2-Bromo-5-chloropyrazine,696-073-7,912773-21-8,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,3,H332:2;H312:2;H302:3;H319:1;H315:1;H335:1
231439,2-Bromo-1-iodo-4-(trifluoromethoxy)benzene,696-074-2,883546-30-3,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H332:1;H312:1;H315:1;H335:1;H302:1
231440,"2,6-Dihydroxybenzeneboronic acid",696-075-8,848409-34-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
231441,Pyrimidine-2-carboxaldehyde,696-076-3,27427-92-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
231442,Ethyl 3-fluoro-2-oxopropanoate,696-077-9,760-10-1,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H226:1;H315:1
231443,3-Chloro-5-methylpyridazine,696-078-4,89283-31-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:2;H315:2;H351:1
231444,"3,5-Dibromo-2-methylpyridine",696-080-5,38749-87-0,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H332:1;H312:1;H315:1;H335:1;H302:1
231445,4-Bromo-5-methyl-1H-indazole,696-081-0,926922-40-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
231446,(RS)-1-[2-(Trifluoromethyl)phenyl]ethylamine 98%,696-082-6,273384-78-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
231447,4-Chloro-5-fluoro-2-nitrophenol,696-083-1,345-25-5,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,2,H319:2;H332:2;H312:2;H315:2;H335:2;H302:2
231448,5-Bromo-2-iodoanisole,696-084-7,791642-68-7,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H332:1;H312:1;H315:1;H335:1;H302:1
231449,Propane-1-sulphonamide,696-085-2,24243-71-8,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,2,H319:2;H332:2;H312:2;H315:2;H335:2;H302:2
231450,6-Nitro-2-(pentafluoroethyl)-1H-benzimidazole,696-086-8,4229-01-0,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
231451,4-Amino-2-ethoxypyridine,696-087-3,89943-12-4,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H332:1;H312:1;H315:1;H335:1;H302:1
231452,1-methyl-1H-indazol-4-amine,696-088-9,77894-69-0,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,2,H319:2;H332:1;H312:1;H315:2;H335:2;H302:2
231453,"5-Methyl-1,3-thiazole-4-carboxylic acid",696-089-4,120237-76-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
231454,3-(Chloromethyl)-5-methylpyridine hydrochloride,696-091-5,1007089-84-0,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,2,H319:2;H332:2;H312:2;H315:2;H335:2;H302:2
231455,"3-Bromo-1H-indole-5-carbonitrile, N-BOC protected",696-092-0,348640-12-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
231456,5-Fluoro-2-methoxynicotinaldehyde,696-093-6,351410-62-3,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H332:1;H312:1;H315:1;H335:1;H302:1
231457,3-Fluoropyridine-4-boronic acid hydrate,696-094-1,1029880-18-9,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,2,H332:1;H312:1;H302:1;H319:1;H335:1;H315:1
231458,"4-[(Ethylcarbamoyl)amino]benzeneboronic acid, pinacol ester",696-095-7,874291-00-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
231459,"1,3-thiazol-2-ylmethanol",696-096-2,14542-12-2,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,2,H319:2;H332:1;H312:1;H315:2;H335:2;H302:2
231460,"6-Chloro-3H-imidazo[4,5-c]pyridine",696-097-8,2589-11-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
231464,Reaction mass of 68439-46-3 and 7320-34-5,938-717-4,,Skin Irrit. 2;Eye Dam. 1,Notified C&L,1,H318:1;H319:1;H315:1
231468,"Decyl alcohol, ethoxylated (EO = 6)",938-720-0,,Acute Tox. 4;Eye Dam. 1,Notified C&L,8,H318:8;H302:8
231470,"Alcohols, C10-12, ethoxylated (EO = 6)",938-721-6,,Acute Tox. 4;Eye Dam. 1,Notified C&L,8,H318:8;H302:8
231471,[No public or meaningful name is available],938-722-1,1793072-86-2,Acute Tox. 2,Notified C&L,6,H330:6
231472,4-amino-1-methyl-3-propyl-1H-pyrazole-5-carboxamide hydrochloride (1:1),938-723-7,,Eye Dam. 1,REACH registration C&L,1,H318:1
231481,trisodium;zinc;2-[bis[2-[bis(carboxylatomethyl)amino]ethyl]amino]acetate,696-103-9,125833-02-5,Eye Irrit. 2;Acute Tox. 4;Repr. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H319:1;H332:1;H361:1;H400:1;H410:1
231482,"(10S)-10-amino-5-hydroxy-3,4-dimethoxy-14-(methylsulfanyl)tricyclo[9.5.0.0^{2,7}]hexadeca-1(16),2(7),3,5,11,14-hexaen-13-one",696-104-4,97043-09-9,Acute Tox. 2;Eye Dam. 1;Acute Tox. 2,Notified C&L,1,H300:1;H318:1;H330:1
231483,"Dibenzo[b,f][1,4]thiazepin-11-amine HCl",696-106-5,1176987-11-3,Not Classified,Notified C&L,1,Not classified:1
231484,"(E)-2-(2-(4-dibenzo[b,f][1,4]thiazepin-11-yl)piperazin- 1-yl)ethoxy)ethanol hydrochloride",696-107-0,930086-71-8,Not Classified,Notified C&L,1,Not classified:1
231485,"Acetamide, N-[(7S)-3-(beta-D-glucopyranosyloxy)-5,6,7,9-tetrahydro-1,2-dimethoxy-10-(methylsulfinyl)-9-oxobenzo[a]heptalen-7-yl]-",696-108-6,1359973-79-7,Acute Tox. 3;Acute Tox. 3,Notified C&L,1,H331:1;H301:1
231486,"Acetamide, N-[(7S)-3-(beta-D-glucopyranosyloxy)-5,6,7,9-tetrahydro-1,2-dimethoxy-10-(methylsulfonyl)-9-oxobenzo[a]heptalen-7-yl]-",696-109-1,1359973-80-0,Acute Tox. 3;Acute Tox. 3,Notified C&L,1,H331:1;H301:1
231490,"Reaction mass of bis(2-ethylhexyl) phthalate and Resins, Aquilaria agallocha",938-731-0,,Repr. 1A,Notified C&L,1,H360:1
231498,"Amines, C12-16 (even numbered)-alkyldimethyl, N-oxides",938-774-5,,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,33,H411:33;H315:33;H318:33;H302:33;H400:33;H410:2
231500,"Phenol, 2,6-bis(1,1-dimethylethyl)-4-(4-morpholinylphenylmethyl)-",696-112-8,17330-10-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 4,Notified C&L,1,H319:1;H413:1;H317:1;H315:1;H335:1;H302:1
231501,"3-Chloro-10,11-dihydro-N,N-(dimethyl-d6)-5H-dibenz[b,f]azepine-5-propanamine",938-741-5,,Acute Tox. 4,Notified C&L,38,H302:38
231507,2-Methyl-1H-benzimidazole-5-boronic acid pinacol ester,696-114-9,1314216-34-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
231508,"2,2,6,6-Tetramethyl-3,6-dihydro-2H-pyran-4-boronic acid pinacol ester",696-115-4,1142363-56-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
231510,"Benzenepropanoic acid, b-(nitromethyl)-, methyl ester",696-117-5,34687-03-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H315:1;H335:1;H319:1;H302:1
231512,"Alcohols, C12-14, propoxylated",938-745-7,,Acute Tox. 4,Notified C&L,8,H312:8
231513,4-Amino-2-chlorophenylboronic acid pinacol ester,696-118-0,877160-63-9,,Notified C&L,2,H319:2;H335:2;H315:2
231531,"4-(1-hydroxy-1,3-dihydrobenzo[c][1,2]oxaborol-5-yloxy)benzonitrile",696-120-1,906673-24-3,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,92,H315:90;H319:91;H302:90;Not classified:1
231533,"1-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-1H-pyrazole",696-121-7,852227-94-2,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
231534,1-(phenylsulfonyl)-1H-indol-3-ylboronic acid,696-122-2,129271-98-3,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
231535,"(1S,3S,5S)-2-[(2S)-2-Amino-2-(3-hydroxyadamantan-1-yl)acetyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile hydrochloride",696-124-3,709031-78-7,Skin Sens. 1B;STOT SE 3;Carc. 2;Repr. 2;STOT RE 1,Notified C&L,1,H335:1;H372:1;H317:1;H351:1;H361:1
231541,1-(3-Phenoxycarbonamidophenyl)-5-mercaptotetrazole,696-125-9,92339-43-0,Flam. Sol. 2,Notified C&L,1,H228:1
231542,"sodium 3-((2,3-dicyanophenyl)sulfonyl)propane-1-sulfonate",696-126-4,886592-17-2,Not Classified,Notified C&L,1,Not classified:1
231543,"Poly{oxy(methyl-1,2-ethanediyl)], a-(2-aminopropyl)-w(3-aminopropoxyl)-",938-755-1,,Skin Corr. 1C;Eye Dam. 1,Notified C&L,446,H314:446;H318:446
231544,"Poly[oxy(methyl-1,2-ethanediyl)], a-(2-aminopropyl)-w-hydroxy-",938-756-7,,Skin Corr. 1C;Eye Dam. 1,Notified C&L,446,H314:446;H318:446
231545,"N,N-dibutyl-N-methyl-Poly(oxy-1,2-ethanediyl)-1-aminium methyl sulfate",938-757-2,,Acute Tox. 4;Eye Dam. 1;Aquatic Chronic 2,Notified C&L,446,H318:446;H411:446;H302:446
231548,Di-sec-butyl dimethoxysilane,696-128-5,248590-11-6,Skin Irrit. 2;Skin Sens. 1;Aquatic Chronic 3,Notified C&L,17,H412:17;H317:17;H315:17
231559,"Reaction mass of bis(polysubstituted hexanoic acid) bis(3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluorooctyl) diphosphate and bis(polysubstituted hexanoic acid) 3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluorooctyl phosphate and polysubstituted hexanoic acid bis(3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluorooctyl) hydrogen diphosphate and polysubstituted hexanoic acid bis(3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluorooctyl) phosphate and polysubstituted hexanoic acid 3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluorooctyl hydrogen phosphate",,,Acute Tox. 3;STOT SE 1,REACH registration C&L,2,H331:2;H370:2
231561,[No public or meaningful name is available],696-129-0,101377-41-7,Eye Irrit. 2,Notified C&L,2,H319:2
231568,Acryloxybuthyl chloroformate,938-767-7,,Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1,Notified C&L,1,H318:1;H317:1;H315:1
231570,"Glycine, N-(phosphonomethyl)-, compd. with N-methylmethanamine (1:1)",696-134-8,34494-04-7,Aquatic Chronic 2,Notified C&L,56,H411:56
231576,"N,N,N-trimethylcyclohexanaminium hydroxide",696-139-5,19895-48-8,Met. Corr. 1;Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1,REACH registration C&L,84,H290:84;H314:84;H318:84;H302:84
231580,2-[3-chloro-5-(trifluoromethyl)pyridin-2-yl]acetonitrile,696-141-6,157764-10-8,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H332:1;H312:1;H315:1;H335:1;H302:1
231581,"Alcohols C12-15, ethoxylated",938-775-0,,Eye Dam. 1;Aquatic Acute 1,Notified C&L,10,H318:10;H400:10
231582,"Alcohols, C12-15 ethoxylated",938-776-6,,Acute Tox. 4;Aquatic Acute 1,Notified C&L,10,H400:10;H302:10
231587,"Reaction mass of 1-(1,1-dimethoxyethyl)-3,3-dimethylcyclohexene and 1-(1,1-dimethoxyethyl)-5,5-dimethylcyclohexene",938-779-2,,Flam. Liq. 3,REACH registration C&L,1,H226:1
231590,2-benzo[b]furan-3-ylethylamine,696-142-1,27404-31-5,Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1,Notified C&L,3,H314:3;H318:2;H302:2
231591,"Alcohols, C12-14(even numbered), ethoxylated, propoxylated (polymer)",938-783-4,,Aquatic Acute 1,Notified C&L,1,H400:1
231592,"1,10-phenanthroline; (trifluoromethyl)copper",696-143-7,1300746-79-5,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,40,H315:40;H319:40;H312:40;H302:40
231593,1-BOC-3-Aminopiperidine,696-144-2,144243-24-3,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H315:39;H335:39;H319:39;H302:39
231594,5-(2-(4-(benzo[d]isothiazol-3-yl)piperazin-1-yl)ethyl)-6-chloroindolin-2-one hydrogen sulfate,938-785-5,,Skin Sens. 1;STOT SE 3;Aquatic Chronic 1,Notified C&L,1,H336:1;H317:1;H410:1
231599,Emulsion based on a cationic polyacrilamide,938-790-2,,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
231603,"Tetrasodium {3,3',3'',3'''-[(29H,31H-phthalocyanine-1,8,15,22-tetrayl-k4N29,N30,N31,N32)tetrasulfonyl]tetrapropane-1-sulfonato(6-)}cuprate(4-)",696-145-8,944730-39-6,Aquatic Chronic 3,Notified C&L,1,H412:1
231606,"Reaction mass of 202667-46-7 and 1-(tert-butylaminodimethylsilyl)-2-methyl-3,5,6,7-tetrahydro-s-indacene",938-796-5,273750-73-5,Acute Tox. 4,Notified C&L,1,H302:1
231609,"3-Chloro-10,11-dihydro-N-(methyl-d3)-5H-dibenz[b,f]azepine-5-propanamine Hydrochloride",938-798-6,,Acute Tox. 4,Notified C&L,38,H302:38
231610,"10,11-DIHYDRO-N,β-DIMETHYL-N-(METHYL-D3)-5H-DIBENZ[B,F]AZEPINE-5-PROPANAMINE (2Z)-2-BUTENEDIOATE",938-799-1,,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H315:38;H335:38;H319:38;H302:38
231611,10-(2-Methyl-3-(dimethyl-d6)aminopropyl)phenothiazine Tartrate,938-800-5,,Acute Tox. 3,Notified C&L,1,H301:1
231612,(R)-N-(Methyl-d3)-(2-methylphenoxy)benzenepropanamine Hydrochloride,938-801-0,,Acute Tox. 3;Eye Irrit. 2;Acute Tox. 3;Aquatic Acute 1,Notified C&L,38,H319:38;H331:38;H400:38;H301:38
231615,Reaction mass of 7704-98-5 and 7778-74-7,938-803-1,,Ox. Sol. 1;Acute Tox. 4,Notified C&L,20,H271:20;H302:20
231621,Long oil ZA alkyd resin,938-806-8,,Asp. Tox. 1,Notified C&L,1,H304:1
231622,(+)-(S)-NMethyl-γ-(1-naphthyloxy-d7)-2-thiophenepropylamine Maleate;,938-807-3,,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1,Notified C&L,38,H315:38;H318:38;H302:38
231623,Benzamide derivative,,,STOT RE 2,Notified C&L,35,H373:35
231624,Reaction mass of 138-86-3 and 562-74-3 and 586-62-9 and 80-56-8 and 8000-41-7 and 99-86-5 and 99-87-6,938-809-4,,Flam. Liq. 3;Acute Tox. 4;Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1;Aquatic Chronic 2,Notified C&L,1,H411:1;H226:1;H317:1;H315:1;H304:1;H302:1
231625,β-(AMINOMETHYL)-4-CHLORO-BENZENEPROPANOIC ACID-D4,938-811-5,,Acute Tox. 3;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Resp. Sens. 1;STOT SE 3;Repr. 1B,Notified C&L,38,H319:38;H360:38;H317:38;H315:38;H334:38;H335:38;H301:38
231626,"(alpha-R)-2, 2-Dimethyl-alpha-[{(phenylmethyl)amino}methyl]-4H-1, 3-benzodioxin-6-methanol",696-147-9,452342-08-4,Skin Irrit. 2;Aquatic Chronic 2,Notified C&L,1,H411:1;H315:1
231631,"Reaction mass of 4-hydroxybenzene-1,3-disulphonic acid and 4-hydroxybenzenesulphonic acid and sulphuric acid and water",938-815-7,,Met. Corr. 1;Skin Corr. 1A;Eye Dam. 1,REACH registration C&L,2,H290:2;H314:2;H318:2
231637,N-(1-methylcyclobutyl)-1-[(1-carbethoxy)azepan-4-(S)-yl]piperidine-4-carboxamide,938-817-8,,Acute Tox. 4;Acute Tox. 4;STOT RE 2;Aquatic Chronic 3,Notified C&L,1,H412:1;H332:1;H373:1;H312:1
231638,N-(1-Methylcyclobutyl)-1-[(1-carbethoxy)azepan-4-(S)-yl]piperidine-4-carboxamide hydrochloride,938-818-3,,Acute Tox. 4;Acute Tox. 4;STOT RE 2;Aquatic Chronic 3,Notified C&L,1,H412:1;H332:1;H373:1;H312:1
231645,[No public or meaningful name is available],696-153-1,676647-57-7,Flam. Sol. 2;Asp. Tox. 1;Skin Irrit. 2;STOT SE 3;Repr. 2;STOT RE 2;Aquatic Chronic 3,Notified C&L,1,H412:1;H373:1;H315:1;H228:1;H336:1;H304:1;H361:1
231648,alkaline distillation residues from epsilon-caprolactam,938-820-4,,Met. Corr. 1;Skin Corr. 1C;STOT SE 3,REACH registration C&L,84,H290:84;H314:84;H335:84;H318:83
231649,"Reaction mass of isomers disodium 8-(2-{4-[benzyl(ethyl)amino]-2-methylphenyl}diazen-1-yl)-5-(2-{2,5-dimethyl-4-[2-(3-sulfonatophenyl)diazen-1-yl]phenyl}diazen-1-yl)naphthalene-2-sulfonate, disodium 5-(2-{4-[benzyl(ethyl)amino]-2-methylphenyl}diazen-1-yl)-8-(2-{2,5-dimethyl-4-[2-(3-sulfonatophenyl)diazen-1-yl]phenyl}diazen-1-yl)naphthalene-2-sulfonate",700-946-0,,Skin Sens. 1B,REACH registration C&L,2,H317:2
231655,"1-(4-Chloro-1,1-dimethoxybutyl)-4-fluorobenzene",696-157-3,57390-39-3,Acute Tox. 4;Muta. 2,Notified C&L,1,H341:1;H302:1
231658,"(2R)-2-[[2-amino-5-[(1S)-1-phenylethyl]sulfanyl-thiazolo[4,5-d]pyrimidin-7-yl]amino]-4-methyl-pentan-1-ol",938-825-1,,STOT RE 2;STOT RE 2,Notified C&L,3,H373:3
231660,2-[2-[4-(benzenesulfonyl)-2-fluoro-phenyl]-4-chloro-phenoxy]acetic acid,938-826-7,,Acute Tox. 4,Notified C&L,3,H302:3
231661,"(5S)-5-methyl-5-[[4-[4-(1,1,2,2-tetrafluoroethoxy)phenoxy]-1-piperidyl]sulfonylmethyl]imidazolidine-2,4-dione",938-827-2,,STOT RE 1;STOT RE 1,Notified C&L,3,H372:3
231662,"Iron(III) chloride, complex with reaction products of 2,2'-(ethane-1,2-diyldiimino)diacetic acid, formaldehyde, phenol and potassium hydroxide",938-828-8,,Not Classified,REACH registration C&L,1,Not classified:1
231663,"2-[(3-nitropyrazolo[1,5-a]pyridin-2-yl)oxy]ethanol",938-829-3,936103-10-5,Aquatic Chronic 2,REACH registration C&L,3,H411:3
231665,2-Bromo-4'-methylpropiophenone,696-162-0,1451-82-7,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
231666,"3,4-Dichlorophenylmagnesium bromide",696-163-6,79175-35-2,Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1,Notified C&L,1,H314:1;H318:1;H302:1
231667,(2S)-2-[(tert-butoxycarbonyl)amino]butanoic acid,696-164-1,34306-42-8,,REACH registration C&L,3,Not classified:1;H319:2;H335:2;H315:2
231675,"1,3-diethyl 2-{[(pyridin-3-yl)amino]methylidene}propanedioate",696-166-2,14029-71-1,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
231676,[No public or meaningful name is available],696-167-8,59878-63-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,38,H319:38;H335:38;H315:38
231677,"6-iodo-2,3-dihydro-1H-indole-2,3-dione",696-168-3,20780-77-2,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
231678,3-{[(tert-butoxy)carbonyl]amino}benzoic acid,696-169-9,111331-82-9,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,2,H332:1;H312:1;H302:2;H315:1;H335:1;H319:1
231679,[4-({5-[4-(aminomethyl)phenoxy]pentyl}oxy)phenyl]methanamine,696-170-4,224054-40-4,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
231680,"methyl 2-(2-amino-5-ethyl-1,3-thiazol-4-yl)acetate",696-172-5,28942-54-3,Skin Sens. 1,Notified C&L,39,H317:38;H332:1;H312:1;H302:1
231681,"2,3,5-trifluoro-6-hydrazinylpyridin-4-amine",696-173-0,105252-94-6,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
231682,"ethyl 4-{2,4-dioxo-3- azatricyclo[7.3.1.0^{5,13}]trideca-1(13),5,7,9,11- pentaen-3-yl}butanoate",696-174-6,150705-10-5,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
231683,1-methyl-4-(methylsulfanyl)carbothioylpiperazine,696-175-1,98428-90-1,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
231684,N-(6-Aminohexyl)-N-Methyl-1.6-Hexanediamine,696-176-7,41318-22-3,Acute Tox. 4;Skin Corr. 1A;Skin Sens. 1;Acute Tox. 3;Aquatic Chronic 2,Notified C&L,4,H411:4;H314:4;H317:4;H331:4;H302:4
231685,"4-hydrazinyl-2,6-bis(trifluoromethyl)pyridine",938-837-7,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
231686,3-chloro-5-(ethoxycarbonyl)pyridine-2-carboxylic acid,696-177-2,1200497-77-3,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
231687,"6-iodo-8-methyl-2,4-dihydro-1H-3,1-benzoxazine-2,4-dione",696-178-8,913194-96-4,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
231688,2-chloro-1-(4-hydroxy-3-methoxyphenyl)propan-1-one,696-179-3,68505-86-2,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H332:1;H312:1;H315:1;H335:1;H302:1
231689,"ethyl 6-{2,4-dioxo-3- azatricyclo[7.3.1.0^{5,13}]trideca-1(13),5,7,9,11- pentaen-3-yl}hexanoate",938-838-2,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
231690,"Ethyl 1H,4H,5H,6H-cyclopenta[c]pyrazole-3-carboxylate",696-180-9,5932-31-0,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,2,H332:2;H312:2;H302:2
231691,tert-butyl 4-[(2-fluoro-5-nitrophenyl)carbonyl]piperazine-1-carboxylate,938-839-8,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
231692,"4-{2-methyl-1H-imidazo[4,5-b]pyridin-1-yl}piperidine dihydrochloride",938-840-3,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
231693,"8-bromo-7-methoxy-1,2,3,4-tetrahydronaphthalen-1-one",696-181-4,61362-78-5,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H332:1;H312:1;H315:1;H335:1;H302:1
231694,"1H,4H,5H,6H-cyclopenta[c]pyrazole-3-carboxamide",696-183-5,851776-30-2,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
231696,5-(4-chlorophenyl)pyridin-2-amine,696-184-0,84596-08-7,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
231698,(1-azaniumyl-2-methylpropan-2-yl)(benzyl)azanium dichloride,938-844-5,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
231699,methyl 2-methyl-2-[(4-methylphenyl)amino]propanoate,938-845-0,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
231700,tert-butyl 4-[(2-amino-3-methylphenyl)carbonyl]piperazine-1-carboxylate,938-846-6,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
231701,"3-bromo-7-chloro-1H-pyrrolo[2,3-c]pyridine",938-847-1,,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H332:1;H312:1;H315:1;H335:1;H302:1
231704,"Alcohols, C12-16, ethoxylated, propoxylated (EO=12, PO=2)",938-850-8,,Eye Dam. 1,Notified C&L,8,H318:8
231707,"Dinonylphenols, branched, ethoxylated (EO = 4)",938-852-9,,Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,8,H319:8;H411:8;H315:8
231709,(R)-(+)-2-[6-(4-Chlorophenoxy)hexyl]-oxirane-2-carboxylic acid sodium salt,696-186-1,828934-41-4,Acute Tox. 3,Notified C&L,1,H301:1
231710,"Bis(2,2'-bipyridine-N,N')bis(S-nicotine-N1) ruthenium(2+) dichloride",696-187-7,1256362-30-7,Acute Tox. 3;Acute Tox. 2;Aquatic Chronic 2,Notified C&L,1,H310:1;H411:1;H301:1
231711,"ethyl 4,5,6,7-tetrahydro-1H-indazole-3-carboxylate",696-188-2,4492-02-8,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
231712,"Benzenesulfonic acid, C14-24-branched and linear alkyl derivs., sodium salts",938-855-5,,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,8,H319:8;H315:8
231713,4-methyl-N-(propan-2-yl)aniline,938-856-0,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
231714,5-(4-chlorophenyl)-3-iodopyridin-2-amine,938-857-6,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
231715,"methyl 5-oxo-4H,5H,6H,7H,8H-furo[3,2-b]azepine-3-carboxylate",938-858-1,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
231716,"1H,4H,5H,6H-cyclopenta[c]pyrazole-3-carbonitrile",696-189-8,851776-29-9,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
231717,"N-methyl-1H,4H,5H,6H-cyclopenta[c]pyrazole-3-carboxamide",938-859-7,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
231718,"4,5,6,7-tetrahydro-1H-indazole-3-carbohydrazide",696-190-3,90434-92-7,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
231719,"Benzyl 3,4-dihydro-4-oxo-pyridine-1(2H)-carboxylate",696-191-9,185847-84-1,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,2,H332:2;H312:2;H302:2
231720,"1-(3-bromophenyl)-4,5,6,7-tetrahydro-1H-indazol-4-one",938-860-2,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
231721,"1-[(4-chlorophenyl)methyl]-5,5-dimethylimidazolidin-2-one",938-861-8,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
231722,"4,5,6,7-tetrahydro-1H-indazole-3-carboxamide",938-862-3,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
231723,methyl 2-{[(4-chlorophenyl)methyl]amino}-2-methylpropanoate,938-863-9,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
231724,"Branched C11-14, C13-rich alcohols, sulfated, ethoxylated, propoxylated, sodium salts (EO = 0.1, PO = 4)",938-864-4,,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,8,H319:8;H315:8
231726,"Dinonylphenol, ethoxylated, propoxylated, carboxylated, sodium salt (EO = 10, PO = 20)",938-866-5,,Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 4,Notified C&L,8,H319:8;H413:8;H315:8
231727,2-Bromo-4-fluoro-5-methylbenzonitrile,696-194-5,916792-07-9,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Notified C&L,1,H331:1;H311:1;H301:1
231728,2-Bromo-6-hydroxybenzaldehyde,696-195-0,22532-61-2,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,3,H332:3;H312:2;H302:3;H319:1;H315:1;H335:1
231729,Methyl 6-bromo-5-fluoropyridine-2-carboxylate,696-196-6,1210419-26-3,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H332:1;H312:1;H315:1;H335:1;H302:1
231730,5-Bromoquinoxaline,696-197-1,76982-23-5,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Acute Tox. 4,Notified C&L,2,H314:1;H332:1;H312:1;H302:2;H315:1;H335:1;H318:1
231731,1-(Perfluorohexyl)octane,696-198-7,133331-77-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:2;H315:2
231732,Fmoc-3-iodo-L-phenylalanine,696-199-2,210282-31-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
231733,"4-Amino-6-chloro-3H-imidazo[4,5-c]pyridine",696-200-6,52559-17-8,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
231734,7-Bromo-2-methyl-2H-indazole,696-201-1,701910-14-7,Acute Tox. 4,Notified C&L,39,H302:38;H319:1;H335:1;H315:1
231735,2-Bromofuran,696-202-7,584-12-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,3,H319:1;H335:1;H315:1;H225:2
231736,"1H,1H-Tridecafluoroheptylamine",696-203-2,423-49-4,Skin Corr. 1B,Notified C&L,1,H314:1
231737,"4-(tert-Butyl)-2,6-dibromoaniline",696-204-8,10546-67-5,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
231738,(isoquinolin-6-yl)boronic acid,696-205-3,899438-92-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,41,H319:41;H335:41;H315:41;H302:1
231739,"1,2-thiazol-3-ol",696-206-9,1003-07-2,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,2,H319:2;H332:1;H312:1;H315:2;H335:2;H302:2
231740,6-Bromo-4-hydroxyquinazoline,696-207-4,32084-59-6,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,3,H319:3;H332:1;H312:1;H315:3;H335:2;H302:1
231741,2-(Methylsulfonyl)phenylboronic Acid,696-209-5,330804-03-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:1;H315:2
231742,1-Methylindolin-5-yl isocyanate,696-210-0,921938-71-8,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Notified C&L,1,H331:1;H311:1;H301:1
231743,3-Amino-6-bromo-2-methoxypyridine,696-211-6,89466-18-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
231744,1-benzothiophene-2-sulfonyl chloride,696-212-1,90001-64-2,Skin Corr. 1B,Notified C&L,2,H314:2
231745,"2,6-Dimethylisonicotinic acid",696-213-7,54221-93-1,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H332:1;H312:1;H315:1;H335:1;H302:1
231746,2-Bromo-5-iodobenzotrifluoride,696-214-2,364-11-4,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H332:1;H312:1;H315:1;H335:1;H302:1
231747,"N2-Cyclopropylpyridine-2,3-diamine",696-215-8,290313-23-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
231748,Ethyl 3-hydroxyisonicotinate,696-216-3,18342-97-7,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H332:1;H312:1;H315:1;H335:1;H302:1
231749,2-Bromo-3-fluoro-6-methylpyridine,696-217-9,374633-36-0,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H332:1;H312:1;H315:1;H335:1;H302:1
231750,Triethylene glycol isobutyl ether,938-867-0,,Eye Irrit. 2,Notified C&L,8,H319:8
231754,"Reaction mass of disodium [2,2'-(imino-κN)dibutanedioato-κ2O1,O4(4-)]cuprum(2-) and sodium sulphate",938-868-6,,Acute Tox. 4;Aquatic Chronic 3,Notified C&L,1,H412:1;H302:1
231755,"Amides, C18 (saturated and unsaturated)",938-869-1,,Not Classified,Notified C&L,2,Not classified:2
231759,"8-sec-Butyl-5,6,7,8-tetrahydroquinoline",938-871-2,,Skin Sens. 1;Aquatic Chronic 2,Notified C&L,1,H411:1;H317:1
231761,"Reactionmass of 2-Piperazin-1-ylethanol, Piperazine-1,4-diethanol, Piperazine, Water",938-872-8,,Skin Corr. 1B;Skin Sens. 1;Eye Dam. 1;Resp. Sens. 1;Repr. 2,Notified C&L,83,H314:83;H317:83;H318:83;H334:83;H361:83
231763,"[2-(hexanoyloxymethyl)-1,3-dihydroperimidin-2-yl]methyl hexanoate",696-218-4,211933-17-4,Acute Tox. 4;Skin Sens. 1B,REACH registration C&L,3,H317:2;H302:2;H319:1;H335:1;H315:1
231765,"(2S)-1-(3,3-dimethyl-2-oxopentanoyl)pyrrolidine-2-carboxylic acid",696-220-5,186268-78-0,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
231766,"ethyl 1H-pyrrolo[2,3-c]pyridine-7-carboxylate",696-221-0,945840-74-4,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
231767,"5-nitro-3,4-dihydro-2H-1,4-benzoxazin-3-one",696-222-6,132522-81-7,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
231768,"1H-pyrrolo[2,3-c]pyridine-7-carboxylic acid",696-223-1,945840-82-4,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
231769,"1H-pyrrolo[2,3-c]pyridin-7-ylmethanol",696-224-7,1260385-31-6,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
231770,ethyl 2-methylpyridine-4-carboxylate,696-225-2,25635-17-0,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
231771,ethyl 2-methylpyridine-4-carboxylate,696-226-8,137469-90-0,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
231772,"5-amino-3,4-dihydro-2H-1,4-benzoxazin-3-one",696-227-3,148890-63-5,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
231773,ethyl 4-chloro-5-(trifluoromethyl)-1H-pyrazole-3-carboxylate,938-873-3,,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H332:1;H312:1;H315:1;H335:1;H302:1
231774,"1H-pyrrolo[2,3-c]pyridin-7-ylmethanol",938-874-9,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
231775,"Decene, hydroformylation products, low boiling",938-875-4,,Flam. Liq. 3;Asp. Tox. 1;STOT SE 3;Aquatic Chronic 2,Notified C&L,1,H304:1;H336:1;H226:1;H411:1
231776,"ethyl 5,7-bis(trifluoromethyl)-1,8-naphthyridine-2-carboxylate",938-877-5,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
231777,2-methylpyridine-4-carbaldehyde,696-228-9,63875-01-4,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,3,H332:2;H312:2;H302:2;H319:2;H335:2;H315:2
231778,"5,7-bis(trifluoromethyl)-1,8-naphthyridine-2-carboxylic acid",938-878-0,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
231779,ethyl 6-[cyano(phenyl)methyl]pyridine-2-carboxylate,938-879-6,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
231780,2-(10H-phenothiazin-10-yl)ethan-1-amine hydrochloride,696-229-4,50971-79-4,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
231781,6-[cyano(phenyl)methyl]pyridine-2-carboxylic acid,938-880-1,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
231782,4-methyl-2-[4-(trifluoromethyl)phenyl]benzoic acid,938-881-7,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
231783,"ethyl 5-bromo-4-chloro-1-methyl-6-oxo-1,6-dihydropyridine-3-carboxylate",938-882-2,,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H332:1;H312:1;H315:1;H335:1;H302:1
231785,"1-Hexyl 4,5-diamino pyrazole hemisulfate",696-231-5,1361000-03-4,Acute Tox. 3;Acute Tox. 4;Skin Sens. 1B;Acute Tox. 3;STOT RE 1;Aquatic Chronic 2,REACH registration C&L,3,H411:3;H312:3;H372:3;H317:3;H331:3;H301:3
231787,steardimmonium hydroxypropyl oxyethyl cellulose,696-233-6,154608-55-6,Skin Irrit. 2;Eye Dam. 1,Notified C&L,18,H318:18;H315:18
231788,"Keratins, hydrolyzates, C12-alkyl-quaternized",696-234-1,124046-49-7,Eye Irrit. 2,Notified C&L,18,H319:18
231789,"Butanedioic acid, 2-sulfo-, 1,4-di-C11-14-isoalkyl esters, C13-rich, sodium salts",844-234-9,848588-96-5,Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 2,Notified C&L,13,H318:13;H411:13;H315:13
231790,"2-(methylthio)-3-nitropyrazolo[1,5-a]pyridine",696-235-7,63432-37-1,Not Classified,Notified C&L,1,Not classified:1
231791,tert-butyl N-(tert-butoxycarbonyl)glycinate,696-236-2,111652-20-1,Acute Tox. 4,Notified C&L,39,H302:38;Not classified:1
231792,"2-amino-N,N-dimethylethane-1-sulfonamide hydrochloride",696-237-8,91893-69-5,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,2,H332:1;H312:1;H302:1;H319:1;H335:1;H315:1
231794,"Quaternary Ammonium Compounds, Coco Alkyl (2,3-Dihydroxypropyl)Dimethyl, 3- Ethers with Cellulose 2-Hydroxyethyl Ether, Chlorides",696-238-3,130353-64-9,Skin Irrit. 2;Eye Dam. 1,Notified C&L,18,H318:18;H315:18
231795,2-(4-hydroxyphenoxy)-N-(propan-2-yl)propanamide,938-885-9,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
231796,"2-{[(tert-butoxy)carbonyl]amino}-3,5-dimethylbenzoic acid",938-886-4,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
231797,2-chloro-N'-[3-chloro-5-(trifluoromethyl)pyridin-2-yl]acetohydrazide,938-888-5,,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H332:1;H312:1;H315:1;H335:1;H302:1
231798,"4-[2-(4-chlorophenyl)-4-methyl-1,3-thiazol-5-yl]pyrimidin-2-amine",938-889-0,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
231799,"4,4'-(6-chloropyrimidine-2,4-diyl)dimorpholine",696-239-9,10244-24-3,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,2,H319:2;H332:2;H312:2;H315:2;H335:2;H302:2
231800,1-(benzenesulfonyl)-1H-indole-5-carbaldehyde,696-240-4,671215-62-6,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
231802,"5-amino-1-methyl-2,3-dihydro-1H-1,3-benzodiazol-2-one",938-891-1,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
231803,N-(2-{[3-chloro-5-(trifluoromethyl)pyridin-2-yl]amino}ethyl)-2-isocyanoacetamide,938-892-7,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
231804,tert-butyl 4-[(2-chloro-5-nitrophenyl)carbonyl]piperazine-1-carboxylate,938-893-2,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
231805,4-iodo-2-(trifluoromethoxy)aniline,938-894-8,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
231808,"3,3'-(3,3,4,4,5,5-hexafluorocyclopent-1-ene-1,2-diyl)bis(2,5-dimethylthiophene)",696-243-0,190394-25-3,Flam. Sol. 2;Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H317:2;H315:2;H228:2;H335:2;H302:2
231809,"[6-[(methylsulfonyl)oxy]-2-[4- [(methylsulfonyl)oxy]phenyl]benzo[b]thien-3-yl][4-[2-(1-piperidinyl)ethoxy]phenyl]-, hydrochloride (9CI)",696-244-6,84449-85-4,Carc. 2;Repr. 2,REACH registration C&L,1,H351:1;H361:1
231810,"4-(3,4-dimethoxyphenyl)-1H-pyrazol-5-amine",696-245-1,278600-50-3,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
231811,"4-chloro-7-methyl-7H-pyrrolo[2,3-d]pyrimidine",696-246-7,7781-10-4,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,3,H319:3;H332:1;H312:1;H315:3;H335:3;H302:3
231812,"6-{2,4-dioxo-3-azatricyclo[7.3.1.0^{5,13}]trideca- 1(13),5,7,9,11-pentaen-3-yl}hexanoic acid",696-247-2,202805-07-0,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
231813,methyl (2S)-1-(2-methoxy-2-oxoacetyl)pyrrolidine-2-carboxylate,696-248-8,139419-63-9,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
231814,"3-N-cyclopentylpyridine-2,3-diamine",696-249-3,1286273-74-2,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
231815,3-(1-benzenesulfonyl-1H-indol-5-yl)-acrylic acid,938-896-9,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
231816,"2-[3-(trifluoromethyl)phenyl]-3,4-dihydropyrimidin-4-one",696-250-9,125903-84-6,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
231817,"N'-[(1E)-2,2-dimethylpropylidene]benzohydrazide",696-251-4,372960-11-7,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
231818,tert-butyl 4-[2-(methoxycarbonyl)-4-nitrophenyl]piperazine-1-carboxylate,696-253-5,870703-73-4,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
231819,"5-bromo-4-chloro-7-methyl-7H-pyrrolo[2,3-d]pyrimidine",696-254-0,1266343-30-9,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
231820,"1-cyclopentyl-1H,2H,3H-imidazo[4,5-b]pyridin-2-one",938-897-4,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
231821,"6-chloro-1H,2H,3H-pyrrolo[3,2-c]pyridin-2-one",696-255-6,1000342-80-2,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
231822,"1-tert-butyl 2-methyl 4-iodo-1H-pyrrole-1,2-dicarboxylate",938-899-5,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
231823,"3-bromo-2-methoxy-5-methyl-1,6-naphthyridine",938-900-9,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
231824,"(7-bromo-2,3-dihydro-1-benzofuran-5-yl)methanol",938-901-4,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
231825,"2-(hydroxymethyl)-4,6-dimethylpyridine-3-carbonitrile",938-903-5,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
231826,"5-Bromo-6-hydroxy-1,3-benzodioxole",696-256-1,6941-70-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:1;H315:2
231828,methyl-bis[2-(4-methylalicyclyl)propyl]dihydro-heteropolycyle,,,Skin Sens. 1B;Aquatic Chronic 4,REACH registration C&L,2,H413:2;H317:2
231829,[No public or meaningful name is available],696-258-2,148019-46-9,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H317:1;H315:1
231830,1-carbamoylcyclobutane-1-carboxylic acid,696-259-8,845621-11-6,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,2,H332:1;H312:1;H302:2;H315:1;H335:1;H319:1
231831,"2,3-dihydro-1-benzofuran-7-carbaldehyde",696-260-3,196799-45-8,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,2,H332:1;H312:1;H302:1;H319:1;H335:1;H315:1
231832,9-(pyrrolidin-1-ylmethyl)-9H-carbazole,696-261-9,111960-23-7,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
231833,4-fluoro-N-[(4-fluorophenyl)methyl]aniline,696-262-4,80143-73-3,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
231836,2-(2-bromo-5-methoxyphenyl)-N-methylacetamide,696-264-5,1005346-97-3,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
231837,"(3S,8aS)-3-propyl-octahydropyrrolo[1,2-a]pyrazine-1,4-dione",696-265-0,26626-89-1,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,2,H332:1;H312:1;H302:1;H319:1;H335:1;H315:1
231838,"2-[(1,1'-biphenyl)-3-yl]ethanol",696-266-6,71912-71-5,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
231839,"(2S,3S)-3-(tert-butoxy)-1-[(9H-fluoren-9-ylmethoxy)carbonyl]pyrrolidine-2-carboxylic acid",696-267-1,266359-42-6,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
231840,(2S)-1-[(9H-fluoren-9-ylmethoxy)carbonyl]-4-[(allyloxy)carbonyl]piperazine-2-carboxylic acid,938-906-1,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
231841,2-Isopropoxyphenylboronic acid,696-268-7,138008-97-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
231843,N-[2-hydroxy-3-(stearyldimethylammonio)propyl] hydrolyzed collagen,696-269-2,87914-10-1,Eye Irrit. 2,Notified C&L,18,H319:18
231844,Acetato de (R)-5-(2-amino-1-((tert-butildimetilsilil)oxi)etil)-8-hidroxiquinolin-2(1H)-ona,938-908-2,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
231845,"1,36-Di-(Trimethoxysilylpropyl carbamoyloxy) hexatricontan",696-270-8,1416510-34-3,Skin Irrit. 2;Skin Sens. 1;STOT SE 3,Notified C&L,1,H336:1;H317:1;H315:1
231847,"Fatty acids, C18-unsaturated, dimers, reaction products with diethylenetriamine and vegetable-oil",938-909-8,,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Acute Tox. 3,Notified C&L,1,H319:1;H331:1;H317:1;H315:1
231848,Rhododendron anthopogon oil,938-910-3,,Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1;Aquatic Chronic 2,Notified C&L,1,H304:1;H411:1;H317:1;H315:1
231856,Sodium dichromate solution,938-917-1,,Acute Tox. 3;Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1;Acute Tox. 2;Resp. Sens. 1;STOT SE 3;STOT SE 3;Muta. 1B;Carc. 1B;Repr. 1B;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H330:1;H340:1;H350:1;H314:1;H360:1;H410:1;H312:1;H317:1;H372:1;H336:1;H334:1;H335:1;H400:1;H301:1
231859,"3-[4-(4-chlorophenyl)-2,6-dimethyl-phenyl]-4-oxo-2-bicyclo[3.2.1]oct-2-enyl] acetate",938-920-8,,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,89,H400:89;H410:89
231861,"Condensation products of cyclopentanone and pentaldehyde, fractionation pitch",938-923-4,,Skin Sens. 1B;Aquatic Chronic 2,REACH registration C&L,1,H411:1;H317:1
231862,"Reaction products of n-octanol and acrylic acid, first distillation pitch",938-925-5,,Not Classified,REACH registration C&L,1,Not classified:1
231865,[No public or meaningful name is available],696-275-5,5238-56-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:40;H335:40;H315:40
231866,"5-Heptenoic acid, (±)-7-[(1S*,2S*,3S*,5R*)-2-[(3S*)-4-(3-chlorophenoxy)-3-hydroxybutyl]-3,5-dihydroxycyclopentyl]-, (5Z)-",696-276-0,871543-06-5,Acute Tox. 4,Notified C&L,1,H302:1
231867,[No public or meaningful name is available],696-277-6,5883-17-0,Acute Tox. 4,Notified C&L,39,H302:39;H319:1;H332:1;H312:1;H315:1;H335:1
231875,(3S)-piperidin-3-ylmethanol,696-282-3,144539-77-5,Skin Corr. 1B,Notified C&L,3,H314:3
231877,[No public or meaningful name is available],696-284-4,115396-93-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H335:39;H315:39
231883,Di-(C12-C18-alkanol-5 EO)-amine,938-929-7,,Skin Corr. 1A;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H314:1;H400:1;H410:1
231884,"(Poly(oxy-1,2-ethanediyl), α-(nonylphenyl)-ω-hydroxy-) (CAS# 9016-45-9)",938-930-2,,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 2,Notified C&L,1,H315:1;H411:1;H318:1;H302:1
231885,"Poly(oxy-1,2-ethanediyl), α-(9Z)-9-octadecenyl-ω-hydroxy- (CAS# 9004-98-2)",938-931-8,,Acute Tox. 4;Eye Dam. 1,Notified C&L,1,H318:1;H302:1
231886,"Poly(oxy-1,2-ethanediyl), α-(1-oxododecyl)-ω-methoxy- (CAS# 9006-27-3)",938-932-3,,Eye Irrit. 2,Notified C&L,1,H319:1
231887,"Poly(oxy(methyl-1,2- ethanediyl)), α-hydro-ω-hydroxy- (CAS# 25322-69-4)",938-933-9,,Acute Tox. 4,Notified C&L,1,H302:1
231890,Triethoxysilylbutyraldehyde,696-293-3,917773-12-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,23,H319:23;H335:23;H315:23
231895,2-(2-phenylacetamido)benzoic acid,696-297-5,28565-98-2,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,2,H332:2;H312:2;H302:2;H319:1;H315:1;H335:1
231896,"1H-Imidazole-4-carboxylic acid, 5-(1-hydroxy-1-methylethyl)-2-propyl-,ethyl ester",696-298-0,144690-96-0,Not Classified,REACH registration C&L,1,Not classified:1
231898,methyl 2-(4-formylphenoxy)propanoate,696-299-6,70129-95-2,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
231899,methyl 2-(3-formylphenoxy)acetate,696-301-5,37748-10-0,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
231900,methyl 4-hydroxypiperidine-1-carboxyl,696-302-0,75250-52-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,3,H315:2;H335:2;H319:2;H302:3;H332:1;H312:1
231902,methyl 4-iodo-1-methyl-1H-pyrrole-2-carboxylate,696-304-1,40740-42-9,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
231903,"5,7-dimethyl-4-oxo-4H-chromene-3-carbaldehyde",938-938-6,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
231904,"Dodecanaminium, modified, chloride~",845-731-3,126758-30-3,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,13,H400:13;H410:13
231906,tert-Butyl 2-(trifluoromethyl)acrylate,696-305-7,105935-24-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:1;H335:1;H315:1;H226:1;H302:1
231907,"Poly(oxy-1,2-ethanediyl), α-decyl-ω-hydroxy- (CAS# 26183-52-8)",938-939-1,,Acute Tox. 4;Eye Dam. 1,Notified C&L,1,H318:1;H302:1
231908,"Poly(oxy-1,2-ethanediyl), α,α'-[[(9Z)-9-octadecenylimino]di-2,1-ethanediyl]bis[ω-hydroxy-] (CAS# 26635-93-8)",938-940-7,,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H315:1;H318:1;H302:1;H400:1;H410:1
231909,"N,N -Bis-α-ethyl-ω-hydroxypoly(oxy-1,2-ethanediyl) C8-C18 saturated and unsaturated alkylamines (CAS# 61791-14-8)",938-941-2,,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H315:1;H318:1;H302:1;H400:1;H410:1
231910,"1,3,5-Triazine-2,4,6-triamine, polymer with formaldehyde, methylated (CAS# 68002-20-0)",938-942-8,,Aquatic Chronic 3,Notified C&L,1,H412:1
231912,"N-n-Butyl-aza-2,2-dimethoxysilacyclopentane",696-307-8,618914-44-6,,Notified C&L,2,H319:1;H335:2;H315:2;H318:1
231913,"2,2-difluoro-2H-1,3-benzodioxole-5,6-diamine",696-308-3,1744-12-3,,Notified C&L,2,H319:2;H332:2;H312:2;H315:2;H335:2;H302:2
231915,"reaction product of pentaerythritol triacrylate and 3,7-Dioxa-4-aza-6-phosphanonanoic acid, 4,5-bis(1,1-dimethylethyl)-6-ethoxy-2,2-dimethyl-, 6-oxide (1:3)",938-943-3,,Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;Repr. 2,Notified C&L,1,H318:1;H361:1;H317:1;H315:1
231916,"2-(4-chlorophenoxy)-N,N-dimethylethanamine",696-309-9,2401-47-0,Acute Tox. 4,Notified C&L,1,H302:1
231917,(2E)-3-methylhex-2-enoic acid,696-310-4,27960-21-0,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,3,H315:2;H335:2;H319:2;H302:2;H314:1
231918,trifluoroethanecarbonyl isocyanate,696-312-5,14565-32-3,,Notified C&L,2,H334:2;H330:2;H317:2;H302:2;H319:1;H315:1;H225:1;H335:1
231919,[No public or meaningful name is available],696-313-0,59378-87-9,Eye Dam. 1,Notified C&L,39,H318:38;H319:1;H335:1;H315:1
231920,[No public or meaningful name is available],696-314-6,36493-41-1,Skin Corr. 1B,Notified C&L,39,H314:39
231925,"2-Propenoic acid, polymer with 2-methyloxirane polymer with oxirane mono-2-propen-1-yl ether, graft",938-944-9,,Skin Corr. 1B,Notified C&L,1,H314:1
231926,Siloxane platinum complex~,696-319-3,73018-55-0,Eye Irrit. 2,Notified C&L,15,H319:15;H335:2;H315:2
231930,N-cyclopropyl-2-nitroaniline,696-323-5,55432-23-0,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
231932,"4-bromo-3-chloro-1H-pyrrolo[2,3-b]pyridine",696-325-6,943323-92-0,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
231933,"5-amino-4-methyl-3,4-dihydro-2H-1,4-benzoxazin-3-one",696-326-1,132522-83-9,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
231935,"2-chloro-1-methyl-5-nitro-1H-1,3-benzodiazole",696-328-2,15965-66-9,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H332:1;H312:1;H315:1;H335:1;H302:1
231936,methyl 5-acetyl-4-bromo-1H-pyrrole-2-carboxylate,696-329-8,157425-54-2,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
231937,[No public or meaningful name is available],696-330-3,18395-29-4,,Notified C&L,2,H319:2;H335:2;H226:2;H315:2;Not classified:1;H332:1;H302:1
231938,3-iodo-8-nitroquinoline,696-331-9,497084-46-5,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
231942,"Reaction mass of 1-methyl-4-(1-methylethyl)-7-oxabicyclo[2.2.1]heptane and cineole and p-mentha-1,4(8)-diene",938-945-4,,Flam. Liq. 3;Asp. Tox. 1;Skin Sens. 1B;Eye Irrit. 2;Aquatic Chronic 2,REACH registration C&L,7,H319:7;H411:7;H226:7;H317:7;H304:7
231943,ethyl 1-acetylcyclopropane-1-carboxylate,696-336-6,32933-03-2,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,2,H332:2;H312:2;H302:2
231944,ethyl 1-acetylcyclopentane-1-carboxylate,696-337-1,28247-15-6,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
231945,cyclohexanecarboximidamide hydrochloride,696-338-7,2498-48-8,,Notified C&L,2,H319:2;H335:2;H315:2
231946,1-carbamoylcyclohexane-1-carboxylic acid,696-339-2,137307-65-4,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
231947,ethyl 1-acetylcyclobutane-1-carboxylate,696-340-8,126290-87-7,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
231949,"tert-butyl 2,6-diazaspiro[4.5]decane-2-carboxylate",696-341-3,1086394-55-9,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,2,H332:1;H312:1;H302:2;H315:1;H335:1;H318:1
231950,"2,6-diamino-5-chloropyrimidin-4-ol",696-342-9,71552-22-2,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
231951,"(2S,3S)-3-amino-2-hydroxy-4-phenylbutanoic acid",696-343-4,62023-62-5,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
231952,"tert-butyl N-(2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepin-3-yl)carbamate",696-345-5,86499-69-6,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
231953,(2S)-2-amino-3-methylbutan-1-ol hydrochloride,696-346-0,17016-89-6,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
231954,"4,5-bis(2,2-dimethyl-1,3-dioxolan-4-yl)-2,2-dimethyl-1,3-dioxolane",696-347-6,1214702-92-7,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
231955,"(2S)-2-(Hydroxymethyl)morpholine, N-BOC protected",696-348-1,135065-76-8,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,2,H332:2;H312:2;H302:2
231956,"ethyl 2-(4,6-dihydroxypyrimidin-5-yl)acetate",696-349-7,1095822-20-0,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
231957,6-[(tert-butyldimethylsilyl)oxy]-1H-indole,696-350-2,106792-41-0,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
231958,Diethyl 2-{[(6-methoxypyridin-3-yl)amino]methylene}malonate,696-351-8,53241-90-0,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
231959,"Poly(oxy-1,2-ethanediyl), α-(C12-C18) alkyl-ω-hydroxy- (CAS# 68213-23-0)",938-947-5,,Eye Dam. 1;Aquatic Acute 1,Notified C&L,1,H318:1;H400:1
231960,"Poly(oxy-1,2-ethanediyl), α-(C9-C11) alkyl-ω-hydroxy- (CAS# 68439-46-3)",938-948-0,,Acute Tox. 4;Eye Dam. 1,Notified C&L,1,H318:1;H302:1
231961,"Poly(oxy-1,2-ethanediyl), α-hydro-ω-hydroxy-, mono-C12-14-alkylethers, phosphates (CAS# 68511-37-5)",938-949-6,,Skin Irrit. 2;Eye Dam. 1,Notified C&L,1,H318:1;H315:1
231962,"Poly(oxy-1,2-ethanediyl), α-(C16-C18, C18') alkyl-ω-hydroxy- (CAS# 68920-66-1)",938-950-1,,Skin Irrit. 2;Aquatic Acute 1,Notified C&L,1,H400:1;H315:1
231963,"Alcohols, coco, ethers with polyethylene glycol mono-Me ether (CAS# 95823-33-9)",938-951-7,,Eye Irrit. 2,Notified C&L,1,H319:1
231964,spiro[2.3]hexane-1-carboxylic acid,696-352-3,17202-56-1,,Notified C&L,2,H314:2;H335:1
231969,"5-Amino-2,4-di-tert-butylphenyl methyl carbonate",696-357-0,1182822-31-6,Not Classified,REACH registration C&L,1,Not classified:1
231970,"Zinc -[(L-ascorbato O2),(L-ascorbato O2 O3)]-",696-358-6,134343-96-7,Eye Irrit. 2,Notified C&L,1,H319:1
231973,"Glutamic acid, N,N-diacetic acid, copper disodium complex",938-953-8,,Acute Tox. 4;Eye Irrit. 2,Notified C&L,1,H319:1;H302:1
231974,"Amines, N-C16-18-alkyl (evennumbered) propane-1,3-diamine",696-364-9,133779-11-0,Skin Irrit. 2;Eye Dam. 1;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,2,H411:2;H372:2;H315:2;H318:2;H400:2;H410:2
231975,"(3-Dimethylamino-4,5-dihydro-5-oxo-1-phenyl-1H-pyrazol-4-ylidene)(4-dimethylaminophenyl)acetonitrile",696-360-7,124621-37-0,Aquatic Chronic 3,Notified C&L,1,H412:1
231979,"(1S,3R)-methyl 3-[(tert-butoxycarbonyl)amino]cyclopentanecarboxylate",696-365-4,554451-12-6,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
231980,"methyl 4-hydroxy-2,2-dimethyl-2,3-dihydro-1-benzofuran-6-carboxylate",696-367-5,955884-97-6,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
231981,(dimethanesulfinylidene)amine,696-368-0,1520-31-6,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,3,H332:3;H312:3;H302:3
231982,O-[(benzyloxy)methyl]hydroxylamine,696-369-6,895588-70-2,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
231983,(2S)-3-amino-2-methylpropan-1-ol,696-370-1,88586-62-3,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,2,H332:1;H312:1;H302:2;H314:1;H227:1;H335:1
231987,Tetraalkyldi(alkan-2-yl)biphenyldiol,,,Acute Tox. 4,Notified C&L,1,H302:1
231988,ethyl N-{[3-chloro-5-(trifluoromethyl)pyridin-2-yl]carbamothioyl}carbamate,938-954-3,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
231989,"8-chloro-6-(trifluoromethyl)-[1,2,4]triazolo[1,5-a]pyridin-2-amine",938-955-9,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
231990,"tert-butyl 4-formyl-2,6-dimethoxyphenyl carbonate",938-956-4,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
231991,"ethyl 7-methyl-7H-pyrrolo[2,3-d]pyrimidine-4-carboxylate",938-958-5,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
231992,"2-[3-chloro-5-(trifluoromethyl)pyridin-2-yl]-1H-1,3-benzodiazole",938-959-0,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
231993,"5-bromo-3-N-cyclopentylpyridine-2,3-diamine",938-960-6,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
231994,methyl 6-{bis[(tert-butoxy)carbonyl]amino}-5-bromopyridine-3-carboxylate,938-961-1,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
231995,4-iodo-1-methyl-1H-pyrrole-2-carboxylic acid,938-962-7,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
231996,"5-bromo-4-methoxy-7-methyl-7H-pyrrolo[2,3-d]pyrimidine",938-963-2,,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H332:1;H312:1;H315:1;H335:1;H302:1
231997,ethyl 2-[(4-cyanophenyl)amino]pyrimidine-4-carboxylate,938-964-8,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
231998,2-[(4-cyanophenyl)amino]pyrimidine-4-carboxylic acid,938-965-3,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
231999,"6-bromo-1-cyclopentyl-1H,2H,3H-imidazo[4,5-b]pyridin-2-one",938-966-9,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232000,4-{[4-(hydroxymethyl)pyrimidin-2-yl]amino}benzonitrile,938-967-4,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232001,1-carbamoylcyclopentane-1-carboxylic acid,938-969-5,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232002,N-(3-iodoquinolin-8-yl)acetamide,938-970-0,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232003,"tert-butyl 2H,4H,5H,6H,7H-pyrazolo[4,3-b]pyridine-4-carboxylate",938-971-6,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232004,"3-{[3-chloro-5-(trifluoromethyl)pyridin-2-yl]amino}propane-1,2-diol",938-972-1,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232005,2-amino-N-methyl-2-phenylacetamide,938-973-7,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232006,2-bromo-1-(diethoxymethyl)-4-fluorobenzene,938-974-2,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232007,"4-iodo-1,2-dihydropyridin-2-one",938-975-8,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232008,4-(5-methyl-1H-imidazol-4-yl)piperidine dihydrochloride,938-976-3,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232009,tert-butyl 3-[methoxy(methyl)carbamoyl]cyclohexane-1-carboxylate,938-977-9,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232010,"N,N-dimethyl-2-(2-oxocyclopentyl)acetamide",938-978-4,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232011,Bis(mesitylene) Niobium,696-375-9,68088-96-0,Flam. Sol. 1;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H228:1;H335:1;H315:1
232012,(DiMethylEthoxySilyl)(DiEthoxySilyl)Methane,696-376-4,1242241-05-9,Flam. Liq. 2;Eye Irrit. 2,Notified C&L,1,H225:1;H319:1
232013,Titanium Bis(isopropoxy)bis(dimethylamino),696-378-5,16530-80-6,Flam. Liq. 2;Water-react. 1;Skin Corr. 1B,Notified C&L,1,H225:1;H314:1;H260:1
232014,Tris(isopropylcyclopentadiényl) Scandium,696-379-0,75249-90-0,Flam. Liq. 2;Water-react. 1,Notified C&L,1,H225:1;H260:1
232015,[No public or meaningful name is available],696-380-6,91298-74-7,Acute Tox. 4;Aquatic Chronic 3,Notified C&L,39,H412:38;H302:38;H314:1
232022,2-(3-bromophenoxy)acetic acid,696-386-9,1798-99-8,,Notified C&L,2,H319:2;H335:2;H315:2;H302:1
232023,1-(pyridin-2-yl)propan-2-amine,696-387-4,51038-40-5,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H315:40;H335:40;H319:39;H301:38;H332:2;H312:1;H302:2;H318:1
232025,3-(2-oxopyrrolidin-1-yl)propanoic acid,696-390-0,77191-38-9,,Notified C&L,2,H315:2;H335:2;H319:2;H302:1
232027,"Amines, polyethylenepoly-, benzyl chloride-quaternized, polymers with glyoxal",696-392-1,78330-33-3,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,15,H319:15;H315:15
232028,3-(methoxymethyl)pyrrolidine,696-393-7,936940-38-4,Flam. Liq. 3;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,3,H318:2;H335:3;H226:2;H315:3;H319:1
232033,pyrrolidine-1-sulfonyl chloride,696-398-4,1689-02-7,,Notified C&L,2,H314:2;H302:1
232036,"2,2-dimethylmorpholine",696-402-4,147688-58-2,Flam. Liq. 3;Eye Dam. 1,Notified C&L,3,H318:2;H226:2;H314:1
232037,2-phenylazetidine,696-404-5,22610-18-0,,Notified C&L,2,H314:2
232038,2-(morpholin-2-yl)ethan-1-ol,696-405-0,132995-76-7,,Notified C&L,2,H319:2;H332:1;H312:1;H315:2;H335:2;H302:2
232039,[1-(aminomethyl)cyclopropyl]methanol,696-406-6,45434-02-4,,Notified C&L,2,H225:1;H335:1;H314:1;H302:2
232040,[1-(aminomethyl)cyclopentyl]methanol,696-407-1,2239-31-8,,Notified C&L,2,H319:1;H335:2;H315:1;H314:1;H227:1
232044,3-(Aminomethyl)benzoic acid,696-411-3,2393-20-6,,Notified C&L,2,H315:2;H335:2;H319:2;H302:2;H412:1
232057,"Glycine max. (L.) Merr. (Fabacee) aqueous alcoholic ext., concentrate by sequential extractions and filtration",938-980-5,,Not Classified,Notified C&L,1,Not classified:1
232059,4-bromo-N-(propan-2-yl)aniline,696-426-5,121086-19-9,,Notified C&L,2,H319:2;H335:2;H315:2;H302:1
232061,5-(morpholin-4-ylmethyl)quinolin-8-ol,696-428-6,312611-90-8,,Notified C&L,2,H315:2;H335:2;H319:2;H302:2
232062,Dimethyl butylphosphonate,696-429-1,24475-23-8,Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 3,Notified C&L,1,H412:1;H319:1;H315:1
232063,"2H,2H,3H,3H-Pentadecafluorodecanoic acid",696-430-7,812-70-4,,Notified C&L,2,H314:2
232065,"2,6-bis(trifluoromethyl)aniline",696-432-8,313-13-3,,Notified C&L,3,H332:3;H312:3;H302:3;H315:1;H318:1;H227:1;H335:1
232067,"Phosphonium, [3-(diphenylphosphino)phenyl] triphenyl-, perchlorate",696-434-9,867022-77-3,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3;STOT SE 3,Notified C&L,1,H319:1;H332:1;H315:1;H335:1;H302:1
232068,4-(Pyrrolidin-2-yl)pyridine,696-435-4,128562-25-4,,Notified C&L,3,H319:3;H335:3;H315:3
232069,"(2,4,4-trimethylpentyl)phosphonic acid, dimethyl ester",938-982-6,,Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 3,Notified C&L,1,H412:1;H319:1;H315:1
232073,2-hexyldecylphosphonic acid,938-983-1,,Met. Corr. 1;Skin Corr. 1B,Notified C&L,1,H290:1;H314:1
232074,dimethyl 2-hexyldecylphosphonate,938-984-7,,Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 3,Notified C&L,1,H412:1;H319:1;H315:1
232076,4-(1H-pyrazol-1-yl)aniline,696-442-2,17635-45-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
232077,"1-((2R,5R)-5-ethynyl-5-(hydroxymethyl)-2,5-dihydro-2-furanyl)-5-methyl-2,4(1H,3H)-pyrimidinedione",696-443-8,634907-30-5,Muta. 2;STOT RE 2,Notified C&L,1,H373:1;H341:1
232079,"2-Propenoic acid,2-methyl-, 2-(4,6-diamino-1,3,5-triazin-2-yl)ethyl ester",696-445-9,106241-72-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
232082,3-Amino-6-bromo-2-chloropyridine,696-449-0,169833-70-9,,Notified C&L,2,H319:2;H332:1;H312:1;H315:2;H335:1;H302:1
232084,3-BROMO-5-CHLOROANILINE,696-451-1,96558-78-0,,Notified C&L,2,H319:1;H332:1;H312:1;H315:1;H335:1;H302:1;H314:1;H331:1;H311:1;H301:1
232086,"1,1,3,3,5,5-Hexaethoxy-1,3,5-trisilacyclohexane",696-453-2,17955-67-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:40;H335:39;H315:40
232089,"Stannane, dichlorodipropyl-",,867-36-7,,Notified C&L,1,H301:1;H330:1;H400:1;H311:1;H410:1
232090,"1-(2-hydroxyethyl)-2,5-dihydro-1H-pyrrole-2,5-dione",696-457-4,1585-90-6,Eye Irrit. 2,Notified C&L,41,H319:41;H335:2;H315:3;H302:1
232091,4-methylheptan-2-one,696-459-5,6137-06-0,,Notified C&L,2,H226:2;H319:1;H335:1;H315:1
232093,"3-amino-4-methoxy-N,N-dimethylbenzamide",696-461-6,953888-49-8,,Notified C&L,2,H319:2;H335:2;H315:2;H302:1
232096,5-chlorofuran-2-carboxylic acid,696-464-2,618-30-4,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,3,H319:3;H335:3;H315:3
232099,"4,6-dimethyl-1,3-benzothiazol-2-amine",696-467-9,64036-71-1,,Notified C&L,2,H319:2;H335:2;H315:2;H302:1
232104,Isoxazole-4-boronic acid,696-473-1,1008139-25-0,,Notified C&L,3,H319:3;H335:2;H315:2;H302:2
232106,"2-Methoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine",696-475-2,408502-23-8,,Notified C&L,3,H319:3;H335:2;H315:3
232108,n-Boc-4-piperidineacetate,696-477-3,206989-61-9,Acute Tox. 3,Notified C&L,3,H301:2;H319:1;H335:1;H315:1
232109,5-methoxypyridin-3-amine,696-478-9,64436-92-6,,Notified C&L,2,H319:1;H335:2;H315:2;H318:1;H302:1
232111,"N-C16-18-(even numbered, C18-unsaturated)-alkyl-1-C16-18-(even numbered, C18-unsaturated)-amine",696-481-5,1219826-47-7,Skin Corr. 1B;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,35,H314:35;H400:35;H410:35
232112,Reaction mass of choline hydrogen carbonate and water,938-985-2,,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
232113,(4-chlorothiophen-2-yl)(4-fluorophenyl)methanone,696-482-0,207852-56-0,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232114,methyl (3E)-4-(2-bromophenyl)-2-oxobut-3-enoate,696-483-6,956476-32-7,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232115,"5-bromo-[1,3]thiazolo[5,4-b]pyridin-2-amine",696-484-1,934266-82-7,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232116,4-amino-6-methyl-2-(methylsulfanyl)pyrimidine-5-carbonitrile,696-485-7,89853-27-0,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232117,"8-Bromo-2-methoxy-1,5-naphthyridine",696-486-2,881658-92-0,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,3,H332:2;H312:2;H302:3;H315:1;H335:1;H319:1
232118,1-bromo-2-(chloromethyl)-4-fluorobenzene,696-487-8,857276-61-0,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H332:1;H312:1;H315:1;H335:1;H302:1
232119,Reaction mass of tetrahydrofuran and di(tert-butyl) carbonate,938-986-8,,Flam. Liq. 2;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Acute Tox. 2;STOT SE 3;Carc. 2,Notified C&L,1,H319:1;H330:1;H317:1;H315:1;H225:1;H351:1;H335:1
232120,1-(5-amino-1-methyl-1H-pyrazol-4-yl)ethan-1-one,696-488-3,856860-17-8,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,2,H332:1;H312:1;H302:2;H315:1;H335:1;H319:1
232121,"5-benzyl-octahydropyrrolo[3,4-c]pyrrole-1,3-dione",696-489-9,848591-86-6,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232122,"(2S,3R,5R)-5-hydroxy-3-((4-methylphenyl)sulfanyl)-5-((trimethylsilyl)ethynyl)tetrahydro-2H-pyran-2-yl benzoate",938-987-3,,Skin Sens. 1A,Notified C&L,1,H317:1
232123,"(1S)-1-(3,4-difluorophenyl)propan-1-amine hydrochloride",696-490-4,847448-32-2,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232124,"methyl 4-(2H-1,2,3,4-tetrazol-5-yl)benzoate",696-492-5,82544-82-9,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,2,H332:1;H312:1;H302:2;H315:1;H335:1;H319:1
232125,"(1R)-1-(3,4-dichlorophenyl)propan-1-amine hydrochloride",696-493-0,742107-61-5,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232126,3-methoxy-2-methylbenzohydrazide,696-494-6,740799-69-3,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232127,"8-bromo-1,2-dihydroquinolin-2-one",696-495-1,67805-67-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,3,H315:2;H335:2;H319:2;H302:3;H332:1;H312:1
232128,"2,4-dioxo-1,2,3,4-tetrahydro-pyrimidin-5-ylamino)-fumaric acid dimethyl ester",696-496-7,60458-95-9,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232129,"ethyl 2,6-dichloronicotinate",696-497-2,58584-86-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,5,H319:5;H335:3;H315:5;H332:1;H312:1;H302:1
232130,1-acetylcyclopropane-1-carboxylic acid,696-498-8,56172-71-5,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,2,H332:1;H312:1;H302:1;H318:1;H335:1;H315:1
232131,"tert-butyl 11-azatricyclo[6.2.1.0^{2,7}]undeca- 2,4,6,9-tetraene-11-carboxylate",696-499-3,5176-28-3,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232132,methyl (2E)-2-(N-hydroxyimino)-3-(4-hydroxyphenyl)propanoate,696-500-7,50563-23-0,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232133,1-[(4-fluorophenyl)methyl]-1H-indazole-3-carboxylic acid,696-501-2,50264-63-6,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232134,"methyl 6-amino-2,5-dichloropyrimidine-4-carboxylate",696-502-8,502142-81-6,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H332:1;H312:1;H315:1;H335:1;H302:1
232135,methyl 2-(4-hydroxy-2-methoxyphenyl)acetate,696-503-3,499789-92-3,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232136,"7-chloro-3-methyl-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one",696-504-9,4699-82-5,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232137,4-(4-hydroxy-3-iodophenyl)benzonitrile,696-505-4,460746-47-8,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232138,2-chlorobenzene-1-carboximidamide,696-507-5,45743-05-3,Acute Tox. 4;Aquatic Chronic 3,Notified C&L,39,H412:38;H302:39;H332:1;H312:1
232139,4-Iodo-1-acetyl-7-azaindole,696-508-0,443729-67-7,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232140,3-fluoro-6-methoxyquinoline,696-509-6,426842-85-5,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232141,5-Amino-4-chloropyridazin-3(2H)-one,696-510-1,6339-19-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,3,H315:2;H335:2;H319:2;H302:3
232142,"1-(7-bromo-9,9-difluoro-9H-fluoren-2-yl)-2-chloroethanone",696-512-2,1378387-81-5,Not Classified,REACH registration C&L,3,Not classified:1;H371:1;H319:1;H315:1
232144,4-(5-Chloro-2-nitrophenyl)morpholine,696-513-8,65976-63-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
232145,"3,3-dimethyl-azetidinium bromide",938-992-0,,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H315:1;H335:1;H319:1;H302:1
232146,[2-(oxan-2-yl)-2H-indazol-4-yl]boronic acid,938-993-6,,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H315:1;H335:1;H319:1;H302:1
232148,sodium (dodecanoylamino)acetate,696-514-3,18777-32-7,Eye Dam. 1,Notified C&L,53,H318:53
232153,1-(6-aminopyridin-3-yl)ethan-1-one,696-518-5,19828-20-7,,Notified C&L,2,H315:2;H335:2;H319:2;H302:2
232156,"Pyrimidine-4,6-dicarboxylic acid",696-521-1,16490-02-1,,Notified C&L,2,H315:2;H335:2;H319:2;H302:1
232160,"Mixed O,O-bis(1,3-dimethylbutyl and isopropyl) dithiophosphate",696-524-8,84605-28-7,Skin Corr. 1C;Eye Dam. 1,Notified C&L,441,H314:441;H318:441
232161,(S)-piperazin-2-ylmethanol dihydrochloride,696-525-3,149629-73-2,Met. Corr. 1;Acute Tox. 4;Skin Corr. 1B,Notified C&L,1,H290:1;H314:1;H302:1
232162,"7-[(2-bromo-5-chlorophenyl)methoxy]-1,2,3,4-tetrahydronaphthalen-1-one",696-526-9,1378388-19-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H315:1;H335:1;H319:1;H302:1
232164,"7-hydroxy-3,4-dihydronaphthalen-1(2H)-one",696-527-4,22009-38-7,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,5,H315:5;H335:4;H319:5;H302:3
232165,"1-(5-bromo-2-pyridyl)-2-(2,4-difluorophenyl)-1,1-difluoro-3-(1,2,4-triazol-1-yl)propan-2-ol",938-998-3,,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,89,H400:89;H410:89
232166,"Benzeneacetic acid, α-methyl-4-[(2-oxocyclopentyl)methyl]-, sodium salt, hydrate",696-529-5,226721-96-6,Acute Tox. 3,Notified C&L,2,H301:2
232167,"3-[2-(Imidazo[1,2-b]pyridazin-3-yl)ethynyl]-4-methyl -N-{4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluorom ethyl)phenyl}benzamide monohydrochloride",696-530-0,1114544-31-8,,Notified C&L,2,H302:1;H360:1;H372:2;H301:2;H351:1;H361:1;H410:1
232168,Sulfonation products of dipotassium sulfite with (esterification products of C9-11 (branched and linear) Alkyl Polyglycosides with maleic anhydride),938-999-9,,Eye Irrit. 2,Notified C&L,1,H319:1
232169,"1,3-Bis(diphenylphosphino)propane dioxide",696-531-6,16524-41-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;STOT SE 3;Aquatic Chronic 4,Notified C&L,1,H319:1;H335:1;H413:1;H315:1
232176,"Reaction mass of substituted-(naphthalen-1-methyl)heteromonocyclic chloride and propane-1,2-diol",,,Skin Corr. 1B;Aquatic Chronic 2,REACH registration C&L,7,H314:7;H411:7
232180,"Fatty alcohols, C12-22 (even numbered), manuf. of, by-products from",939-008-2,,Asp. Tox. 1;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H319:1;H304:1;H400:1;H410:1
232182,Reaction mass of 3-isopropyl-6-methylenecyclohexene and (4R)-1-methyl-4-(prop-1-en-2-yl)cyclohexene and (4S)-1-methyl-4-(prop-1-en-2-yl)cyclohexene,939-009-8,,Flam. Liq. 3;Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1;Aquatic Chronic 2,REACH registration C&L,4,H411:4;H226:4;H317:4;H315:4;H304:4
232183,6-Amino-2-pyridinecarboxylic acid hydrazide,696-537-9,5584-18-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H315:1;H335:1;H319:1;H302:1;H317:1
232184,4-bromo-2-(oxan-2-yl)-2H-indazol,696-538-4,1266386-31-5,Flam. Liq. 3;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Repr. 2,Notified C&L,1,H319:1;H361:1;H226:1;H315:1;H335:1;H302:1
232185,"(E)-N'-(6-{N'-[(1E)- (dimethylamino)methylidene]hydrazinecarbonyl}pyridin-2- yl)-N,N-dimethylmethanimidamide",939-010-3,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232186,2-METHYLTHIOPHENE-3-CARBOXYLIC ACID,696-540-5,1918-78-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:2;H315:2;H302:1
232191,2-Bromo-4-chloro-1-isopropylbenzene,696-543-1,1369828-32-9,Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,34,H400:34;H410:34
232192,methyl (2S)-2-amino-2-cyclohexylacetate hydrochloride,696-544-7,14328-63-3,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H315:39;H335:39;H319:39;H302:38;Not classified:1
232194,3-methyl-1H-indazol-5-amine,696-546-8,90764-90-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,3,H315:3;H335:3;H319:3;H302:3
232201,"N,3,4,5-tetramethoxy-N-methyl-Benzamide",696-553-6,118779-14-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
232202,hexaamminecobalt(III) carbonate,939-015-0,,Acute Tox. 4;Skin Sens. 1;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H319:1;H317:1;H302:1;H400:1;H410:1
232204,"Fatty acids, C16-18 (even numbered) (linear and branched) and C18 unsatd. (linear and branched), reaction products with diethanolamine",939-017-1,,Not Classified,REACH registration C&L,2,Not classified:2
232205,2-(4-bromophenyl)-2-methylpropanoic acid,696-555-7,32454-35-6,Acute Tox. 4,Notified C&L,39,H302:38;Not classified:1
232206,"1-{[4-(tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methyl}piperidine",696-556-2,859833-22-0,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,3,H332:1;H312:1;H302:1;H314:1;H319:1;H335:1;H315:1
232207,3-(Phenylcarbamoyl)benzeneboronic acid,696-557-8,397843-71-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
232208,1-(5-bromopyridin-2-yl)ethan-1-one,696-558-3,214701-49-2,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,2,H319:2;H332:2;H312:2;H315:2;H335:2;H302:2
232209,4-(Cyclopropylcarbamoyl)benzeneboronic acid,696-559-9,515140-26-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
232210,4-Ethoxy-3-(trifluoromethyl)benzeneboronic acid,696-560-4,871329-83-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:1;H315:2
232211,2-Ethoxypyrimidine-5-boronic acid,696-562-5,1003043-55-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
232212,6-Bromo-1-methyl-1H-indole,696-563-0,125872-95-9,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;STOT SE 3,Notified C&L,2,H319:2;H315:2;H331:1;H335:2;H311:1;H301:1;H302:1
232213,"4-Hydroxypyridine-2,6-dicarboxylic acid",696-564-6,499-51-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
232214,4-Bromothiophene-3-boronic acid,696-565-1,101084-76-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:2;H315:2
232215,2-Bromo-3-fluorobenzonitrile,696-566-7,425379-16-4,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,2,H332:2;H312:2;H302:2;H319:1;H315:1;H335:1
232216,"3-(Methylamino)propanoic acid, N-BOC protected",696-567-2,124072-61-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,4,H319:4;H335:4;H315:4
232217,"3,5-Bis(trifluoromethyl)phenyl propyl ether",696-568-8,1420977-70-3,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H332:1;H312:1;H315:1;H335:1;H302:1
232218,"2',4'-Difluoro-3'-(trifluoromethyl)acetophenone",696-569-3,1202679-46-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
232219,Methyl 3-aminophenylacetate hydrochloride,696-570-9,150319-83-8,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
232220,5-Chloro-3-fluoropyridine-2-carboxylic acid,696-571-4,207994-08-9,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,2,H319:2;H332:1;H312:1;H315:2;H335:2;H302:1
232221,Methyl 6-bromo-5-chloronicotinate,696-573-5,78686-80-3,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H332:1;H312:1;H315:1;H335:1;H302:1
232222,4-(Aminomethyl)-3-fluoropyridine dihydrochloride,696-574-0,1257535-26-4,Skin Corr. 1B,Notified C&L,1,H314:1
232223,4-(Aminomethyl)-2-fluoropyridine dihydrochloride,696-575-6,667906-60-7,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H332:1;H312:1;H315:1;H335:1;H302:1
232233,3-endo-[2-propoxy-4-(trifluoromethyl)phenoxy]-9-[5-(trifluoromethyl)-2- pyridyloxy]-9-azabicyclo[3.3.1]nonane,696-576-1,1332838-17-1,Aquatic Acute 1,Notified C&L,2,H400:2
232235,"Formaldehyde, polymeric reaction products with phenol containing under 15% of phenol and under 1 % of formaldehyde",939-027-6,,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1;Eye Dam. 1;Acute Tox. 3;STOT SE 3;Muta. 2;Carc. 1B;STOT RE 2,Notified C&L,1,H350:1;H314:1;H373:1;H312:1;H317:1;H318:1;H331:1;H335:1;H341:1;H302:1
232236,Reaction mass of 10058-44-3 and 6132-04-3 and 7647-14-5,939-028-1,,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
232237,"Fatty acids, C16-18 (even numbered), ammonium salts",939-066-9,,Not Classified,REACH registration C&L,12,Not classified:12
232238,"Phenylphosphonic acid, zinc salt (1:1)",696-577-7,34335-10-9,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,2,H400:2;H410:2
232250,"1,5-dimethyl 2-({4-[1-(2,4-diaminopteridin-6-yl)pent-4-yn-2-yl]phenyl}formamido)pentanedioate",939-038-6,,Acute Tox. 3;Skin Irrit. 2;Repr. 1A,Notified C&L,1,H315:1;H360:1;H301:1
232252,"Alkanol reaction products with bis(aminoalkyl(C=1~6))carbomonocycle, alkoxy(C=3~8)alkanol(C=2~7) and 2,4-TDI",939-039-1,,Not Classified,REACH registration C&L,2,Not classified:2
232255,ethyl 5-bromo-2-hydroxybenzoate,696-580-3,37540-59-3,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232256,"bis{2-[4-(4,6-diphenyl-1,3,5-triazin-2-yl)-3-hydroxyphenoxy]ethyl} dodecanedioate",939-042-8,,Aquatic Chronic 4,Notified C&L,1,H413:1;H317:1
232265,Reaction mass of water and zinc phosphonate and manganese phosphonate,939-051-7,,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
232266,Reaction mass of water and zinc phosphonate,939-052-2,,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
232267,"Reaction mass of benzene-1,3-disulphonic acid and sulphuric acid",939-053-8,,Skin Corr. 1A,REACH registration C&L,3,H314:3
232268,Reaction mass of water and magnesium dimetaphosphate and magnesium phosphonate(1:1) and calcium hydrogen phosphonate and calcium phosphonate,939-054-3,,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
232269,Reaction mass of water and calcium hydrogen phosphonate and calcium phosphonate,939-055-9,,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
232273,"Reaction mass of 1,2-dibromo-4,5-dichlorobenzene ; 1,3-dibromo-4,5-dichlorobenzene and 1,2-dibromo-3,4-dichlorobenzene",939-059-0,,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 4,Notified C&L,1,H319:1;H335:1;H413:1;H315:1
232274,"7-Amino-1,2,3,4-tetrahydronaphthalen-1-one",696-582-4,22009-40-1,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:2;H315:2
232278,1-(4-methoxyphenyl)cyclopropan-1-amine hydrochloride,696-586-6,1187931-04-9,,Notified C&L,2,H319:2;H335:2;H315:2
232279,cyclopentylmethanamine hydrochloride,696-587-1,58714-85-5,Acute Tox. 4;Eye Dam. 1,Notified C&L,41,H318:40;H302:40;H319:1;H335:1;H315:1
232283,"4-bromo-N-(1,3,4-thiadiazol-2-yl)benzene-1-sulfonamide",696-591-3,349614-28-4,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232284,"4-bromo-N-(1,3-thiazol-2-yl)benzene-1-sulfonamide",696-592-9,331972-47-5,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232285,"3,4-dihydro-2H-1,4-benzothiazine",696-593-4,3080-99-7,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,2,H332:2;H312:1;H302:2;H319:1;H315:1;H335:1
232286,tert-butyl 3-iodo-1H-indazole-1-carboxylate,696-595-5,290368-00-2,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232287,"2,5-dimethylpyrazolo[1,5-a]pyrimidin-7-ol",696-596-0,27166-46-7,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232288,(4-fluoro-3-iodophenyl)methanol,696-597-6,227609-87-2,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232289,tert-butyl N-(5-bromopyrimidin-2-yl)-N-[(tert-butoxy)carbonyl]carbamate,696-598-1,209959-33-1,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232290,"methyl 6-nitro-2-oxo-2,3-dihydro-1H-1,3-benzodiazole-5-carboxylate",696-599-7,205259-23-0,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232291,"tert-butyl 5-benzyl-octahydropyrrolo[3,4-c]pyrrole-2-carboxylate",696-600-0,186202-73-3,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232292,methyl 1-benzofuran-2-carboxylate,696-601-6,1646-27-1,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232293,8-bromo-2-chloroquinoline,696-602-1,163485-86-7,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,2,H319:2;H332:2;H312:2;H315:2;H335:2;H302:2
232294,"6-Methyl-1,2,4-triazin-5(2H)-one",696-603-7,16120-00-6,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,157,H332:157;H312:157;H302:157
232295,"1,4-diethyl 2-bromob",696-604-2,154239-21-1,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232296,benzyl 4-[methoxy(methyl)carbamoyl]piperidine-1-carboxylate,696-605-8,148148-48-5,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232297,3-cyano-4-phenylpyridine-2-carboxylic acid,696-606-3,133609-28-6,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232298,[1-(2-fluorophenyl)-1H-pyrrol-2-yl]methanol,696-607-9,132407-66-0,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232299,Calcium aluminate sulphate,818-462-4,12005-25-3,Skin Sens. 1,Notified C&L,22,H317:22
232302,"Mixture of reaction products of substituted copper phthalocyanine, hydrogenated resin acids, alkaline earth metal chlorides, and copper phthalocyanine",,,Skin Sens. 1B;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H400:1;H317:1;H410:1
232303,"3-Quinolinecarboxylic acid, 7-(3-Aminohexahydro-1H-azepin-1-yl]-1-cyclopropyl-6fluoro-1,4-dihydro-4-oxo, hydrochloride",696-608-4,141388-70-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
232304,2-Nitrophenol potassium salt,696-610-5,824-38-4,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4;STOT RE 2,Notified C&L,1,H332:1;H373:1;H312:1;H302:1
232305,D-Lysine lactamhydrochloride (±)-3-Aminohexahydro-2H-azepin-2-onehydrochloride 3-Amino-2-ohexamethyleneimine hydrochloride,939-064-8,,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H315:1;H335:1;H319:1;H302:1
232308,"7-[(3R)-3-Aminohexahydro-1H-azepin-1-yl]-8-chloro-1-cyclopropyl-6 fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid monohydrochloride",696-612-6,405165-61-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
232309,"3-Quinolinecarboxylic acid, 1-cyclopropyl-6 fluoro-7-[(3R)-hexahydro-3-[[3-nitrophenyl)methylene]amino]-1H-azepin-1-yl]-1,4-dihydro-4-oxo",696-613-1,1040207-19-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
232310,α-D-glükopiranozil-2-amino-2-dezoxi-α-D-glükopiranozid-hidroklorid (1:1),696-614-7,203317-42-4,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H226:1;H315:1
232313,"Ethyl (4S,5R)-5-[(4R)-2,2-dimethyl-1,3-dioxolan-4- yl]-4-methyl-2,2-dioxo-1,3,2lambda6-dioxathiolane-4- carboxylate",939-067-4,,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
232314,"Amines, N-(C18 unsaturated, alkyl) trimethylenedi-, ethoxylated (NLP)",696-616-8,1268344-02-0,Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,1,H314:1;H410:1;H372:1;H318:1;H400:1;H302:1
232315,"(R, R)-(-)-N-[2-hydroxy-5-[1-hydroxy-2-[[2-(4-methoxyphenyl)-1-methylethyl] amino]ethyl] phenylformamide (2R, 3R)-dihydroxy butanedioate, 1:1 salt",696-617-3,200815-49-2,Acute Tox. 4;Acute Tox. 3;Resp. Sens. 1;Carc. 2;Repr. 2;STOT RE 1,Notified C&L,2,H372:2;H331:1;H334:2;H351:2;H361:2;H302:2;H412:1;H330:1
232317,4-Piperidinobenzophenone,939-069-5,,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
232319,"Reaction mass of 4-tert-butylphenol and 1,3-phenylenedimethanamine and 2-({[3-(aminomethyl)benzyl]amino}methyl)-4-tert-butylphenol",939-071-6,,Skin Corr. 1B;Skin Sens. 1;Eye Dam. 1;STOT SE 3;Repr. 2;Aquatic Chronic 2,REACH registration C&L,1,H335:1;H411:1;H314:1;H317:1;H318:1;H361:1
232322,methyl 7-bromo-1-benzofuran-2-carboxylate,696-619-4,1247406-14-9,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232323,2-[(2-fluoro-6-nitrophenyl)sulfanyl]acetic acid,696-621-5,1247021-61-9,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232324,"tert-butyl 4-{[8-(ethoxycarbonyl)-[1,2,4]triazolo[4,3-a]pyridin-3-yl]methyl}piperidine-1-carboxylate",696-622-0,1211592-94-7,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232325,"4-propanoylphenyl 2,2-dimethylpropanoate",696-623-6,120703-45-9,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232326,"6-benzyl-2,6-diazaspiro[4.5]decane",696-624-1,1158750-93-6,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232327,"Copolymer of N,N-bis(triethoxysilylpropyl)amine, N,N-bis(trimethoxysilylpropyl)amine, hexane-1,6-diisocyanate",939-074-2,,Skin Sens. 1;Resp. Sens. 1,Notified C&L,1,H334:1;H317:1
232328,"ethyl 2-[(4-methoxyphenyl)amino]-4-methyl-1,3-thiazole-5-carboxylate",696-625-7,109688-84-8,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232329,1-(5-ethyl-1-benzofuran-2-yl)ethan-1-one,696-626-2,106989-39-3,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232330,tert-butyl 5-amino-3-methyl-1H-pyrazole-1-carboxylate,696-627-8,1065204-79-6,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232331,"7'-methyl-2',3',4',6'-tetrahydrospiro[cyclohexane-1,1'-pyrazolo[3,4-b]pyridine]-3'-one",696-628-3,1029475-77-1,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232333,"Reaction mass of 2-({[(5-isocyanato-1,3,3-trimethylcyclohexyl)methyl]carbamoyl}oxy)ethyl 2-methylprop-2-enoate and 2-({[3-(isocyanatomethyl)-3,5,5-trimethylcyclohexyl]carbamoyl}oxy)ethyl 2-methylprop-2-enoate",939-075-8,,Skin Sens. 1;Acute Tox. 4;Resp. Sens. 1;Aquatic Chronic 3,Notified C&L,1,H334:1;H412:1;H332:1;H317:1
232335,"2-{[(6-Isocyanato-2,2,4 (or 2,4,4 or 3,3,5 or 3,5,5)-trimethylhexyl)carbamoyl]oxy}ethyl prop-2-enoate",939-077-9,,Skin Corr. 1C;Skin Sens. 1;Resp. Sens. 1,Notified C&L,1,H334:1;H314:1;H317:1
232337,N-(4-fluoro-2-methyl-6-nitrophenyl)acetamide,939-080-5,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232338,"3-(triphenylphosphoranylidene)-2,5-pyrrolidinedione",939-081-0,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232339,methyl 5-acetyl-4-iodo-1H-pyrrole-2-carboxylate,939-082-6,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232340,"methyl 4-({8-chloro-2-methyl-1H,2H,3H,4H,5H-pyrido[4,3-b]indol-5-yl}methyl)benzoate",939-083-1,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232341,3-iodoquinolin-8-amine,939-084-7,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232342,methyl 3-{4-[(2-bromo-5-fluorophenyl)methoxy]phenyl}propanoate,939-085-2,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232343,methyl 3-(3-bromo-4-hydroxyphenyl)-2-(hydroxyimino)-propanoate,939-086-8,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232344,6-bromo-N-[(4-methylphenyl)methyl]hexanamide,939-087-3,,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H332:1;H312:1;H315:1;H335:1;H302:1
232345,4-tert-butyl-2-ethoxyphenylglycine,939-088-9,,Aquatic Chronic 1,Notified C&L,1,H410:1
232350,N-(2-Chloroethyl)diethylamine hydrochloride~N-(2-Chloroethyl)diethylammonium chloride,696-630-4,679809-58-6,Skin Sens. 1,Notified C&L,10,H317:9;Not classified:1
232353,3-Methyl-7-azaindole,696-634-6,5654-93-3,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H315:1;H335:1;H319:1;H302:1
232360,1-methylpiperazin-2-one,696-637-2,59702-07-7,,Notified C&L,2,H319:2;H335:2;H315:2;H302:1
232361,1-(azetidin-3-yl)-1H-pyrazole,696-638-8,1107627-16-6,,Notified C&L,2,H319:2;H335:2;H315:2
232362,(1-phenyl-1H-pyrazol-4-yl)methanamine,696-639-3,400877-10-3,,Notified C&L,2,H319:2;H335:2;H315:2;H303:1
232364,methyl 3-fluoro-4-{[(2-hydroxyphenyl)methyl]amino}benzoate,939-094-1,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232366,"tert-butyl 2,6-diazaspiro[4.5]decane-6-carboxylate hydrochloride",939-096-2,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232367,3-(3-bromo-4-hydroxyphenyl)-2-(hydroxyimino)propanoic acid,939-097-8,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232368,(6-chloro-4-methoxypyridin-3-yl)methanol,939-098-3,,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H332:1;H312:1;H315:1;H335:1;H302:1
232369,"5-acetyl-3-iodo-6-methyl-1,2-dihydropyridin-2-one",939-099-9,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232370,ethyl 3-cyano-4-phenylpyridine-2-carboxylate,939-100-2,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232371,6-chloro-4-methoxypyridine-3-carbaldehyde,939-101-8,,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H332:1;H312:1;H315:1;H335:1;H302:1
232375,ethyl 5-[(4-methylpiperazin-1-yl)methyl]pyridine-2-carboxylate,939-102-3,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232376,1-(6-chloro-5-iodo-2-methylpyridin-3-yl)ethan-1-one,939-103-9,,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H332:1;H312:1;H315:1;H335:1;H302:1
232377,ethyl 4-chloro-5-(trifluoromethyl)pyridine-2-carboxylate,939-104-4,,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H332:1;H312:1;H315:1;H335:1;H302:1
232379,tert-butyl 4-(3-bromo-5-nitropyridin-4-yl)piperazine-1-carboxylate,939-106-5,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232380,4-chloro-5-(trifluoromethyl)pyridine-2-carboxylic acid,939-107-0,,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H332:1;H312:1;H315:1;H335:1;H302:1
232381,methyl 3-bromo-2-hydroxy-5-phenylbenzoate,939-108-6,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232382,"3-iodo-5-methyl-1,2-dihydro-1,6-naphthyridin-2-one",939-109-1,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232383,methyl 4-chloro-1-benzofuran-2-carboxylate,939-110-7,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232384,4-amino-2-methoxy-6-methylpyrimidine-5-carbonitrile,939-111-2,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232385,N-(2-amino-4-fluoro-6-methylphenyl)acetamide,939-112-8,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232386,1-(5-iodo-6-methoxy-2-methylpyridin-3-yl)ethan-1-one,939-113-3,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232387,methyl 5-bromo-6-(methylamino)pyridine-3-carboxylate,939-114-9,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232388,"2-chloro-3-iodo-5-methyl-1,6-naphthyridine",939-115-4,,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H332:1;H312:1;H315:1;H335:1;H302:1
232389,methyl 5-cyano-2-hydroxy-3-iodobenzoate,939-117-5,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232391,"Benzenesulfonic acid, C14-24-branched and linear, alkyl derivates",939-119-6,,Skin Corr. 1B,Notified C&L,8,H314:8
232392,N-(2-Chloro-1-phenyliminomethyl-1-cyclopentene-3-ylidene)methyl aniline hydrochloride,696-646-1,63856-99-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
232393,"Alcohols, C12-14 (even numbered), ethoxylated ( EO = 10 )",939-120-1,,Acute Tox. 4;Eye Dam. 1,Notified C&L,8,H318:8;H302:8
232394,"Norbornan-endo-2,3-dicarbonacid imide",696-647-7,28871-95-6,Skin Corr. 1C;Eye Irrit. 2;STOT SE 2,Notified C&L,1,H319:1;H335:1;H315:1
232395,"1H-Pyrazole-3-carboxylic acid, 1-(4-carboxyphenyl)-4-((4-(dimethylamino)phenyl)methylene)-4,5-dihydro-5-oxo-, 3-ethyl ester",696-648-2,117573-92-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
232396,Isobutanol ethoxylated (EO = 15),939-121-7,,Eye Irrit. 2,Notified C&L,8,H319:8
232397,Isobutanol ethoxylated (EO = 5),939-122-2,,Skin Irrit. 2;Eye Dam. 1,Notified C&L,8,H318:8;H315:8
232398,Isobutanol ethoxylated (EO = 10),939-123-8,,Skin Irrit. 2;Eye Dam. 1,Notified C&L,8,H318:8;H315:8
232400,hydrolysis products of 3-(triethoxysilyl)propan-1-amine,939-125-9,,Not Classified,REACH registration C&L,2,Not classified:2
232404,di-isopropylaminotrichlorogermane,696-652-4,1403891-62-2,Flam. Liq. 3;Skin Corr. 1B,Notified C&L,22,H314:22;H226:22
232405,"Reaction mass of mixed (3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluorooctyl) phosphates, ammonium salts",939-126-4,,Acute Tox. 1;STOT RE 2;Aquatic Chronic 1,Notified C&L,22,H330:22;H373:22;H410:22
232410,"(2S,3S)-3-Amino-4-(13C6)phenyl-1-{1-[4-(2-pyridinyl)benzyl]hydrazino}-2-butanol trihydrochloride",696-655-0,198904-87-9,Eye Dam. 1;Aquatic Chronic 2,Notified C&L,1,H318:1;H411:1
232413,Minodronate,696-656-6,155648-60-5,Acute Tox. 3;Repr. 2,Notified C&L,2,H361:1;H301:1;Not classified:1
232414,METHYL 2-METHYLTHIOPROPIONATE,696-657-1,61366-76-5,Flam. Liq. 3,Notified C&L,1,H226:1
232420,"Reaction mass of 1,1,2,2-tetrafluoro-2-{[2,2,4,5-tetrafluoro-5-(trifluoromethoxy)-1,3-dioxolan-4-yl]oxy}ethyl carbonofluoridate and carbonyl difluoride",939-133-2,,Acute Tox. 3;Acute Tox. 3;Skin Corr. 1A;Acute Tox. 3,Notified C&L,1,H314:1;H331:1;H311:1;H301:1
232421,Ethylmethylthiobutyrat,696-659-2,233665-96-8,,Notified C&L,2,Not classified:1;H315:1;H335:1;H319:1;H302:1
232429,STYRENE/MALEIC ACID COPOLYMER,696-666-0,52500-92-2,Eye Irrit. 2,Notified C&L,48,H319:48
232431,"Reaction mass of 2-ethyl-2-[[3-(2-methylaziridin-1-yl)propionyl]methyl]propane-1,3-diyl bis(2-methylaziridine-1-propionate) and 2,2-bis({[3-(2-methylaziridin-1-yl)propanoyl]oxy}methyl)butyl 3-[2,2-bis({[3-(2-methylaziridin-1-yl)propanoyl]oxy}methyl)butoxy]propanoate",939-180-9,,Acute Tox. 4;Skin Sens. 1A;Eye Dam. 1;Muta. 2;STOT RE 2;Aquatic Chronic 2,REACH registration C&L,5,H411:5;H373:5;H317:5;H318:5;H341:5;H302:5
232432,"Reaction mass of (2R,2'R)-2'-methylspiro[4-azoniabicyclo[2.2.2]octane-2,5'-[1,3]oxathiolane] 4-nitrobenzoate and (2S,2'S)-2'-methylspiro[4-azoniabicyclo[2.2.2]octane-2,5'-[1,3]oxathiolane] 4-nitrobenzoate",696-667-6,1292815-90-7,Acute Tox. 4;Acute Tox. 4;Carc. 2;Repr. 2,Notified C&L,1,H351:1;H361:1;H332:1;H302:1
232433,"1,4-Bis(diphenylphosphino)butane doxide",939-135-3,,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;STOT SE 3;Aquatic Chronic 4,Notified C&L,1,H319:1;H335:1;H413:1;H315:1
232434,Reaction mass of 7440-05-3 and 7440-44-0 and 7732-18-5,939-136-9,,Skin Irrit. 2;Eye Irrit. 2;STOT SE 1;STOT RE 1,Notified C&L,1,H372:1;H319:1;H370:1;H315:1
232435,"Reaction mass of 2-Piperazin-1-ylethanol and Piperazine-1,4-diethanol and Piperazine",939-137-4,,Skin Corr. 1B;Skin Sens. 1;Eye Dam. 1;Resp. Sens. 1;Repr. 2,Notified C&L,1,H314:1;H317:1;H318:1;H334:1;H361:1
232436,4-(2-phenylethyl)piperidine hydrochloride,696-668-1,142628-88-4,,Notified C&L,2,H315:2;H335:2;H319:2;H302:2
232442,"Benzenesulfonic acid, 4-(branched alkyl derivs.) and benzenesulfonic acid, 4-(linear alkyl dervis.), calcium salts",,,Skin Sens. 1B,REACH registration C&L,2,H317:1;Not classified:1
232444,"Isopropylidenedicyclohexanol, oligomeric reaction products with 1-chloro-2,3-epoxypropane)",939-143-7,,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Muta. 2;Aquatic Chronic 2,Notified C&L,1,H319:1;H411:1;H317:1;H315:1;H341:1
232446,[No public or meaningful name is available],800-001-3,,Aquatic Chronic 3,Notified C&L,1,H412:1
232447,"Benzene, 1,3-diisocyanatomethyl-, rp. with Poly(oxy-1,2-ethanediyl), α-methyl-ω-hydroxy-",939-145-8,,Acute Tox. 4;Resp. Sens. 1,Notified C&L,1,H334:1;H332:1
232448,2-[2-(ethylamino)ethoxy]ethan-1-ol,800-002-9,106007-99-2,Skin Corr. 1C;Eye Dam. 1,Notified C&L,9,H314:9;H318:8;H335:1
232450,"Fatty acids, sunflower-oil, conjugated, maleated,reation products with diethanolamine, maleated tall-oil fatty acids and triethanolamine",800-003-4,1415316-96-9,Skin Sens. 1;Repr. 2,REACH registration C&L,85,H361:85;H317:85
232451,"Reaction mass of 3-aminopropyldimethylamine and N'-[3-(dimethylamino)propyl]-N,N-dimethylpropane-1,3-diamine and N,N-bis[3-(dimethylamino)propyl]-N',N'-dimethylpropane-1,3-diamine",939-147-9,,Flam. Liq. 3;Acute Tox. 4;Acute Tox. 3;Skin Corr. 1B;Skin Sens. 1;Eye Dam. 1,Notified C&L,8,H314:8;H226:8;H317:8;H318:8;H311:8;H302:8
232452,"Reaction mass of 1,4-dimethylcyclohexane and 1,3-dimethylcyclohexane and ethylcyclohexane",939-148-4,,Flam. Liq. 2;Skin Irrit. 2;Eye Irrit. 2;STOT SE 2;STOT SE 2,Notified C&L,8,H319:8;H411:8;H315:8;H336:8;H225:8;H335:8
232453,2-methoxybenzene-1-sulfonyl chloride,800-005-5,10130-87-7,,Notified C&L,3,H314:2;Not classified:1
232454,"4-[5-(3,5-Dichloro-phenyl)-5-trifluoromethyl-4,5-dihydro-isoxazol-3-yl]-2-methyl-N-(1-oxo-1lambda*4*-thietan-3-yl)-benzamide (mixture of cis and trans diastereomers)",939-150-5,,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,89,H400:89;H410:89
232455,6-Chloro-2-methoxynicotinonitrile,800-006-0,121643-46-7,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H332:1;H312:1;H315:1;H335:1;H302:1
232456,O-Cyclobutyl-hydroxylamine hydrochloride,800-007-6,137270-23-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:2;H315:2;H332:1;H312:1;H302:1
232457,"2,4,6-triisopropylaniline",800-008-1,21524-36-7,Not Classified,REACH registration C&L,34,Not classified:34
232458,"Butanedioic acid, 1,4-bis(1,1-dimethylpropyl) ester",800-009-7,77106-39-9,Aquatic Chronic 3,Notified C&L,83,H412:83
232459,"Acetic acid, 2-[bis(2,4,6-trimethylbenzoyl)phosphinyl]-, methyl ester",800-010-2,888744-68-1,Skin Sens. 1,Notified C&L,83,H317:83
232460,"4-Methyl-1,3-thiazole-5-carbonyl chloride",800-011-8,54237-09-1,Skin Corr. 1B;Eye Dam. 1,Notified C&L,2,H314:2;H318:1
232463,Aromatic polyisocyanate,800-012-3,103051-64-5,Skin Sens. 1;Eye Irrit. 2,Notified C&L,25,H319:25;H317:25
232464,[No public or meaningful name is available],800-013-9,97851-17-7,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Acute Tox. 4;Resp. Sens. 1;STOT SE 3;STOT RE 2,Notified C&L,25,H319:25;H373:25;H332:25;H317:25;H315:25;H334:25;H335:25
232465,[No public or meaningful name is available],800-014-4,103837-32-7,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Acute Tox. 4;Resp. Sens. 1;STOT SE 3;STOT RE 2,Notified C&L,25,H319:25;H373:25;H332:25;H317:25;H315:25;H334:25;H335:25
232466,"1,3-Benzenedicarboxylic acid, polymer with 2-ethyl-2-(hydroxymethyl)-1,3-propanediol, hexanedioic acid, 1,6-hexanediol, 1,3-isobenzofurandione and 5-isocyanato-1-(isocyanatomethyl)-1,3,3-trimethylcycl",800-016-5,918814-85-4,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,25,H319:25;H315:25
232467,"2-Propenoic acid, 2-hydroxyethyl ester, polymer with 1,6-diisocyanatohexane and 1,2-propanediol mono(2-propenoate)",800-017-0,1132673-51-8,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,82,H319:82;H315:82
232469,4-nitro-1H-indazole,800-019-1,2942-40-7,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H311:1;H315:1
232472,"Reaction mass of sodium 4-hydroxybenzenesulfonate and disodium 4-hydroxybenzene-1,3-disulfonate and sodium sulfate",939-154-7,,Not Classified,REACH registration C&L,1,Not classified:1
232480,1-(methylsulfanyl)pentan-3-one,800-020-7,66735-69-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
232481,"2,2'-benzene-1,2-diylbis(1,3-dioxan-5-ol)",939-157-3,,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
232483,ethyl 3-formylpyridine-2-carboxylate,939-159-4,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232484,4-(chloromethyl)-1-fluoro-2-iodobenzene,939-161-5,,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H332:1;H312:1;H315:1;H335:1;H302:1
232485,methyl 5-(trifluoromethyl)-1-benzofuran-2-carboxylate,939-162-0,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232486,methyl 7-ethoxy-1-benzofuran-2-carboxylate,939-163-6,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232487,methyl 6-chloro-1-benzofuran-2-carboxylate,939-164-1,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232488,5-iodo-2-methoxypyridine-3-carboxylic acid,939-165-7,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232489,methyl 7-(trifluoromethyl)-1-benzofuran-2-carboxylate,939-166-2,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232490,"3-iodo-2-methoxy-5-methyl-1,6-naphthyridine",939-167-8,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232491,4-bromo-1-ethyl-2-fluorobenzene,939-168-3,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232492,1-chloro-2-methoxy-4-nitro-5-(prop-2-en-1-yloxy)benzene,939-169-9,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232493,tert-butyl N-(2-methoxyphenyl)carbamate,939-170-4,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232494,tert-butyl 4-(methoxymethyl)piperidine-1-carboxylate,939-172-5,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232495,"3,4-dihydro-2H-spiro[naphthalene-1,4'-piperidine] hydrochloride",800-021-2,95195-98-5,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232496,2-chloro-5-fluoro-4-(methylsulfanyl)pyrimidine,800-022-8,87789-51-3,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H332:1;H312:1;H315:1;H335:1;H302:1
232497,(S)-3-(dimethylamino)-1-phenylpropan-1-ol; oxalic acid,800-023-3,873436-53-4,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232498,"5-fluoro-1H-pyrrolo[2,3-b]pyridine",800-024-9,866319-00-8,Acute Tox. 4;Eye Dam. 1,Notified C&L,40,H318:39;H302:40;H332:2;H312:2
232500,1-benzofuran-3(2H)-one O-methyloxime,939-173-0,,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Aquatic Chronic 3,Notified C&L,1,H412:1;H315:1;H317:1;H302:1
232501,Reaction products of imine and acrylate,939-338-7,,Skin Sens. 1B;Eye Dam. 1;Muta. 2;Aquatic Chronic 3,Notified C&L,1,H412:1;H318:1;H341:1;H317:1
232503,"polymer of vinyl acetate and maleic anidride, sodium salt",939-174-6,,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
232504,"N-(2,4-di-tert-butyl-5-hydroxyphenyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide",800-027-5,873054-44-5,Not Classified,Notified C&L,3,Not classified:2;H319:1;H361:1;H335:1;H315:1
232511,"Amines, N-(C16-18 (even numbered) and C18-unsatd. alkyl) trimethylenedi-, ethoxylated(NLP)",800-029-6,1290049-56-7,Acute Tox. 4;Skin Corr. 1B;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,5,H314:5;H372:5;H302:5;H400:5;H410:5
232513,"Octanoic acid, esters with anhydrosorbitol and dianhydrosorbitol",939-179-3,,Not Classified,REACH registration C&L,1,Not classified:1
232515,"Aspartic acid, N-[(2Z)-3-carboxy-1-oxo-2-propen-1-yl]-N-(9Z)-9-octadecen-1-yl-, 1,4-bis(2-methylpropyl) ester, compd. with 2-(8Z)-8-heptadecen-1-yl-4,5-dihydro-1H-imidazole-1-ethanol",800-030-1,791801-21-3,Skin Corr. 1A;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,18,H314:18;H400:18;H410:18
232516,"[1,3-Bis(2,4,6-trimethylphenyl)-2-imidazolidinyliden]dichloro[2-methyl(phenyl)amino]benzyliden]ruthenium(II)",800-031-7,1416427-09-2,Flam. Sol. 1;Met. Corr. 1;Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;Aquatic Chronic 4,Notified C&L,1,H319:1;H413:1;H312:1;H332:1;H315:1;H290:1;H228:1;H302:1
232517,Di-μ-carbonyl dicarbonyldicyclo pentadienyl diruthenium(II),800-032-2,12132-87-5,Flam. Sol. 1;Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3;Aquatic Chronic 4,Notified C&L,1,H319:1;H413:1;H312:1;H332:1;H315:1;H228:1;H335:1;H302:1
232518,Ethylcyclopentadienyl(pyrrolyl)ruthenium(II),800-033-8,883284-96-6,Flam. Liq. 2;Met. Corr. 1;Acute Tox. 2;Acute Tox. 2;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 2;Aquatic Chronic 4,Notified C&L,1,H319:1;H330:1;H413:1;H300:1;H315:1;H290:1;H310:1;H225:1
232519,"[1,3-Bis(2,6-diisopropylphenyl)-2-imidazolidinyliden]dichloro[2-methyl(phenyl)amino]benzyliden]ruthenium(II)",800-034-3,1416427-12-7,Flam. Sol. 1;Met. Corr. 1;Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;Aquatic Chronic 4,Notified C&L,1,H319:1;H413:1;H312:1;H332:1;H315:1;H290:1;H228:1;H302:1
232520,[No public or meaningful name is available],700-952-3,,Flam. Liq. 2;Asp. Tox. 1;Skin Irrit. 2;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H315:1;H336:1;H225:1;H304:1;H400:1;H410:1
232521,Niobium sulfur tin zinc oxide,800-035-9,1374645-21-2,Not Classified,Notified C&L,1,Not classified:1
232522,"calcium N2,N6-bis(3-carboxypropanoyl)lysine (1:1)",800-036-4,1422423-64-0,Not Classified,REACH registration C&L,2,Not classified:2
232523,"Alcohols, C12-14(even numbered), ethoxylated (EO = 7)",939-181-4,,Acute Tox. 4;Eye Dam. 1;Aquatic Chronic 3,Notified C&L,1,H412:1;H318:1;H302:1
232524,"Benzenesulfonic acid, methyl-, C20-24 (even numbered) sec-alkyl derivs.",939-185-6,,Skin Corr. 1C;Eye Dam. 1;Aquatic Chronic 4,REACH registration C&L,10,H314:10;H413:2;H318:10;H411:8;H317:8;H335:8
232525,Oxidation products containing cobalt oxides and manganese oxide obtained from deactivated cobalt catalyst,,,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Resp. Sens. 1;Carc. 1A;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,1,H319:1;H350:1;H410:1;H317:1;H315:1;H334:1;H400:1;H302:1
232530,Reaction mass of sodium hydrogen N-(1-oxooctadecyl)-L-glutamate and stearic acid,939-201-1,,Eye Irrit. 2A;Aquatic Chronic 3,REACH registration C&L,85,H412:85;H319:85
232532,"Higher oligomers of methylenediphenyl diisocyanate reaction with 1,2-propanediol, propoxylated and 4,4'-methylenediphenyl diisocyanate, homopolymer",939-189-8,,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Acute Tox. 4;Resp. Sens. 1;STOT SE 3;Carc. 2;STOT RE 2,Notified C&L,8,H319:8;H373:8;H332:8;H317:8;H315:8;H334:8;H351:8;H335:8
232533,"Higher oligomers of 1,2-propanediol, propoxylated and methylenediphenyl diisocyanate homopolymer",939-190-3,,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Acute Tox. 4;Resp. Sens. 1;STOT SE 3;Carc. 2;STOT RE 2,Notified C&L,8,H319:8;H373:8;H332:8;H317:8;H315:8;H334:8;H351:8;H335:8
232534,"Reaction mass of Amines, C10-14-branched and linear alkyl, [1-[(2-hydroxy-4-nitrophenyl)azo]-2-naphthalenolato(2-)][1-[(2-hydroxy-5-nitrophenyl)azo]-2-naphthalenolato(2-)]chromate(1-) and Amines, C10-14-branched and linear alkyl, bis[1-[(2-hydroxy-4-nitrophenyl)azo]-2-naphthalenolato(2-)]chromate(1-) and Amines, C10-14-branched and linear alkyl, bis[1-[(2-hydroxy-5-nitrophenyl)azo]-2-naphthalenolato(2-)]chromate(1-)",939-191-9,,Skin Sens. 1B;Repr. 1B;STOT RE 2,REACH registration C&L,85,H373:85;H360:85;H317:85
232536,"1-[[(6R,7R)-7-[2-(2-Amino-4-thiazolyl)glyoxylamido]-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl]-5,6,7,8-tetrahydroquinolinium hydroxide, inner salt 72-(Z)-(O-methyloxime), sulfate (1:1)",800-041-1,118443-89-3,Skin Irrit. 2;Eye Irrit. 2;Resp. Sens. 1;STOT SE 3;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,51,H319:51;H315:51;H334:51;H335:51;H400:51;H410:51
232539,2-phenylsulfanylthiophene,800-042-7,16718-12-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
232540,"Higher oligomers of 4,4'-methylenediphenyl diisocyanate homopolymer reaction with glycerol, polymer with oxirane and methyloxirane",939-196-6,,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Acute Tox. 4;Resp. Sens. 1;STOT SE 3;Carc. 2;STOT RE 2,Notified C&L,8,H319:8;H373:8;H332:8;H317:8;H315:8;H334:8;H351:8;H335:8
232541,"(1R,2S,5S)-N-[(2Ξ)-4-amino-1-cyclobutyl-3,4-dioxobutan-2-yl)]-3-{(2S)-2-[(tert-butylcarbamoyl)amino]-3,3-dimethylbutanoyl}-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide",800-043-2,394730-60-0,Acute Tox. 4;Repr. 2,Notified C&L,13,H361:13;H302:13
232546,2-(4-octylphenyl)ethanol,800-044-8,162358-05-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
232547,"2-Butenamide, N-[4-[(3-chloro-4-fluorophenyl)amino]-7-methoxy-6-quinazolinyl]-4-(1-pi peridinyl)-",800-045-3,869199-47-3,Skin Sens. 1,Notified C&L,29,H317:29
232551,"Benzene, mono, C15-16-alkyl derivs.",939-199-2,,Asp. Tox. 1,Notified C&L,1,H304:1
232554,"Reaction mass of lithium 3-hydroxy-2,2,4-trimethylpentanoate and lithium isobutyrate and sodium 3-hydroxy-2,2,4-trimethylpentanoate and sodium isobutyrate",939-200-6,,Not Classified,REACH registration C&L,1,Not classified:1
232559,"Reaction mass of (1RS,2RS,7SR,8RS,9E)-9-Ethylidene-3-oxatricyclo [6.2.1.0(2,7)] undecane and (1RS,2RS,7SR,8RS,9Z)-9-Ethylidene-3-oxatricyclo [6.2.1.0(2,7)] undecane and (1RS,2SR,7SR,8SR,10E)-10-Ethylidene-3-oxatricyclo[6.2.1.0(2,7)] undecane and (1RS,2SR,7SR,8SR,10Z)-10-Ethylidene-3-oxatricyclo [6.2.1.0(2,7)] undecane",941-194-5,,Skin Sens. 1B;Aquatic Chronic 2,REACH registration C&L,1,H411:1;H317:1
232561,(3-methylbenzoyl) 3-methylbenzoate,800-046-9,21436-44-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
232571,"Reaction mass of 1,2-Benzenedicarboxylic acid, 3-sulfo-, ammonium salt (1:3), 4-Sulphophthalic acid, ammonium salt, Ammonium sulphate",939-221-0,,Not Classified,REACH registration C&L,84,Not classified:84
232573,"Reaction mass of 1,2-Benzenedicarboxylic acid, 4-sulfo-, trisodium salt, 1,2-Benzenedicarboxylic acid, 3-sulfo-, sodium salt (1:3), Sodium sulphate",939-220-5,,Not Classified,REACH registration C&L,84,Not classified:84
232575,"Higher oligomers of isocyanic acid, polymethylenepolyphenylene ester reaction with glycerol, polymer with oxirane",939-205-3,,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Acute Tox. 4;Resp. Sens. 1;STOT SE 3;Carc. 2;STOT RE 2,Notified C&L,8,H319:8;H373:8;H332:8;H317:8;H315:8;H334:8;H351:8;H335:8
232576,"2,6-Dimethylpiperidin-4-one",800-050-0,45717-87-1,Skin Corr. 1C;Eye Dam. 1,Notified C&L,1,H314:1;H318:1
232577,2-Chloro-5-pyrimidinecarbonitrile,800-051-6,1753-50-0,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,67,H319:67;H332:66;H312:66;H315:67;H335:67;H302:66;H331:1;H311:1;H301:1
232579,"Decane-2,9-dione",800-053-7,16538-91-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
232580,1-phenyl-1H-pyrazole-5-carboxylic acid,800-054-2,1133-77-3,,Notified C&L,2,Not classified:1;H315:1;H335:1;H319:1;H302:1
232581,2-Fluoro-4-(cyclopropyl)phenylboronic acid pinacol ester,800-055-8,1338718-13-0,Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,1,H318:1;H335:1;H315:1
232583,Reaction mass of 2-methyldecan-1-ol and 2-propyloctan-1-ol and 2-ethylnonan-1-ol and 2-butylheptan-1-ol,939-213-7,,Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,1,H319:1;H411:1;H400:1
232588,"1,4-dimethyl-7-(prop-1-en-2-yl)-1,2,3,4,5,6,7,8-octahydroazulene; 2,2,6,8-tetramethyltricyclo[5.3.1.0³,⁸]undecan-3-ol; 3,8-dimethyl-5-(prop-1-en-2-yl)-1,2,3,3a,4,5,6,7-octahydroazulene",939-227-3,,Asp. Tox. 1;Aquatic Chronic 2,REACH registration C&L,46,H304:46;H411:46
232593,"Benzenesulfonic acid, C15-16-alkyl derivs.",939-214-2,,Acute Tox. 4;Skin Corr. 1C;Eye Dam. 1;Aquatic Chronic 3,Notified C&L,1,H412:1;H314:1;H318:1;H302:1
232598,Diethyl acetamido[2-(4-octylphenyl)ethyl]malonate,800-060-5,162358-08-9,Carc. 2;Repr. 1B;Lact.;STOT RE 2,Notified C&L,2,H351:1;H360:1;H362:1;H373:1;H335:1;H315:1
232599,"3,5 bisz(2,4,6- tribrómfenoxi)-ciklopentén",800-061-0,84598-98-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
232604,di(phenyl)phosphorylimino-tri(phenyl)-$l^{5}-phosphane,800-063-1,2156-69-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H315:1;H335:1;H319:1;H302:1
232605,5-bromo-N-(diphenylmethylidene)pyrimidin-2-amine,800-064-7,1072850-89-5,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H315:1;H335:1;H319:1;H302:1
232606,"2-chloro-5-(tetramethyl-1,3,2-dioxaborolan-2-al)aniline",800-065-2,850567-56-5,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H315:1;H335:1;H319:1;H302:1
232607,"2-chloro-8-cyclopentyl-5-methyl-8H-pyrido[2,3-d]pyrimidin-7-one",800-066-8,1013916-37-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H315:2;H335:2;H319:2;H302:2
232608,5-bromo-2-chloro-N-cyclopentylpyrimidin-4-amine,800-067-3,733039-20-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H315:2;H335:2;H319:2;H302:2
232612,(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-4-carbamoylbutanoic acid,800-068-9,14608-83-4,Flam. Sol. 2,Notified C&L,1,H228:1
232613,(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-carbamoylpropanoic acid,800-069-4,14608-79-8,Flam. Sol. 2,Notified C&L,1,H228:1
232617,Borate cobalt(2+) C3/C8/C10 carboxylates salts,939-267-1,,Acute Tox. 4;Skin Sens. 1A;Eye Dam. 1;Acute Tox. 4;Repr. 1B;Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,2,H411:2;H332:2;H317:2;H318:2;H360:2;H400:2;H302:2
232620,Reaction products of isobutanol and ethylene oxide,939-232-0,,Flam. Liq. 3;Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3;STOT SE 3,Notified C&L,8,H226:8;H315:8;H318:8;H336:8;H335:8;H302:8
232621,"Alcohols, C9-11 (odd numbered), branched and linear",939-233-6,,Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,1,H319:1;H411:1;H400:1
232625,"Fatty acids, C16-C18 (even numbered) and C18 (unsaturated) and Fatty acids, C16-C18 (even numbered) and C18 (unsaturated) methyl esters",939-235-7,,Not Classified,REACH registration C&L,26,Not classified:13;H313:12;H227:12;H332:13;H302:13;H226:1
232628,"Stearic acid, esters with methyl α-D-glucoside",939-238-3,,Not Classified,REACH registration C&L,1,Not classified:1
232629,"Alcohols, C11-13-branched and linear",939-237-8,,Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 2,Notified C&L,1,H319:1;H411:1;H400:1
232630,"Glycerides, C16-18(even numbered) and C18-unsatd., reaction products with 2,2'-iminodi(ethylamine)",939-271-3,,Skin Corr. 1A;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,1,H314:1;H400:1;H410:1
232631,"Amides, C18-unsatd., N-(hydroxyethyl)",939-272-9,,Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 2,REACH registration C&L,1,H318:1;H411:1;H315:1
232632,"1,2-benzoxazol-3-amine",800-075-7,36216-80-5,,Notified C&L,3,H319:3;H335:3;H315:3;H302:1
232635,"Alcohols, C11-14, C13- rich, ethoxylated, phosphated (EO = 9)",939-239-9,,Acute Tox. 4;Eye Dam. 1;Aquatic Chronic 3,Notified C&L,8,H412:8;H318:8;H302:8
232636,"Alcohols, C14-17-branched and linear",939-240-4,,Aquatic Chronic 1,Notified C&L,1,H410:1
232642,(+/-)-Eriodictyol,800-080-4,4049-38-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
232643,"2,4-Dichloro-D-phenylalanine",800-082-5,114872-98-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
232644,(5-Methoxy-1H-indol-3-yl)acetonitrile,800-083-0,2436-17-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
232645,7-(Aminomethyl)benzo[b]thiophene,800-084-6,880251-15-0,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Acute Tox. 4,Notified C&L,1,H314:1;H332:1;H312:1;H302:1
232646,"5,6-Difluoro-1H-indole",800-085-1,169674-01-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
232647,"4-Amino-1,2,5-oxadiazole-3-carbonitrile",800-086-7,156463-85-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:2;H315:2
232648,1-Iodo-4H-tetrafluorobenzene,800-087-2,5243-24-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
232649,2-Bromo-5-(trifluoromethyl)benzyl alcohol,800-088-8,869725-53-1,,Notified C&L,19,H319:19;H335:19;H315:19
232650,2-(4-Methylphenyl)thiophene,800-089-3,16939-04-1,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H332:1;H312:1;H315:1;H335:1;H302:1
232651,6-METHYL-BENZOTHIOPHENE-2-CARBOXYLIC ACID,800-090-9,1467-86-3,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,3,H319:3;H332:3;H312:3;H315:3;H335:3;H302:3
232652,3-[(Pyrrolidin-1-yl)sulphonyl]pyridine,800-091-4,26103-51-5,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H332:1;H312:1;H315:1;H335:1;H302:1
232653,3-Chloro-2-formylpyridine,800-093-5,206181-90-0,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,3,H319:3;H332:2;H312:2;H315:3;H335:3;H302:2
232654,"1H-Tridecafluoro-3,3-dimethylhex-1-yne",800-094-0,261503-44-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
232655,"(1S,5R)-8-Azabicyclo[3.2.1]octan-3-one hydrochloride",800-095-6,25602-68-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,3,H319:3;H335:3;H315:3
232660,"Alcohols, C12-14-(even numbered) secondary, β-(2-hydroxyethoxy)",939-249-3,,Skin Irrit. 2;Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,1,H411:1;H400:1;H315:1
232661,"1-(3,5-dichloropyridin-2-yl)thiourea",800-097-7,31545-32-1,Not Classified,Notified C&L,2,Not classified:1;H315:1;H335:1;H319:1;H302:1
232664,"Sulfuric acid, mono-C12-14 (even numbered)-alkyl esters, compds. with triethanolamine",939-265-0,,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,196,H412:196;H315:196;H318:196;H302:196;H332:93;H335:93
232665,"D-Glucopyranose, oligomeric, butyl glycoside",939-389-5,,Not Classified,REACH registration C&L,2,Not classified:2
232671,"Reaction mass of sodium(E)-6,7'-carbonylbis(azanediyl)bis(4-hydroxy-3-((E)-phenyldiazenyl) naphthalene-2-sulfonate) and disodium 3-[(4-acetamidophenyl)azo]-4-hydroxy-7-[[[[5-hydroxy-6-(phenylazo)-7-sulphonato-2-naphthyl]amino]carbonyl]amino]naphthalene-2-sulphonate and disodium 7,7'-(carbonyldiimino)bis[4-hydroxy-3-(phenylazo)naphthalene-2-sulphonate]",939-268-7,,Not Classified,REACH registration C&L,4,Not classified:4
232672,"Oxirane, 2,2'-[(1-methylethylidene)bis(4,1-phenyleneoxymethylene)]bis-, polymer with 1,1'-methylenebis[isocyanatobenzene]",800-098-2,60684-77-7,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2,Notified C&L,180,H319:179;H317:179;H315:179;Not classified:1
232673,PROCESS OIL,939-248-8,,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H400:1;H410:1
232674,"Oxirane, 2-methyl-, polymer with oxirane, carboxymethyl octadecyl ether",800-099-8,83271-53-8,Eye Dam. 1;Aquatic Chronic 3,Notified C&L,4,H412:4;H318:4
232678,"3,5-Di-O-(p-toluyl)-2-deoxy-D-ribofuranosyl chloride",800-102-2,3601-89-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 2,Notified C&L,1,H319:1;H335:1;H315:1
232681,"Quaternary ammonium compounds, benzyl C12-C16 (even numbered)-alkyldimethyl chlorides",939-253-5,,Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,43,H314:43;H318:12;H302:43;H400:43;H410:43
232685,[No public or meaningful name is available],800-106-4,476181-74-5,Resp. Sens. 1B,Notified C&L,35,H334:35
232686,"Alcohols, C11-14, C13-rich, ethoxylated, phosphated",939-254-0,,Skin Corr. 1C;Eye Dam. 1,Notified C&L,8,H314:8;H318:8
232687,16-(tert-butoxy)-16-oxohexadecanoic acid,800-108-5,843666-27-3,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232689,4-cyano-1H-pyrrole-2-carboxylic acid,800-109-0,80242-24-6,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232690,"2-fluoro-5-[(4-oxo-3,4-dihydrophthalazin-1-yl)methyl]benzoic acid",800-110-6,763114-26-7,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,90,H332:90;H312:90;H302:90
232692,6-bromo-1H-indole-2-carboxamide,939-256-1,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232693,4-[4-(4-methoxyphenyl)piperazin-1-yl]aniline,800-112-7,736080-30-1,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232694,"6-bromopyrazolo[1,5-a]pyrimidine",800-113-2,705263-10-1,,Notified C&L,3,H319:2;H335:2;H315:2;H332:1;H312:1;H302:1
232695,20-(tert-Butoxy)-20-oxoicosanoic acid,800-114-8,683239-16-9,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,2,H332:2;H312:2;H302:2
232696,2-[(4-nitrophenyl)amino]acetic acid,800-115-3,619-91-0,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232697,"5-acetyl-3-chloro-6-methyl-1,2-dihydropyridin-2-one",800-116-9,58405-00-8,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232699,"Reaction products of diazotised m-phenylendiamine, subsequently coupled with diazotised 4-aminobenzene-1-sulfonic acid, sodium salts",939-292-8,,Not Classified,REACH registration C&L,97,Not classified:97
232700,"Quaternary ammonium compounds, benzyl-C16-C18 (even numbered)-alkyldimethyl, chlorides",939-290-7,,Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,18,H314:18;H318:18;H302:18;H400:18;H410:18
232702,4-[5-[bis(2-hydroxyethyl)amino]-1-methyl-benzimidazol-2-yl]butanoic acid,800-119-5,1247136-71-5,Acute Tox. 3;Skin Irrit. 2;Muta. 2;Carc. 2;Repr. 1B,Notified C&L,1,H315:1;H351:1;H360:1;H341:1;H301:1
232703,4-[5-[2-[4-[5-[bis(2-chloroethyl)amino]-1-methyl-benzimidazol-2-yl]butanoyloxy]ethyl-(2-chloroethyl)amino]-1-methyl-benzimidazol-2-yl]butanoic acid,800-120-0,1228551-91-4,Acute Tox. 3;Skin Irrit. 2;Muta. 2;Carc. 2;Repr. 1B,Notified C&L,1,H315:1;H351:1;H360:1;H341:1;H301:1
232704,ethyl 4-[5-[bis(2-chloroethyl)amino]-1-methyl-benzimidazol-2-yl]butanoate,800-121-6,87475-54-5,Acute Tox. 3;Skin Irrit. 2;Muta. 2;Carc. 2;Repr. 1B,Notified C&L,1,H315:1;H351:1;H360:1;H341:1;H301:1
232705,2-(1-benzofuran-3-yl)acetic acid,800-122-1,64175-51-5,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:2;H315:2;H335:1
232706,"Reaction mass of all possible isomers of Disodium 2,2'-ethene-diylbis[5-({4-[bis(2-hydroxyalkyl)amino]-6-({4-[(2-hydroxyethyl) substituted]phenyl}amino)-1,3,5-triazin-2-yl}amino)benzenesulfonate]",,,Not Classified,REACH registration C&L,1,Not classified:1
232711,"Reaction mass of 3,7-dimethylocta-1,6-diene and 2,6-dimethyloct-7-en-2-ol and 1,2-dimethyl-3-(propan-2-yl)cyclopentene",939-258-2,,Flam. Liq. 3;Asp. Tox. 1;Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,1,H412:1;H319:1;H304:1;H226:1
232714,m-Toluidine 5EO,800-124-2,36356-82-8,Aquatic Chronic 3,Notified C&L,1,H412:1
232716,"Sulfuric acid, mono-C8-14 (even numbered)-alkyl esters, compds. with triethanolamine",939-262-4,,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,2,H412:2;H315:2;H318:2;H302:2;H332:1;H335:1
232717,Benzyl-C12-14-alkyldimethylammonium chlorides,939-350-2,,Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,44,H314:44;H318:13;H302:44;H400:44;H410:44
232718,"Siloxanes and Silicones, di-Ph, Me hydrogen Me vinyl",800-125-8,1229028-03-8,Eye Irrit. 2,Notified C&L,1,H319:1
232719,"D-Glucose, reaction products with alcohols C16-18 (even numbered) (excess)",939-266-6,,Not Classified,REACH registration C&L,2,Not classified:2
232720,(R)-2-(2-aminothiazol-4-yl)-N-(4-(2-((2-hydroxy-2-phenylethyl)amino)ethyl)phenyl)acetamide,800-126-3,223673-61-8,Acute Tox. 4;Skin Sens. 1;Eye Irrit. 2;Repr. 2;STOT RE 2;Aquatic Chronic 1,Notified C&L,8,H319:3;H373:5;H410:4;H317:5;H361:4;H302:7;H371:1;H362:1;H351:1
232721,(S)-N-methyl-N-methoxy-2-(tert-butoxycarbonylamino)-4-methylpentanamide,800-127-9,87694-50-6,Flam. Liq. 2,Notified C&L,3,H225:2;H319:1;H335:1;H315:1
232724,"11,11-dimethyl-5-oxa-3-thia-4-azatetracyclo[6.2.1.01,6.04,6]undecane-3,3-dione",800-131-0,104372-31-8,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
232726,7S)-7-[[2-(2-amino-2-carboxyethyl)sulfanylacetyl]amino]-7-methoxy-3-[(1- methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct- 2-ene-2-carboxylate,800-133-1,92636-39-0,Acute Tox. 4;Resp. Sens. 1A,Notified C&L,1,H334:1;H302:1
232727,"Paraffin waxes and Hydrocarbon waxes C14-17, chloro, sulfochlorinated, low sulphonated, saponified",939-273-4,,Skin Irrit. 2;Skin Sens. 1B;Eye Irrit. 2;Aquatic Acute 1,REACH registration C&L,9,H319:9;H400:9;H317:9;H315:9
232728,"Reaction product of 2-Hexyldecan-1-ol, 2-Octyldodecan-1-ol and Lauric acid",939-270-8,,Not Classified,REACH registration C&L,84,Not classified:84
232730,"2-(dimethyl-1,3-thiazol-5-yl)acetic acid",800-134-7,34272-65-6,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,157,H332:157;H312:157;H302:157
232731,methyl 6-nitro-1-benzothiophene-2-carboxylate,800-135-2,34084-88-3,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232732,1-(1H-indol-3-yl)-2-methylpropan-2-amine,800-136-8,304-53-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,3,H319:2;H335:2;H315:2;H332:1;H312:1;H302:1
232733,"1,3-dichloro-7-methoxyisoquinoline",800-137-3,24623-40-3,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H332:1;H312:1;H315:1;H335:1;H302:1
232734,14-(tert-butoxy)-14-oxotetradecanoic acid,800-138-9,234082-00-9,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,2,H332:1;H312:1;H302:1;H319:1;H315:1
232735,"2,3,4-trifluoro-5-nitrobenzoic acid",800-139-4,197520-71-1,Skin Corr. 1;Eye Dam. 1;STOT SE 3,REACH registration C&L,8,H314:4;H335:6;H318:4;H319:2;H315:2;H332:1;H312:1;H302:2;Not classified:1
232736,18-(benzyloxy)-18-oxooctadecanoic acid,800-141-5,189625-51-2,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232737,"tert-butyl 2,4-dioxo-1,3,8-triazaspiro[4.5]decane-8-carboxylate",800-142-0,183673-70-3,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,2,H332:2;H312:2;H302:2;H319:1;H315:1;H335:1
232738,ethyl 6-{[(tert-butoxy)carbonyl]amino}pyridine-3-carboxylate,800-143-6,169280-82-4,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232739,"1,3-diethyl 2-(3,6-dichloro-5-nitropyridin-2-yl)propanedioate",800-144-1,136888-77-2,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H332:1;H312:1;H315:1;H335:1;H302:1
232740,2-[4-(2-methoxyphenyl)piperazin-1-yl]ethan-1-ol dihydrochloride,939-275-5,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232741,(S)-Methyl 2-hydroxy-3-methylbutanoate,800-145-7,24347-63-5,Flam. Liq. 3;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:2;H226:2;H315:1
232742,5-bromo-6-(trifluoromethyl)-1H-indole-3-carbaldehyde,939-276-0,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232743,"6-fluoro-3-nitroimidazo[1,2-a]pyridine",939-277-6,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232744,"methyl 2,5-dichloro-6-(methylamino)pyrimidine-4-carboxylate",939-278-1,,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H332:1;H312:1;H315:1;H335:1;H302:1
232745,"ethyl 3-(1,3-dioxolan-2-yl)pyridine-2-carboxylate",939-279-7,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232746,(2E)-but-2-enedioic acid bis(tert-butyl 4-[(methylamino)methyl]piperidine-1-carboxylate),939-280-2,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232747,2-(2-bromo-4-chlorophenyl)-N-methylacetamide,939-281-8,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232750,"Reaction mass of tetraalkyl-3,3’-di(propan-2-yl)biphenyldiyl tetrakis(dialkylphenyl) bis(phosphite) and tris(dialkylphenyl) phosphite",,,Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,2,H319:2;H315:2
232755,t-hexyldimethylsilyl methacrylate,939-284-4,,Acute Tox. 4;Skin Sens. 1;Eye Irrit. 2,Notified C&L,19,H319:19;H317:19;H302:19
232757,"Amines,N-(C16-18 and C18 unsaturated alkyl) trimethylenedi-,diacetates.",800-153-0,1313206-64-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT RE 1;Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,10,H319:10;H411:10;H410:10;H372:10;H315:10;H400:10;H302:10
232759,"N-benzyl-4-methoxy-alpha-methylphenethylamine, hydrochloride (1:1)",800-147-8,1199228-78-8,Acute Tox. 3;Skin Corr. 1B,Notified C&L,1,H314:1;H301:1
232760,(R)-Methyl 2-hydroxy-3-methylbutanoate,800-148-3,90244-32-9,Flam. Liq. 3;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:2;H226:2;H315:1
232761,"mono- and di-esterification products of propane-1,2,3-triol and formic acid",800-149-9,1410795-90-2,Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1,REACH registration C&L,17,H314:17;H318:17;H302:17
232762,"2,5-Difluorobenzylmagnesium bromide",800-150-4,522651-57-6,Skin Corr. 1B;Eye Dam. 1,Notified C&L,1,H314:1;H318:1
232763,Pyridazine-4-carboxaldehyde,800-152-5,50901-42-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,3,H319:3;H335:3;H315:3;H312:1;H317:1;H332:1;H302:1
232764,"Titanium, dihydroxybis(2-hydroxypropanoato-O{1},O{2})",800-154-6,79110-90-0,Met. Corr. 1;Skin Corr. 1B,Notified C&L,7,H290:7;H314:7
232765,"3,4-dihydro-2H-1,4-benzoxazine-6-carboxylic acid",800-155-1,918789-44-3,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232766,H-Ile-Phe-Leu-Leu-Trp-Gln-Arg-Cys(10-(4-(4-(maleimido-methyl)cyclohexaneoylaminomethyl)cyclohexanecarboxy)-7-ethylcamptothecin)-Arg-Arg-OH,939-288-6,,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3;Muta. 1B,Notified C&L,1,H331:1;H340:1;H311:1;H301:1
232767,"6-amino-3H,4H-pyrido[2,3-b]pyrazin-3-one",800-156-7,874493-61-5,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232768,4-({[4-(pyridin-3-yl)pyrimidin-2-yl]amino}methyl)benzoic acid,800-157-2,849235-68-3,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232769,methyl 4-({[4-(pyridin-3-yl)pyrimidin-2-yl]amino}methyl)benzoate,800-158-8,849235-67-2,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232770,18-(tert-Butoxy)-18-oxooctadecanoic acid,800-159-3,843666-40-0,,Notified C&L,4,H319:2;H335:2;H315:2;H332:2;H312:2;H302:2
232771,"N,2,6-trimethylaniline",800-160-9,767-71-5,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232772,1-(pyridine-3-carbonyl)piperidine-2-carboxylic acid,800-161-4,67691-59-2,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232773,"2-oxo-5-(pyridin-4-yl)-1,2-dihydropyridine-3-carboxylic acid",800-163-5,62749-61-5,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232774,Methyl 5-bromothiophene-2-carboxylate,800-164-0,62224-19-5,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,3,H319:3;H332:3;H312:3;H315:3;H335:3;H302:3
232775,"8-bromo-1,7-naphthyridin-6-amine",800-165-6,5912-35-6,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H332:1;H312:1;H315:1;H335:1;H302:1
232776,3-(cyanomethyl)pyridine-2-carbonitrile,800-166-1,5912-34-5,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232777,"5-(2-fluorophenyl)-2-methyl-1,3-thiazole-4-carboxylic acid",800-167-7,522646-43-1,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232778,2-hydroxy-3-(prop-2-en-1-yl)benzoic acid,800-168-2,42729-96-4,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232779,2-amino-6-methyl-5-nitropyrimidin-4-ol,800-169-8,4214-85-1,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232781,MEP Oxon,800-170-3,2255-17-6,Acute Tox. 2;Acute Tox. 4,Notified C&L,1,H300:1;H332:1
232785,"Thiophene, tetrahydro-, 1,1-dioxide, 3-(C9-11-isoalkyloxy) derivs., C10-rich",800-172-4,398141-87-2,Aquatic Chronic 2,REACH registration C&L,450,H411:450
232786,"Sulfuric acid, mono-C8-14 (even-numbered)-alkyl esters, ammonium salts",939-291-2,,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Acute Tox. 4;STOT SE 3;Aquatic Chronic 3,REACH registration C&L,170,H412:170;H332:85;H315:170;H318:170;H335:85;H302:170
232789,Reaction mass of endo-2-methyl-exo-3-methyl-exo-2-[(endo-3-methylbicyclo[2.2.1]hept-endo-2-yl)methyl]bicyclo[2.2.1]heptane and endo-2-methyl-exo-3-methyl-exo-2-[(endo-2-methylbicyclo[2.2.1]hept-endo-3-yl)methyl]bicyclo[2.2.1]heptane and endo-2-methyl-exo-3-methyl-exo-2-[(exo-3-methylbicyclo[2.2.1]hept-exo-2-yl)methyl]bicyclo[2.2.1]heptane and endo-2-methyl-exo-3-methyl-exo-2-[(exo-2-methylbicyclo[2.2.1]hept-exo-3-yl)methyl]bicyclo[2.2.1]heptane,939-299-6,,Skin Irrit. 2;Aquatic Chronic 4,Notified C&L,1,H413:1;H315:1
232790,"Sulfuric acid, C10-12 (even numbered)-alkyl esters, sodium salts",939-408-7,,Flam. Sol. 1;Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Acute Tox. 4;STOT SE 3,REACH registration C&L,10,H332:5;H315:10;H318:10;H228:5;H335:5;H302:10
232791,"Monopentaerythritol tetraesters and dipentaerythritol hexaesters of 3,5,5-trimethylhexanoic, n-heptanoic, n-octanoic and n-decanoic acids",939-415-5,,Not Classified,REACH registration C&L,2,Not classified:2
232793,N-ethyl-N-methylformamide,800-174-5,28860-25-5,Flam. Liq. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,90,H319:90;H335:90;H226:89;H315:90;H361:1;H312:1;H332:1;H227:1;H302:1
232795,2-(2-ethyl-6-methyl-N-oxalo-anilino)propanoic acid,939-295-4,,Aquatic Chronic 3,Notified C&L,89,H412:89
232796,"1-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-yl)ethanol",939-297-5,,Acute Tox. 4;Aquatic Chronic 3,Notified C&L,89,H412:89;H302:89
232797,"1-(3,5-dichloro-4-fluorophenyl)-2,2,2-trifluoroethanone",939-298-0,,Acute Tox. 4;Asp. Tox. 1,Notified C&L,89,H304:89;H302:89
232798,"Paraffin waxes and Hydrocarbon waxes, chloro, sulfochlorinated, saponified",939-314-6,,Skin Irrit. 2;Skin Sens. 1B;Eye Irrit. 2,REACH registration C&L,44,H319:44;H317:44;H315:44
232799,"2-chloro-4-[(2,2,2-trifluoroethyl)amino]pyrimidine-5-carbonitrile",800-175-0,389606-51-3,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H332:1;H312:1;H315:1;H335:1;H302:1
232800,"5-amino-3-methyl-1,2-thiazole-4-carboxylic acid",800-176-6,22131-51-7,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,2,H332:1;H312:1;H302:2;H315:1;H335:1;H319:1
232801,"6-chloro-1,2,3,4-tetrahydroquinolin-2-one",800-177-1,19358-40-8,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232802,"tert-butyl N-(2-oxo-2,3-dihydro-1H-indol-6-yl)carbamate",800-178-7,184021-91-8,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232803,"(1S,2R,5S)-2,6,6-trimethylbicyclo[3.1.1]heptane",800-188-1,33626-25-4,Flam. Liq. 3;Asp. Tox. 1,REACH registration C&L,2,H304:2;H226:2
232807,[No public or meaningful name is available],800-179-2,201210-25-5,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Notified C&L,1,H331:1;H311:1;H301:1
232808,[No public or meaningful name is available],800-180-8,38343-58-7,Repr. 2,Notified C&L,1,H361:1
232809,"1,4-Benzenedisulfonic acid, 2,2'-[1,2-ethenediylbis[(3-sulfo-4,1-phenylene)imino[6-[bis(2-hydroxypropyl)amino]-1,3,5-triazine-4,2-diyl]imino]]bis-, hexasodium salt",800-181-3,371756-75-1,Not Classified,REACH registration C&L,38,Not classified:38
232819,"Alcohols, C6-C8-(even numbered, linear)-ethoxylated (<2,5 EO)",800-182-9,1426148-68-6,Eye Irrit. 2,Notified C&L,34,H319:34
232820,"2,5-Furandione, polymer with ethene, ammonium salt",800-183-4,9007-69-6,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,34,H319:34;H315:34
232821,"methyl (2R,4S)-4-hydroxypiperidine-2-carboxylate hydrochloride",800-185-5,175671-44-0,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232822,"(2S,4R)-tert-butyl 2-(dimethylcarbamoyl)-4-hydroxypyrrolidine-1-carboxylate",800-186-0,127423-55-6,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232824,"3-(Difluoromethyl)-N-(7-fluoro-1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl)-1-methyl-1H-pyrazole-4-carboxamide",800-189-7,1383809-87-7,Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,91,H400:91;H317:91;H410:91
232825,"methyl 2-(trifluoromethyl)imidazo[1,2-a]pyridine-6-carboxylate",939-313-0,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232826,"6-fluoro-3-iodoimidazo[1,2-a]pyridine",939-315-1,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232827,methyl 2-(2-formylphenoxy)-5-nitrobenzoate,939-316-7,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232828,"6-bromo-7-methoxy-1-methyl-1,2,3,4-tetrahydroquinolin-2-one",939-317-2,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232829,tert-butyl 4-[(6-chloropyrimidin-4-yl)amino]piperidine-1-carboxylate,800-190-2,939986-76-2,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H332:1;H312:1;H315:1;H335:1;H302:1
232830,"5-tert-butyl-1,3-oxazole-4-carboxylic acid",939-318-8,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232831,"5-tert-butyl-1,3-oxazole-4-carbohydrazide",939-319-3,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232832,5-tert-butyl-1H-imidazole-4-carboxylic acid,939-320-9,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232833,"3,5-dimethyl-4-(4-methylphenyl)-1,2-oxazole",939-321-4,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232834,ethyl 5-tert-butyl-1H-imidazole-4-carboxylate,939-323-5,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232835,"7-hydroxy-6-iodo-1,2,3,4-tetrahydroquinolin-2-one",939-324-0,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232836,"methyl (1R,3S)-3-methyl-1,2,3,4-tetrahydronaphthalene-1-carboxylate",939-325-6,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232837,"4,6-dichloro-N-methoxy-N-methylpyrimidine-5-carboxamide",939-326-1,,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H332:1;H312:1;H315:1;H335:1;H302:1
232839,"Reaction product of dipentaerythritolhexakis (3-mercaptopropionate (EC 246-893-2) and 2,3-epoxypropyl neodecanoate (EC 247-979-2)",939-329-8,,Skin Sens. 1B;Muta. 2;Aquatic Chronic 3,Notified C&L,1,H412:1;H341:1;H317:1
232841,"Sulfuric acid, mono-C8-10 (even numbered)-alkyl esters, sodium salts",939-332-4,,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1,REACH registration C&L,2,H315:2;H318:2;H302:2;H332:1;H228:1;H335:1
232842,"Sulfuric acid, mono (C16-18 and C18-unsatd. alkyl) (even numbered) esters, sodium salts",939-331-9,,Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,168,H412:168;H318:168;H315:168;H335:84
232845,"2-bromo-3,5-dimethylpyridine",800-193-9,92992-85-3,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H332:1;H312:1;H315:1;H335:1;H302:1
232846,"ethyl 2-(2-amino-2,3-dihydro-1H-inden-2-yl)acetate hydrochloride",800-194-4,917391-08-3,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232847,"2-bromo-5-(pyrrolidine-1-carbonyl)-1,3-thiazole",800-196-5,877675-06-4,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H332:1;H312:1;H315:1;H335:1;H302:1
232848,N-[4-(2-fluoro-4-nitrophenoxy)pyridin-2-yl]morpholine-4-carboxamide,800-197-0,864245-86-3,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232849,"Ethyl 6-bromo-1,2-benzothiazole-3-carboxylate",800-198-6,858671-74-6,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,2,H332:2;H312:2;H302:2
232850,3-chloro-7-methoxyquinoline,800-199-1,858279-19-3,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232851,9H-fluoren-9-ylmethyl N-(prop-2-en-1-yl)carbamate,800-200-5,856438-23-8,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232852,"4,5-Dimethyl-1,3-thiazole-2-carboxylic acid",800-201-0,79312-41-7,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,3,H332:2;H312:2;H302:3;H315:1;H335:1;H319:1
232853,"ethyl 4,5-dimethyl-1,3-thiazole-2-carboxylate",800-202-6,79247-88-4,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232855,4-(naphthalen-2-yl)butanoic acid,800-204-7,782-28-5,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232856,tert-butyl N-(2-methylphenyl)carbamate,800-205-2,74965-31-4,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232858,N-(4-aminophenyl)-N-phenylbenzamide,800-207-3,73333-83-2,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232859,1-(4-methylquinazolin-2-yl)guanidine,800-208-9,716-11-0,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H315:38;H335:38;H319:38;H302:39;H332:1;H312:1
232860,"9,9-Dioctylfluorene-2,7-diboronic acid",800-209-4,258865-48-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
232861,"ethyl 5-tert-butyl-1,3-oxazole-4-carboxylate",800-211-5,714273-89-9,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,2,H332:1;H312:1;H302:2;H315:1;H335:1;H319:1
232862,"3,4,5-Trifluoro-L-phenylalanine, N-FMOC protected",800-212-0,205526-30-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:2;H315:2
232863,"(2S,3R)-3-methoxy-2-(methoxycarbonylamino)butanoic acid",800-213-6,1007881-21-1,,Notified C&L,2,Not classified:2
232864,"2,2-diphenylpent-4-enoic acid",800-214-1,6966-03-6,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232865,N'-(Tetrahydro-pyran-4-yl)-hydrazincarbonsäure tert-butyl ester,800-215-7,693287-79-5,Acute Tox. 4,Notified C&L,3,H302:3;H228:1;H332:1;H312:1
232866,3-(cyanomethyl)pyridin-1-ium-1-olate,800-216-2,6635-88-7,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232867,dimethyl (morpholin-4-yl)phosphonate,800-217-8,597-25-1,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232868,2-{[(tert-butoxy)carbonyl]amino}-3-(trifluoromethoxy)benzoic acid,800-218-3,561304-40-3,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232869,"3-methyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine",800-219-9,5399-44-0,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232870,"3-(1H-1,2,3,4-tetrazol-5-yl)-9H-carbazole",800-220-4,503828-19-1,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232871,methyl 2-amino-2-[4-(trifluoromethyl)phenyl]acetate,800-222-5,439088-62-7,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232872,"2-N-[3-(trifluoromethyl)phenyl]-1,3,5-triazine-2,4-diamine",800-223-0,3832-69-7,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232873,"4-(3,4-dimethoxyphenyl)-3-methyl-1H-pyrazol-5-amine",800-224-6,347840-95-3,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232874,"HDI oligomers, biuret",939-340-8,,Skin Sens. 1;Acute Tox. 4;STOT SE 3,REACH registration C&L,7,H335:7;H332:7;H317:7
232878,R-3-amino-Hexahydro-1H-Azepine,800-225-1,124932-43-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
232879,"(2-methyl-1,3-dioxolan-2-yl)methanamine",800-226-7,3289-19-8,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,2,H332:1;H312:1;H302:1;H318:1;H227:1;H335:1;H315:1
232880,[No public or meaningful name is available],800-227-2,1029872-54-5,Acute Tox. 4;Carc. 1A;Repr. 2;STOT RE 2;Aquatic Chronic 4,Notified C&L,1,H413:1;H350:1;H373:1;H361:1;H302:1
232881,"(2E)-3-{1,4-dioxaspiro[4.5]dec-7-en-7-yl}prop-2-enoic acid",800-228-8,226916-19-4,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232882,2-chloro-N-phenylpropanamide,800-229-3,21262-52-2,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,2,H319:2;H332:2;H312:2;H315:2;H335:2;H302:2
232883,[No public or meaningful name is available],800-230-9,661476-67-1,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,441,H400:441;H410:441
232884,methyl 6-amino-5-iodopyridine-3-carboxylate,800-231-4,211308-80-4,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232885,tert-Butyl 5-hydroxy-2-azabicyclo[2.2.1]heptane-2-carboxylate,800-233-5,207405-60-5,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,2,H332:2;H312:2;H302:2
232886,tert-butyl 6-hydroxy-2-azabicyclo[2.2.1]heptane-2-carboxylate,800-234-0,207405-59-2,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232887,"methyl 3-[2-(4-chlorophenyl)-5-oxo-4,5-dihydro-1H-pyrrol-3-yl]propanoate",800-235-6,198063-87-5,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232888,(5R)-5-phenylmorpholin-3-one,800-236-1,192815-71-7,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,2,H332:1;H312:1;H302:2;H315:1;H335:1;H319:1
232889,"4-bromo-7-methoxy-2,2-dimethyl-2,3-dihydro-1-benzofuran",800-237-7,185406-76-2,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232890,4-(benzyloxy)-3-methylbenzaldehyde,800-238-2,158771-31-4,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232891,3-[benzyl(methyl)amino]propanoic acid,800-239-8,149692-49-9,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232892,4-nitro-3-propyl-1H-pyrazole-5-carboxamide,800-240-3,139756-08-4,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232893,"triphenyl(2,2,2-trifluoroethyl)phosphanium trifluoromethanesulfonate",800-241-9,135654-55-6,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232894,methyl 6-(4-methylpiperazin-1-yl)pyridine-3-carboxylate,800-242-4,132144-02-6,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232895,"8-hydroxy-1H,2H,3H,4H-cyclopenta[c]chromen-4-one",800-244-5,131526-88-0,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232896,(1R)-3-(dimethylamino)-1-phenylpropan-1-ol; oxalic acid,800-245-0,1270016-44-8,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232897,{4-fluoro-2-[(tetrahydro-2H-pyran-2-yloxy)methyl]phenyl}boronic acid,800-246-6,943310-74-5,,Notified C&L,2,H318:2;H315:2
232898,tert-butyl 4-{[3-fluoro-5-(trifluoromethyl)benzenesulfonyl]methyl}piperidine-1-carboxylate,800-247-1,1245784-24-0,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232899,5-methoxy-1-benzothiophene-3-carboxylic acid,800-248-7,123392-43-8,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232900,7-chloro-6-fluoro-1-methoxyisoquinoline,800-249-2,1202006-81-2,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232901,"2,5-dichloro-4-(trimethylstannyl)pyridine",800-250-8,1201787-84-9,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H332:1;H312:1;H315:1;H335:1;H302:1
232903,"Poly(oxy-1,2-ethanediyl), alpha-decyl-omega-hydroxy-, phosphate, ammonium salt",800-252-9,181963-82-6,Skin Irrit. 2;Eye Dam. 1,Notified C&L,6,H318:6;H315:6
232908,Reaction products of C16 saturated and C18 unsaturated fatty acids and fatty acid glycerides with by-products from 2-aminoethanol and ammonia reaction,800-253-4,1419212-73-9,Skin Sens. 1B;Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,1,H319:1;H411:1;H317:1
232910,2-METHYL-2-PHENYLOXIRANE,800-256-0,2085-88-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Muta. 1B,Notified C&L,2,H319:2;H340:1;H335:1;H315:1;H350:1;H311:1;H302:1
232911,"6-bromo-7-hydroxy-3,4-dihydro-1H-quinolin-2-one",800-257-6,1194459-28-3,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232912,"2-(4-nitrophenyl)-4H,5H,6H,7H-furo[3,2-c]pyridine",800-258-1,1192968-13-0,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232913,oxan-4-ylhydrazine dihydrochloride,800-259-7,116312-69-7,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232914,"benzyl 4,5-bis(benzyloxy)pyridine-2-carboxylate",800-260-2,112334-42-6,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232919,methyl (3E)-4-(3-chlorophenyl)-2-oxobut-3-enoate,800-266-5,1112238-35-3,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232923,"N-Trifluoromethanesulfonyloxy-5-norbornene-2,3-dicarboxyimide",800-270-7,133710-62-0,Not Classified,Notified C&L,69,Not classified:55;H317:14
232925,"2-(2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepin-3-yl)-2,3-dihydro-1H-isoindole-1,3-dione",800-272-8,105260-10-4,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232926,"2-(4-bromophenyl)-4,5,6,7-tetrahydrofuro[3,2-c]pyridine hydrochloride",800-273-3,104278-48-0,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232927,"2,2-dimethyl-6-nitro-2H,3H,4H-pyrido[3,2-b][1,4]oxazin-3-one",800-274-9,1002726-59-1,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232928,(5S)-5-phenylmorpholin-3-one,800-275-4,1052209-96-7,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232931,"Reaction mass of (1R)-1-[(1S)-3,3-dimethylcyclohexyl]ethyl formate and (1R,2S)-2,6,6-trimethylcycloheptyl formate",939-618-9,,Aquatic Chronic 2,REACH registration C&L,5,H411:5
232934,"Reaction mass of (3R,5R)-3,5,6,6-tetramethyl-4-methylideneheptan-2-one and (3R,5S)-3,5,6,6-tetramethyl-4-methylideneheptan-2-one and (E)-3,4,5,6,6-pentamethylhept-3-en-2-one",939-627-8,,Skin Sens. 1B;Aquatic Chronic 2,REACH registration C&L,1,H411:1;H317:1
232935,pentafluorophenyl 4-phenylbenzene-1-sulfonate,939-341-3,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232936,"3-methyl-4-(3-nitrophenyl)-4,5-dihydro-1H-1,2,4-triazol-5-one",939-342-9,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232938,"1,4-dipentafluorophenyl benzene-1,4-dicarboxylate",939-343-4,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232939,5-bromo-3-chloro-6-(trifluoromethyl)-1H-indole,939-345-5,,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H332:1;H312:1;H315:1;H335:1;H302:1
232940,"5-[(2-fluoro-4-iodophenyl)amino]-6-(methoxycarbonyl)-1-methyl-3-(prop-2-en-1-yl)-1,3-benzodiazol-1-ium iodide",939-346-0,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232941,"1-bromo-3,5-bis(bromomethyl)benzene",939-347-6,,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H332:1;H312:1;H315:1;H335:1;H302:1
232942,(2E)-1-(2-chlorophenyl)-3-(4-hydroxyphenyl)prop-2-en-1-one,939-348-1,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232943,6-bromo-N-[(4-cyanophenyl)methyl]hexanamide,939-349-7,,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H332:1;H312:1;H315:1;H335:1;H302:1
232944,N-[(4-cyanophenyl)methyl]-6-(piperazin-1-yl)hexanamide dihydrochloride,939-351-8,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232946,methyl 5-bromo-2-(methylamino)pyridine-3-carboxylate,939-352-3,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232947,"5-(2-methoxyphenyl)-4-(4-methoxyphenyl)-4H-1,2,4-triazole-3-thiol",939-353-9,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232948,"4-chloro-8,17- diazatetracyclo[8.7.0.0^{2,7}.0^{11,16}]heptadeca- 1(10),2,4,6,11(16),12,14-heptaen-9-one",939-354-4,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232949,6-bromo-1H-indole-2-carbonitrile,939-356-5,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232950,6-bromo-1-methylindole-2-carbaldehyde,939-357-0,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232951,"Reaction product of naphthalene, propan-2-ol, sulfonated and neutralized by caustic soda",939-368-0,,Acute Tox. 4;Eye Dam. 1;Acute Tox. 4;STOT SE 3,REACH registration C&L,3,H318:2;H335:2;H332:2;H302:2;Not classified:1
232952,6-bromo-3-methoxy-2-methylbenzamide,939-358-6,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232953,"2,3,5-trichloro-4-trifluoromethyl pyridine",939-359-1,,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H332:1;H312:1;H315:1;H335:1;H302:1
232954,[No public or meaningful name is available],804-055-9,722542-79-2,Flam. Liq. 3,Notified C&L,38,H226:38
232955,[No public or meaningful name is available],804-054-3,722542-80-5,Flam. Liq. 3,Notified C&L,38,H226:38
232959,"Reaction mass of melamine and Nickel, 5,5'-azobis-2,4,6(1H,3H,5H)-pyrimidinetrione complexes",939-379-0,,Not Classified,REACH registration C&L,8,Not classified:8
232961,"Chromium(III) complexes with 3-(4-{[2-hydroxy-5-(2-methylbutan-2-yl)-3-nitrophenyl]diazenyl}-3-methyl-5-oxo-2,5-dihydro-1H-pyrazol-1-yl)benzenesulfonamide, C11-C12-(branched)-alkylammonium salts",939-383-2,,Aquatic Chronic 2,REACH registration C&L,85,H411:85
232962,6-bromo-3-methoxy-2-methylbenzonitrile,939-362-8,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232963,"2,3,5-trichloro-4,6-bistrifluoromethyl pyridine",939-363-3,,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H332:1;H312:1;H315:1;H335:1;H302:1
232964,5-bromo-N-methyl-2-(methylamino)pyridine-3-carboxamide,939-364-9,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232965,5-bromo-3-iodo-6-(trifluoromethyl)-1H-indole,939-365-4,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232966,methyl 5-(chloromethyl)-2-fluorobenzoate,939-367-5,,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H332:1;H312:1;H315:1;H335:1;H302:1
232967,2-(4-iodopyridin-2-yl)-2-methylpropanenitrile,939-369-6,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232968,"(2S,3R)-3-(tert-butoxy)-1-[(9H-fluoren-9-ylmethoxy)carbonyl]pyrrolidine-2-carboxylic acid",939-370-1,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232969,2-(4-methylbenzoyl)pyrimidine,939-371-7,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232970,methyl (3E)-4-(4-bromophenyl)-2-oxobut-3-enoate,939-372-2,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232972,methyl (3E)-4-(3-bromophenyl)-2-oxobut-3-enoate,939-374-3,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232973,"2-methyl-2-[4-(tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl]propanenitrile",939-375-9,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232974,2-(2-amino-3-benzoylphenyl)-2-(methylsulfanyl)acetamide,939-376-4,,Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H302:1
232976,[No public or meaningful name is available],800-277-5,10118-90-8,Eye Irrit. 2;Repr. 2;Lact.,Notified C&L,1,H319:1;H361:1;H362:1
232977,"1-[(1R,2S)-2,6,6-trimethylcyclohex-3-en-1-yl]ethanone",800-278-0,41435-93-2,Not Classified,REACH registration C&L,2,Not classified:2
232981,"Reaction products of diazotised 4,4-diaminodiphenylamine-2-sulfonic acid, subsequently coupled with 6-amino-4-hydroxynaphthalene-2-sulfonic acid, further diazotised and coupled with metaphenylendiamine, sodium salts",939-382-7,,Not Classified,REACH registration C&L,14,Not classified:14
232982,"(2R)-2,3-Dimethyl-1-butanol",800-279-6,15019-27-9,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232983,"6,8-Dichlorochromone-3-carboxaldehyde",800-280-1,64481-10-3,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,2,H332:1;H312:1;H302:1;H319:1;H315:1
232984,1-(2-fluorophenyl)-4-oxocyclohexane-1-carbonitrile,800-281-7,179064-61-0,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232985,"2,2-dimethyl-2H-chromene-6-carboxylic acid",800-282-2,34818-56-9,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232986,"3,5-dibromophenoxytrimethylsilane",800-283-8,856766-98-8,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
232987,1-Methyl-4-isopropoxymethylpiperazine,800-284-3,67232-27-3,Acute Tox. 4;Skin Irrit. 2;STOT SE 3,Notified C&L,1,H315:1;H335:1;H302:1
232988,Bis(methoxymethyl)piperazine,800-285-9,14970-89-9,Acute Tox. 4;Skin Irrit. 2;STOT SE 3,Notified C&L,1,H315:1;H335:1;H302:1
232989,"Fatty acids, tall-oil, reaction products with acrylic acid",939-424-4,,Skin Irrit. 2;Eye Dam. 1,REACH registration C&L,76,H318:76;H315:3;H314:73
232991,"4,9-bis(7’,8’-dibutilbenzo[1’,2’-b’:4’,3’-b’′]ditien-5’-il)-nafto[2,3-c][1,2,5]tiadiazolo",939-384-8,,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2B,Notified C&L,1,H315:1;H319:1;H302:1
232992,11-mercaptoundecyltrimethoxysilane,800-286-4,877593-17-4,Flam. Liq. 2;Acute Tox. 3;Acute Tox. 3;Eye Dam. 1;Acute Tox. 3;STOT SE 1,Notified C&L,1,H370:1;H318:1;H331:1;H225:1;H311:1;H301:1
232994,"4,9-bis(tien-2’-il)-nafto[2,3-c][1,2,5]tiadiazolo",939-386-9,,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2B,Notified C&L,1,H315:1;H319:1;H302:1
232995,"(5α)-3,14-Dihydroxy-4,5-epoxymorphinan-6-one bitartrate",939-387-4,,Acute Tox. 4;Skin Sens. 1;Acute Tox. 4;Resp. Sens. 1,Notified C&L,1,H334:1;H332:1;H317:1;H302:1
232996,2-methyl-5-nitro-1H-imidazole,800-288-5,100215-29-0,Acute Tox. 4,Notified C&L,1,H302:1
232997,O-Methyl [2-(2-methyl-5-nitro-1H-imidazol-1-yl)ethyl]carbamate,800-289-0,55455-45-3,Acute Tox. 4,Notified C&L,1,H332:1
232998,[No public or meaningful name is available],939-390-0,,Aquatic Chronic 3,Notified C&L,25,H412:25
232999,[No public or meaningful name is available],939-391-6,,Skin Sens. 1,Notified C&L,25,H317:25
233000,S-Methyl [2-(2-methyl-5-nitro-1H-imidazol-1-yl)ethyl]carbamothioate,939-392-1,,Acute Tox. 4,Notified C&L,1,H332:1
233001,S-Methyl [2-(2-methyl-5-nitro-1H-imidazol-1-yl)ethyl]carbamodithioate,939-393-7,,Acute Tox. 4,Notified C&L,1,H332:1
233002,[No public or meaningful name is available],939-395-8,,Skin Sens. 1;Eye Irrit. 2,Notified C&L,25,H319:25;H317:25
233005,Reaction mass of 2-(cis-4-methylcyclohexyl)propan-2-ol and 2-(trans-4-methylcyclohexyl)propan-2-ol and cis-1-methyl-4-(propan-2-yl)cyclohexanol and trans-1-methyl-4-(propan-2-yl)cyclohexanol,939-396-3,,Skin Irrit. 2;Skin Sens. 1B;Eye Irrit. 2,REACH registration C&L,9,H319:8;H317:8;H315:8;Not classified:1
233006,Alkylammoniumsalt,939-397-9,,Skin Irrit. 2;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,25,H319:25;H410:25;H400:25;H315:25
233010,"Reaction mass of 2,6-dimethylheptan-4-ol and 4,6-dimethylheptan-2-ol",939-420-2,,Not Classified,REACH registration C&L,3,Not classified:3
233011,C16-18(even numbered)-alkylamine acetate,800-526-8,1273322-45-4,Skin Irrit. 2;Eye Dam. 1;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,35,H373:35;H315:35;H318:35;H400:35;H410:35
233012,5-Carboxythiophene-2-boronic acid,800-291-1,465515-31-5,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,40,H319:39;H315:39;Not classified:1;H335:1
233013,"Chromium (III) complexes with 2-[{2,4-dihydroxy-3-[(5-sulfo-1-naphthyl)diazenyl]phenyl}diazenyl]benzoic acid (1:2), sodium salts",700-953-9,,Not Classified,REACH registration C&L,11,Not classified:11
233014,[4-(morpholin-4-yl)phenyl]methanamine,800-292-7,214759-74-7,,Notified C&L,2,Not classified:1;H314:1
233015,"1-BROMO-3,3-DIMETHYLBUTANE",800-293-2,1647-23-0,Flam. Liq. 2;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,3,H319:3;H315:3;H225:1;H335:2;H302:2;H226:1
233019,"Reaction mass of (4RS,4aRS,8RS,8aRS)-4-Ethyl-8-methyloctahydronaphthalen-1(2H)-one and (4RS,4aSR,8SR,8aRS)-4-Ethyl-8-methyloctahydronaphthalen-1(2H)-one and (4RS,4aSR,8SR,8aSR)-4-Ethyl-8-methyloctahydronaphthalen-1(2H)-one",939-400-3,,Skin Irrit. 2;Skin Sens. 1B;Acute Tox. 4;Aquatic Chronic 2,REACH registration C&L,2,H411:2;H332:2;H317:2;H315:2
233021,"C18-C22 alcohols (even numbered), reaction products with maleic anhydride and Sodium bisulfite",939-404-5,,Eye Irrit. 2,REACH registration C&L,2,H319:2
233022,"Reaction mass of (S)-p-mentha-1,8-diene and p-mentha-1,4(8)-diene",939-405-0,,Flam. Liq. 3;Asp. Tox. 1;Skin Irrit. 2;Skin Sens. 1B;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,2,H226:2;H317:2;H315:2;H304:2;H400:2;H410:2
233025,"Reaction mass of Tetrahydro-4-methyl-2-(2-methylpropen-1-yl)pyran (2S,4R) and Tetrahydro-4-methyl-2-(2-methylpropen-1-yl)pyran (2S,4S) andTetrahydro-4-methyl-2-(2-methylpropen-1-yl)pyran (2R,4R) andTetrahydro-4-methyl-2-(2-methylpropen-1-yl)pyran (2R,4S)",939-429-1,,Skin Irrit. 2;Eye Irrit. 2;Repr. 2,Notified C&L,83,H319:83;H361:83;H315:83
233030,"Amines, N-C16-C18-alkyl-(evennumbered, C18 unsaturated) propane-1,3-diaminium di[(9Z)-octadec-9-enoate]",800-362-7,1307863-78-0,Skin Irrit. 2;Eye Irrit. 2;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,3,H319:3;H411:3;H373:3;H315:3;H400:3;H410:3
233031,"Alcohols, C10-12 (even numbered), ethoxylated (1-2.5 EO)",939-592-9,,Eye Irrit. 2;Aquatic Acute 1,REACH registration C&L,2,H319:2;H400:2
233032,"2H-Benzimidazole-2-thione, 1,3-dihydro-ar-methyl, sodium salt (1:1)",939-407-1,,Acute Tox. 4;Skin Corr. 1A;Acute Tox. 4;Repr. 1B;STOT RE 2;Aquatic Chronic 1,REACH registration C&L,4,H314:4;H373:4;H332:3;H410:4;H360:4;H302:4;H318:2
233033,"Reaction mass of 1-Methyl-4-(1-methylethenyl)cyclohexene and 1-Methyl-4-(1-methylethylidene)-cyclohexene and 1-methyl-4-(propan-2-yl)cyclohexa-1,3-diene",939-409-2,,Flam. Liq. 3;Asp. Tox. 1;Skin Sens. 1B;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,1,H226:1;H317:1;H304:1;H400:1;H410:1
233034,methyl N-[(2S)-1-[(2S)-2-{5-[4-(4-{2-[(2S)-1-[(2S)-2-[(methoxycarbonyl)amino]-3-methylbutanoyl]pyrrolidin-2-yl]-1H-imidazol-5-yl}phenyl)phenyl]-1H-imidazol-2-yl}pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate,939-410-8,,Skin Sens. 1B;Eye Irrit. 2;STOT SE 3;STOT RE 2,Notified C&L,1,H319:1;H371:1;H373:1;H317:1
233035,2-[(2S)-pyrrolidin-2-yl]-5-[4-(4-{2-[(2S)-pyrrolidin-2-yl]-1H-imidazol-5-yl}phenyl)phenyl]-1H-imidazole,939-411-3,,Resp. Sens. 1,Notified C&L,1,H334:1
233036,"Sulfuric acid, mono-C8-18 (even numbered)-alkyl esters, magnesium salts, compds. with triethanolamine",939-412-9,,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,168,H412:168;H315:168;H318:168;H302:168;H332:84;H335:84
233038,"Poly(oxy(methyl-1,2-ethanediyl)), .alpha.-hydro-.omega.- (oxiranylmethoxy)-, ether with 2-ethyl-2-(hydroxymethyl)-1,3- propanediol",800-294-8,51887-70-8,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 3,Notified C&L,13,H412:13;H319:13;H317:13;H315:13
233040,"2,2'-[1,1'-binaphthalene-2,2'-diylbis(oxy)]diethanol",800-296-9,55441-95-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,REACH registration C&L,2,H319:2;H335:2;H315:2
233042,"Formaldehyde, reaction products with aniline and phenol",800-299-5,68954-37-0,Acute Tox. 4;Acute Tox. 4;Skin Sens. 1;Acute Tox. 2;Muta. 2;Carc. 2;Repr. 1A;STOT SE 1;STOT RE 1;Aquatic Acute 2,Notified C&L,50,H330:25;H312:25;H317:25;H372:50;H401:25;H351:25;H360:50;H341:25;H370:50;H302:50;H319:25;H402:25;H332:25;H315:25;H340:25
233047,Styrene-Butadiene Rubber (SBR),939-416-0,,Skin Sens. 1,Notified C&L,1,H317:1
233049,"bee, ext",939-417-6,,Flam. Liq. 2,Notified C&L,1,H225:1
233053,"1-(2,2-difluoro-1,3-benzodioxol-5-yl)cyclopropanecarboxylic acid",800-301-4,862574-88-7,Not Classified,REACH registration C&L,1,Not classified:1
233054,tert-butyl 3-(6-amino-3-methylpyridin-2-yl)benzoate,800-303-5,1083057-14-0,Not Classified,REACH registration C&L,1,Not classified:1
233056,{2-[(diphenylphosphino)methyl]-2-ethylhexyl}(diphenyl)phosphine,800-304-0,1190439-15-6,Aquatic Chronic 1,Notified C&L,83,H410:83
233061,[No public or meaningful name is available],800-307-7,1048373-72-3,Acute Tox. 1;Skin Sens. 1;Eye Dam. 1;Aquatic Chronic 2,Notified C&L,56,H318:55;H411:55;H317:55;H302:55;Not classified:1
233062,COCCUS CACTI,939-426-5,,Flam. Liq. 2,Notified C&L,1,H225:1
233063,"tert-butyl 3-[6-({[1-(2,2-difluoro-1,3-benzodioxol-5-yl)cyclopropyl]carbonyl}amino)-3-methylpyridin-2-yl]benzoate",800-308-2,1160221-25-9,,,0,No data
233080,Pentapropenyl succinic anhydride,800-310-3,78683-74-6,Skin Irrit. 2;Skin Sens. 1A;Eye Dam. 1,Notified C&L,34,H318:34;H317:34;H315:34
233083,3-(2-methylpropoxy)-5-(propan-2-yloxy)benzoic acid,800-311-9,852520-45-7,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
233084,methyl 2-(cyclohexylamino)-5-nitrobenzoate,800-312-4,83909-56-2,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
233085,"2-(chloromethyl)-5-methyl-1,3,4-oxadiazole",800-314-5,3914-42-9,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,3,H319:2;H332:1;H312:1;H315:2;H335:2;H302:1;H314:1
233087,"3-bromo-1-phenyl-5-(pyridin-2-yl)-1,2-dihydropyridin-2-one",800-315-0,381248-06-2,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
233088,3-(Benzyloxy)cyclobutan-1-one,800-316-6,30830-27-4,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,3,H332:3;H312:3;H302:3
233090,4-iodo-1-phenyl-1H-pyrazole,800-318-7,23889-85-2,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
233091,2-chloro-N'-phenylacetohydrazide,800-319-2,22940-21-2,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4,Notified C&L,1,H319:1;H332:1;H312:1;H315:1;H335:1;H302:1
233092,"6-bromo-1,2,3,4-tetrahydroquinoline",800-320-8,22190-35-8,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,2,H332:2;H312:2;H302:2
233093,"ethyl 2-(4-cyano-1H-1,2,3-triazol-1-yl)acetate",800-321-3,202003-10-9,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
233094,2-bromo-2-methyl-1-(pyrrolidin-1-yl)propan-1-one,800-322-9,1225773-74-9,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H332:1;H312:1;H315:1;H335:1;H302:1
233095,"4-ethyl-1,3-thiazole-2-carboxylic acid",800-323-4,1181456-13-2,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
233099,"4'-Chloro[1,1'-biphenyl]-4-carbaldehyde",800-325-5,80565-30-6,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3;STOT SE 3,Notified C&L,3,H319:2;H332:2;H312:3;H315:2;H335:2;H302:3;H411:1
233107,"3-((C9-11-iso,C10-rich)alkyloxy)propan-1-amine acetate (1:1)",939-448-5,,Acute Tox. 4;Skin Corr. 1B;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H314:1;H410:1;H400:1;H302:1
233111,"Reaction products of (2,2,3-trimethylcyclopent-3-en-1-yl)acetaldehyde and butan-2-one, hydrogenated",939-525-3,,Eye Irrit. 2;Aquatic Chronic 2,REACH registration C&L,4,H319:4;H411:4
233112,(2S-CIS)-N-[[2-METHOXY-5-[5-(TRIFLUOROMETHYL)-1H-TETRAZOL-1-YL]PHENYL]METHYL]-2-PHENYL-3-PIPERIDINAMINE DIHYDROCHLORIDE,800-326-0,168266-51-1,Eye Dam. 1;STOT RE 1;STOT RE 1;Aquatic Chronic 3,Notified C&L,1,H412:1;H318:1;H372:1
233113,"1-Propanaminium, N-(3-aminopropyl)-2-hydroxy-N,N-dimethyl-3-sulfo-, N-(C12-18(even numbered) acyl) derivs., hydroxides, inner salts",939-457-4,,Eye Dam. 1;Aquatic Chronic 2,REACH registration C&L,5,H318:5;H411:5
233114,"1-Propanaminium, N-(3-aminopropyl)-2-hydroxy-N,N-dimethyl-3-sulfo-, N-(C8-18(even numbered) acyl) derivs., hydroxides, inner salts",939-455-3,,Eye Dam. 1;Aquatic Chronic 2,REACH registration C&L,5,H318:5;H411:5
233117,Halophosphate,,,Not Classified,REACH registration C&L,1,Not classified:1
233118,"1,3-dichloro-2-methyl-5-nitrobenzene",800-328-1,7149-69-1,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
233119,"Formaldehyde, polymeric reaction products with phenol, containing under 20 % of phenol, up to 2 % of formaldehyde",939-453-2,,Acute Tox. 4;Acute Tox. 3;Skin Corr. 1B;Skin Sens. 1;Eye Dam. 1;Acute Tox. 3;Muta. 2;Carc. 1B;STOT RE 2,Notified C&L,1,H350:1;H314:1;H373:1;H317:1;H318:1;H331:1;H341:1;H311:1;H302:1
233121,[No public or meaningful name is available],800-329-7,37798-08-6,Eye Irrit. 2,Notified C&L,39,H319:38;Not classified:1
233123,"Reaction products of tryglycerides, C8-C18 (even numbered) and C18-unsaturated, glycerine and ethylene oxide",939-459-5,,Not Classified,REACH registration C&L,1,Not classified:1
233124,2-Iminothiolane hydrochloride,800-330-2,4781-83-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
233125,1H-Pyrazol-3-ol,800-331-8,60456-92-0,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
233126,"Reaction product of 1,3,4-thiadiazolidine-2,5-dithione, formaldehyde and phenol, heptyl derivs.",939-460-0,,Flam. Liq. 3;Skin Irrit. 2;Skin Sens. 1B;Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,839,H412:839;H226:839;H317:839;H315:839;H318:839
233127,"3-((C9-11-iso,C10-rich)alkyloxy)propan-1-amine",939-485-7,,Acute Tox. 4;Skin Corr. 1B;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,3,H314:3;H410:3;H400:3;H302:3;H318:1
233128,(oxetan-3-yl)methanamine,800-332-3,6246-05-5,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;STOT SE 3,Notified C&L,40,H315:39;H335:39;H318:39;H302:39;H314:1;H319:1
233129,"Benzenesulfonic acid, 4-C10-13-sec-alkyl derivs., compds. with triethanolamine",939-464-2,,Skin Corr. 1C;Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,20,H412:20;H314:20;H318:20
233130,"2-BOC-1,2,3,4-Tetrahydroisoquinoline-5-carboxylic acid",800-333-9,872001-50-8,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:2;H315:2;H335:1
233131,3-methoxypyridin-4-amine,800-334-4,52334-90-4,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,2,H319:2;H332:1;H312:1;H315:2;H335:2;H302:2
233132,"Ethyl 1,3-thiazole-4-carboxylate",800-336-5,14527-43-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H319:40;H335:40;H315:40
233133,4-Bromo-5-fluoro-2-nitrophenol,800-337-0,1016234-87-9,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H332:1;H312:1;H315:1;H335:1;H302:1
233134,"1,3-Bis(pentafluorothio)-5-bromobenzene",800-338-6,432028-10-9,Flam. Sol. 2;Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H228:1;H332:1;H312:1;H302:1
233135,4-Methoxypyridine-3-boronic acid monohydrate,800-339-1,1256355-26-6,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H332:1;H312:1;H315:1;H335:1;H302:1
233136,3-Fluoro-6-methylpyridine-2-carboxylic acid,800-340-7,1256806-43-5,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H332:1;H312:1;H315:1;H335:1;H302:1
233137,4-Bromo-2-fluoro-6-nitrotoluene,800-341-2,502496-34-6,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H332:1;H312:1;H315:1;H335:1;H302:1
233138,"4-(Bromomethyl)-2,6-dichloropyridine",800-342-8,175204-45-2,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Notified C&L,158,H331:157;H311:157;H301:157;H314:1;H318:1
233139,4-(Pyrimidin-2-yl)benzaldehyde,800-343-3,77232-38-3,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H332:1;H312:1;H315:1;H335:1;H302:1
233140,"2-Methyl-2H-indazole-4-boronic acid, pinacol ester",800-344-9,885698-95-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
233141,"4-Chlorofuro[3,2-c]pyridine",800-345-4,31270-80-1,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,2,H319:2;H332:2;H312:2;H315:2;H335:2;H302:2
233142,2-Chloro-thiazole-5-carboxylic acid,800-347-5,101012-12-8,Acute Tox. 4;Aquatic Chronic 1,Notified C&L,94,H410:92;H302:94;H319:2;H332:1;H312:1;H315:2;H335:2
233143,"4-Amino-1H-indazole, N1-BOC protected",800-348-0,801315-74-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
233144,2-Iodo-5-(trifluoromethyl)benzoic acid,800-349-6,702641-04-1,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H332:1;H312:1;H315:1;H335:1;H302:1
233145,"(3R)-3-Hydroxy-4,4,4-trifluorobutanoic acid",800-350-1,108211-36-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
233146,methyl 2-[(dimethylcarbamothioyl)oxy]-4-methoxybenzoate,800-351-7,104795-54-2,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
233147,"6-bromo-7-methoxy-1,2,3,4-tetrahydroquinolin-2-one",939-462-1,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
233148,2-Chloro-5-cyclopropylpyrimidine,800-352-2,166740-44-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
233151,"Benzenesulfonic acid, 4-C10-13-sec-alkyl derivs.-, compd. with 1-aminopropane-2-ol",939-479-4,,Acute Tox. 4;Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,1,H412:1;H318:1;H302:1
233152,Diethylmethylcyclohexanediamine,939-465-8,,Eye Irrit. 2,Notified C&L,1,H319:1
233155,Reaction mass of 2-hydroxyethyl N-{4-[(4-{[(2-hydroxyethoxy)carbonyl]amino}cyclohexyl)methyl]cyclohexyl}carbamate and 2-hydroxyethyl N-{4-[(4-aminocyclohexyl)methyl]cyclohexyl}carbamate,939-466-3,,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H318:1;H319:1;H315:1
233156,"amides, C18-unsatd., N-[3-(dimethylamine)propyl]",800-353-8,1379524-06-7,Skin Corr. 1B;Skin Sens. 1B;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,17,H314:17;H317:17;H318:17;H400:17;H410:17
233158,methyl 2-(methylsulfanyl)-5-nitrobenzoate,939-468-4,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
233159,"5-(Chloromethyl)-4-methyl-2,4-dihydro-3H-1,2,4-triazol-3-one",800-354-3,1338226-21-3,Acute Tox. 2;Skin Sens. 1A;Eye Irrit. 2A,Notified C&L,11,H300:11;H319:11;H317:11
233160,"1-phenyl-5-(pyridin-2-yl)-1,2-dihydropyridin-2-one",939-470-5,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
233161,"6-bromo-7-ethoxy-1,2,3,4-tetrahydroquinolin-2-one",939-471-0,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
233162,"6-bromo-1,2,3,4-tetrahydroquinolin-7-ol",939-472-6,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
233165,"6-bromo-7-ethoxy-1-methyl-1,2,3,4-tetrahydroquinolin-2-one",939-474-7,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
233166,"6-bromo-7-ethoxy-1,2,3,4-tetrahydroquinoline",939-475-2,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
233167,"Ethyl 3-(dimethylamino)-2-(4-cyano-1H-1,2,3-triazol-1-yl)acrylate",939-476-8,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
233168,"6-bromo-7-methoxy-1,2,3,4-tetrahydroquinoline",939-477-3,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
233169,"C8-22, distn. residues, sulphosuccinate",939-486-2,,STOT RE 2,REACH registration C&L,1,H373:1
233171,"Reaction mass of bis[4-(vinyloxy)butyl] hexane-1,6-diylbiscarbamate and 9,18-dioxo-3,8,19-trioxa-10,17-diazapentacos-1-en-25-yl [6-({[4-(vinyloxy)butoxy]carbonyl}amino)hexyl]carbamate",939-478-9,,Not Classified,REACH registration C&L,1,Not classified:1
233176,FURAN-2-SULPHONYL CHLORIDE,800-355-9,52665-48-2,Acute Tox. 4;Skin Corr. 1B,Notified C&L,2,H314:2;H302:2;H335:1
233177,3-TRIFLUOROMETHYLBENZOIC ANHYDRIDE,800-356-4,25753-15-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
233178,4-FLUOROBENZOIC ANHYDRIDE,800-358-5,25569-77-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
233180,3-DIMETHYLAMINOBENZOIC ANHYDRIDE,800-359-0,4629-50-9,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
233183,"4-Methyl-1,3-oxazole-5-carboxylic acid",800-361-1,2510-32-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,4,H319:3;H315:3;Not classified:1;H335:2;H302:1
233184,thian-4-ol,800-363-2,29683-23-6,,Notified C&L,2,Not classified:1;H319:1;H332:1;H315:1;H335:1;H302:1
233187,"Reaction mass of 1,1,1,5,5,5-hexamethyl-3-phenyl-3-((trimethylsilyl)oxy)trisiloxane and 1,1,1,7,7,7-hexamethyl-3,5-diphenyl-3,5-bis[(trimethylsilyl)oxy]tetrasiloxane and 1,1,1,9,9,9-hexamethyl-3,5,7-triphenyl-3,5,7-tris((trimethylsilyl)oxy)pentasiloxane",939-487-8,,Acute Tox. 2,REACH registration C&L,9,H330:8;Not classified:1
233188,"Reaction product of Maleic anhydride, 2-Ethylhexylamine and Triethanolamine",939-488-3,,Skin Irrit. 2;Skin Sens. 1B;Eye Dam. 1,REACH registration C&L,84,H318:84;H317:84;H315:84
233189,"Reaction products of 2,4-dinitrotoluene and 2,6-dinitrotoluene and hydrogen",939-489-9,,Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1,REACH registration C&L,93,H314:93;H318:93;H302:93
233191,3-Amino-4-(isobutylamino)quinoline Hydrochloride,800-365-3,935521-01-0,Not Classified,Notified C&L,2,Not classified:1;H319:1;H315:1
233192,"thieno[3,2-b]pyridine-7-carbonitrile",939-490-4,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
233194,"2-bromothieno[3,2-b]pyridine-7-carboxylic acid",939-492-5,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
233195,ethyl 2-[3-chloro-5-(trifluoromethyl)pyridin-2-yl]acetate,939-493-0,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
233196,"3-chloro-5-(trifluoromethyl)-1H-pyrrolo[2,3-b]pyridine",939-494-6,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
233197,6-bromo-3-methoxy-2-methylbenzohydrazide,939-495-1,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
233199,"N-{3-[(5R)-3-Amino-2,5-dimethyl-1,1-dioxo-5,6-dihydro-2H -1λ6,2,4-thiadiazin-5-yl]-4-fluorophenyl}-5-fluoropyridine-2-carboxamide",939-496-7,,Acute Tox. 4;STOT RE 2,Notified C&L,36,H373:36;H302:36
233202,"Reaction mass of 1,1,2,2,3,3,4,4,4-nonafluoro-N,N-bis(nonafluorobutyl)butan-1-amine and 1,1,2,2,3,3,4,4,4-nonafluoro-N-[1,1,2,3,3-hexafluoro-2-(trifluoromethyl)propyl]-N-(1,1,2,2,3,3,4,4,4-nonafluorobutyl)butan-1-amine",939-511-7,,Not Classified,REACH registration C&L,6,Not classified:4;H319:2;H311:2;H302:2
233207,"5-Isobenzofurancarboxylic acid, octahydro-1,3-dioxo-",800-369-5,53611-01-1,Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1,Notified C&L,13,H318:13;H317:13;H315:13
233208,"4-(Piperazine-1-carbonyl)phenylboronic acid, pinacol ester, hydrochloride",800-370-0,1256360-65-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
233210,"Sodium salts of [[(2-hydroxyethyl)imino]dimethylene]bisphosphonic acid and [(2-hydroxy-2-oxo-1,4,2-oxazaphosphinan-4-yl)methyl]phosphonic acid",939-513-8,,Met. Corr. 1;Aquatic Chronic 3,REACH registration C&L,8,H290:8;H412:8
233211,Reaction product of fatty acids C14-18/C16-18 unsaturated with dihydrogendioxide and Ammonia,939-498-8,,Eye Dam. 1,REACH registration C&L,84,H318:84
233213,"(1R,2S,5R)-5-methyl-2-(propan-2-yl)cyclohexyl 5-(4-amino-5-fluoro-2-oxopyrimidin-1(2H)-yl)-1,3-oxathiolane-2-carboxylate",939-499-3,,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3;Repr. 1B,Notified C&L,1,H319:1;H360:1;H332:1;H312:1;H315:1;H335:1;H302:1
233214,[No public or meaningful name is available],939-500-7,,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Acute Tox. 4;STOT SE 3;STOT RE 2,Notified C&L,25,H319:25;H373:25;H332:25;H317:25;H315:25;H334:25;H335:25
233215,[No public or meaningful name is available],939-501-2,,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Acute Tox. 4;Resp. Sens. 1;STOT SE 3;STOT RE 2,Notified C&L,25,H319:25;H373:25;H332:25;H317:25;H315:25;H334:25;H335:25
233216,[No public or meaningful name is available],939-502-8,,Skin Sens. 1;Resp. Sens. 1,Notified C&L,25,H334:25;H317:25
233217,Reaction mass of p-t-butylphenyldiphenyl phosphate and bis(p-t-butylphenyl) phenyl phosphate,939-505-4,,Not Classified,REACH registration C&L,3,Not classified:3
233221,sodium 2-amino-4-acetamido-5-[2-(4-{[2-(sulfonatooxy)ethane]sulfonyl}phenyl)diazen-1-yl]benzene-1-sulfonate,940-436-7,,Skin Sens. 1B,REACH registration C&L,3,H317:3
233227,"reaction mass of 1,3-dichloro-4-nitrobenzene and 1,3-dichloro-2-nitrobenzene",939-509-6,,Acute Tox. 4;Acute Tox. 3;Skin Sens. 1;Muta. 2;Carc. 1B;Aquatic Chronic 2,Notified C&L,1,H411:1;H350:1;H317:1;H341:1;H311:1;H302:1
233232,2-amino-4-bromobenzaldehyde,800-375-8,59278-65-8,,Notified C&L,2,H319:2;H335:1;H315:2
233238,"7-bromo-4-chloropyrido[3,2-d]pyrimidine",800-385-2,573675-31-7,,Notified C&L,2,H315:2;H335:2;H318:1;H302:2;H319:1
233243,4-amino-4-methylpentanoic acid hydrochloride,800-386-8,62000-69-5,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,3,H319:3;H335:3;H315:3
233245,1-methyl-1H-imidazol-2-amine hydrochloride,800-388-9,1450-94-8,,Notified C&L,2,H319:2;H335:2;H315:2
233254,3-amino-2-methylbutan-2-ol,800-397-8,6291-17-4,,Notified C&L,2,H319:1;H335:2;H315:2;H318:1
233260,2-chloro-6-(4-methylpiperazine-1-carbonyl)pyrazine,800-403-9,959241-37-3,,Notified C&L,2,H315:2;H335:2;H319:1;H302:2;H318:1
233263,"2-Methoxycarbonyl-5-pyridineboronic acid, pinacol ester",800-407-0,957065-99-5,,Notified C&L,2,H319:2;H335:2;H315:2;H302:1
233264,Quinoline-2-boronic acid,800-408-6,745784-12-7,,Notified C&L,2,H319:2;H335:2;H315:2;H332:1;H312:1;H302:1
233265,4-Chloro-2-methylpyrimidine,800-409-1,4994-86-9,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,4,H319:2;H315:4;H335:2;H318:2;H302:2
233266,"1H,2H,3H,4H-pyrrolo[1,2-a]pyrazine",800-410-7,71257-38-0,,Notified C&L,2,H332:1;H312:1;H302:2;H315:1;H335:1;H318:1
233267,"1-(1,3-dimethyl-1H-pyrazol-4-yl)ethan-1-one",800-411-2,52773-23-6,,Notified C&L,2,H315:2;H335:2;H319:2;H302:1
233268,3-(pyrrolidine-1-carbonyl)aniline,800-412-8,160647-74-5,,Notified C&L,2,H332:2;H312:2;H302:2;H319:1;H315:1;H335:1
233269,[No public or meaningful name is available],800-413-3,131610-11-2,Acute Tox. 4;Eye Dam. 1,Notified C&L,39,H318:38;H302:38;H319:1;H335:1;H315:1
233270,"Acetic acid, 2-sulfo-, mono-C12-14(even numbered)-alkyl esters, sodium salt",939-512-2,,Acute Tox. 4;Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,15,H412:15;H318:15;H302:15
233271,(3-Methyloxetan-3-yl)methanamine,800-414-9,153209-97-3,Flam. Liq. 3;Acute Tox. 4,Notified C&L,41,H226:40;H302:39;H225:1;H314:2;H331:1;H400:1;H311:1;H301:1
233273,"Propanoic acid, 2-hydroxy-, C12-13-branched-alkyl esters",939-514-3,,Aquatic Chronic 3,REACH registration C&L,2,H412:2
233274,"3-[(5-difluoromethoxy)-1-methyl-3-(trifluoromethyl)pyrazol-4-ylmethylsulfonyl]-4,5-dihydro-5,5-dimethyl-1,2-oxazole",800-417-5,447399-55-5,STOT RE 1;Aquatic Chronic 1,Notified C&L,157,H372:157;H410:157;H400:1
233275,"1H-Imidazolium, 3-butyl-1-methyl-, .mu.-bromodibromodicuprate(1-) (1:1)",800-418-0,1082748-49-9,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,83,H319:83;H373:83;H410:83;H315:83;H400:83;H301:83
233276,"Pyrrolo[3,4-c]pyrrole-1,4-dione, 3,6-bis(4-bromophenyl)-2,5-dihydro-",800-419-6,84632-54-2,Acute Tox. 4,Notified C&L,83,H332:83
233280,"4,4'-(dichlorovinylidene)diphenol diglycidyl ether",939-515-9,,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2,Notified C&L,9,H319:9;H317:9;H315:9
233281,2-(2-Hydroxyethoxy)ethyl methacrylate,800-422-2,2351-43-1,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,78,H319:78;H317:78;H315:65
233282,"Reaction product of 1-chloro-2,3-expoxypropane, sodium hydroxide, sodium carbonate and water",939-516-4,,Eye Irrit. 2,Notified C&L,1,H319:1
233283,"Alcohols, C16-18 (even numbered), ethoxylated, < 2.5 EO",939-518-5,,Aquatic Chronic 2,REACH registration C&L,93,H411:93
233284,"Hydrocarbons, C13-C14, n-alkanes, <2% aromatics",939-519-0,,Asp. Tox. 1,REACH registration C&L,2,H304:2
233286,"(-)-6-(propylamino)-5,6,7,8-tetrahydronaphthalen-1-ol",800-424-3,101470-23-9,Aquatic Chronic 4,Notified C&L,2,H413:2
233287,"disodium 2,2'-(1,2-ethenediyl)bis[5-[[4-(2-hydroxypropoxy)-6-(phenylamino)-1,3,5-triazin-2-yl]amino]-benzenesulfonate",800-425-9,68003-30-5,Eye Irrit. 2,Notified C&L,1,H319:1
233288,"Fatty acids, C18 unsaturated, trimers, hydrogenated",800-426-4,1373883-45-4,Not Classified,Notified C&L,1,Not classified:1
233291,Reaction mass of [(2-substituted-4-nitroaryl)diazenyl]methyl(arylamino)-[(2-arylethyl)amino]pyridinecarbonitrile and [(2-substituted-4-nitroaryl)diazenyl]methyl(arylamino)-[(2-arylethyl)amino]pyridine-3-carbonitrile,,,Aquatic Chronic 4,REACH registration C&L,1,H413:1
233292,"Decan-1-ol, ethoxylated (EO = 5)",939-521-1,,Eye Dam. 1,Notified C&L,8,H318:8
233293,"Alcohols, C8-10, ethoxylated, sulfates, sodium salts",939-523-2,,Skin Irrit. 2;Eye Dam. 1,REACH registration C&L,2,H412:2;H318:2;H315:2
233295,"tert-butyl (1R,3S,4S)-3-(5-bromo-1H-benzimidazol-2-yl)-2-azabicyclo[2.2.1]heptane-2-carboxylate",800-428-5,1256387-74-2,Acute Tox. 4,REACH registration C&L,5,H302:4;H371:1
233297,"Eucalyptus citriodora oil, hydrated, cyclized (EC Oil (H/C))",800-429-0,1245629-80-4,Eye Irrit. 2,Notified C&L,5,H319:5
233298,"Phosphoric acid, mono- and di-C16-18 (even numbered) alkyl esters",939-526-9,,Eye Irrit. 2,REACH registration C&L,3,H319:3
233300,"Fatty acid chlorides, C12-18 (even numbered) and C18 unsatd., reaction products with sodium N-methyltaurinate",939-529-5,,Eye Irrit. 2,REACH registration C&L,41,H319:41
233301,Reaction products of tall oil fatty acids with diethylenetriamine and maleic anhydride,800-430-6,1419212-76-2,Skin Sens. 1B,Notified C&L,1,H317:1
233303,"Fatty acid chlorides, C18 unsatd., reaction products with sodium N-methyltaurinate",939-538-4,,Eye Irrit. 2,REACH registration C&L,40,H319:40
233305,"6-bromo-2-chloro-8-cyclopentyl-5-methylpyrido[2,3-d]pyrimidin-7(8H)-one",800-433-2,1016636-76-2,,REACH registration C&L,4,Not classified:2;H315:1;H335:1;H319:1;H302:2;H334:1;H373:1
233311,"no CAS C21H24BN3O2 2-(1,1-Diphenylpentylamino)-pyrimidine-5-boronic acid",939-532-1,,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H315:1;H335:1;H319:1;H302:1
233313,"Reaction mass of butane-2,2-diyl dihydroperoxide and dioxydibutane-2,2-diyl dihydroperoxide",700-954-4,1338-23-4,Org. Perox. D;Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;Acute Tox. 4,REACH registration C&L,7,H314:7;H332:7;H242:7;H318:7;H302:7
233317,2-methoxyethanimidamide hydrochloride,800-436-9,1903-91-9,,Notified C&L,2,H319:2;H335:2;H315:2
233328,Reaction products of ricinoleic acid with 2-aminoethanol and maleic acid and sodium hydrogensulfite,939-654-5,,Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,1,H319:1;H315:1
233329,tert-butyl 4-(2-aminoacetyl)piperazine-1-carboxylate,800-439-5,352359-09-2,,Notified C&L,2,H319:1;H335:2;H315:2;H318:1
233330,6-(trifluoromethoxy)-2H-indazole-3-carboxylic acid,800-440-0,869782-97-8,,Notified C&L,2,H319:2;H302:2;H315:1;H335:1
233331,"2-oxo-2,3-dihydro-1H-imidazole-4-carboxylic acid",800-441-6,39828-47-2,,Notified C&L,2,H315:2;H335:2;H319:2;H302:1
233332,"Butanedioic acid, 2(or3)-sulfo-, 4-[2-[(1-oxo(C12-C18(even numbered) and C18 unsaturated)alkyl)amino]ethyl]esters, disodium salts",939-637-2,,Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,2,H319:2;H315:2
233333,"pyrido[2,3-d]pyrimidine-2,4-diol",800-442-1,21038-66-4,,Notified C&L,2,H315:2;H335:2;H319:2;H302:2
233334,"Reaction mass of 1-Hexanol, 2-ethyl-, reaction products with 1,6-diisocyanatohexane and Hexane, 1,6-diisocyanato-, homopolymer",939-549-4,,Skin Irrit. 2;Skin Sens. 1B;Acute Tox. 4;STOT SE 3,REACH registration C&L,1,H335:1;H332:1;H317:1;H315:1
233337,"Aspartic acid, N-(3-carboxy-1-oxo-sulfopropyl)-N-(C16-C18 (even numbered), C18 unsaturated alkyl) tetrasodium salts",939-704-6,,Eye Irrit. 2,REACH registration C&L,3,H319:3
233338,3-[Diethoxy(methyl)silyl]propyl Methacrylate,800-443-7,65100-04-1,,Notified C&L,2,H319:2;H335:1;H315:2
233343,MARRON CREME EXTRAIT LIQUIDE HYDROALCOOLIQUE,939-536-3,,Flam. Liq. 3;Eye Irrit. 2,Notified C&L,1,H319:1;H226:1
233344,2-chloro-N-methylpropanamide,800-448-4,42275-47-8,,Notified C&L,2,H302:2;H315:1;H335:1;H318:1
233345,PROPOLIS BULK ETHANOLIC EXTRACT,939-537-9,,Flam. Liq. 2;Skin Sens. 1;Eye Irrit. 2,Notified C&L,1,H225:1;H319:1;H226:1;H317:1
233347,"Dodecanoic acid, ester with 1,2,3-propanetriol, acetylated",939-588-7,,Not Classified,REACH registration C&L,1,Not classified:1
233348,4-[(Ethoxycarbonyl)methyl]phenylboronic acid,800-450-5,92243-74-8,,Notified C&L,2,H319:2;H335:2;H315:2
233350,GINKGO BILOBA LEAAF DRY EXTRACT,939-541-0,,Skin Sens. 1,Notified C&L,1,H317:1
233352,"2-(2,4-dimethoxyphenyl)ethan-1-amine",800-453-1,15806-29-8,,Notified C&L,3,H319:1;H335:3;H315:3;H332:2;H318:2;H302:2
233354,PROPOLIS PURE EXTRAIT LIQUIDE HYDROALCOOLIQUE (<60%),939-542-6,,Flam. Liq. 3;Skin Sens. 1;Eye Irrit. 2,Notified C&L,1,H319:1;H226:1;H317:1
233356,nettle root dry extract,939-543-1,,Skin Sens. 1,Notified C&L,1,H317:1
233359,2-chloro-5-fluoro-4-iodopyridine,800-457-3,884494-49-9,,Notified C&L,3,H315:3;H335:3;H318:1;H302:3;H319:2;H332:1
233362,"tert-Butyl 4-[4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)pyrazol-1-yl]piperidine-1-carboxylate",800-459-4,877399-74-1,,Notified C&L,4,H319:4;H335:3;H315:4;H302:1
233363,3-(Methylsulphonyl)pyrrolidine,800-461-5,433980-62-2,,Notified C&L,2,H319:2;H335:2;H315:2
233364,4-Ethynylbenzoic Acid,800-462-0,10602-00-3,,Notified C&L,42,H319:42;H302:40;H315:4;H335:3;H332:2
233367,2-Bromo-4-chlorobenzaldehyde,800-465-7,84459-33-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;Aquatic Chronic 2,Notified C&L,41,H319:41;H411:38;H315:41;H335:40;H302:39;H332:1;H312:1
233368,SEIGLE RADICELLE EXTRAIT LIQUIDE MACERAT GLYCERINE CONCENTRE,939-545-2,,Flam. Liq. 3;Eye Irrit. 2,Notified C&L,1,H319:1;H226:1
233370,Aritchoke leaf glycerinated extract,939-547-3,,Skin Sens. 1,Notified C&L,1,H317:1
233371,BOLDO FEUILLE EXTRAIT LIQUIDE HYDROALCOOLIQUE,939-548-9,,Flam. Liq. 3;Skin Sens. 1;Eye Irrit. 2,Notified C&L,1,H319:1;H226:1;H317:1
233373,BOLDUS HYDROGLYCOLIC EXTRACT,939-551-5,,Skin Sens. 1,Notified C&L,1,H317:1
233374,ARTICHOKE HYDROGLYCOLIC EXTRACT,939-552-0,,Skin Sens. 1,Notified C&L,1,H317:1
233375,MALLOW FLOWER HYDROALCOHOLIC EXTRACT,939-553-6,,Flam. Liq. 3;Eye Irrit. 2,Notified C&L,1,H319:1;H226:1
233377,"Fatty alcohols, C12-18 (even numbered), manuf. of, destn. residues",939-562-5,,Not Classified,REACH registration C&L,1,Not classified:1
233390,2-(1H-indazol-1-yl)acetic acid,800-472-5,32829-25-7,Acute Tox. 4;Eye Dam. 1,Notified C&L,40,H318:38;H302:38;H319:2;H335:2;H315:2
233394,Reaction mass of Ammonium bisethanedioato bisaquo niobate(V) (anhydrous form) and Ammonium hydrogen ethanedioate ethanedioic acid (anhydrous form),939-559-9,,Met. Corr. 1;Acute Tox. 4;Skin Sens. 1B;Eye Dam. 1;STOT SE 3;Aquatic Chronic 3,REACH registration C&L,1,H412:1;H317:1;H290:1;H318:1;H335:1;H302:1
233396,(Methylamino)propionitrile),800-475-1,180181-02-6,Acute Tox. 4,Notified C&L,196,H302:195;H319:2;H335:2;H315:2
233397,"1-(3-tert-butyl-5-iodo-4-methoxyphenyl)pyrimidine-2,4(1H,3H)-dione",800-476-7,1132940-53-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,51,H315:50;H335:42;H319:50;H302:43;H301:7;Not classified:1
233409,"Quaternary ammonium compounds, C12-14 (even-numbered)-alkylethyldimethyl, ethyl sulphates",939-607-9,,Acute Tox. 4;Acute Tox. 3;Skin Corr. 1C;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,31,H314:31;H410:31;H318:31;H400:31;H311:6;H302:31
233410,1-methylpiperidine-4-carbaldehyde,800-487-7,50675-21-3,Eye Irrit. 2;Aquatic Acute 1,Notified C&L,40,H319:39;H400:38;H335:2;H315:2;H226:1;H318:1;H302:1
233413,"Ethyl(1R,2S)-1-[[(2S,4R)-1-[(2S)-2-[(5-methylheteromonocycle-2-carbonyl)amino]alkenoyl]-4-heteropolycycle-6-yloxy-heteromonocycle-2-carbonyl]amino]-2-vinyl-alicyclecarboxylate",,,,,0,No data
233424,"rac-(2R,3R)-1-{[(9H-fluoren-9-yl)methoxy]carbonyl}-3-phenylazetidine-2-carboxylic acid",800-496-6,204320-45-6,Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,40,H400:38;H410:38;H319:2;H335:2;H315:2;H302:1
233427,"Reaction Products of alcohols, C14-18, C18 unsat., esterified with phosphorus pentoxide and salted with amines, C12-14,-tert-alkyl",939-591-3,,Aquatic Chronic 3,REACH registration C&L,442,H412:442
233428,Masil XL-1 Crosslinker,800-499-2,69013-23-6,Eye Irrit. 2,Notified C&L,3,H319:1;Not classified:1;H361:1
233430,"2-(4-methyl-4H-1,2,4-triazol-3-yl)ethan-1-amine dihydrochloride",800-501-1,1158631-54-9,,Notified C&L,2,H319:2;H335:2;H315:2
233431,2-cyclopentylethan-1-amine hydrochloride,800-502-7,684221-26-9,,Notified C&L,2,H319:2;H335:2;H315:2;H302:1
233434,"Alcohols, C12-14 (linear, even-numbered), ethoxylated, sulfates, ammonium salts, < 2.5 mol EO",939-575-6,,Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,5,H412:5;H318:5;H315:5
233440,"(3aS,4R,6S,6aR)-6-(2-hydroxyethoxy)-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-aminium hydrogen oxalate",800-506-9,1402150-30-4,Acute Tox. 4;Acute Tox. 4;Eye Dam. 1,REACH registration C&L,2,H318:2;H312:2;H302:2
233441,1-(Triethoxysilyl)-2-(diethoxymethylsilyl)-ethane,800-507-4,18418-54-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,22,H319:22;H335:22;H315:22
233442,"Alcohols, C12-14 (even-numbered), ethoxylated, magnesium salts, < 2.5 mol EO",939-578-2,,Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,2,H412:2;H318:2;H315:2
233444,"3-[2-{(2R,3S)-3-[(1R)-1-{[tert-butyl(dimethyl)silyl]oxy}ethyl]-4-oxoazetidin-2-yl}propanoyl]-4,4-dimethyl-1,3-oxazolidin-2-one",939-570-9,,Not Classified,REACH registration C&L,1,Not classified:1
233447,"Ruthenium (pentamethylcyclopentadienyl) (2,2-dihydro-3,3-dimethyl-5,6-diethylpyrazyl)",939-571-4,,Skin Corr. 1C,Notified C&L,22,H314:22
233450,"1-(1H-1,3-benzodiazol-5-yl)ethan-1-one",800-513-7,58442-16-3,,Notified C&L,2,H319:2;H335:2;H315:2;H302:1
233451,Germanium Tetra-n-propoxide,939-573-5,,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,22,H319:22;H335:22;H315:22
233452,4'-Chloro-biphenyl-3-carboxylic acid,800-514-2,4655-10-1,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,2,H332:1;H312:1;H302:1;H319:1;H335:1;H315:1
233453,"3-C12-18-(even numbered)-alkylamido-N,N-dimethylpropan-1-amino oxide",939-581-9,,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 3,REACH registration C&L,11,H412:11;H315:11;H318:11;H400:11;H302:11
233456,"Cobalt(2,4,5-tri-tertbutylimidazolate)(cyclopentadienyl)",939-576-1,,Flam. Liq. 3;Acute Tox. 3;Acute Tox. 2;Skin Corr. 1C;Skin Sens. 1;Acute Tox. 3;Resp. Sens. 1;Muta. 2;Carc. 2;Aquatic Chronic 3,Notified C&L,22,H412:22;H314:22;H226:22;H317:22;H310:22;H331:22;H334:22;H351:22;H341:22;H311:22;H301:22
233457,"Butanedioic acid, sulfo-, 4-C12-14 (even numbered)-alkyl esters, disodium salts",939-638-8,,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1,REACH registration C&L,5,H315:5;H318:5;H302:5
233458,"1,1-Bis(methyldiethoxysilyl)Ethane",939-577-7,,Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,22,H315:22;H335:22;H319:22;H301:22
233459,"Fatty acids, C16-18 (even numbered), aluminum salts",939-582-4,,Not Classified,REACH registration C&L,6,Not classified:6
233462,Reaction mass of sodium 3-{[3-(diethylamino)propyl]carbamoyl}-2-(dodecylamino)propanoate and sodium 3-{[3-(diethylamino)propyl]carbamoyl}-3-(dodecylamino)propanoate,939-579-8,,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Skin Sens. 1;Eye Dam. 1;STOT RE 2;Aquatic Chronic 2,REACH registration C&L,2,H411:2;H314:2;H373:2;H312:2;H317:2;H318:2;H302:2
233464,"TRANS-4-{[(5S)-5-{[3,5-BIS(TRIFLUOROMETHYL)BENZYL](2-METHYL-2H-TETRAZOL-5-YL)AMINO}-7,9-DIMETHYL-2,3,4,5-TETRAHYDRO-1H-1-BENZAZEPIN-1-YL]METHYL}CYCLOHEXANECARBOXYLIC ACID",800-517-9,1186486-62-3,Repr. 2;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H361:1;H400:1;H410:1
233465,CORNOUILLER CONCENTRATED GLYCERINATED MACERAT LIQUID EXTRACT,939-584-5,,Flam. Liq. 3;Eye Irrit. 2,Notified C&L,1,H319:1;H226:1
233466,Alnus glutinosa bud concentrated glycerinated macerat liquid extract,939-585-0,,Flam. Liq. 3;Eye Irrit. 2,Notified C&L,1,H319:1;H226:1
233467,SEQUOIA CONCENTRATED GLYCERINATED MACERAT LIQUIDE EXTRACT,939-586-6,,Flam. Liq. 3;Eye Irrit. 2,Notified C&L,1,H319:1;H226:1
233468,1-(4-azidophenyl)ethan-1-one,800-518-4,20062-24-2,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:1;H335:1;H315:1;H331:1;H311:1;H301:1
233470,2-(3-Aminophenyl)propan-2-ol,800-520-5,23243-05-2,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,2,H319:2;H332:1;H315:2;H335:2;H302:2
233471,Maitoxin,800-521-0,59392-53-9,Acute Tox. 2;Acute Tox. 1;Acute Tox. 1,Notified C&L,1,H300:1;H310:1;H330:1
233472,"(2R)-6-Chloro-2-methyl-8-nitro-2H-1,4-benzoxazin-3(4H)-one",800-522-6,327026-91-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
233473,Amino-(4-chloro-phenyl)acetic acid methyl ester,800-523-1,43189-20-4,Skin Corr. 1C;Eye Dam. 1,Notified C&L,1,H314:1;H318:1
233474,Methyl 6-chloro-2-methoxynicotinate,800-524-7,65515-32-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H315:2;H335:2;H319:2;H302:2
233475,(R)-Methyl 2-hydroxylbutanoate,800-525-2,73349-07-2,Flam. Liq. 3;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H226:1
233477,Reaction mass of potassium ethyl octylphosphonate and diethyl octylphosphonate,939-595-5,,Skin Irrit. 2;Eye Dam. 1;STOT RE 2;Aquatic Chronic 2,REACH registration C&L,33,H318:33;H411:33;H373:33;H315:33
233479,"(S)-3-tert-butyoxycarbonylamino-2-[4-(propane-2-sulfonyl)-piperazin-yl-propionic methyl ester, sulfate",939-590-8,,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;STOT SE 3;Repr. 2,Notified C&L,1,H335:1;H315:1;H361:1;H311:1;H301:1
233480,"Alcohols, C10-12 (even numbered), ethoxylated (1-2.5 EO), sulfated, sodium salts",939-597-6,,Skin Irrit. 2;Eye Dam. 1,REACH registration C&L,2,H318:2;H315:2
233482,"Reaction mass of 2,3,4,5,6,7-hexahydro-1H-indene and (2s,3aR,7aS)-1,1,2,3,3-pentamethyloctahydro-1H-indene",939-655-0,,Not Classified,REACH registration C&L,1,Not classified:1
233483,"Reaction products of 1,2-dichloroethane with ammonia, 2-(2-aminoethylamino)ethanol distillation fraction",939-593-4,,Skin Corr. 1B;Skin Sens. 1B;Eye Dam. 1;Repr. 1B,REACH registration C&L,1,H314:1;H360:1;H317:1;H318:1;H361:1
233486,"2,6-Difluoro-4-hydroxybenzeneboronic acid",800-531-5,957065-87-1,,Notified C&L,2,H319:2;H335:2;H315:2
233488,"Bis(2,4,6-trichlorophenyl) malonate",800-533-6,15781-70-1,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,3,H319:3;H335:3;H315:3
233490,3-(Methylcarbamoyl)benzeneboronic acid,800-535-7,832695-88-2,,Notified C&L,2,H319:1;H335:1;H315:1;H332:1;H312:1;H302:1
233491,3-(2-Cyanoethylaminocarbonyl)benzeneboronic acid,800-536-2,762262-11-3,,Notified C&L,2,H319:2;H335:2;H315:2;H302:1
233495,"Reaction mass of (3E)-4-(2,6,6-trimethylcyclohex-2-en-1-yl)but-3-en-2-one and 4-(dodecylsulfanyl)-4-(2,6,6-trimethylcyclohex-1-en-1-yl)butan-2-one and 4-(dodecylsulfanyl)-4-(2,6,6-trimethylcyclohex-2-en-1-yl)butan-2-one",700-956-5,,Skin Sens. 1B;Aquatic Chronic 3,REACH registration C&L,4,H412:4;H317:4
233496,isoxazolidine hydrochloride,800-538-3,39657-45-9,,Notified C&L,2,H319:2;H335:2;H315:2;H302:1
233501,"3-bromo-5-methyl-1,2,4-oxadiazole",800-544-6,1228427-07-3,,Notified C&L,2,H332:2;H312:2;H302:2;H319:1;H315:1;H335:1
233502,[No public or meaningful name is available],800-545-1,872362-98-6,Acute Tox. 4,Notified C&L,39,H302:39;H315:1;H319:1
233503,2-(1-Methylpiperidin-4-yl)ethanamine,800-546-7,20845-38-9,,Notified C&L,3,H314:2;H335:1;H301:1
233504,Ethyl azetidine-3-carboxylate hydrochloride,800-547-2,405090-31-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,3,H319:3;H335:3;H315:3
233505,"2,3-Difluoro-4-methoxyphenylboronic Acid",800-548-8,170981-41-6,,Notified C&L,2,H319:2;H335:1;H315:2
233508,"Benzene, mono-C16-18 (even numbered), branched and linear, alkyl derivs.",939-596-0,,Asp. Tox. 1;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,8,H319:8;H304:8;H315:8
233509,2-(propan-2-ylsulfanyl)acetic acid,800-551-4,22818-59-3,,Notified C&L,2,H302:2;H315:1;H335:1;H318:1
233513,2-Bromo-4-methoxypyridine,800-556-1,89488-29-9,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,3,H319:3;H332:1;H312:1;H315:3;H335:3;H302:2
233516,5-Bromo-2-hydroxynicotinonitrile,800-559-8,405224-22-8,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,3,H319:3;H332:3;H312:3;H315:3;H335:3;H302:3
233520,(pyrrolidin-3-yl)methanol hydrochloride,800-562-4,644971-22-2,,Notified C&L,2,H319:2;H335:2;H315:2
233521,6-bromopyridazin-3-ol,800-564-5,51355-94-3,,Notified C&L,2,H319:2;H335:2;H315:2;H302:1
233524,"Alcohols, C16-18 (even numbered) and C18 unsaturated, propoxylated, < 2.5 PO",939-600-0,,Aquatic Chronic 3,REACH registration C&L,2,H412:2
233525,"Amides, C18-unsatd, N,N-bis(hydroxyethyl)",952-616-2,,Skin Irrit. 2;Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,8,H319:8;H411:8;H315:8
233526,METHYL TETRAHYDROTHIOPYRAN-4-CARBOXYLATE,800-565-0,128094-82-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H315:2;H335:2;H319:2;H302:2;H332:1;H312:1
233528,"OCTADECANOIC ACID, REACTION PRODUCTS WITH DIETHANOLAMINE, DI-ME SULFATE-QUATERNIZED",800-566-6,120793-10-4,Skin Irrit. 2,Notified C&L,1,H315:1
233536,"Vanadate(7-), (dodeca-μ-oxooctaoxooctamolybdate)dodeca-μ-oxotetraoxo[μ12-[phosphato(3-)-κO:κO:κO:κO':κO':κO':κO'':κO'':κO'':κO''':κO''':κO''']]tetra-, sodium hydrogen (1:4:3)",800-567-1,1138238-51-3,Met. Corr. 1;Skin Corr. 1C;Eye Dam. 1,Notified C&L,1,H290:1;H314:1;H318:1
233544,2-(dimethylamino)pyrimidine-5-carbaldehyde,800-577-6,55551-49-0,,Notified C&L,2,H319:2;H335:2;H315:2
233547,"2H,3H-thieno[3,4-b][1,4]dioxine-5-carboxylic acid",800-580-2,260063-21-6,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,40,H319:40;H332:39;H312:39;H315:40;H335:40;H302:40
233550,2-cyclopropylpyrimidine-5-carboxylic acid,800-583-9,648423-79-4,,Notified C&L,2,H315:2;H335:2;H319:2;H302:2
233551,1-benzyl-1H-pyrazole-4-carboxylic acid,800-584-4,401647-24-3,,Notified C&L,2,H319:2;H302:2;H315:1;H335:1
233552,"2-(Chloromethyl)-1,3-oxazole",800-586-5,185246-17-7,,Notified C&L,2,H314:1;H319:1;H332:1;H312:1;H315:1;H335:1;H302:1
233556,"N',3-dihydroxypropanimidamide",800-590-7,53370-50-6,,Notified C&L,2,H319:2;H335:2;H315:2;H302:1
233558,3-(1H-pyrazol-1-yl)propan-1-ol,800-592-8,180741-37-1,,Notified C&L,2,H319:2;H335:2;H315:2;H302:1
233559,[No public or meaningful name is available],939-604-2,,Skin Irrit. 2;Skin Sens. 1;Aquatic Chronic 2,REACH registration C&L,3,H411:3;H317:3;H315:3
233560,(3S)-1-methylpyrrolidin-3-amine dihydrochloride,800-593-3,874348-06-8,,Notified C&L,2,H319:2;H335:2;H315:2
233561,"Sulfuric acid, mono-C8-14 (even-numbered)-alkyl esters, ammonium salts, compds. with triethanolamine",939-606-3,,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Acute Tox. 4;STOT SE 3;Aquatic Chronic 3,REACH registration C&L,168,H412:168;H332:84;H315:168;H318:168;H335:84;H302:168
233563,"5-chloro-3-phenyl-1,2,4-oxadiazole",800-595-4,827-44-1,,Notified C&L,2,H319:2;H335:2;H315:2;H302:1
233567,"4-bromo-1,5-dimethyl-1H-pyrazole",800-601-5,5775-86-0,,Notified C&L,2,H319:2;H335:2;H315:2;H332:1;H312:1;H302:1
233569,"DIstilled tall oil, maleated",939-605-8,,Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;Aquatic Chronic 3,Notified C&L,1,H412:1;H318:1;H317:1;H315:1
233571,"(1H,1H,2H,2H-Heptadecafluorodec-1-yl)phosphonic acid",800-604-1,80220-63-9,,Notified C&L,3,H319:3;H335:2;H315:3;H332:1;H312:1;H302:1
233573,2-Oxa-6-aza-spiro[3.3]heptane hemioxalate,800-606-2,1045709-32-7,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,4,H332:2;H312:3;H302:3;H319:1;H335:1;H315:1
233575,"4,4,5,5-tetramethyl-2-{4-[(trifluoromethyl)sulfanyl]phenyl}-1,3,2-dioxaborolane",800-609-9,1005206-25-6,,Notified C&L,2,H319:2;H335:2;H315:2;H302:1
233580,Ethyl 1H-imidazole-4-carboxylate,800-612-5,23785-21-9,,Notified C&L,3,H319:3;H335:2;H315:3
233581,"Quaternary ammonium compounds, C12-C18 (even numbered) alkyltrimethyl chloride",939-616-8,,Acute Tox. 3;Acute Tox. 3;Skin Corr. 1C;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,4,H314:4;H410:4;H318:4;H400:4;H311:4;H301:4
233583,PEG-3 Dioleoylamidoethylmonium Methosulfate,800-613-0,224948-78-1,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,18,H319:18;H315:18
233588,(S)-Methyl-2-hydroxybutanoate,800-614-6,73349-08-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
233591,"5-Heptenoic acid, 7-((1R,2R,3R,5S)-3,5-dihydroxy-2-(3-oxodecyl)cyclopentyl)-, (5Z)-",800-615-1,120373-36-6,Repr. 1B,Notified C&L,1,H360:1
233592,Reaction mass of halomethyl thiocyanate and methylene bis(thiocyanate),,,Acute Tox. 3;Skin Corr. 1B;Skin Sens. 1;Acute Tox. 2;Aquatic Acute 1;Ozone 1,REACH registration C&L,1,H330:1;H314:1;H317:1;H420:1;H400:1;H301:1
233593,(2R)-1-(tert-Butoxycarbonyl)piperazine-2-carboxylic acid,800-616-7,278788-60-6,,Notified C&L,2,H319:2;H335:2;H315:2;H302:1
233594,"Methyl 2,3-Diaminobenzoate",800-617-2,107582-20-7,,Notified C&L,3,H319:3;H335:2;H315:3
233598,4-Chloropyrazole,800-621-4,15878-00-9,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,4,H315:4;H319:4;H302:4;H335:2
233606,"3-chloro-5-methyl-1H-1,2,4-triazole",800-630-3,15285-15-1,,Notified C&L,2,H319:2;H335:2;H315:2
233608,"5-cyclopentyl-1,3,4-oxadiazol-2-amine",800-632-4,90221-15-1,,Notified C&L,2,H319:2;H335:2;H315:2;H302:1
233609,"imidazo[1,2-a]pyridin-2-ylmethanamine",800-634-5,165736-20-9,,Notified C&L,2,H319:2;H335:2;H315:2;H302:1
233610,"4-hydroxy-6,7-dichloroquinoline",800-635-0,203626-51-1,,Notified C&L,2,H319:2;H335:2;H315:2;H302:1
233613,"2,2,2-trifluoro-1-(pyridin-2-yl)ethan-1-one",800-638-7,33284-17-2,,Notified C&L,2,H319:2;H335:2;H315:2;H302:1
233615,"Reaction products of aromatic hydrocarbons, C10-13 with branched nonene, sulfonated, sodium salts",800-660-7,1258274-08-6,Skin Irrit. 2;Eye Dam. 1,REACH registration C&L,122,H318:122;H315:122
233621,"5-ethyl-1-methyl-1H-1,2,4-triazol-3-amine",800-646-0,90708-10-4,,Notified C&L,2,H319:1;H335:2;H315:2;H318:1;H302:1
233623,5-(chloromethyl)-1H-pyrazole hydrochloride,800-648-1,69658-97-5,,Notified C&L,2,H319:1;H335:2;H315:2;H318:1
233624,3-methyloxetane-3-carbaldehyde,800-649-7,99419-31-5,Acute Tox. 4;Aquatic Chronic 2,Notified C&L,40,H411:39;H302:39;H319:1;H335:1;H226:1;H315:1;H401:1;H227:1
233630,3-Cyano-4-methoxy-2-pyridone,800-656-5,21642-98-8,,Notified C&L,2,H319:2;H332:1;H312:1;H315:2;H335:1;H302:1;H331:1;H311:1;H301:1
233631,[No public or meaningful name is available],800-657-0,113092-96-9,Acute Tox. 4;Eye Dam. 1;Aquatic Chronic 4,Notified C&L,39,H318:38;H413:38;H302:39;H332:1;H312:1
233633,tert-butyl 4-[(methanesulfonyloxy)methyl]piperidine-1-carboxylate,800-659-1,161975-39-9,,Notified C&L,2,H319:2;H335:2;H315:2;H302:1
233634,[No public or meaningful name is available],800-661-2,123990-76-1,Acute Tox. 4;Eye Dam. 1,Notified C&L,39,H318:38;H302:38;H319:1;H335:1;H315:1
233638,"4-(chloromethyl)-2-ethyl-1,3-thiazole",800-665-4,40516-60-7,,Notified C&L,2,H319:1;H335:1;H315:1;H314:1;H302:1
233644,"Benzoic acid, 5-amino-2-hydroxy-, potassium salt (1:1)",939-617-3,,Not Classified,Notified C&L,1,Not classified:1
233645,Methyl 3-Chloropyrazine-2-carboxylate,800-672-2,27825-21-4,,Notified C&L,2,H319:2;H335:1;H315:2
233656,"2,2-dimethyloxane-4-carboxylic acid",800-683-2,52916-16-2,,Notified C&L,2,H319:2;H335:2;H315:2
233657,4-Bromo-3-methoxybenzyl alcohol,800-684-8,17100-64-0,,Notified C&L,2,H319:2;H335:2;H315:2;H332:1;H312:1;H302:1
233664,"3,6-Dibromothieno[3,2-b]thiophene",800-692-1,392662-65-6,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
233665,(2E)-3-phenyl-2-pentyl-prop-2-enal,800-696-3,78605-96-6,Skin Sens. 1B;Aquatic Chronic 2,REACH registration C&L,5,H411:4;H317:4;H400:1;H410:1
233670,"Sulphonation product of diisopropylbenzene, neutralised by sodium hydroxide",939-651-9,,Eye Irrit. 2,REACH registration C&L,2,H319:2
233678,Reaction mass of 2-hexyldodecan-1-ol and 2-octyldecan-1-ol,939-621-5,,Not Classified,REACH registration C&L,2,Not classified:2
233680,[No public or meaningful name is available],800-704-5,6628-07-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H319:39;H335:39;H315:39;H332:1;H312:1;H302:1
233686,[No public or meaningful name is available],800-710-8,849068-61-7,Acute Tox. 4;Eye Irrit. 2,Notified C&L,39,H319:39;H302:38;H335:1;H315:1
233690,39947_Reaction mass of 1-(3-((C12-18-(even numbered))-alkyl-amino)propyl)guanidine acetate salt and 1-(C12-18-(even numbered))-alkyl-1-(3-guanidinopropyl)guanidine acetate salt and 1-(C12-18-(even numbered))-alkyl-tetrahydropyrimidin-2(1H)-imine acetate salt,939-650-3,,Acute Tox. 4;Skin Corr. 1C;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,34,H314:34;H410:34;H400:34;H302:34;H373:31
233693,2-Carbamoylbenzeneboronic acid,800-713-4,380430-54-6,,Notified C&L,2,H319:2;H335:2;H315:2;H332:1;H312:1;H302:1
233694,2-azaspiro[4.4]nonan-3-one,800-715-5,75751-72-3,,Notified C&L,2,H319:2;H335:2;H315:2;H302:1
233695,"4,4-Dimethylpyrrolidin-2-one",800-716-0,66899-02-3,,Notified C&L,3,H319:3;H335:3;H315:3;H302:2
233699,Polyethyleneglycol diamine,939-622-0,,Acute Tox. 4;Skin Corr. 1C;Eye Dam. 1;Aquatic Chronic 3,Notified C&L,8,H412:8;H314:8;H318:8;H302:8
233701,3-hydroxy-N-methylpropanamide,800-721-8,6830-81-5,,Notified C&L,2,H332:1;H312:1;H302:1;H319:1;H335:1;H315:1
233702,"Alkane C6-C8 (even numbered), 1-sulphonic acid, sodium salt",939-625-7,,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,1,H315:1;H319:1;H302:1
233706,"reaction mass of 1-chloro-3-(dodecyloxy)propan-2-ol andalpha-dodecyl-omega-hydroxy-di[oxy[(chloromethyl)-1,2-ethanediyl]] andalpha-dodecyl-omega-hydroxy-tri[oxy[(chloromethyl)-1,2-ethanediyl]]",939-623-6,,Skin Irrit. 2;Skin Sens. 1;Aquatic Acute 1,Notified C&L,1,H400:1;H317:1;H315:1
233708,(2S)-2-amino-3-(dimethylamino)propanoic acid dihydrochloride,800-724-4,31697-39-9,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,3,H319:3;H335:3;H315:3
233712,"Reaction mass of 1-chloro-3-[(Z)-octadec-9-en-1-yloxy]propan-2-ol and alpha-(Z)-octadec-9-en-1-yl-omega-hydroxy-di[oxy[(chloromethyl)-1,2-ethanediyl]] and alpha-(Z)-octadec-9-en-1-yl-omega-hydroxy-tri[oxy[(chloromethyl)-1,2-ethanediyl]]",939-624-1,,Aquatic Acute 1,Notified C&L,1,H400:1
233713,2-{[(tert-butoxy)carbonyl]amino}-2-(4-chlorophenyl)acetic acid,800-726-5,209525-73-5,,Notified C&L,2,H319:2;H335:2;H315:2;H302:1
233714,"4-(TETRAHYDRO-2H-PYRAN-4-YL)BENZENE-1,3-DIOL",800-727-0,1228321-01-4,Aquatic Chronic 2,Notified C&L,1,H411:1
233717,(2-BROMOTHIEN-3YL)METHANOL,800-730-7,70260-16-1,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H332:1;H312:1;H315:1;H335:1;H302:1
233718,"Fatty acids, C18 unsat, reaction products with pentaethylenehexamine, acetate salts",939-626-2,,Acute Tox. 4;Skin Irrit. 2;Skin Sens. 1;Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,1,H410:1;H317:1;H315:1;H318:1;H400:1;H302:1
233720,"HDI oligomers, allophanate",939-657-1,,Skin Irrit. 2;Skin Sens. 1;Acute Tox. 4;STOT SE 3,REACH registration C&L,2,H335:2;H332:2;H317:2;H315:2
233721,C8-18 alkylampho(di)propionates,,,Skin Sens. 1B;Eye Dam. 1;STOT SE 2;STOT SE 2;Aquatic Chronic 2,REACH registration C&L,1,H318:1;H371:1;H411:1;H317:1
233722,[No public or meaningful name is available],939-629-9,,Not Classified,Notified C&L,1,Not classified:1
233726,N-(4-aminophenyl)-N-methyl-2-(4-methylpiperazin-1-yl)acetamide,939-634-6,262368-30-9,Not Classified,REACH registration C&L,3,Not classified:2;H319:1;H335:1;H315:1
233727,Esterification products of Fatty acids C18 unsaturated and triethanolamine,939-649-8,1474044-69-3,Not Classified,REACH registration C&L,3,Not classified:3
233728,Reaction products of C12-18-(even numbered)-alkylamines and acrylic acid and sodium hydroxide,939-647-7,,Skin Irrit. 2;Eye Dam. 1,REACH registration C&L,1,H318:1;H315:1
233729,"Reaction mass of 2,3-dimethylpentanal and 3-methylpentan-2-one",939-635-1,,Flam. Liq. 3;Skin Sens. 1,REACH registration C&L,1,H226:1;H317:1
233730,Cyanocyclopropyl derivative,,,Acute Tox. 4;STOT SE 2;STOT RE 2,Notified C&L,36,H371:35;H373:36;H302:35
233732,"isothiazolidine 1,1-dioxide",800-732-8,5908-62-3,Acute Tox. 4,Notified C&L,40,H302:40;H319:2;H332:1;H312:1;H315:2;H335:2
233736,"3,4-Dihydro-2H-pyran-5-boronic acid, pinacol ester",800-737-5,1046811-99-7,,Notified C&L,2,H319:2;H335:2;H315:2;H332:1;H312:1;H302:1
233737,"1,4:3,6-dianhydro-2,5-bis-O-(2,3-epoxypropyl)-glucitol",800-738-0,13374-44-2,Skin Irrit. 2;Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 2,Notified C&L,11,H319:10;H411:10;H317:11;H315:10
233739,1-(hydroxymethyl)cyclopropane-1-carboxylic acid,800-740-1,49640-66-6,,Notified C&L,2,H319:1;H335:2;H315:2;H318:1
233745,"Diethyl 1H-imidazole-4,5-dicarboxylate",800-746-4,1080-79-1,,Notified C&L,2,H319:2;H335:2;H315:2
233747,4-bromo-2-methoxybenzonitrile,800-749-0,330793-38-9,,Notified C&L,2,H319:2;H332:2;H312:2;H315:2;H335:2;H302:2
233748,(1-ethyl-1H-pyrazol-4-yl)methanamine,800-750-6,856696-09-8,,Notified C&L,2,H314:1;H315:1;H335:1;H318:1;H302:1
233749,tert-butyl 4-ethynylpiperidine-1-carboxylate,800-751-1,287192-97-6,,Notified C&L,4,H319:4;H335:4;H315:4;H302:2
233752,3-aminopyridine-2-carboxamide,800-754-8,50608-99-6,,Notified C&L,2,H319:2;H335:2;H315:2;H302:1
233755,3-[2-(dimethylamino)ethoxy]benzaldehyde,800-757-4,81068-25-9,,Notified C&L,2,H319:1;H335:2;H315:2;H318:1;H302:1
233757,"Fatty acids, tall oil, maleated",800-760-0,68139-89-9,Skin Sens. 1,Notified C&L,5,H317:4;H319:2
233761,6-Bromo-4-hydroxyquinoline,800-764-2,145369-94-4,,Notified C&L,2,H332:1;H312:1;H302:1;H319:1;H315:1
233762,"Esterification products of acrylic acid and 2,2,2',2'-tetrakis(hydroxymethyl)-3,3'-oxydipropan-1-ol",800-838-4,1384855-91-7,Skin Sens. 1A;Eye Irrit. 2;Aquatic Chronic 3,REACH registration C&L,98,H412:85;H319:98;H317:98;H411:13
233763,sodium/triethanolamine 4-((2-hydroxyethyl)amino)-3-pentaproenyl-4-oxobutanoate,800-765-8,1424149-03-0,Skin Irrit. 2;Eye Dam. 1,Notified C&L,67,H318:67;H315:67
233764,"sodium/triethanolamine- 6-(2,5-dioxo-3-C12-18-alkenyl(even and odd, branched, unsaturated)-pyrrolidin-1-yl)hexanoate",800-766-3,1424148-97-9,Skin Irrit. 2;Repr. 1B,Notified C&L,31,H360:31;H315:31
233765,"6-(3-pentapropenyl-2,5-dioxopyrrolidin-1-yl)hexanoic acid",800-767-9,1424148-94-6,Repr. 1B,Notified C&L,31,H360:31
233767,"6-(3-tetrapropenyl-2,5-dioxopyrrolidin-1-yl)hexanoic acid",800-770-5,1424148-99-1,Eye Irrit. 2;Repr. 1B,Notified C&L,31,H319:31;H360:31
233769,"Reaction mass of (1-methylethylidene)bis(4,1-phenyleneoxy-2,1-ethanediyl) bismethacrylate and 2-{4-[2-(4-{2-[2-(methacryloyloxy)ethoxy]ethoxy}phenyl)propan-2-yl]phenoxy}ethyl methacrylate",939-702-5,,Not Classified,REACH registration C&L,1,Not classified:1
233770,"TERT-BUTYL-4-[4-(HYDROXYMETHYL)-1,3-THIAZOL-2-YL]PIPERIDINE-1-CARBOXYLATE",800-771-0,864068-79-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H315:1;H335:1;H319:1;H302:1
233771,"4-Chloro-3,5-difluorobromobenzene",800-772-6,176673-72-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H319:2;H335:2;H315:2
233772,N-BOC-trans-4-N-FMOC-amino-L-proline,800-773-1,176486-63-8,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;STOT SE 3,Notified C&L,1,H315:1;H335:1;H319:1;H302:1
233773,N-Benzy 3-(tert-butyldimethylsilanyloxymethyl)piperid-4-one,800-774-7,325486-37-1,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
233774,"4-METHYL-7-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)-3,4-DIHYDRO-2H-1,4-BENZOXAZINE",800-775-2,519054-54-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
233776,"2-Butenedioic acid (2Z)-, reaction products with ammonium di-µ3-hydroxyhexacosa-µ-oxododecaoxododecatungstate(6-) (6:1), ammonium octa-µ-oxodi-µ3-oxo-µ4-oxododecaoxoheptamolybdate(6-) (6:1), nickel(2+) nitrate (1:2) and nickel(2+) sulfate (1:1)",800-777-3,1351378-24-9,Skin Sens. 1;Carc. 1A;STOT RE 1;Aquatic Chronic 4,REACH registration C&L,2,H372:1;H413:1;H317:1;H350:1;H319:1;H411:1;H302:1
233781,"Reaction mass of nicotine and glycerol and propane-1,2-diol and linalool and vanillin and 8024-06-4",939-643-5,,Acute Tox. 3,Notified C&L,1,H311:1
233783,methyl(pyrazin-2-ylmethyl)amine,800-779-4,120739-79-9,,Notified C&L,2,H319:1;H332:1;H312:1;H315:2;H335:2;H302:2;H318:1
233785,methyl[(1-methyl-1H-pyrazol-4-yl)methyl]amine,800-782-0,179873-43-9,,Notified C&L,2,H314:2;H319:1;H315:1;H335:1;H302:1
233788,3-chloro-1-benzothiophene-2-carbaldehyde,800-785-7,14006-54-3,,Notified C&L,2,H319:2;H335:2;H315:2
233790,"4H,5H,6H,7H,8H-cyclohepta[b]thiophene-2-carboxylic acid",800-787-8,40133-08-2,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,3,H319:3;H335:3;H315:3
233797,3-bromo-5-methoxyphenol,800-795-1,855400-66-7,,Notified C&L,2,H319:2;H335:2;H315:2;H302:1
233801,"3,4-Dibromopyridine",800-799-3,13534-90-2,,Notified C&L,4,H319:4;H335:3;H315:4;H302:1
233802,[No public or meaningful name is available],800-800-7,263368-72-5,Acute Tox. 4;Eye Irrit. 2,Notified C&L,40,H319:40;H302:38;H335:2;H315:2
233803,2-chloro-6-fluoroquinoline,800-801-2,77119-53-0,,Notified C&L,3,H319:3;H335:3;H315:3
233806,4-bromo-N-methylbenzamide,800-804-9,27466-83-7,,Notified C&L,4,H319:4;H335:4;H315:4
233808,"1-methyl-3,4-dihydroisoquinoline",800-807-5,2412-58-0,,Notified C&L,2,H315:2;H335:2;H319:2;H302:2
233809,Methyl 1-(tert-Butoxycarbonyl)-3-pyrrolidinecarboxylate,800-808-0,122684-33-7,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H319:2;H315:2;H335:1
233810,"Benzenesulfonic acid, mono-C16-18 (even numbered), branched and linear, alkyl derivs.",939-644-0,,Skin Corr. 1B;Eye Dam. 1,Notified C&L,8,H314:8;H318:8
233811,"Benzenesulfonic acid, mono-C16-18 (even numbered), branched and linear, alkyl derivs., sodium salts",939-645-6,,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,8,H319:8;H315:8
233814,Sodium hydride in Paraffin oils,939-646-1,,Water-react. 1;Skin Corr. 1B,Notified C&L,1,H314:1;H260:1
233815,(3R)-4-(4-bromophenyl)-3-{[(tert-butoxy)carbonyl]amino}butanoic acid,800-811-7,331763-75-8,,Notified C&L,2,H319:2;H335:2;H315:2
233816,1-(furan-3-yl)methanamine,800-812-2,4543-47-9,Acute Tox. 3;Eye Irrit. 2,Notified C&L,42,H319:38;H301:39;H314:4;H226:2;H334:1;H312:1;H302:1;H331:1;H311:1
233817,2-ethylbenzonitrile,800-813-8,34136-59-9,,Notified C&L,2,H319:2;H332:2;H312:2;H315:2;H335:2;H302:2
233818,[No public or meaningful name is available],800-814-3,4038-97-5,Acute Tox. 4,Notified C&L,39,H302:39;H332:1;H312:1
233819,"5,6-Dichloronicotinonitrile",800-815-9,65189-15-3,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H332:1;H312:1;H315:1;H335:1;H302:1
233822,"methyl 2-fluoro-4-(tetramethyl-1,3,2-dioxaborolan-2-yl)benzoate",800-819-0,603122-52-7,,Notified C&L,2,H319:2;H335:2;H315:2;H302:1
233828,"Sulfuric acid, mono-C12-14 (even numbered)-alkyl esters, potassium salts",939-693-8,,Flam. Sol. 1;Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Acute Tox. 4;STOT SE 3;Aquatic Chronic 3,REACH registration C&L,2,H412:2;H332:1;H315:2;H318:2;H228:1;H335:1;H302:2
233829,6-chloro-N-(2-cyclopropylethyl)pyridazine-3-carboxamide,800-824-8,840488-85-9,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H332:1;H312:1;H315:1;H335:1;H302:1
233830,"1-(1-benzyl-1H-1,2,3-triazol-4-yl)ethan-1-one",800-825-3,80819-67-6,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
233831,"2-iodo-1,3-dimethyl-4-nitrobenzene",800-826-9,4102-46-9,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
233833,(5-bromo-2-chloropyridin-4-yl)methanol,800-829-5,1211531-97-3,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H332:1;H312:1;H315:1;H335:1;H302:1
233835,5-Bromo-2-chloropyridine-4-carbaldehyde,800-831-6,1060802-23-4,,Notified C&L,40,H315:40;H335:40;H319:40;H301:39;H332:1;H312:1;H302:1
233841,(1-Imidazolyl)acetonitrile,800-836-3,98873-55-3,,Notified C&L,3,H319:3;H332:2;H312:2;H315:3;H335:2;H302:2;H331:1;H311:1;H301:1
233843,"methyl 6-{4-[(tert-butoxy)carbonyl]piperazin-1-yl}-2,5-dichloropyrimidine-4-carboxylate",939-656-6,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
233845,"methyl 6-({[(tert-butoxy)carbonyl]amino}amino)-2,5-dichloropyrimidine-4-carboxylate",939-658-7,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
233846,N'-[(1E)-(4-amino-6-chloropyrimidin-5-yl)methylidene](tert-butoxy)carbohydrazide,939-659-2,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
233847,methyl 5-bromo-2-methoxypyridine-4-carboxylate,939-660-8,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
233848,3-(4-chlorophenyl)-4-(dimethylamino)but-3-en-2-one,939-661-3,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
233849,(5-tert-butyl-1H-imidazol-4-yl)methanol,939-662-9,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
233850,"methyl 3-iodo-2-(trifluoromethyl)imidazo[1,2-a]pyridine-6-carboxylate",939-663-4,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
233851,"8-(3-nitrophenyl)-1,7-naphthyridin-6-amine",939-665-5,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
233852,"6-bromo-1-methyl-1,2,3,4-tetrahydroquinolin-2-one",939-666-0,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
233853,5-tert-butyl-1H-imidazole-4-carbaldehyde,939-667-6,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
233854,"3-(6-amino-1,7-naphthyridin-8-yl)benzonitrile",939-668-1,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
233855,"(3,6-dimethoxy-2-nitrophenyl)methanol",939-669-7,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
233856,"1-(1-benzyl-1H-1,2,3-triazol-4-yl)ethan-1-ol",939-670-2,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
233857,"(+/-)-cis-2-methyl-1,2,3,4-tetrahydro-quinoline-4-carboxylic acid methyl ester",939-671-8,,Acute Tox. 4;Acute Tox. 4;Acute Tox. 4,Notified C&L,1,H332:1;H312:1;H302:1
233864,3-amino-2-methylpropan-1-ol,800-844-7,15518-10-2,,Notified C&L,2,H319:1;H335:2;H315:2;H318:1;H302:1
233871,Fatty acids C12-18 (even numbered); C16-20 (even numbered)-alkyl esters,939-715-6,,Not Classified,REACH registration C&L,1,Not classified:1
233873,"1-Phenyl-1,2-dicarbadodecaborane",800-847-3,16390-61-7,Flam. Sol. 2;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H315:1;H228:1;H319:1;H302:1
233876,"Cesium bis(1,2-dicarbollide)cobaltate",800-851-5,60146-18-1,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
233877,"1-Methyl-1,2-dicarbadodecaborane, 10B",939-672-3,,Flam. Sol. 2;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H315:1;H228:1;H319:1;H302:1
233880,2-(pyrazin-2-yl)ethan-1-ol,800-854-1,6705-31-3,Eye Dam. 1,Notified C&L,40,H318:38;H315:2;H335:2;H319:2;H302:2
233881,"Calcium Borodeuteride, 11B-enriched",939-673-9,,Water-react. 2;Acute Tox. 3;Acute Tox. 3;Skin Corr. 1B;Acute Tox. 3,Notified C&L,1,H314:1;H331:1;H261:1;H311:1;H301:1
233884,Sodium dodecabromo-closo-dodecaborate,939-674-4,,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
233885,2-[(Carboxymethyl)amino]-6-chlorobenzoic acid mono potassium salt,939-676-5,,Acute Tox. 4,Notified C&L,1,H302:1
233888,"Tributoxyborane, 10B",939-677-0,,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
233889,"methyl 5-chloro-1H-1,2,4-triazole-3-carboxylate",800-859-9,21733-05-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,3,H315:3;H335:3;H319:3;H302:2
233890,4-ethynyl-1-methyl-1H-pyrazole,800-860-4,39806-89-8,,Notified C&L,2,H319:2;H335:2;H315:2;H302:1
233892,4-(aminomethyl)-N-methylbenzamide,800-863-0,164648-64-0,,Notified C&L,2,H319:2;H335:2;H315:2;H302:1
233894,methyl 2-(morpholin-3-yl)acetate hydrochloride,800-865-1,1187929-21-0,,Notified C&L,2,H319:2;H335:2;H315:2;H302:1
233895,"Butanoic acid, 4-amino-4-oxo-2(or 3)-sulfo-,N-(C16-C18 (even numbered), C18 unsaturated alkyl)), disodium salts",939-691-7,,Skin Irrit. 2;Eye Dam. 1;Repr. 1B,REACH registration C&L,22,H318:22;H360:22;H315:22
233896,"Lithium bromide, 7Li-enriched",939-678-6,,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
233899,"3,6-dichloro-4,5-dimethylpyridazine",800-868-8,34584-69-5,,Notified C&L,2,H315:2;H335:2;H319:2;H302:2
233901,3-amino-N-ethylbenzamide,800-870-9,81882-77-1,,Notified C&L,2,H319:2;H335:2;H315:2
233907,"1H-1,3-benzodiazol-4-amine",800-877-7,4331-29-7,,Notified C&L,2,H319:2;H335:2;H315:2;H302:1
233910,"1H-1,3-benzodiazol-4-ol",800-880-3,67021-83-4,,Notified C&L,2,H319:2;H335:2;H315:2;H302:1
233913,"N-(2-hydroxyethyl)-3,5,5-trimethylhexanamide",800-884-5,1154308-86-7,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 3,Notified C&L,1,H412:1;H315:1;H318:1;H302:1
233916,4-(Tetrazol-5-yl)phenylboronic acid,800-887-1,179942-55-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3;STOT SE 3,Notified C&L,2,H319:2;H335:2;H315:2
233918,"4,4-dimethylcyclohexan-1-ol",800-888-7,932-01-4,,Notified C&L,3,H319:3;H332:1;H315:3;H335:2;H302:1
233919,"Morpholine, 4-C12-14-alkyl derivs.",800-906-3,1402434-48-3,Acute Tox. 4;Skin Irrit. 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,1,H315:1;H410:1;H400:1;H302:1
233920,1-METHYL-2-PHENYLPIPERAZINE DIHYDROCHLORIDE,800-889-2,5271-28-3,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,2,H315:2;H319:2;H302:2;H335:1
233922,3-chloro-N-methylpyrazin-2-amine,800-891-3,53265-29-5,,Notified C&L,2,H319:1;H335:2;H315:2;H318:1;H302:1
233923,4-(2-methylpropyl)pyrrolidin-2-one,800-892-9,61312-87-6,,Notified C&L,3,H319:3;H335:3;H315:3;H318:1
233924,3-(3-chlorophenyl)pyrrolidine hydrochloride,800-893-4,1095545-16-6,,Notified C&L,2,H319:2;H335:2;H315:2;H302:1
233925,[No public or meaningful name is available],800-895-5,71082-54-7,Acute Tox. 4;Eye Irrit. 2,Notified C&L,39,H319:39;H302:38;H335:1;H315:1
233926,3-(aminomethyl)-N-methylbenzamide,800-896-0,515131-51-8,,Notified C&L,2,H319:1;H335:2;H315:2;H318:1;H302:1
233927,Cesium Octahydrotriborate,800-897-6,28109-81-1,Water-react. 1;Acute Tox. 3;Acute Tox. 3;Skin Corr. 1B,Notified C&L,1,H301:1;H314:1;H311:1;H260:1
233929,6-Bromo-2-oxindole,800-899-7,99365-40-9,,Notified C&L,3,H319:3;H335:3;H315:3;H332:1;H312:1;H302:2
233930,"3-(3,4-difluorophenyl)-3-oxopropanenitrile",800-900-0,71682-97-8,,Notified C&L,2,H319:2;H332:2;H312:2;H315:2;H335:2;H302:2
233933,"pyrazolo[1,5-a]pyrimidine",800-903-7,274-71-5,,Notified C&L,2,H315:2;H335:2;H319:2;H302:2;H332:1
233935,"Calcium Borohydride, 10B-enriched",939-679-1,,Water-react. 2;Acute Tox. 3;Acute Tox. 3;Skin Corr. 1B;Acute Tox. 3,Notified C&L,1,H314:1;H331:1;H261:1;H311:1;H301:1
233936,"9-Mercapto-1,7-dicarbadodecaborane",800-905-8,64493-44-3,Flam. Sol. 2;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H315:1;H228:1;H319:1;H302:1
233937,"Calcium Borohydride, 11B-enriched",939-680-7,,Flam. Sol. 2;Water-react. 2;Acute Tox. 3;Acute Tox. 3;Skin Corr. 1B;Acute Tox. 3,Notified C&L,1,H261:1;H314:1;H331:1;H228:1;H311:1;H301:1
233939,"Cesium bis(1,2-dicarbollide)ferrate",939-681-2,,Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H319:1;H315:1
233940,"1-Propanaminium, 2-hydroxy-N-(2-hydroxypropyl)-N,N-dimethyl-, esters with fatty acids, C18 unsatd., Me sulfates (salts)",939-685-4,,Skin Irrit. 2;Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,16,H412:16;H318:16;H315:16
233942,"Trimethylammonium 7,8,9,10,11,12-Hexachloro-1-carba-closo-dodecaborate",939-683-3,,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
233943,"1-Methyl-2-(prop-1-yn-3-yl)-1,2-dicarba-closo-dodecaborane",939-684-9,,Flam. Sol. 2;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2,Notified C&L,1,H315:1;H228:1;H319:1;H302:1
233944,"Reaction mass of 2-(methylamino)ethanol, compound with sulphur dioxide and bis[(2-hydroxyethyl)ammonium] sulphite",939-689-6,,Acute Tox. 5;Skin Irrit. 2,REACH registration C&L,1,H303:1;H315:1
233947,"5,7-Dihydro-7,7-dimethylindeno[2,1-b]carbazole",800-908-4,1257220-47-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
233948,"Fatty acids, C16-18 (even numbered), reaction products with tetraethylenepentamine, acetates (salts)",939-688-0,,Skin Sens. 1;Eye Irrit. 2;Aquatic Chronic 2,REACH registration C&L,2,H319:2;H411:2;H317:2
233949,"Reaction mass of 2-methylaminoethanol and water and disodium 4,4'-bis[[4-anilino-6-[(2-carbamoylethyl)(2-hydroxyethyl)amino]-1,3,5,-triazin-2-yl]amino]stilbene-2,2'-disulphonate",939-687-5,,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B,Notified C&L,1,H314:1;H315:1;H312:1;H302:1
233950,"2,6-dimethylquinoline-4-carboxylic acid",800-910-5,104175-33-9,,Notified C&L,2,H319:2;H335:2;H315:2
233951,benzyl(2-methylprop-2-en-1-yl)amine,800-911-0,52853-55-1,,Notified C&L,2,H319:1;H335:2;H315:2;H318:1;H302:1
233953,tert-butyl (2R)-2-amino-3-methylbutanoate hydrochloride,800-913-1,104944-18-5,,Notified C&L,2,H319:2;H335:2;H315:2
233963,"(1R,5S)-2-(6,6-dimethylbicyclo[3.1.1]hept-2-en-2-yl) ethyl acetate",800-940-9,35836-72-7,Skin Sens. 1B;Eye Irrit. 2;Aquatic Chronic 2,REACH registration C&L,4,H319:4;H411:4;H317:4
233964,"1,3,4-Thiadiazolidine-2,5-dithione, reaction products with hydrogen peroxide and tert-dodecanethiol",939-692-2,,Aquatic Chronic 3,REACH registration C&L,3,H412:3
233967,"Reaction mass of 2,2-bis(hydroxymethyl)propane-1,3-diyl bis(2-ethylhexanoate) and 3-[(2-ethylhexanoyl)oxy]-2-{[(2-ethylhexanoyl)oxy]methyl}-2-(hydroxymethyl)propyl 2-ethylhexanoate and 3-[(2-ethylhexanoyl)oxy]-2,2-bis{[(2-ethylhexanoyl)oxy]methyl}propyl 2-ethylhexanoate",939-690-1,,Not Classified,Notified C&L,1,Not classified:1
233968,methyl 2-bromo-6-fluorobenzoate,800-919-4,820236-81-5,,Notified C&L,2,H315:2;H335:2;H319:2;H302:2
233970,[No public or meaningful name is available],800-922-0,96938-26-0,Acute Tox. 4;Eye Dam. 1,Notified C&L,39,H318:38;H302:39;H315:1;H335:1
233971,"C11-12-(branched)-alkylammonium 1-amino-9,10-dioxo-4-[(2,4,6-trimethylphenyl)amino]anthracene-2-sulfonate",700-958-6,,Eye Dam. 1;Aquatic Acute 1;Aquatic Chronic 1,Notified C&L,83,H318:83;H400:83;H410:83
233975,"2,6-DIBROMO-3-FLUOROPYRIDINE",800-926-2,41404-59-5,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H315:2;H335:2;H319:2;H302:1
233987,tert-butyl 4-amino-4-(2-methoxy-2-oxoethyl)piperidine-1-carboxylate,800-939-3,362703-57-9,,Notified C&L,2,H319:1;H335:2;H315:2;H318:1;H302:1
233991,"Reaction products of D-Glucose, n-Butanol and C10-12 (even numbered) alcohols",939-698-5,,Eye Dam. 1,REACH registration C&L,85,H318:85
233996,"Reaction mass of 1H-Benzotriazole-1-methanamine, N,N-bis(2-ethylhexyl)-6-methyl- and 2H-Benzotriazole-2-methanamine, N,N-bis(2-ethylhexyl)-5-methyl- and N,N-bis(2-ethylhexyl)-4-methyl-1H-benzotriazole-1-methylamine and 2H-Benzotriazole-2-methanamine, N,N-bis(2-ethylhexyl)-4-methyl- and N,N-bis(2-ethylhexyl)-5-methyl-1H-benzotriazole-1-methylamine",939-700-4,,Skin Irrit. 2;Skin Sens. 1B;Aquatic Acute 1;Aquatic Chronic 2,REACH registration C&L,13,H411:13;H400:13;H317:13;H315:13
233997,"Benzotriazol, ar-methyl-, reaction product with formaldehyde and Diethanolamine",939-703-0,,Acute Tox. 4;Skin Sens. 1B;Eye Dam. 1;Aquatic Chronic 3,REACH registration C&L,85,H412:85;H318:85;H317:85;H302:85
233998,"Benzene, mono-C10-13-alkyl derivs., fractionation bottoms, heavy ends, sulfonated, calcium salts",800-941-4,148520-84-7,Eye Irrit. 2,Notified C&L,3,H319:2;H317:1
234001,2-(4-CHLOROPHENOXY)ACETAMIDE HYDROCHLORIDE,800-945-6,59104-19-7,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H315:1;H335:1;H319:1;H302:1
234002,PYRAZINE-2-CARBOXAMIDINE HYDROCHLORIDE,800-946-1,138588-41-7,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,2,H315:2;H335:2;H319:2;H302:2
234003,"2-(1H-1,2,4-TRIAZOL-1-YL)ETHANIMIDAMIDE HYDROCHLORIDE",800-947-7,446276-04-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H315:1;H335:1;H319:1;H302:1
234004,"Cyclopropane, hexafluoro-",,931-91-9,,Notified C&L,2,H220:2;H319:2;H315:2;H280:2;H335:2
234007,2-(methylamino)propan-1-ol,800-951-9,27646-78-2,,Notified C&L,2,H314:2;H302:1
234009,(2-methyl-1H-indol-5-yl)methanamine,800-954-5,36798-25-1,,Notified C&L,2,H315:2;H335:2;H319:1;H302:2;H318:1
234010,1-(4-FLUOROPHENYL)-1-METHYLETHYLAMINE,800-955-0,17797-10-3,Skin Corr. 1B;STOT SE 3,Notified C&L,2,H314:2;H335:2
234013,2-Ethoxy-4-fluoronitrobenzene,800-958-7,28987-44-2,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,3,H319:3;H332:1;H312:1;H315:3;H335:3;H302:2
234015,[No public or meaningful name is available],,,,Notified C&L,2,H319:2;H335:2;H315:2
234020,Methyl 5-Bromo-2-methylbenzoate,800-966-0,79669-50-4,,Notified C&L,4,H319:4;H335:3;H315:4
234022,Reaction products of 4-hydroxy-2-butanone and ammonia and hydrogen,939-705-1,2867-59-6,Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1,REACH registration C&L,84,H314:84;H318:84;H302:84;H412:83
234024,2-MORPHOLIN-4-YL-BENZYLAMINE,800-969-7,204078-48-8,Acute Tox. 4;Skin Corr. 1B,Notified C&L,2,H314:2;H302:1
234025,"2-[1,2,4]TRIAZOL-1YL-ETHYLAMINE",800-970-2,51444-31-6,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H315:1;H335:1;H319:1;H302:1
234027,N-NITROSODIISONONYLAMINE,800-971-8,643014-99-7,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H315:1;H335:1;H319:1;H302:1
234028,PENT-4-ENYLAMINE,800-972-3,22537-07-1,Acute Tox. 3;Eye Dam. 1,Notified C&L,40,H318:38;H301:38;H225:1;H314:1;H226:1
234029,"Reaction product of naphthalene, butanol, sulfonated and neutralized by caustic soda",939-707-2,,Acute Tox. 4;Eye Dam. 1;Acute Tox. 4;STOT SE 3,REACH registration C&L,3,H318:3;H335:3;H332:3;H302:3
234030,THIAZOLIDINE-3-CARBOXIMIDAMIDE HYDROIODIDE,800-973-9,200401-80-5,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H314:1;H315:1;H335:1;H302:1
234031,MORPHOLINE-4-CARBOXIMIDAMIDE HYDROIODIDE,800-974-4,102392-87-0,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H315:1;H335:1;H319:1;H302:1
234033,Reaction mass of cis-4-(isopropyl)cyclohexanemethanol and trans-4-(isopropyl)cyclohexanemethanol,939-719-8,5502-75-0,Skin Irrit. 2;Skin Sens. 1B,REACH registration C&L,7,H317:5;H315:7;H319:2;H335:2
234037,Decachlorotetrasilane,800-976-5,13763-19-4,Skin Corr. 1A;Eye Dam. 1,Notified C&L,1,H314:1;H318:1
234038,[4-(piperidin-1-yl)phenyl]methanamine,800-977-0,214759-73-6,Eye Dam. 1,Notified C&L,40,H318:38;Not classified:1;H315:1;H332:1;H312:1;H302:1
234039,3-(MORPHOLIN-4-YLMETHYL)ANLINE,800-978-6,123207-48-7,Acute Tox. 4;Acute Tox. 4;Skin Corr. 1B;Eye Dam. 1;Acute Tox. 4,Notified C&L,2,H314:1;H332:2;H312:2;H318:1;H302:2;H319:1;H315:1;H335:1
234040,2-CHLOROBENZOIC ANHYDRIDE,800-979-1,49619-43-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
234041,3-CHLOROBENZOIC ACID,800-980-7,30070-63-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
234042,2-METHOXYBENZOIC ANHYDRIDE,800-981-2,64508-50-5,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
234043,5-Chlorothiophene-2-carbonyl Chloride,800-982-8,42518-98-9,Skin Corr. 1B,Notified C&L,3,H314:3;H290:1;H318:2
234044,"3,3-DIMETHYLBUTANOIC ANHYDRIDE",800-983-3,38965-26-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
234048,"Fatty acids, C16-18, compds. with C16-18-alkyl amines",800-984-9,1428547-35-6,Eye Dam. 1;STOT RE 2;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,10,H318:10;H373:10;H400:10;H410:10
234049,"[3-(1,3-THIAZOL-2-YL)PHENYL]METHYLAMINE",800-985-4,672324-88-8,Acute Tox. 4;Skin Corr. 1B,Notified C&L,1,H314:1;H302:1
234052,"calcium bis(di C8-C10, branched, C9 rich, alkylnaphthalenesulphonate)",939-717-7,,Skin Irrit. 2;Eye Irrit. 2,REACH registration C&L,3,H319:3;H315:3
234053,"barium bis(di C8-C10, branched, C9 rich, alkylnaphthalenesulphonate)",939-718-2,,Acute Tox. 4;Skin Irrit. 2,REACH registration C&L,1,H315:1;H302:1
234054,4-NITRO-1-(TRICHLOROMETHOXY)BENZENE,939-716-1,,Acute Tox. 3;Acute Tox. 3;Acute Tox. 3,Notified C&L,1,H331:1;H311:1;H301:1
234057,"(2E)-ethyl-4-(2,2,3-trimethylcyclopent-3-en-1-yl) but-2-enal",801-014-7,179107-88-1,Not Classified,REACH registration C&L,1,Not classified:1
234060,1-(3-chlorophenyl)cyclopropan-1-amine hydrochloride,800-988-0,1217031-87-2,,Notified C&L,3,H319:3;H335:3;H315:3
234063,"7-methyl-10,10-bis(3-methyl-11-oxo-2,4,7,10-tetraoxatridec-12-en-1-yl)-12-oxo-13-[(10-oxo-10H-dibenzo[b,e]thiopyran-2-yl)oxy]-3,6,8-trioxa-11-azatridec-1-yl acrylate",800-991-7,1427388-03-1,Acute Tox. 4;Skin Sens. 1;Aquatic Chronic 2,Notified C&L,1,H411:1;H317:1;H302:1
234066,"2,3-Dihydro-[1,4]dioxino[2,3-b]pyridin-8-amine",800-994-3,1246088-52-7,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
234069,"5-methyl-1,2,4-oxadiazol-3-amine",800-998-5,40483-47-4,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,40,H315:40;H335:40;H319:40;H302:40;H332:1;H312:1
234070,3-pyrrolidineacetic acid methyl ester hydrochloride,800-999-0,1126794-67-9,Skin Irrit. 2;Eye Irrit. 2A;STOT SE 3,Notified C&L,3,H319:3;H335:3;H315:3
234071,"2-hydroxy-N,N-dimethylacetamide",801-000-0,14658-93-6,,Notified C&L,2,H319:2;H335:2;H315:2
234072,1-propyl-1H-imidazole-2-carbaldehyde,801-001-6,161500-05-6,,Notified C&L,2,H319:2;H335:2;H315:2;H302:1
234073,"5-amino-1,2-dihydroisoquinolin-1-one",801-002-1,93117-08-9,,Notified C&L,2,H319:2;H335:2;H315:2
234077,"3,3,5,5-tetramethylcyclohexan-1-amine",801-006-3,32939-18-7,,Notified C&L,2,H319:2;H335:2;H315:2;H314:1;H312:1;H332:1;H302:1
234083,Reaction mass of cis-1-methyl-1-(4-methylcyclohexyl) ethyl acetate and trans-1-methyl-1-(4-methylcyclohexyl) ethyl acetate and cis- 4-isopropyl-1-methylcyclohexyl acetate and trans-4-isopropyl-1-methylcyclohexyl acetate,939-728-7,,Skin Sens. 1B;Eye Irrit. 2;Aquatic Chronic 2,REACH registration C&L,6,H319:6;H411:6;H317:6
234086,piperazine-1-sulfonamide,801-011-0,5906-30-9,,Notified C&L,2,H319:2;H335:2;H315:2
234089,"Reaction products of (2,2,3-trimethylcyclopent-3-en-1-yl)acetaldehyde and butan-2-one",939-720-3,,Not Classified,REACH registration C&L,1,Not classified:1
234091,3-chloro-N-methylpropanamide,801-016-8,41789-28-0,Acute Tox. 4;Eye Irrit. 2,Notified C&L,40,H319:39;H302:40;H332:1;H315:1;H335:1
234092,2-hydroxy-N-methylacetamide,801-017-3,5415-94-1,Acute Tox. 4,Notified C&L,40,H302:39;H319:2;H332:1;H312:1;H315:2;H335:2
234099,"1,3,4-oxadiazol-2-amine",801-025-7,3775-60-8,Skin Corr. 1B,Notified C&L,3,H314:2;H319:1;H335:1;H315:1
234100,2-amino-2-(4-fluorophenyl)propanoic acid,801-026-2,312-44-7,,Notified C&L,2,H319:2;H335:2;H315:2
234101,"Imidazo[1,2-a]pyridin-2-ylacetic acid",801-027-8,19741-30-1,Eye Dam. 1,Notified C&L,195,H318:194;H319:1;H335:1;H315:1
234105,4-bromo-5-ethyl-1H-pyrazole,801-032-5,15802-79-6,,Notified C&L,2,H319:1;H335:2;H315:2;H332:1;H318:1;H302:1
234108,[No public or meaningful name is available],801-035-1,24211-54-9,Eye Dam. 1,Notified C&L,39,H318:38;H319:1;H335:1;H315:1
234111,3-Bromo-5-nitrobenzonitrile,801-037-2,49674-15-9,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,3,H319:3;H332:2;H312:3;H315:2;H335:2;H302:3;H412:1
234118,4-Nitro-3-iodoanisole,801-045-6,214279-40-0,Acute Tox. 3;Acute Tox. 3;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 3;STOT SE 3,Notified C&L,1,H319:1;H315:1;H331:1;H335:1;H311:1;H301:1
234119,6-Chloro-5-methylnicotinonitrile,801-046-1,66909-33-9,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,2,H319:2;H332:2;H312:2;H315:2;H335:2;H302:2
234120,"5-Chloro-2,4-difluorobenzoic acid",801-047-7,130025-33-1,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H332:1;H312:1;H315:1;H335:1;H302:1
234121,"2,4-Difluoro-5-nitropyridine",801-048-2,60186-15-4,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,157,H319:157;H332:157;H312:157;H315:157;H335:157;H302:157
234122,"1,2-thiazole-3-carboxylic acid",801-049-8,4576-90-3,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,2,H319:2;H332:2;H312:2;H315:2;H335:2;H302:2
234123,Ethyl difluoro(pyridin-2-yl)acetate,801-050-3,267876-28-8,Flam. Liq. 3,Notified C&L,1,H226:1
234124,4-(Benzyloxy)-3-methoxybenzeneboronic acid,801-051-9,243990-53-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
234125,"3,6-Difluoropyridazine",801-052-4,33097-39-1,Acute Tox. 4;Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3,Notified C&L,1,H319:1;H332:1;H312:1;H315:1;H335:1;H302:1
234126,"5-Bromo-2-methyl-1,3-thiazole",801-054-5,57268-16-3,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,3,H319:2;H335:3;H315:3;H302:2
234128,dihydro-2h-thiopyran-3(4h)-one,801-056-6,19090-03-0,Not Classified,Notified C&L,2,Not classified:1;H225:1
234131,1-(2-Hydroxyethyl)-1H-pyrazole,801-059-2,6314-23-4,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,3,H319:2;H335:3;H315:3;H318:1;H302:1
234132,"6-(Methylethyl)-2H,4H-benzo[b]1,4-dioxepin-3-one",801-060-8,950919-29-6,Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H315:1
234134,2-Chloropyrimidine-5-sulfonyl chloride,801-061-3,98026-88-1,Skin Corr. 1B;Eye Dam. 1,Notified C&L,2,H314:2;H318:1
234141,"2-(cyclopent-1-en-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane",801-068-1,287944-10-9,,Notified C&L,2,H319:2;H335:2;H315:2
234145,"2-[3-(9-butyl-1,1,3,3,5,5,7,7,9,9-decamethylpentasiloxanyl)propoxy]ethyl methacrylate",801-072-3,1052075-57-6,Not Classified,Notified C&L,1,Not classified:1
234152,4-(2-Hydroxyethyl)oxindole,801-080-7,139122-19-3,Skin Sens. 1;Resp. Sens. 1,Notified C&L,40,H334:38;H317:38;H319:1;H315:1;Not classified:1
234155,"Reaction mass of N,N-dimethylformamide and N,N-dimethylformamide hydrochloride",939-725-0,,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;Acute Tox. 4;STOT SE 3;Repr. 1B,REACH registration C&L,1,H319:1;H360:1;H332:1;H312:1;H315:1;H335:1
234159,"Reaction mass of 3-[(Z)-(octadec-9-en-1-yloxy)]propane-1,2-diol andalpha-(Z)-octadec-9-en-1-yl-omega-hydroxy-di[oxy[(hydroxymethyl)-1,2-ethanediyl]] andalpha-(Z)-octadec-9-en-1-yl-omega-hydroxy-tri[oxy[(hydroxymethyl)-1,2-ethanediyl]]",939-727-1,,Skin Irrit. 2;Eye Irrit. 2;Aquatic Acute 1;Aquatic Chronic 3,REACH registration C&L,2,H412:2;H319:2;H400:2;H315:2
234171,4-Bromo-1-methylpyridin-2(1H)-one,801-088-0,214342-63-9,,Notified C&L,3,H319:3;H335:3;H315:3;H302:2;H332:1
234174,2-(1H-pyrazol-1-yl)acetic acid,801-091-7,16034-48-3,,Notified C&L,2,H302:1;H319:1;H335:1;H315:1
234176,"7,7,8,9,9-pentamethyl-6,7,8,9-tetrahydro-5H-cyclopenta[h]quinazoline",801-093-8,1315251-11-6,Acute Tox. 4;Skin Sens. 1;Aquatic Acute 1;Aquatic Chronic 1,REACH registration C&L,14,H410:14;H400:14;H317:14;H302:14;H373:13
234178,"3-(3-formyl-2,5-dimethyl-1H-pyrrol-1-yl)-4-methylbenzoic acid",801-095-9,505071-98-7,,Notified C&L,2,H319:2;H332:1;H312:1;H315:2;H335:2;H302:2
234183,4-Ethylcyclohexylamine,801-102-5,42195-97-1,,Notified C&L,3,H314:3;H332:2;H312:2;H225:1;H302:2;H226:2;H318:1
234184,pyrrolidine-3-carbonitrile hydrochloride,801-103-0,1187930-86-4,,Notified C&L,2,H332:2;H312:2;H302:2;H319:1;H315:1;H335:1
234185,4-(bromomethyl)-2-chloro-1-methoxybenzene,801-104-6,320407-92-9,,Notified C&L,2,H315:1;H335:1;H319:1;H302:1;H314:1
234187,2-chloro-5-methylpyridine-3-carboxylic acid,801-106-7,66909-30-6,,Notified C&L,2,H319:2;H335:2;H315:2;H302:1
234194,3-hydroxypropanimidamide hydrochloride,801-114-0,53868-56-7,,Notified C&L,2,H319:2;H335:2;H315:2
234200,[No public or meaningful name is available],801-120-3,875781-18-3,Acute Tox. 4,Notified C&L,39,H302:39;H332:1;H312:1
234201,methyl 4-chloropyrimidine-5-carboxylate,801-121-9,1246471-45-3,,Notified C&L,2,H332:1;H312:1;H302:2;H315:1;H335:1;H319:1
234206,"5-Amino-3H-thiazolo[4,5]pyrimidine-2-one",801-127-1,848691-22-5,Acute Tox. 4;Acute Tox. 4;Eye Irrit. 2;Acute Tox. 4,Notified C&L,1,H319:1;H332:1;H312:1;H302:1
234209,ethyl 2-hydroxy-3-methylbutanoate,801-128-7,2441-06-7,Flam. Liq. 3;Eye Irrit. 2;STOT SE 3,Notified C&L,1,H319:1;H335:1;H226:1
234218,"Alkyl 4-(6-(6-bromo-8-cycloalkyl-5-alkyl-7-oxo-7,8-dihydropyirdo[2,3-d]pyrimidin-2-ylamino)pyridin-3-yl)piperazine-1-carboxylate",,,,REACH registration C&L,1,Not classified:1
234219,"Alkyl 4-(6-(6-(1-butoxyvinyl)-8-cycloalkyl-5-alkyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-ylamino)pyridine-3-yl)piperazine-1-caboxylate",,,,REACH registration C&L,1,Not classified:1
234222,4-Ethyl-2-methyloctanoic acid,801-131-3,7203-78-3,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1,Notified C&L,1,H315:1;H318:1;H302:1
234225,"Hexanoic acid, 2-(1-methylethyl)",801-133-4,27610-89-5,Acute Tox. 4;Skin Irrit. 2;Eye Dam. 1,Notified C&L,1,H315:1;H318:1;H302:1
234226,[No public or meaningful name is available],801-135-5,66938-02-1,Acute Tox. 4;Skin Irrit. 2;Eye Irrit. 2;STOT SE 3,Notified C&L,39,H315:39;H335:39;H319:39;H302:38
